Omega Healthcare Investors (OHI) 10-K 13 Feb 25 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) shares in Thousands	12 Months Ended
	Dec. 31, 2024	Feb. 07, 2025	Jun. 28, 2024
Document and Entity Information [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS, INC.
Entity Incorporation, State or Country Code	MD
Entity File Number	1-11316
Entity Tax Identification Number	38-3041398
Entity Address, Address Line One	303 International Circle, Suite 200
Entity Address, City or Town	Hunt Valley
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	21030
City Area Code	410
Local Phone Number	427-1700
Title of 12(b) Security	Common Stock
Trading Symbol	OHI
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 8,700,286,277
Entity Common Stock Shares Outstanding		281,837
Amendment Flag	false
Entity Central Index Key	0000888491
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Auditor Name	Ernst & Young LLP
Auditor Firm ID	42
Auditor Location	Baltimore, Maryland
Document Financial Statement Error Correction [Flag]	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Real estate assets
Buildings and improvements	$ 7,342,497	$ 6,894,045
Land	996,701	870,310
Furniture and equipment	510,106	469,654
Construction in progress	210,870	138,410
Total real estate assets	9,060,174	8,372,419
Less accumulated depreciation	(2,721,016)	(2,469,893)
Real estate assets - net	6,339,158	5,902,526
Investments in direct financing leases - net	9,453	8,716
Real estate loans receivable - net	1,428,298	1,212,162
Investments in unconsolidated joint ventures	88,711	188,409
Assets held for sale	56,194	67,116
Total real estate investments	7,921,814	7,378,929
Non-real estate loans receivable - net	332,274	275,615
Total investments	8,254,088	7,654,544
Cash and cash equivalents	518,340	442,810
Restricted cash	30,395	1,920
Contractual receivables - net	12,611	11,888
Other receivables and lease inducements	249,317	214,657
Goodwill	643,664	643,897
Other assets	189,476	147,686
Total assets	9,897,891	9,117,402
LIABILITIES AND EQUITY
Revolving credit facility		20,397
Secured borrowings	243,310	61,963
Senior notes and other unsecured borrowings - net	4,595,549	4,984,956
Accrued expenses and other liabilities	328,193	287,795
Total liabilities	5,167,052	5,355,111
Preferred stock $1.00 par value authorized - 20,000 shares, issued and outstanding - none
Common stock $0.10 par value authorized - 350,000 shares, issued and outstanding - 279,129 shares as of December 31, 2024 and 245,282 shares as of December 31, 2023	27,912	24,528
Additional paid-in capital	7,915,873	6,671,198
Cumulative net earnings	4,086,907	3,680,581
Cumulative dividends paid	(7,516,750)	(6,831,061)
Accumulated other comprehensive income	22,731	29,338
Total stockholders' equity	4,536,673	3,574,584
Noncontrolling interest	194,166	187,707
Total equity	4,730,839	3,762,291
Total liabilities and equity	$ 9,897,891	$ 9,117,402

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares shares in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement Of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	20,000	20,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.1	$ 0.1
Common stock, shares authorized	350,000	350,000
Common stock, shares issued	279,129	245,282
Common stock, shares outstanding	279,129	245,282

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues
Rental income	$ 887,910	$ 826,394	$ 751,231
Interest income	157,207	119,888	123,919
Miscellaneous income	6,273	3,458	3,094
Total revenues	1,051,390	949,740	878,244
Expenses
Depreciation and amortization	304,648	319,682	332,407
General and administrative	88,001	81,504	69,397
Real estate taxes	14,561	15,025	15,500
Acquisition, merger and transition related costs	11,615	5,341	42,006
Impairment on real estate properties	23,831	91,943	38,451
(Recovery) provision for credit losses	(15,483)	44,556	68,663
Interest expense	221,716	235,529	233,244
Total expenses	648,889	793,580	799,668
Other income (expense)
Other income (expense) - net	6,826	20,297	(1,997)
Loss on debt extinguishment	(1,749)	(492)	(389)
Gain on assets sold - net	13,168	79,668	359,951
Total other income	18,245	99,473	357,565
Income before income tax expense and income (loss) from unconsolidated joint ventures	420,746	255,633	436,141
Income tax expense	(10,858)	(6,255)	(4,561)
Income (loss) from unconsolidated joint ventures	7,916	(582)	7,261
Net income	417,804	248,796	438,841
Net income attributable to noncontrolling interest	(11,478)	(6,616)	(11,914)
Net income available to common stockholders	$ 406,326	$ 242,180	$ 426,927
Basic:
Net income available to common stockholders	$ 1.57	$ 1.01	$ 1.81
Diluted:
Net income available to common stockholders	$ 1.55	$ 1	$ 1.8

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 417,804	$ 248,796	$ 438,841
Other comprehensive income (loss)
Foreign currency translation	(8,373)	20,531	(32,770)
Cash flow hedges	1,602	(11,245)	55,949
Total other comprehensive (loss) income	(6,771)	9,286	23,179
Comprehensive income	411,033	258,082	462,020
Comprehensive income attributable to noncontrolling interest	(11,314)	(6,889)	(12,568)
Comprehensive income attributable to common stockholders	$ 399,719	$ 251,193	$ 449,452

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total Stockholders' Equity [Member]	Common Stock Par Value	Additional Paid-in Capital	Cumulative Net Earnings [Member]	Cumulative Dividends	AOCI Including Portion Attributable to Noncontrolling Interest [Member]	Noncontrolling Interest [Member]	Total
Beginning balance at Dec. 31, 2021	$ 3,906,838	$ 23,906	$ 6,427,566	$ 3,011,474	$ (5,553,908)	$ (2,200)	$ 201,388	$ 4,108,226
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	27,487		27,487					27,487
Issuance of common stock	8,112	40	8,072					8,112
Repurchase of common stock	(142,267)	(521)	(141,746)					(142,267)
Common dividends declared	(633,078)				(633,078)			(633,078)
Vesting/exercising of Omega OP Units	(7,176)		(7,176)				7,176
Conversion and redemption of Omega OP Units to common stock							(9,704)	(9,704)
Omega OP Units distributions							(20,498)	(20,498)
Net change in noncontrolling interest holder in consolidated JV							2,984	2,984
Other comprehensive income (loss)	22,525					22,525	654	23,179
Net income	426,927			426,927			11,914	438,841
Balance ending at Dec. 31, 2022	3,609,368	23,425	6,314,203	3,438,401	(6,186,986)	20,325	193,914	3,803,282
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	35,276		35,276					35,276
Issuance of common stock	336,402	1,100	335,302					336,402
Common dividends declared	(644,075)				(644,075)			(644,075)
Vesting/exercising of Omega OP Units	(14,570)		(14,570)				14,570
Conversion and redemption of Omega OP Units to common stock	1,021	3	1,018				(1,098)	(77)
Omega OP Units distributions							(26,397)	(26,397)
Net change in noncontrolling interest holder in consolidated JV	(31)		(31)				(171)	(202)
Other comprehensive income (loss)	9,013					9,013	273	9,286
Net income	242,180			242,180			6,616	248,796
Balance ending at Dec. 31, 2023	3,574,584	24,528	6,671,198	3,680,581	(6,831,061)	29,338	187,707	3,762,291
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	36,940		36,940					36,940
Issuance of common stock	1,235,657	3,383	1,232,274					1,235,657
Common dividends declared	(685,689)				(685,689)			(685,689)
Vesting/exercising of Omega OP Units	(25,011)		(25,011)				25,011
Conversion and redemption of Omega OP Units to common stock	473	1	472				(1,157)	(684)
Omega OP Units distributions							(29,254)	(29,254)
Net change in noncontrolling interest holder in consolidated JV							545	545
Other comprehensive income (loss)	(6,607)					(6,607)	(164)	(6,771)
Net income	406,326			406,326			11,478	417,804
Balance ending at Dec. 31, 2024	$ 4,536,673	$ 27,912	$ 7,915,873	$ 4,086,907	$ (7,516,750)	$ 22,731	$ 194,166	$ 4,730,839

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Dividend per Common Share	$ 2.68	$ 2.68	$ 2.68

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income	$ 417,804	$ 248,796	$ 438,841
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	304,648	319,682	332,407
Impairment on real estate properties	23,831	91,943	38,451
Provision for rental income	4,174	20,633	124,758
(Recovery) provision for credit losses	(15,483)	44,556	68,663
Amortization of deferred financing costs and loss on debt extinguishment	12,146	14,189	13,337
Accretion of direct financing leases	148	114	83
Stock-based compensation expense	36,696	35,068	27,302
Gain on assets sold - net	(13,168)	(79,668)	(359,951)
Amortization of acquired in-place leases - net	(1,686)	(9,450)	(5,662)
Straight-line rent and effective interest receivables	(43,018)	(41,849)	(58,994)
Interest paid-in-kind	(11,463)	(11,365)	(9,423)
Loss from unconsolidated joint ventures	1,947	182	455
Change in operating assets and liabilities - net:
Contractual receivables	(845)	(3,660)	3,031
Lease inducements	(61)	(15,210)	5,957
Other operating assets and liabilities	33,760	3,775	6,472
Net cash provided by operating activities	749,430	617,736	625,727
Cash flows from investing activities
Acquisition of real estate	(408,628)	(262,453)	(229,987)
Net proceeds from sale of real estate investments	95,045	585,031	759,047
Investments in construction in progress	(68,980)	(44,495)	(17,130)
Placement of loan principal	(470,011)	(420,626)	(371,987)
Collection of loan principal	207,617	165,191	345,665
Investments in unconsolidated joint ventures	(971)	(12,350)	(113)
Distributions from unconsolidated joint ventures in excess of earnings	1,017	8,807	3,328
Capital improvements to real estate investments	(37,757)	(38,011)	(47,221)
Proceeds from net investment hedges	8,429	11,378
Receipts from insurance proceeds	3,075	6,758	1,251
Net cash (used in) provided by investing activities	(671,164)	(770)	442,853
Cash flows from financing activities
Proceeds from long-term borrowings	657,819	507,072	597,403
Payments of long-term borrowings	(1,145,301)	(734,991)	(589,292)
Payments of financing related costs	(7,018)	(3,827)	(389)
Net proceeds from issuance of common stock	1,235,657	336,402	8,112
Repurchase of common stock			(142,267)
Dividends paid	(685,445)	(643,867)	(632,893)
Net payments to noncontrolling members of consolidated joint venture	545	(202)	81
Proceeds from derivative instruments		92,577
Redemption of Omega OP Units	(684)	(77)	(9,704)
Distributions to Omega OP Unit Holders	(29,254)	(26,397)	(20,498)
Net cash provided by (used in) financing activities	26,319	(473,310)	(789,447)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(580)	430	(2,900)
Increase in cash, cash equivalents and restricted cash	104,005	144,086	276,233
Cash, cash equivalents and restricted cash at beginning of period	444,730	300,644	24,411
Cash, cash equivalents and restricted cash at end of period	$ 548,735	$ 444,730	$ 300,644

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2024
ORGANIZATION [Abstract]
ORGANIZATION	NOTE 1 - ORGANIZATION Omega Healthcare Investors, Inc. (“Parent”), is a Maryland corporation that, together with its consolidated subsidiaries (collectively, “Omega”, the “Company”, “we”, “our”, “us”) invests in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”), assisted living facilities (“ALFs”), and to a lesser extent, independent living facilities (“ILFs”), rehabilitation and acute care facilities (“specialty facilities”) and medical office buildings (“MOBs”). Our core portfolio consists of our long-term “triple-net” leases and real estate loans with healthcare operating companies and affiliates (collectively, our “operators”). In addition to our core investments, we make loans to operators and/or their principals. From time to time, we also acquire equity interests in joint ventures or entities that support the long-term healthcare industry and our operators. Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of December 31, 2024, Parent owned approximately 97% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3% of the outstanding Omega OP Units.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2024
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Consolidation The consolidated financial statements include the accounts of Omega Healthcare Investors, Inc, its wholly-owned subsidiaries, joint venture (“JVs”) and variable interest entities (“VIEs”) that it controls, through voting rights or other means. All intercompany transactions and balances have been eliminated in consolidation. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise, if any, is the primary beneficiary of VIEs. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. We may change our original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affects the characteristics or adequacy of the entity’s equity investments at risk and the disposition of all or a portion of an interest held by the primary beneficiary. Our variable interests in VIEs may be in the form of equity ownership, leases and/or loans with our operators. We analyze our agreements and investments to determine whether our operators or unconsolidated joint ventures are VIEs and, if so, whether we are the primary beneficiary. We consolidate a VIE when we determine that we are its primary beneficiary. We identify the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Factors considered in determining whether we are the primary beneficiary of an entity include: (i) our voting rights, if any; (ii) our involvement in day-to-day capital and operating decisions; (iii) our risk and reward sharing; (iv) the financial condition of the operator or joint venture and (iv) our representation on the VIE’s board of directors. We perform this analysis on an ongoing basis. As of December 31, 2024 and 2023, we have one joint venture that is a consolidated VIE as we have concluded that we are the primary beneficiary through our equity investment in the entity. Revenue Recognition Rental Income Rental income from operating leases is recognized on a straight-line basis, inclusive of fixed annual escalators, over the lease term when we have determined that the collectibility of substantially all of the lease payments is probable. Certain of our operating leases contain provisions for an increase based on the change in pre-determined formulas from year to year (e.g., increases in the Consumer Price Index). We do not include in our measurement of our lease receivables these variable increases until the specific events that trigger the variable payments have occurred. Certain payments made to operators are treated as lease inducements and are amortized as a reduction of revenue over the lease term. Our leased real estate properties are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years. Some of our leases have options to extend, terminate or purchase the facilities, which are considered when determining the lease term. We assess the probability of collecting substantially all payments due under our leases on several factors, including, among other things, payment history, the financial strength of the lessee and any guarantors, as applicable, historical operations and operating trends, current and future economic conditions, and expectations of performance (which includes known substantial doubt about an operator’s ability to continue as a going concern). If our evaluation of these factors indicates it is not probable that we will be able to collect substantially all rents, we recognize a charge to rental income to write off straight-line rent receivables, contractual receivables and lease inducements and limit our rental income to the lesser of lease income on a straight-line basis plus variable rents when they become accruable or cash collected. Provisions for uncollectible lease payments are recognized as a direct reduction to rental income. If we change our conclusion regarding the probability of collecting rent payments required by a lessee, we may recognize an adjustment to rental income in the period we make a change to our prior conclusion, potentially resulting in increased volatility of rental income. Under the terms of our leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties. Certain of our operating leases require the operators to reimburse us for property taxes and other expenditures that are not considered components of the lease and therefore no consideration is allocated to them as they do not result in the transfer of a good or service to the operators. We have determined that all of our leases qualify for the practical expedient, under Accounting Standards Codification (“ASC”) 842, Leases (“Topic 842”), to not separate the lease and non-lease components because (i) the lease components are operating leases and (ii) the timing and pattern of recognition of the non-lease components are the same as the lease components. Certain operators are obligated to pay directly their obligations under their leases for real estate taxes, insurance and certain other expenses. These obligations, which have been assumed by the tenants under the terms of their respective leases, are not reflected in our consolidated financial statements. To the extent any tenant responsible for these obligations under their respective lease defaults on its lease or if it is deemed probable that the tenant will fail to pay for such costs, we would record a liability for such obligation. We have elected to exclude sales and other similar taxes from the measurement of lease revenue and expense. Loan Interest Income Interest income is recognized as earned over the term of the related real estate and non-real estate loans receivable. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method. In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms. Direct Financing Lease Income As of December 31, 2024 and 2023, we have one lease for a facility that is classified as a direct financing lease. For leases accounted for as direct financing leases, we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record interest income based on the contractual terms of the lease agreement. Costs related to originating direct financing leases are deferred and amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases. Income from direct financing leases is included within rental income on the Consolidated Statements of Operations. Real Estate Sales We recognize gains on the disposition of real estate when the recognition criteria have been met, generally at the time the risks and rewards and title have transferred, and we no longer have substantial continuing involvement with the real estate sold. Gains on the sale of real estate are recognized pursuant to provisions under Accounting Standards Codification (“ASC”) 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets. Under ASC 610-20, we determine whether the transaction is a sale to a customer or non-customer. As a REIT, we do not sell real estate within the ordinary course of our business and therefore, expect that our sale transactions will not be contracts with customers. ASC 610-20 refers to the revenue recognition principles under ASC 606, Revenue from Contracts with Customers. Under ASC 610-20, if we determine we do not have a controlling financial interest in the entity that holds the asset and the arrangement meets the criteria to be accounted for as a contract, we will dispose of the asset and recognize a gain or loss on the sale of the real estate when control of the underlying asset transfers to the buyer. If we determine a sale has not occurred under ASC 610-20, we continue to record the asset on the Consolidated Balance Sheets and related depreciation expense on the Consolidated Statements of Operations. Fair Value Measurement The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: ● Level 1 - quoted prices for identical instruments in active markets; ● Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and ● Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies such items in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, these items could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Monte Carlo valuation models. Real Estate Acquisitions Upon acquisition of real estate properties, we evaluate the acquisition to determine if it is a business combination or an asset acquisition. Our real estate acquisitions are generally accounted for as asset acquisitions as substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the acquisition is determined to be an asset acquisition, the Company records the purchase price and other related costs incurred to the acquired tangible assets and identified intangible assets and liabilities on a relative fair value basis. In addition, costs incurred for asset acquisitions, including transaction costs, are capitalized. If the acquisition is determined to be a business combination, we record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at fair value. Goodwill is measured as the excess of the fair value of the consideration transferred over the fair value of the identifiable net assets. Transaction costs are expensed as incurred as part of a business combination. In making estimates of fair value for purposes of recording asset acquisitions and business combinations, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. The Company determines the fair value of acquired assets and liabilities as follows: ● Land is determined based on third-party appraisals which typically include market comparables. ● Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenues and costs and consider capitalization and discount rates using current market conditions as well as the residual approach. ● Furniture and fixtures are determined based on third-party appraisals which typically utilize a replacement cost approach. ● Real estate loans and non-real estate loans are valued using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings. ● Investments in joint ventures are valued based on the fair value of the joint ventures’ assets and liabilities. Differences, if any, between the Company’s basis and the joint venture’s basis are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings (losses) of the joint venture. ● Intangible assets and liabilities acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset or liability being acquired. When evaluating below market leases we consider extension options controlled by the lessee in our evaluation. ● Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition. ● Assumed debt balances are valued by discounting the remaining contractual cash flows using a current market rate of interest. ● Noncontrolling interests are valued using a stock price, if available, or by other methods to estimate the fair value on the acquisition date. Real Estate Properties Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $7.3 million, $4.3 million and $3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings, eight three Management evaluates our real estate properties for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance including the current payment status of contractual obligations and expectations of the ability to meet future contractual obligations, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to management’s estimate of future undiscounted cash flows of the underlying facilities. The estimated future undiscounted cash flows are generally based on the related lease which relates to one or more properties and may include cash flows from the eventual disposition of the asset. In some instances, there may be various potential outcomes for a real estate investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess the recoverability of the assets are probability-weighted based on management’s best estimates as of the date of evaluation. Impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and considers matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home or other healthcare facility as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property as well as the fair value of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment to our assets in a future period that could be material to our results of operations. Assets Held for Sale We consider properties to be assets held for sale when (1) management commits to a plan to sell the property; (2) it is unlikely that the disposal plan will be significantly modified or discontinued; (3) the property is available for immediate sale in its present condition; (4) actions required to complete the sale of the property have been initiated; (5) sale of the property is probable and we expect the completed sale will occur within one year; and (6) the property is actively being marketed for sale at a price that is reasonable given our estimate of current market value. Upon designation of a property as an asset held for sale, we record the property’s value at the lower of its carrying value or its estimated fair value, less estimated costs to sell, and we cease depreciation. Lessee Accounting Omega leases real estate (corporate headquarters and certain other facilities), office equipment and is party to certain ground leases on our owned facilities. We determine if an arrangement is or contains a lease at inception. Leases are classified as either finance or operating at inception of the lease. Short-term leases, defined as leases with an initial term of 12 months or less that do not contain a purchase option, are not recorded on the balance sheet. Lease expense for short-term leases is recognized on a straight-line basis over the lease term. As of December 31, 2024 and 2023, all of the leases where we are the lessee were classified as operating leases. We have leases that contain both lease and non-lease components and have elected, as an accounting policy, to not separate lease components and non-lease components. Operating and finance lease right-of-use ("ROU") assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Our ROU assets and lease liabilities are included in other assets and accrued expenses and other liabilities, respectively, on our Consolidated Balance Sheets. The lease liability is calculated as the present value of the remaining minimum rental payments for existing leases using either the rate implicit in the lease or, if none exists, the Company's incremental borrowing rate, as the discount rate. Certain leases have options to extend, terminate or purchase the asset and have been considered in our analysis of the lease term and the measurement of the ROU assets and lease liabilities. On a quarterly basis, we record our lease liabilities at the present value of the future lease payments using the discount rate determined at lease commencement. Rental expense from operating leases is generally recognized on a straight-line basis over the lease term. Lease expense derived from our operating leases is recorded in general and administrative in our Consolidated Statements of Operations. We do not include in our measurement of our lease liability certain variable payments, including changes in an index until the specific events that trigger the variable payments have occurred. We record on a straight-line basis rental income and ground lease expense for those assets we lease and are reimbursed by our operators and/or are paid for directly by our operators. In-Place Leases In-place lease assets and liabilities result when we assume a lease as part of an asset acquisition or business combination. The fair value of in-place leases consists of the following components, as applicable (1) the estimated cost to replace the leases and (2) the above or below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases. Above market leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Operations as an adjustment to rental income over the estimated remaining term of the underlying leases. Should a tenant terminate the lease, the unamortized portion of the lease intangible is recognized immediately as an adjustment to rental income. Allowance for Credit Losses The allowance for credit losses reflects our current estimate of the potential credit losses on our real estate loans, non-real estate loans, and our investment in direct financing leases and is recorded as a valuation account as a direct offset against these financial instruments on our Consolidated Balance Sheets. Expected credit losses inherent in non-cancelable unfunded loan commitments are accounted for as separate liabilities included in accrued expenses and other liabilities on the Consolidated Balance Sheets. The Company has elected to not measure an allowance for credit losses on accrued interest receivables related to all of its real estate loans and non-real estate loans because we write off uncollectible accrued interest receivable in a timely manner pursuant to our non-accrual policy, described below. Changes to the allowance for credit losses on loans resulting from quarterly evaluations are recorded through provision for credit losses on the Consolidated Statements of Operations. We assess the creditworthiness of our borrowers on a quarterly basis. For purposes of determining our allowance for credit loss, we pool financial assets that have similar risk characteristics. We aggregate our financial assets by financial instrument type (i.e. real estate loan, non-real estate loan, etc.) and by our internal risk rating. Our internal credit ratings consider several factors including the collateral and/or security, the performance of borrowers underlying facilities, if applicable, available credit support (e.g., guarantees), borrowings with third parties, and other ancillary business ventures and real estate operations of the borrower. Our internal ratings range between 1 and 7. An internal rating of 1 reflects the lowest likelihood of loss and a 7 reflects the highest likelihood of loss. The characteristics associated with each risk rating is as follows: ● Risk Rating 1 through 3 – Instruments with minimal to marginally acceptable risk. ● Risk Rating 4 - Instruments with potential weaknesses identified (Special mention). ● Risk Rating 5 - Instruments with well-defined weaknesses that may result in possible losses (Substandard). ● Risk Rating 6 – Instruments that are unlikely to be repaid in full and will probably result in losses (Doubtful). ● Risk Rating 7 – Instrument that will not be repaid in full and losses will occur (Loss). Periodically, the Company may identify an individual loan for impairment. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreements. Our assessment of collectibility considers several factors, including, among other things, payment history, the financial strength of the borrower and any guarantors, historical operations and operating trends, current and future economic conditions, expectations of performance (which includes known substantial doubt about an operator’s ability to continue as a going concern) and the fair value of the underlying collateral of the agreement, a Level 3 measurement, if any. Consistent with this definition, all loans on non-accrual status may be deemed impaired. To the extent circumstances improve and the risk of collectibility is diminished, we will return these loans to full accrual status. When we identify a loan impairment, the loan is written down to the present value of the expected future cash flows or to the fair value of the underlying collateral. Financial instruments are charged off against the allowance for credit losses when collectibility is determined to be permanently impaired. We account for impaired loans using (a) the cost-recovery method, and/or (b) the cash basis method. We generally utilize the cost-recovery method for impaired loans for which impairment reserves were recorded. Under the cost-recovery method, we apply cash received against the outstanding loan balance prior to recording interest income. Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement. Investments in Unconsolidated Joint Ventures We account for our investments in unconsolidated joint ventures using the equity method of accounting as we exercise significant influence, but do not control the entities. Under the equity method of accounting, the net equity investments of the Company are reflected in the accompanying Consolidated Balance Sheets and the Company’s share of net income and comprehensive income from the joint ventures are included in the accompanying Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income, respectively. On a periodic basis, management assesses whether there are any indicators that the value of the Company’s investments in the unconsolidated joint ventures may be other-than-temporarily-impaired. An investment is impaired only if management’s estimate of the value of the investment is less than the carrying value of the investment, and such a decline in value is deemed to be other than-temporary. To the extent impairment has occurred, the loss is measured as the excess of the carrying amount of the investment over the estimated fair value of the investment. The estimated fair value of the investment is determined using a discounted cash flow model which is a Level 3 valuation. We consider a number of assumptions that are subject to economic and market uncertainties including, among others, rental rates, operating costs, capitalization rates, holding periods and discount rates. In Substance Real Estate Investments We provide loans to third parties for the acquisition, development and construction of real estate. Under these arrangements, it is possible that we will participate in the expected residual profits of the project through the sale, refinancing or acquisition of the property. We evaluate the characteristics of each arrangement, including its risks and rewards, to determine whether they are more similar to those associated with a loan or an investment in real estate. Arrangements with characteristics implying loan classification are presented as real estate loans receivable and result in the recognition of interest income. Arrangements with characteristics implying real estate joint ventures are treated as in substance real estate investments and presented as investments in unconsolidated joint ventures and are accounted for using the equity method. The classification of each arrangement as either a real estate loan receivable or investment in unconsolidated joint venture involves judgment and relies on various factors, including market conditions, amount and timing of expected residual profits, credit enhancements in the form of guarantees, estimated fair value of the collateral, and significance of borrower equity in the project, among others. The classification of such arrangements is performed at inception, and periodically reassessed when significant changes occur in the circumstances or conditions described above. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased. The majority of our cash, cash equivalents and restricted cash are held at major commercial banks. Certain cash account balances exceed FDIC insurance limits of $250,000 per account and, as a result, there is a concentration of credit risk related to amounts in excess of the insurance limits. Restricted Cash Restricted cash consists primarily of liquidity deposits escrowed for tenant obligations required by us pursuant to certain contractual terms and other deposits required by our lenders in connection with financing arrangements. Deposits We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three The liquidity deposits and other deposits, security deposits and the letters of credit may be used in the event of lease and/or loan defaults, subject to applicable limitations under bankruptcy law with respect to operators filing under Chapter 11 of the U.S. Bankruptcy Code. Liquidity deposits and other deposits are recorded as restricted cash on our Consolidated Balance Sheets with the offset recorded as a liability in accrued expenses and other liabilities on our Consolidated Balance Sheets. Security deposits related to cash received from the operators are primarily recorded in cash and cash equivalents on our Consolidated Balance Sheets with a corresponding offset in accrued expenses and other liabilities on our Consolidated Balance Sheets. Additional security for rental and loan interest revenue from operators is provided by covenants regarding minimum working capital and net worth, liens on accounts receivable and other operating assets of the operators, provisions for cross-default, provisions for cross-collateralization and by corporate or personal guarantees. Goodwill We test goodwill for potential impairment at least annually in the fourth quarter, or more frequently if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. An impairment loss is recognized to the extent that the carrying a

REAL ESTATE ASSET ACQUISITIONS

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT	12 Months Ended
	Dec. 31, 2024
REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT [Abstract]
REAL ESTATE ASSETS	NOTE 3 – REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT 2024 Acquisitions The following table summarizes the significant asset acquisitions that occurred in 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ Cash Yield (1) ​ Q1 ​ 1 — WV ​ $ 8.1 ​ 10.0 % Q1 ​ — 1 ​ U.K. ​ ​ 5.2 ​ 9.5 % Q2 ​ 1 — ​ MI ​ ​ 31.0 ​ 11.5 % Q2 ​ — 32 ​ U.K. ​ ​ 50.8 (2) 10.0 % Q2 ​ 1 — ​ LA ​ ​ 21.0 ​ 10.0 % Q3 ​ — 63 ​ U.K. ​ ​ 421.0 (3) 9.9 % (4) Q3 ​ — 1 ​ U.K. ​ ​ 5.1 ​ 10.0 % Q3 ​ 1 — ​ NC ​ ​ 8.8 ​ 10.0 % Q3 ​ — 1 ​ U.K. ​ ​ 10.8 ​ 10.0 % Q4 ​ — 3 ​ U.K. ​ ​ 39.7 ​ 10.0 % Q4 ​ — 1 ​ OR ​ ​ 8.0 ​ 10.0 % Q4 ​ 2 — ​ TX ​ ​ 19.5 ​ 10.0 % Q4 ​ — 6 ​ U.K. ​ ​ 111.5 ​ 10.0 % Total 6 108 ​ ​ $ 740.5 ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) Total consideration paid for this acquisition was $62.7 million. We allocated $11.9 million of the purchase consideration to a deferred tax asset related to net operating losses acquired in the transaction. See Note 17 - Taxes for additional information. (3) Relates to our acquisition of the remaining 51% ownership interest in the Cindat Joint Venture, discussed below under “Cindat Portfolio Acquisition.” Total costs to be allocated for this acquisition was $461.9 million, inclusive of our previously held equity interest of $97.0 million. We allocated $53.8 million of the costs to be allocated to other assets acquired in the transaction and we allocated $13.0 million of the costs to be allocated to other liabilities assumed in the transaction. (4) Reflects the yield based on cash consideration, the assumption of a mortgage loan, deferred contingent consideration and the previously held equity interest in the unconsolidated real estate joint venture. See “Cindat Portfolio Acquisition” below for additional information. Cindat Portfolio Acquisition As of December 31, 2023, we held a 49% interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $43.6 million per annum with minimum escalators between 1.0% to 2.0% that can escalate further based on certain inflationary measures. In July 2024, we acquired the remaining 51% interest in the Cindat Joint Venture for total consideration of $364.9 million inclusive of: (i) $98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair value of $264.0 million and (iii) deferred contingent consideration of $2.0 million that was paid in December 2024. The fair market value of the mortgage debt assumed was determined by discounting the remaining contractual cash flows using a current market rate of interest of comparable debt instruments. Following the acquisition, we own 100% of the equity interests in the entity that owns the Cindat portfolio, and accordingly, we will consolidate its results in our consolidated financial statements going forward. The acquired interest was accounted for as an asset acquisition as substantially all of the fair value of the gross assets acquired is concentrated in a group of similar identifiable assets. Under our existing accounting policy election, we follow the asset acquisition cost accumulation and allocation model. Accordingly, we did not remeasure our previously held $97.0 million equity interest, as of the acquisition date, at fair value. The following table summarizes the assets and liabilities recorded as part of the acquisition as of the date of the acquisition: ​ ​ ​ ​ ​ ​ (in thousands) Costs to be allocated: ​ ​ ​ ​ $ 96,971 Consideration for additional ​ ​ 100,921 Fair market value of debt assumed ​ ​ 263,990 Total acquisition cost to be allocated ​ $ 461,882 ​ ​ ​ ​ Net assets acquired: ​ ​ ​ Real estate assets ​ $ 421,044 Non-real estate loans receivable ​ ​ 1,632 Cash and cash equivalents ​ ​ 6,866 Restricted cash ​ ​ 14,050 Contractual receivables ​ ​ 8 Other assets ​ ​ 31,278 Total assets ​ ​ 474,878 Accrued expenses and other liabilities ​ ​ (12,996) Net assets acquired ​ $ 461,882 ​ 2023 Acquisitions The following table summarizes the significant asset acquisitions that occurred in 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ Cash Yield (1) ​ Q1 — 6 U.K. ​ $ 26.4 (2) 8.0 % Q2 ​ 4 — ​ WV ​ ​ 114.8 (3) 9.5 % Q2 ​ 1 — ​ WV ​ ​ 13.7 ​ 10.0 % Q3 ​ 1 — ​ VA ​ ​ 15.6 ​ 10.0 % Q3 ​ — 14 ​ U.K. ​ ​ 39.5 ​ 10.2 % Q4 ​ 1 — ​ MD ​ ​ 22.5 ​ 10.0 % (4) Q4 ​ — 1 ​ U.K. ​ ​ 3.8 ​ 9.0 % Q4 ​ 2 — ​ LA ​ ​ 24.9 ​ 10.0 % Total 9 21 ​ $ 261.2 ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) In connection with this acquisition, the Company recorded $9.9 million of right-of-use assets and lease liabilities associated with ground leases assumed in the acquisition. (3) In connection with this acquisition, the Company also provided $104.6 million of mezzanine financing discussed further in Note 7 – Real Estate Loans Receivable and Note 8 – Non-Real Estate Receivable. (4) Of the 10% initial annual cash yield for this acquisition, 2% can be deferred. 2022 Acquisitions The following table summarizes the significant asset acquisitions that occurred in 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ ​ Cash Yield (1) ​ Q1 — 1 U.K. ​ $ 8.7 (2) 8.0 % Q1 ​ — 1 ​ U.K. ​ ​ 5.0 ​ ​ 8.0 % Q1 — 27 U.K. ​ 86.6 (2) 8.0 % Q1 ​ 1 — ​ MD ​ ​ 8.2 (3) ​ 9.5 % Q3 ​ — 4 ​ U.K. ​ ​ 28.2 ​ ​ 8.0 % Q4 6 1 PA, NC ​ 88.5 (4) 9.0 % Total 7 34 ​ $ 225.2 ​ ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) The total consideration paid for the one-facility U.K. acquisition and the 27 -facility U.K. acquisition was $8.2 million and $100.0 million, respectively. In connection with these acquisitions, we allocated $0.5 million of the purchase consideration to a deferred tax liability related to the one -facility U.K. acquisition, and $13.4 million to a deferred tax asset related to the 27 -facility U.K. acquisition. See Note 17 – Taxes for additional information. (3) Total consideration for the one -facility Maryland acquisition was paid on December 30, 2021, but the closing of the acquisition did not occur until January 1, 2022. (4) During the fourth quarter of 2022, we acquired seven facilities using a reverse like-kind exchange structure pursuant to Section 1031 of the Code (a “reverse 1031 exchange”). As of December 31, 2022, we had completed the reverse 1031 exchange for three of the acquired facilities and the remaining four acquired facilities remained in the possession of the EATs. During the second quarter of 2023, the remaining four facilities were released from the possession of the EATs, as we did not identify any qualifying exchange transactions. The EATs were classified as VIEs as they do not have sufficient equity investment at risk to permit the entity to finance its activities. The Company consolidated the EATs because it had the ability to control the activities that most significantly impacted the economic performance of the EATs and was, therefore, the primary beneficiary of the EATs. The properties held by the EATs were reflected as real estate with a carrying value of $55.2 million as of December 31, 2022. The EATs also held cash of $23.9 million as of December 31, 2022. Construction in progress and capital expenditure investments We invested $106.7 million, $82.5 million and $64.4 million, respectively under our construction in progress and capital improvement programs during the years ended December 31, 2024, 2023 and 2022. As of December 31, 2024, construction in progress included three projects consisting of the development of a SNF in Virginia, a SNF in Florida and an ALF in Washington D.C. During the second quarter of 2023, we purchased land located in Virginia (not reflected in the table above) for approximately $0.8 million that we plan to develop into a SNF. Concurrent with the acquisition, we amended our lease with an existing operator to include the land in the lease. We are committed to a maximum funding of $15.2 million for the development of the land. As of December 31, 2024 and 2023, $2.5 million and $2.4 million, respectively, was included in construction in progress related to this development project. During the third quarter of 2021, we purchased a real estate property located in Washington, D.C. for approximately $68.0 million and are redeveloping the property into a 174 bed ALF. Concurrent with the 2021 acquisition, we entered into a single facility lease for this property with Maplewood Senior Living (along with affiliates, “Maplewood”). The original lease was terminated in November 2024 and replaced with a new 24-year single facility lease with an entity that is jointly owned by Maplewood and a third-party investor. For accounting purposes, the new lease will commence upon the substantial completion of construction of the ALF, which is currently expected to be in February 2025. The lease provides for the accrual of financing costs at a rate of 5% per annum during the construction phase. The lease provides for an annual cash yield of 6% in the first year following the completion of construction, increasing to 7% in year two and 8% in year three with 2.5% annual escalators thereafter. Rent can be deferred by the operator for months in which certain operating metrics are not met. Deferred rent bears interest at 5% per annum and is required to be repaid in any month in which certain operating metrics are met. In connection with the new lease, the operator prefunded $5.5 million into an account, which can be drawn from by Omega to pay rent once it commences. We are committed to a maximum funding of $225.8 million for the redevelopment of the real estate property, subject to ordinary development related cost changes (see Note 20 Commitments and Contingencies) . Excluding the initial acquisition cost associated with the land, Omega capitalized costs of $72.0 million, $51.2 million and $14.9 million, respectively, related to this development project for the years ended December 31, 2024, 2023 and 2022. As of December 31, 2024 and 2023, $208.0 million and $136.0 million, respectively, was included in construction in progress related to this development project.

ASSETS HELD FOR SALE, DISPOSITI

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS	12 Months Ended
	Dec. 31, 2024
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS [Abstract]
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS	NOTE 4 – ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS We periodically sell facilities to reduce our concentration in certain operators, geographies and non-strategic assets or due to the exercise of a tenant purchase option. The following is a summary of our assets held for sale: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 Number of facilities held for sale ​ 12 ​ ​ 14 Amount of assets held for sale (in thousands) $ 56,194 ​ $ 67,116 ​ Ten of the facilities that were classified as held for sale at December 31, 2024 were subsequently sold during the first quarter of 2025 for gross cash proceeds of $54.2 million. Asset Sales 2024 Activity During the year ended December 31, 2024, we sold 21 facilities (14 SNFs, six ALFs and one specialty facility) for $95.0 million in net cash proceeds, recognizing a net gain of approximately $13.2 million. 2023 Activity During the year ended December 31, 2023, we sold 69 facilities (64 SNFs, two ALFs, one ILF, one specialty facility and one MOB) for $585.0 million in net cash proceeds, recognizing net gains of $79.7 million. Our 2023 facility sales were primarily driven by restructuring transactions and negotiations related to our lease agreements with Guardian Healthcare (“Guardian”) and LaVie Care Centers, LLC (“LaVie”). In the second quarter of 2023, we sold five facilities that were previously leased to Guardian and were included in assets held for sale as of March 31, 2023. The net cash proceeds from the sale were $23.8 million, and we did not recognize any gain or loss on the sale because we had already impaired the facilities down to the estimated fair value less costs to sell during the first quarter of 2023. Additionally, we sold one facility, also previously leased to Guardian, for a sales price of $12.0 million during the second quarter of 2023, which was fully financed by Omega through a $12.0 million first lien mortgage on the facility. The one facility sale during the second quarter of 2023 and related seller financing did not meet the contract criteria to be recognized under ASC 610-20. In the third quarter of 2023, we sold seven facilities subject to operating agreements with LaVie for $84.4 million in purchase consideration, which included cash proceeds of $14.8 million and an aggregate $69.6 million pay-off of the outstanding principal and accrued interest on seven HUD mortgages on the sold properties made by the buyer, on Omega’s behalf. The sale resulted in a net loss of $5.5 million. Also in the third quarter of 2023, we recognized the sale of 11 facilities, previously leased to LaVie, related to a December 2022 transaction, further discussed below, that did not meet the contract criteria to be recognized under ASC 610-20 at the legal sale date. During the third quarter of 2023, Omega received an aggregate $104.8 million of principal prepayments for the mortgage from the seller. As a result of the principal prepayments, the Company determined the transaction met the contract criteria under ASC 610-20 and recognized the sale, resulting in a $50.2 million gain during the year ended December 31, 2023, which includes a $25 million contract liability and $5.7 million of deferred interest income received to date. In the fourth quarter of 2023, we sold 30 facilities subject to operating agreements with LaVie for $317.9 million in purchase consideration, which included cash proceeds of $104.6 million and an aggregate $213.3 million pay-off of the outstanding principal and accrued interest on 22 HUD mortgages on the sold properties made by the buyer, on Omega’s behalf. The sale resulted in a net gain of $6.5 million. 2022 Activity During the year ended December 31, 2022, we sold 66 facilities for approximately $759.0 million in net cash proceeds, recognizing a net gain of approximately $360.0 million. Our 2022 sales were primarily driven by restructuring transactions and negotiations related to our lease agreements with the following operators: Gulf Coast Health Care LLC (together with certain affiliates “Gulf Coast”), Guardian and Agemo Holdings, LLC (“Agemo”). In addition, during the fourth quarter of 2022, we sold 11 facilities previously leased to and operated by LaVie which did not meet the contract criteria to be recognized under ASC 610-20. As discussed above, this sale was recognized in the third quarter of 2023, and as such are not included in the 2022 sale amounts above. In the first quarter of 2022, we sold 22 facilities that were previously leased and operated by Gulf Coast. The net cash proceeds from the sale, including related costs accrued for as of the end of the fourth quarter, were $304.9 million, and we recognized a net gain of $114.5 million. The agreement includes an earnout clause pursuant to which the buyer is obligated to pay an additional $18.7 million to Omega if certain financial metrics are achieved at the facilities in the three years following the sale. As we have determined it is not probable that we will receive any additional funds, we have not recorded any income related to the earnout clause. In addition, we transitioned one facility that was previously leased and operated by Gulf Coast to another operator in the second quarter of 2022. The transition and sale of these facilities completed our exit from our relationship with Gulf Coast. During the first and second quarter of 2022, we sold nine total facilities that were leased to Guardian for $39.5 million in net proceeds, which resulted in a net gain of $13.7 million. In the third and fourth quarter of 2022, we sold 22 facilities that were previously leased to Agemo for $358.7 million in net proceeds, which resulted in a net gain of $218.9 million. Sales Not Recognized As of December 31, 2024 and 2023, we had three and one facility sales, respectively, that were not recognized as a result of not meeting the contract criteria under ASC 610-20 at the legal sale date. During the years ended December 31, 2024 and 2023, we received interest of $1.7 million and $6.4 million, respectively, related to seller financing provided in connection with sales that were not recognized at the legal sale date. The interest received was deferred and recorded as a contract liability within accrued expenses and other liabilities on our Consolidated Balance Sheets. Real Estate Impairments 2024 Activity During the year ended December 31, 2024, we recorded impairments of approximately $23.8 million on 14 facilities. Of the $23.8 million, $10.9 million related to six facilities that were classified as held for sale (four of which were subsequently sold) for which the carrying values exceeded the estimated fair values less costs to sell, and $12.9 million related to eight held for use facilities (of which $7.2 million relates to four closed facilities) for which the carrying value exceeded the fair value. Of the $12.9 million, $5.3 million related to three facilities that were subsequently sold during the year but did not meet the criteria to be classified as held for sale when the impairments were recognized. 2023 Activity During the year ended December 31, 2023, we recorded impairments of approximately $91.9 million on 25 facilities. Of the $91.9 million, $2.6 million related to two facilities that were classified as held for sale (and subsequently sold) for which the carrying values exceeded the estimated fair values less costs to sell, and $89.3 million related to 23 held for use facilities (of which $48.0 million relates to three facilities that were closed during the year) for which the carrying value exceeded the fair value. Of the $89.3 million, $51.7 million related to 20 facilities that were subsequently sold during the year but did not meet the criteria to be classified as held for sale when the impairments were recognized. 2022 Activity During the year ended December 31, 2022, we recorded impairments of approximately $38.5 million on 22 facilities. Of the $38.5 million, $3.5 million related to two facilities that were classified as held for sale (and subsequently sold) for which the carrying values exceeded the estimated fair values less costs to sell, and $35.0 million related to 20 held for use facilities for which the carrying value exceeded the fair value, of which $17.2 million relates to 12 facilities that were leased to and operated by LaVie. $10.0 million of the 2022 impairments recorded on four held-for-use facilities relate to the 2.0% Operator discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements.

CONTRACTUAL RECEIVABLES AND OTH

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS	12 Months Ended
	Dec. 31, 2024
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS	NOTE 5 – CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception, modification or renewal of the lease, and are amortized as a reduction of rental income over the non-cancellable lease term. A summary of our net receivables by type is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Contractual receivables – net ​ $ 12,611 ​ $ 11,888 ​ ​ ​ ​ ​ ​ ​ ​ ​ Effective yield interest receivables ​ $ 1,839 ​ $ 3,127 ​ Straight-line rent receivables ​ 238,690 ​ 202,748 ​ Lease inducements ​ 8,788 ​ 8,782 ​ Other receivables and lease inducements ​ $ 249,317 ​ $ 214,657 ​ ​ Cash basis operators and straight-line rent receivable write-offs We review our collectibility assumptions related to our operator leases on an ongoing basis. During the year ended December 31, 2024, we placed one existing operator and three new operators, which Omega did not previously have a relationship with prior to 2024, on a cash basis of revenue recognition as collection of substantially all contractual lease payments due from them was not deemed probable. There was a $2.8 million write-off of straight-line rent receivable associated with placing the existing operator on a cash basis of revenue recognition. The lease agreements with the three new operators were executed in 2024 as part of the transitions of facilities from other operators, and we placed them on a cash basis concurrent with the lease commencement dates, so there were no straight-line rent receivable write-offs associated with placing these operators on a cash basis. During the year ended December 31, 2023, we placed one existing operator and two new operators on a cash basis of revenue recognition as collection of substantially all contractual lease payments due from them was not deemed probable. There was no straight-line write-off associated with placing the existing operator on a cash basis of revenue recognition because the lease agreement did not contain any rent escalators. Omega did not previously have relationships with the two new operators placed on a cash basis of revenue recognition prior to the second quarter of 2023. The new lease agreements with each of the two new operators were executed in the respective lease commencement dates, so there were no straight-line rent receivable write-offs associated with moving these operators to a cash basis. During the year ended December 31, 2023, we transitioned the portfolios of four cash basis operators with an aggregate of 48 facilities to new or amended leases with five operators. We are recognizing revenue on a straight-line basis for the leases associated with these five operators. The aggregate initial contractual rent related to the 48 facilities transitioned to these five operators is $48.0 million per annum. The transitioned facilities included 14 facilities related to the operator referred to as the “1.2% Operator” below and 20 facilities related to the operator referred to as the “2.0% Operator” below for the year ended December 31, 2022. In connection with the transition of the 14 facilities, Omega made or agreed to make termination payments of $15.5 million in aggregate that were recorded as initial direct costs related to the lease with the new operator of the 14 transitioned facilities in the first quarter of 2023. These termination payments are deferred and recognized within depreciation and amortization expense on a straight-line basis over the term of the master lease. During the year ended December 31, 2022, we placed nine additional operators on a cash basis of revenue recognition as collection of substantially all contractual lease payments due from them was no longer deemed probable. In connection with placing these operators on a cash basis, we recognized $119.8 million in total straight-line rent receivable and lease inducement write-offs through rental income during the year ended December 31, 2022. During the years ended December 31, 2024, 2023 and 2022, we also wrote-off $1.4 million, $8.1 million and $3.2 million of straight-line rent receivable balances through rental income as a result of transitioning facilities between existing operators. As of December 31, 2024, we had 21 operators on a cash basis for revenue recognition, which represent 20.5%, 22.1% and 25.6% of our total revenues for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2023, we had 19 operators on a cash basis for revenue recognition, which represent 23.1% and 25.9% of our total revenues for the years ended December 31, 2023 and 2022, respectively. These amounts include the impact of straight-line rent receivable, lease inducement and effective yield interest receivable write-offs of $4.2 million, $20.6 million and $124.8 million for the years ended December 31, 2024, 2023 and 2022, respectively. Rent Deferrals and Application of Collateral During the years ended December 31, 2024, 2023 and 2022, we allowed four, ten and ten operators to defer $4.3 million, $35.9 million and $27.0 million of contractual rent and interest, respectively. The deferrals during the year ended December 31, 2024 primarily related to Maplewood ($3.5 million). The deferrals during the year ended December 31, 2023 primarily related to the following operators: LaVie ($19.0 million), Healthcare Homes Limited (“Healthcare Homes”) ($8.2 million), Agemo ($1.9 million) and Maplewood ($1.8 million). During the years ended December 31, 2024, 2023 and 2022, we received repayments of deferred rent of $2.1 million, $1.4 million and $0.3 million, respectively. Additionally, we allowed six, six and seven operators to apply collateral, such as security deposits or letters of credit, to contractual rent and interest during the years ended December 31, 2024, 2023 and 2022, respectively. The total collateral applied to contractual rent and interest was $2.2 million, $17.6 million and $11.0 million for the years ended December 31, 2024, 2023 and 2022 respectively. Operator updates Agemo Agemo, an operator on a cash basis of revenue recognition, did not pay contractual rent and interest due under its lease and loan agreements during the year ended December 31, 2022. Omega had previously entered into a forbearance agreement related to Agemo’s defaults under its lease and loan agreements (the “Agemo Forbearance Agreement”) in 2021. As part of a May 2018 restructuring agreement, we also agreed to, among other things, allow for the deferral of $6.3 million of rent per annum for a 3-year period (the “Agemo Rent Deferral”). The Agemo Forbearance Agreement was amended multiple times throughout 2022 and the most recent 2022 amendment on December 30, 2022 extended the forbearance period through January 31, 2023 In the first quarter of 2023, Omega and Agemo entered into a restructuring agreement, an amended and restated master lease and a replacement loan agreement for two replacement loans. As part of the restructuring agreement and related agreements, Omega agreed to, among other things: ● forgive and release Agemo from previously written off past due rent and interest obligations related to certain periods prior to the 2018 Restructuring and from August 2021 through January 2023, with contractual rent under the lease agreement and contractual interest under the loan agreements scheduled to resume on April 1, 2023; ● reduce monthly contractual base rent from $4.8 million to $1.9 million following the sales of the 22 facilities, previously leased and operated by Agemo, that occurred in the third and fourth quarters of 2022 (See Note 4 – Assets Held For Sale, Dispositions and Impairments); ● extend the initial Agemo lease term from December 31, 2030 , to December 31, 2036 with three consecutive tenant 10-year extension options; and ● refinance and restructure the $25.0 million secured working capital loan (the “Agemo WC Loan”), the $32.0 million term loan (the “Agemo Term Loan”) and the aggregate deferred rent balance of $25.2 million into two replacement loans to Agemo that mature on December 31, 2036, with aggregate principal of $82.2 million and an annual interest rate of 5.63% through October 2024, which increases to 5.71% until maturity. Agemo resumed making contractual rent and interest payments during the second quarter of 2023 in accordance with the restructuring terms discussed above. We recorded rental income of $23.8 million and $17.4 million for the years ended December 31, 2024 and 2023, respectively, for the contractual rent payments that were received. No interest income was recognized during the years ended December 31, 2024 and 2023 on the two loans with Agemo because these loans are on non-accrual status and we are utilizing the cost recovery method, under which any payments are applied against the principal amount. See Note 8 – Non-Real Estate Loans Receivable for further discussion on the impact of the restructuring on the loans. LaVie In the fourth quarter of 2022, Omega began the process of restructuring the portfolio with LaVie, which primarily consists of two master lease agreements and two term loan agreements. On December 30, 2022, we sold 11 facilities previously subject to one of the two leases agreements with LaVie. See further discussion on the sale and the accounting treatment in Note 4 – Assets Held For Sale, Dispositions and Impairments. Concurrent with the sale, we also amended the lease agreement impacted by the sale and our loan agreements with LaVie. The amendments to the loan agreements are discussed in Note 8 – Non-Real Estate Loans. With the lease amendment and other related documents, Omega and LaVie agreed to, among other terms: ​ ● remove the 11 sold facilities from the lease agreement and reduce monthly contractual rent due under all agreements from $8.3 million to $7.3 million; ● provide Omega the ability to enact a one-time rent reset on one of the lease agreements, if LaVie’s coverage exceeds a threshold, after February 1, 2027; and ● require Omega to pay LaVie a $35.0 million termination fee in connection with transitioning the 11 facilities sold in the fourth quarter and the additional facilities sold in the restructure ( $25.0 million was assumed by the third-party buyer of the 11 facilities). As a result of the restructuring activities during 2022 and future expected restructuring activities, during the fourth quarter of 2022, we placed LaVie on a cash basis of revenue recognition and wrote-off approximately $58.0 million of straight-line rent receivables and lease inducements. During 2023, we continued the process of restructuring our portfolio with LaVie by amending the lease agreements with LaVie to allow for a partial rent deferral of $19.0 million for the first four months of 2023, transitioning two facilities previously subject to the master lease with LaVie to another operator during the second quarter of 2023 and selling seven facilities previously subject to the master lease with LaVie to a third party during the third quarter of 2023. In the fourth quarter of 2023, Omega sold an additional 30 facilities and amended the master lease with LaVie to further reduce monthly rent to $3.3 million. LaVie began to short pay contractual rent during the third quarter of 2023, which continued into the fourth quarter of 2023 with LaVie paying $5.3 million of contractual rent, a short pay of $7.8 million of the $13.1 million due under its lease agreement. For the year ended December 31, 2023, LaVie paid total contractual rent of $37.0 million, a total short pay of $21.1 million of the $58.1 million due under the lease agreement after reflecting the deferral discussed above. As LaVie was placed on a cash basis of revenue recognition for lease purposes in the fourth quarter of 2022, only the $5.3 million and $37.0 million, respectively, of contractual rent payments that were received from LaVie were recorded as rental income during the three months and year ended December 31, 2023. LaVie continued to short pay contractual rent throughout the first quarter of 2024 and into the second quarter of 2024. In June 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Georgia, Atlanta Division (the “Bankruptcy Court”). LaVie will continue to operate, as a debtor-in-possession, the 30 facilities subject to a master lease agreement with Omega, unless and until LaVie’s leasehold interest under the master lease agreement is rejected or assumed and assigned. On December 5, 2024, a plan of reorganization was confirmed by the Bankruptcy Court, pursuant to which the LaVie master lease agreement will be assumed and assigned by certain of the reorganized debtor(s) upon the effective date of the plan. We committed to provide, along with another lender, $10 million of a $20 million junior secured debtor-in-possession (“DIP”) financing to LaVie, as further discussed in Note 8 – Non-Real Estate Loans Receivable. As a condition of the DIP financing, LaVie is required to pay Omega full contractual rent under its lease agreement. We determined LaVie was a VIE after it became a debtor-in-possession and following the issuance of the DIP financing loan. Omega is not the primary beneficiary of LaVie because we do not have the power to control the activities that most significantly impact LaVie’s economic performance. See Note 10 – Variable Interest Entities, for additional disclosures surrounding our VIEs. Prior to its bankruptcy filing, LaVie paid Omega $1.5 million in April 2024 and $1.5 million in May 2024. The April 2024 and May 2024 payments were short of full contractual rent by $1.7 million and $1.5 million, respectively. Following the bankruptcy filing, LaVie paid contractual rent of $2.9 million in June 2024, which reflects full contractual rent prorated for the period after LaVie entered bankruptcy and a $0.1 million short pay for the several days prior to the filing. In the third quarter of 2024, LaVie resumed making full contractual rent payments of $9.2 million due under its lease agreement, which continued through the fourth quarter of 2024 with LaVie making a full contractual rent payment of $9.1 million. As LaVie is on a cash basis of revenue recognition for lease purposes, rental income recorded was equal to cash received of $28.6 million during the year ended December 31, 2024. We did not recognize any interest income related to LaVie during the years ended December 31, 2024, 2023 and 2022 as the three loans outstanding have PIK interest and are on non-accrual status. Maplewood During the fourth quarter of 2022, Omega began discussions with Maplewood to restructure its portfolio, which includes a lease agreement and a secured revolving credit facility (the “Maplewood Revolver”). During the fourth quarter of 2022, we placed Maplewood on a cash basis of revenue recognition and wrote-off approximately $29.3 million of straight-line rent receivables and lease inducements. In the first quarter of 2023, we agreed to a formal restructuring agreement, master lease amendments and loan amendments with Maplewood. As part of the restructuring agreement and related agreements, Omega agreed to, among other things: ● extend the maturity date of the master lease from December 2033 to December 2037 with two consecutive 5-year tenant extension options; ● fix contractual rent at $69.3 million per annum (December 2022 rent annualized) and defer the 2.5% annual escalators under our lease agreement through December 31, 2025, with mandatory repayments to be made subject to certain metrics and due in full by the maturity date; ● fund $22.5 million of capital expenditures through December 31, 2025; ● extend the maturity date of the Maplewood Revolver from June 2030 to June 2035 with one borrower 2-year extension option; ● increase the capacity of the secured revolving credit facility from $250.5 million to $320.0 million, inclusive of payment-in-kind (“PIK”) interest applied to principal ; ● convert the 7% per annum cash interest due on the Maplewood Revolver to all PIK interest in 2023, 1% cash interest and 6% PIK interest in 2024, and 4% cash interest and 3% PIK interest in 2025 and through the maturity date; ● pay a one-time option termination fee of $12.5 million to Maplewood; and ● reduce Maplewood’s share of any future potential sales proceeds (in excess of our gross investment) by the unpaid deferred rent balance, the $22.5 million of capital expenditures and the $12.5 million option termination fee payment. Shortly after the restructuring was completed, on March 31, 2023, Greg Smith, the principal and chief executive officer of Maplewood, passed away. Mr. Smith had been a guarantor of Maplewood’s contractual obligations pursuant to a $40.0 million limited unconditional guaranty agreement. In order to accelerate a negotiated transition process, in May 2024, Omega sent a demand letter to Maplewood and the Estate notifying them of multiple events of default under Maplewood’s lease, loan and related agreements with Omega, including Mr. Smith’s guaranty, including failure to pay full contractual rent and interest for periods in 2023 and 2024. Omega exercised its contractual rights in connection with these defaults, demanded immediate repayment of past due contractual rent and replenishment of the security deposit and accelerated all principal and accrued interest due to Omega under the Maplewood Revolver, which had $301.7 million outstanding as of December 31, 2024, including PIK interest that is not recorded for accounting purposes. We also filed a lawsuit during the second quarter of 2024 to, among other things, foreclose on the pledged equity and assets of Maplewood. After sending the demand letter, in June 2024, Omega executed a non-binding term sheet with the Key Principals outlining the terms of the proposed transition, which includes maintaining the Maplewood lease agreement and the Maplewood Revolver provided by Omega. On July 31, 2024, we entered into a settlement agreement (the “Settlement Agreement”) with the Estate and submitted it to the probate court for approval. The Settlement Agreement, among other things, grants Omega the right to direct the assignment of Mr. Smith’s equity to the Key Principals, their designee(s) or another designee of Omega’s choosing, with the Estate remaining liable under Mr. Smith’s guaranty until the transition is complete or one year from the court’s approval date, if earlier, and requires Omega to refrain from exercising contractual rights or remedies in connection with the defaults. On August 26, 2024, the probate court approved the Settlement Agreement, and in October 2024, following the probate court’s final and non-appealable order approving the Settlement Agreement, we requested and were granted a dismissal without prejudice of our lawsuit against, among others, the Estate. We are still awaiting regulatory approvals related to licensure of the operating assets before the transition will be completed. Maplewood began to short pay contractual rent during the second quarter of 2023, which continued throughout 2023 and 2024. For the year ended December 31, 2023, Maplewood paid total contractual rent of $ million, a total short pay of $ million of the $ million due under the lease agreement for the year. As discussed further in Note 7 – Real Estate Loans Receivable, we recorded interest income of zero, $1.5 million and $14.7 million on the Maplewood Revolver during the years ended December 31, 2024, 2023 and 2022, respectively. Guardian Guardian, an operator on a cash basis of revenue recognition, did not pay contractual rent and interest due under its lease and mortgage loan agreements during the first quarter of 2022. During the first and second quarters of 2022, we completed significant restructuring activities related to the Guardian lease and loan portfolio. In the first quarter of 2022, we transitioned eight facilities previously leased to Guardian to two other operators as part of the planned restructuring. Additionally, during the six months ended June 30, 2022, we sold nine facilities to a third party that were previously leased to Guardian and three facilities previously subject to the Guardian mortgage loan. In the second quarter of 2022, we agreed to a formal restructuring agreement, master lease amendments and mortgage loan amendments with Guardian. As part of the restructuring agreement and related agreements, Omega agreed to, among other things: ● reduce the combined rent and mortgage interest to an aggregate $24.0 million per year as of July 1, 2022 ( $15.0 million in rent and $9.0 million in interest) with annual escalators of 2.25% beginning in January 2023; and ● allow Guardian to retrospectively defer $18.0 million of aggregate contractual rent and interest that it failed to pay from October 2021 through March 2022 (consisting of $12.2 million of deferred rent and $5.8 million of deferred interest), with repayment required beginning after September 30, 2024, based on certain financial metrics, and in full by December 31, 2031, or the earlier termination of the lease for any reason. Following the execution of the restructuring agreement, Guardian resumed paying contractual rent and interest during the second quarter of 2022 and continued such payments for the remainder of 2022, in accordance with the restructuring terms. For the year ended December 31, 2022, we recorded rental income of $11.3 million for the contractual rent payments that were received. Guardian continued to make contractual rent and interest payments in accordance with the restructuring terms during the first and second quarters of 2023. As discussed in Note 4 – Assets Held For Sale, Dispositions and Impairments, we sold 6 facilities previously leased to Guardian in the second quarter of 2023 and amended the master lease agreement to further reduce rent to $1.5 million. As discussed further in Note 7 – Real Estate Loans Receivable, Guardian also sold the remaining 4 facilities subject to Guardian mortgage loan in the second quarter of 2023 and used the proceeds from the sale to make a principal repayment to Omega, in the same amount, against the mortgage note. Following the repayment, Omega agreed to release the mortgage liens on the facilities. Guardian continued to fail to make the contractual rent payment due under its lease agreement during the first quarter of 2024. As such, we only recorded rental income of $0.1 million related to our lease with Guardian for the three months ended March 31, 2024 for the application of Guardian’s remaining security deposit to fund a portion of the unpaid rent. In April 2024, we transitioned the remaining six facilities previously included in Guardian’s master lease to a new operator for minimum initial contractual rent of $5.5 million per annum with the potential to increase contractual rent dependent on revenue received by the operator. We recorded rental income of $8.3 million related to our lease with the new operator for the year ended December 31, 2024. Additionally, as discussed further in Note 7 – Real Estate Loans Receivable, no mortgage interest income has been recognized on the Guardian mortgage loan during the years ended December 31, 2023 and 2022, respectively, as we were accounting for this loan under the cost recovery method. Healthcare Homes In December 2022, we agreed to allow Healthcare Homes, a U.K. based operator, to defer £6.7 million of contractual rent from January 2023 through April 2023 with regular payments required to resume in May 2023. During the fourth quarter of 2023, the rent deferral agreement and lease agreement were amended to, among other things, extend the repayment period for the rent deferral to six years, with full repayment due by April 1, 2030, and grant Omega the right to extend the lease by two years. In May 2023, Healthcare Homes resumed making full contractual rent payments. In the third quarter of 2024, Healthcare Homes began making quarter repayments of the deferred rent. Healthcare Homes has remained on a straight-line basis of revenue recognition. 1.2% Operator In March 2022, an operator (the “1.2% Operator”), representing 1.2% of total revenue for the year ended December 31, 2022, did not pay its contractual amounts due under its lease agreement. In April 2022, the lease with the 1.2% Operator was amended to allow the operator to apply its $2.0 million security deposit toward payment of March 2022 rent and to allow for a short-term rent deferral for April 2022 with regular rent payments required to resume in May 2022. The 1.2% Operator paid contractual rent in May 2022, but it failed to pay the full contractual rent for June 2022 on a timely basis. We placed the 1.2% Operator on a cash basis of revenue recognition during the second quarter of 2022 and wrote-off approximately $8.3 million of straight-line rent receivables. During the third and fourth quarters of 2022, the 1.2% Operator made partial contractual rent payments totaling $4.0 million. As discussed above, we transitioned all 14 facilities previously include in the 1.2% Operator’s master lease to another operator during the first quarter of 2023. 2.0% Operator In June 2022, an operator (the “2.0% Operator”), representing 2.0% of total revenue for the year ended December 31, 2022, short-paid the contractual rent amount due under its lease agreement by $0.6 million. In July 2022, we drew the full $5.4 million letter of credit that was held as collateral from the 2.0% Operator and applied $0.6 million of the proceeds to pay the unpaid portion of June 2022 rent. In the third quarter of 2022, the 2.0% Operator continued to short-pay the contractual amount due under its lease agreement. As such, we applied $3.3 million of the remaining proceeds of the letter of credit to pay the unpaid portion of July, August and September 2022 rent. We placed the 2.0% Operator on a cash basis of revenue recognition during the third quarter of 2022 and wrote-off approximately $10.5 million of straight-line rent receivables and lease inducements. In the fourth quarter of 2022, the 2.0% Operator paid $2.2 million in contractual rent and we applied the remaining $1.5 million of collateral against the remaining unpaid rent. During the fourth quarter of 2022, we transitioned three of the facilities previously included in the 2.0% Operator’s master lease to another operator. As discussed above, during the first quarter of 2023, we transitioned the remaining 20 facilities previously included in the 2.0% Operator’s master lease to other operators. Lease Inducements For the year ended December 31, 2024, we provided a funding of $1.0 million to one of our operators subject to operating leases, which was accounted for as a lease inducement and will be amortized as a reduction to rental income over the remaining term of the lease. As discussed in the “Maplewood” section above, the $12.5 million option termination fee payment made in the first quarter of 2023 in connection with the Maplewood restructuring agreement was accounted for as a lease inducement. In addition, for the year ended December 31, 2023, we provided a funding of $3.4 million to Healthcare Homes, which was accounted for as a lease inducement and will be amortized as a reduction to rental income over the remaining contractual term of the lease.

LEASES

LEASES	12 Months Ended
	Dec. 31, 2024
LEASES [Abstract]
LEASES	NOTE 6 –LEASES Lease Income The following table summarizes the Company’s rental income: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ 2022 ​ (in thousands) Fixed income from operating leases $ 871,189 ​ $ 811,123 ​ $ 735,247 Variable income from operating leases ​ 15,718 ​ ​ 14,257 ​ ​ 14,961 Interest income from direct financing leases ​ 1,003 ​ ​ 1,014 ​ ​ 1,023 Total rental income $ 887,910 ​ $ 826,394 ​ $ 751,231 ​ Our variable lease income primarily represents the reimbursement of real estate taxes by operators that Omega pays directly. Lessor – Operating Leases The following amounts reflect the future minimum lease payments due to us for the remainder of the initial terms of our operating leases as of December 31, 2024: ​ ​ ​ ​ (in thousands) 2025 $ 927,069 2026 ​ 947,098 2027 ​ 941,009 2028 ​ 917,667 2029 ​ 905,495 Thereafter ​ 6,282,523 Total $ 10,920,861 ​ Lessor – Direct Financing Leases The components of investments in direct financing leases consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Minimum lease payments receivable ​ $ 21,478 ​ $ 22,628 ​ Less unearned income ​ (10,420) ​ (11,423) ​ Investment in direct financing leases ​ 11,058 ​ 11,205 ​ Less allowance for credit losses on direct financing leases ​ (1,605) ​ (2,489) ​ Investment in direct financing leases – net ​ $ 9,453 ​ $ 8,716 ​ ​ ​ ​ ​ ​ ​ ​ ​ Properties subject to direct financing leases ​ 1 ​ 1 ​ Number of direct financing leases ​ 1 ​ 1 ​ ​ Lessee – Operating Leases As of December 31, 2024, the Company is a lessee under ground leases and/or facility leases related to 10 SNFs, four ALFs and one MOB and our corporate The following table summarizes the balance sheet information related to leases where the Company is a lessee: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 ​ 2023 ​ ​ (in thousands) Other assets - right of use assets ​ $ 28,302 ​ $ 30,178 ​ ​ ​ ​ ​ ​ ​ Accrued expenses and other liabilities – lease liabilities ​ $ 30,328 ​ $ 31,625 ​ In connection with a 6-facility asset acquisition in the first quarter of 2023, the Company recorded $9.9 million of right-of-use assets and lease liabilities associated with ground leases assumed in the acquisition. ​

REAL ESTATE LOANS RECEIVABLE

REAL ESTATE LOANS RECEIVABLE	12 Months Ended
	Dec. 31, 2024
REAL ESTATE LOANS RECEIVABLE [Abstract]
REAL ESTATE LOANS RECEIVABLE	NOTE 7 – REAL ESTATE LOANS RECEIVABLE Real estate loans consist of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien or a leasehold mortgage on, or an assignment of the partnership interest in the related properties. As of December 31, 2024, our real estate loans receivable consists of 21 fixed rate mortgages on 97 long-term care facilities and 18 other real estate loans. The facilities subject to the mortgage notes are operated by 16 independent healthcare operating companies and are located in 10 states and within the U.K. The other real estate loans are with 13 of our operators as of December 31, 2024. We monitor compliance with the loans and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding real estate loans. A summary of our real estate loans receivable by loan type and by borrower and/or guarantor is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Mortgage notes due 2030; interest at 11.39% (1)(2) ​ $ 525,530 $ 514,866 ​ Mortgage notes due 2025; interest at 10.59% (1) ​ ​ 172,476 ​ ​ — ​ Mortgage notes due 2027 and 2037; interest at 10.60% (1) ​ ​ 84,951 ​ ​ 72,420 ​ Mortgage note due 2028; interest at 10.00% ​ ​ 53,750 ​ ​ 50,000 ​ Mortgage note due 2025; interest at 7.85% ​ ​ — ​ ​ 62,010 ​ Other mortgage notes outstanding (3) ​ 145,620 ​ 55,141 ​ Mortgage notes receivable – gross ​ 982,327 ​ 754,437 ​ Allowance for credit losses on mortgage notes receivable ​ ​ (39,562) ​ ​ (55,661) ​ Mortgage notes receivable – net ​ ​ 942,765 ​ ​ 698,776 ​ Other real estate loan due 2035; interest at 7.00% ​ ​ 263,580 ​ ​ 263,520 ​ Other real estate loans due 2025-2030; interest at 11.85% (1) ​ ​ 101,904 ​ ​ 120,576 ​ Other real estate loan due 2025; interest at 10.00% (4) ​ ​ 13,000 ​ ​ 106,807 ​ Other real estate loans outstanding (5) ​ ​ 138,736 ​ ​ 57,812 ​ Other real estate loans – gross ​ ​ 517,220 ​ ​ 548,715 ​ Allowance for credit losses on other real estate loans ​ (31,687) ​ (35,329) ​ Other real estate loans – net ​ ​ 485,533 ​ ​ 513,386 ​ Total real estate loans receivable – net ​ $ 1,428,298 ​ $ 1,212,162 ​ (1) Approximates the weighted average interest rate on facilities as of December 31, 2024. (2) All mortgage notes mature in 2030 with the exception of one mortgage note with an outstanding principal balance of $21.3 million with a maturity date of December 31, 2024, which was extended to December 31, 2025 subsequent to year end. (3) Other mortgage notes outstanding consists of 12 loans to multiple borrowers that have a weighted average interest rate of 9.80% as of December 31, 2024, with maturity dates ranging from 2025 through 2029 (with $18.8 million maturing in 2025). Two of the mortgage notes with an aggregate principal balance of $12.9 million are past due and have been written down, through our allowance for credit losses, to the estimated fair value of the underlying collateral of $1.5 million. (4) During the third quarter of 2024, we modified the priority of collateral available to use under the loan agreements for two loans with aggregate principal balances of $115.9 million and $106.8 million as of December 31, 2024 and December 31, 2023, respectively. As a result of these modifications, we adjusted the presentation of the loans from real estate loans receivable to non-real estate loans receivable as of September 30, 2024. See Note 8 – Non-Real Estate Loans Receivable for additional information. Additionally, we issued a new $13.0 million other real estate loan to the same borrower during the third quarter of 2024. (5) Other real estate loans outstanding consists of 11 loans to multiple borrowers that have a weighted average interest rate of 11.0% as of December 31, 2024, with maturity dates ranging from 2027 to 2033 . Interest income on real estate loans is included within interest income on the Consolidated Statements of Operations and is summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ 2022 ​ (in thousands) Mortgage notes – interest income $ 91,434 ​ $ 68,340 ​ $ 74,233 Other real estate loans – interest income ​ 35,366 ​ ​ 29,426 ​ ​ 36,089 Total real estate loans interest income $ 126,800 ​ $ 97,766 ​ $ 110,322 ​ During the year ended December 31, 2024, we funded $370.2 million under 29 real estate loans that were originated during 2024 with a weighted average interest rate of 10.5%. We also advanced $7.9 million under existing real estate loans during the year ended December 31, 2024. We received principal repayments of $77.9 million on real estate loans during the year ended December 31, 2024. Mortgage Notes due 2030 ; interest at 11.39% At December 31, 2024, Omega had $525.5 million of Mortgage Notes with Ciena Healthcare Management, Inc (“Ciena”). This primarily includes one master mortgage agreement consisting of the following: ● A Ciena master mortgage note with initial principal of $415 million that matures on June 30, 2030 (the “Ciena Master Mortgage”). Following an amendment in May 2020, the Ciena Master Mortgage interest rate was adjusted to 10.67% per annum with annual escalators of 0.225% . During 2022, Ciena repaid $92.4 million under the Ciena Master Mortgage. Concurrent with this repayment, we released the mortgage liens on five facilities in exchange for the partial repayment. As of December 31, 2024, the outstanding principal balance of the Ciena Master Mortgage note is $277.0 million and it is secured by 19 facilities. The interest rate on the Ciena Master Mortgage was 11.8% at December 31, 2024. ● Multiple incremental facility mortgages, construction and/or improvement mortgages with maturities through 2030 with initial annual interest rates ranging between 8.5% and 10% and fixed annual escalators of 2% or 2.5% over the prior year’s interest rate, or a fixed increase of 0.225% per annum. During the fourth quarter of 2024, one construction mortgage, included in the mortgage notes described above, with an original maturity date of 2023 was extended to 2030 and converted into a facility mortgage. During 2022, Ciena repaid $51.0 million under seven additional mortgages. Concurrent with this repayment, we released the mortgage liens on two facilities in exchange for the partial repayment. As of December 31, 2024, the outstanding principal balance of these mortgage notes is $116.1 million. The notes are secured by five facilities and have a weighted average rate of 10.96% . ● A mortgage note with initial principal of $44.7 million that was originally secured by five SNFs located in Michigan. The mortgage note matures on June 30, 2030 and bore an initial annual interest rate of 9.5% which increases each year by 0.225% . During 2022, Ciena repaid $15.1 million under this mortgage. Concurrent with this repayment, we released the mortgage liens on one facility in exchange for the partial repayment. As of December 31, 2024, the outstanding principal balance of this mortgage note is $28.5 million and it is secured by four SNFs. The interest rate on the mortgage note was 10.85% at December 31, 2024. ● A mortgage note with initial principal of $83.5 million secured by eight SNFs and one ALF located in Michigan. The mortgage note matures on June 30, 2030 and bore an initial annual interest rate of 10.31% which increases each year by 2% . The interest rate on the mortgage note was 11.16% at December 31, 2024. As of December 31, 2024, the outstanding principal balance of this mortgage note is $82.6 million. In addition, Omega has a $21.3 million mortgage note with Ciena secured by one SNF located in Ohio. The mortgage note had an original maturity date of March 31, 2022 and bore an initial annual interest rate of 9.5%. The mortgage note has since been amended multiple times, extending the maturity date to December 31, 2024 and increasing the interest rate to 9.74% beginning April 1, 2022, to 9.98% beginning April 1, 2023 and to 10% beginning January 1, 2024. Subsequent to year end, the mortgage note was amended to extend the maturity date to December 31, 2025. As of December 31, 2024, the outstanding principal balance of this mortgage note is $21.3 million. The mortgage notes with Ciena are cross-defaulted and cross-collateralized with our existing master lease and other non-real estate loans with Ciena. Mortgage Notes due 2025 ; interest at 10.59% In May 2024, we funded an aggregate $71.7 million under two new mortgage loans to an existing U.K. operator. Both mortgage loans bear interest at 10.0% and had original maturity dates of October 28, 2024. Interest is payable monthly in arrears and no principal payments are due until maturity. The loans are secured by first mortgage liens on two parcels of land that the U.K. operator intends to develop into two facilities. During the fourth quarter of 2024, the $18.5 million mortgage loan was extended to February 28, 2025 and the $53.2 million mortgage loan was extended to May 31, 2025. During the fourth quarter of 2024, we funded an additional $61.7 million and $39.1 million, respectively, under two new mortgage loans to the same existing U.K. operator discussed above. Both Mortgage Notes due 2027 and 2037 ; interest at 10.60% In July 2021, we financed six SNFs in Ohio and amended an existing $6.4 million mortgage, inclusive of two Ohio SNFs, to include the six facilities in a consolidated $72.4 million mortgage for eight Ohio facilities bearing interest at an initial rate of 10.5% per annum. The mortgage loan originally had a maturity date of December 31, 2032, which was subsequently amended in the second quarter of 2023 to December 31, 2037. Mortgage Note due 2028 ; interest at 10.00% In December 2023, we funded a $50.0 million mortgage loan to a new operator for the purpose of acquiring four Illinois facilities. The mortgage loan bears interest at 10% and matures on December 28, 2028. During the fourth quarter of 2024, the mortgage loan was amended to increase the maximum principal to $60.0 million. Interest is payable monthly in arrears. The loan is secured by a first mortgage lien on the four facilities. As of December 31, 2024, the outstanding principal balance of this mortgage note is $53.8 million. Mortgage Note due 2025 ; interest at 7.85% In connection with our acquisition of MedEquities Realty Trust, Inc. in May 2019, the Company acquired a first mortgage lien issued to Lakeway Realty, L.L.C., an unconsolidated joint venture discussed in Note 11 – Investments in Joint Ventures. The loan had original principal of approximately $73.0 million and bore interest at 8% per annum based on a 25-year amortization schedule with a March 20, 2025 maturity date. The remaining outstanding principal balance of $60.1 million was repaid in full in December 2024. Mortgage Note due 2031 ; interest at 11.27% In January 2014, we entered into a $112.5 million first mortgage loan with Guardian. The mortgage loan was placed on non-accrual status for interest recognition in October 2021 and was being accounted for under the cost recovery method as a result of ongoing liquidity issues. Guardian did not pay contractual rent and interest due under its lease and mortgage loan agreements during the first quarter of 2022. In February 2022, Guardian completed the sale of three facilities subject to the Guardian mortgage loan with Omega. Concurrent with the sale, Omega agreed to release the mortgage liens on these facilities in exchange for a partial paydown of $21.7 million. In connection with the partial paydown, we recorded a $5.1 million recovery for credit losses in the first quarter of 2022 related to the Guardian mortgage loan. In the second quarter of 2022, we agreed to a formal restructuring agreement and amendments to the master lease and mortgage loan with Guardian, which among other adjustments, allowed for the deferral of certain contractual interest as discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements. These amendments were treated as a loan modification provided to a borrower experiencing financial difficulty. Following the execution of the restructuring agreement, Guardian resumed paying contractual rent and interest during the second quarter of 2022 and continued such payments throughout the remainder of 2022, in accordance with the restructuring terms. In the second quarter of 2023, Guardian completed the sale of the four remaining facilities subject to the mortgage note with Omega. Guardian used $35.2 million of proceeds from the sale of the facilities to make a principal repayment to Omega, in the same amount, against the mortgage note. Following the repayment, Omega agreed to release the mortgage liens on these facilities and forgive the remaining $46.8 million of outstanding principal due under the mortgage note. We had previously established an allowance for credit loss to reserve this loan down to $35.2 million in anticipation of this settlement. During the years ended December 31, 2023 and 2022, we received $3.9 million and $6.0 million, respectively, of interest payments that we applied against the outstanding principal balance of the loan and recognized a recovery for credit loss equal to the amount of payments applied against principal. Other mortgage notes outstanding As of December 31, 2024, our other mortgage notes outstanding represent 12 mortgage loans to 12 operators with liens on 19 facilities. Included below are significant new mortgage loans within this line item that were entered into during the years ended December 31, 2024 and 2023 and significant updates to any existing loans. Mortgage Note due 2027 In January 2024, we funded $11.7 million under a new mortgage loan to a new operator. In June 2024, we amended the loan and funded an additional $18.0 million under the mortgage loan. The mortgage loan bears interest at 10.0% and matures on January 31, 2027. Interest is payable monthly in arrears and no principal payments are due until maturity. The loan is secured by a first mortgage lien on three SNFs and one ALF. Mortgage Note due 2026 In October 2023, we funded a $29.5 million mortgage loan to a new operator for the purpose of acquiring two Pennsylvania facilities. The mortgage loan bears interest at 10% and matures on October 1, 2026. Interest is payable monthly in arrears; however, under certain conditions prior to August 31, 2025, the borrower can elect to pay a portion of interest as PIK interest. The maximum PIK interest allowable under the mortgage loan is $3.0 million. Due to the fact that the borrower can elect to pay a portion of interest as PIK interest, this loan will initially be accounted for on a non-accrual status for interest recognition. The loan is secured by a first mortgage lien on the two facilities. Other real estate loan due 2035 ; interest at 7.00% In July 2020, we entered into the Maplewood Revolver with maximum borrowings of $220.5 million as a part of an overall restructuring with this operator. Loan proceeds under the Maplewood Revolver may be used to fund Maplewood’s working capital needs. Advances made under the Maplewood Revolver bear interest at a fixed rate of 7% per annum and the facility originally matured on June 30, 2030. In June 2022, we amended the Maplewood Revolver to increase the maximum commitment under the facility from $220.5 million to $250.5 million. Maplewood was determined to be a VIE when this loan was originated in 2020. Our balances and risk of loss associated with Maplewood are included within our disclosures in Note 10 – Variable Interest Entities. As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, we began negotiations to restructure and amend Maplewood’s lease and loan agreements during the fourth quarter of 2022. As a result of the anticipated restructuring, we placed the Maplewood Revolver on non-accrual status for interest recognition during the fourth quarter of 2022 due to the anticipated restructuring of its lease and loan agreement. In the first quarter of 2023, Omega entered into a restructuring agreement and a loan amendment that modified the Maplewood Revolver. As part of the restructuring agreement and loan amendment, Omega agreed to extend the maturity date to June 2035, increase the capacity of the Maplewood Revolver from $250.5 million to $320.0 million, including PIK interest applied to the principal, and to convert the 7% cash interest due on the Maplewood Revolver to all PIK interest in 2023, 1% cash interest and 6% PIK interest in 2024, and 4% cash interest and 3% PIK interest in 2025 and through the maturity date. The maximum PIK interest allowable under the Maplewood Revolver, as amended, is $52.2 million. This amendment was treated as a loan modification provided to a borrower experiencing financial difficulty. Omega sent a demand letter to Maplewood during the second quarter of 2024 notifying Maplewood that due to multiple existing events of default under Maplewood’s lease, loan, and related agreements, Omega had exercised its contractual rights to immediately accelerate the outstanding principal and accrued interest under the Maplewood Revolver agreement. After sending the demand letter, in June 2024 Omega executed a non-binding term sheet with the Key Principals outlining the terms of a proposed transition, which includes the assignment of Mr. Smith’s equity in Maplewood to the Key Principals and maintaining the existing Maplewood lease agreement and the Maplewood Revolver (without reflecting the acceleration of the maturity) provided by Omega. On July 31, 2024, we entered into the Settlement Agreement with the Estate and submitted it to the probate court for approval. The Settlement Agreement, among other things, grants Omega the right to direct the assignment of Mr. Smith’s equity to the Key Principals, their designee(s) or another designee of Omega’s choosing, with the Estate remaining liable under Mr. Smith’s guaranty until the transition is complete or one year from the court’s approval date, if earlier, and requires Omega to refrain from exercising contractual rights or remedies in connection with the defaults. On August 26, 2024, the probate court approved the Settlement Agreement, and in October 2024, following the probate court’s final and non-appealable order approving the Settlement Agreement, we requested and were granted a dismissal without prejudice of our lawsuit against, among others, the Estate. We are still awaiting regulatory approvals related to licensure of the operating assets before the transition will be completed. There is no certainty that the regulatory approvals will be received or that this transition will be completed as intended, on a timely basis, or at all. If the proposed transition plan is not completed, we may incur a substantial loss on the Maplewood Revolver up to the amortized cost basis of the loan. We adjusted the internal risk rating on the Maplewood Revolver, utilized as a component of our allowance for credit loss calculation, from a 3 to a 4 in the second quarter of 2023 when Maplewood began to short-pay contractual rent under its lease agreement. In the first quarter of 2024, we again adjusted the internal risk rating from a 4 to 5 to reflect the increased risk of the Maplewood Revolver as a result of the missed interest payments in the first quarter of 2024, discussed below, and due to the status of the on-going negotiations with the Estate. We believe the internal risk rating of a 5 appropriately reflects the risks as of December 31, 2024. See the allowance for credit losses attributable to real estate loans with a 5 internal risk rating within Note 9 – Allowance for Credit Losses. During the year ended December 31, 2024, Maplewood failed to make aggregate cash interest payments of $2.7 million that were required under the Maplewood Revolver agreement. During the three months ended March 31, 2023, we recorded interest income of $1.5 million on the Maplewood Revolver for the contractual interest payment received related to December 2022, as the loan was placed on non-accrual status for interest recognition during the fourth quarter of 2022. During the year ended December 31, 2022, we recorded interest income of $14.7 million on the Maplewood Revolver. We did not record any interest income related to the PIK interest during the years ended December 31, 2024 and 2023. As of December 31, 2024, the amortized cost basis of the Maplewood Revolver was $263.6 million, which represents 17.6% of the total amortized cost basis of all real estate loan receivables. As of December 31, 2024, the remaining commitment under the Maplewood Revolver, including the unrecognized PIK interest, was $18.3 million. Other real estate loans due 2025 - 2030 ; interest at 11.85% In June 2022, we entered into a $35.6 million mezzanine loan with an existing operator related to new operations undertaken by the operator. The loan bears interest at a fixed rate of 12% per annum and matures on June 30, 2025. The loan also requires quarterly principal payments of $1.0 million commencing on January 1, 2023 and additional payments contingent on the operator’s achievement of certain metrics. The loan is secured by a leasehold mortgage and a pledge of the operator’s equity interest in a joint venture. As of December 31, 2024, the outstanding principal balance of this loan is $27.6 million. In April 2023, we entered into two mezzanine loans, with principal balances of $68.0 million and $6.6 million, respectively, with an existing operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia. The $68.0 million loan matures on April 13, 2029 and bears interest at a variable rate that results in a blended interest rate of 12% per annum across this loan and three other loans, including the $6.6 million mezzanine loan and both Other real estate loans outstanding As of December 31, 2024, our other real estate loans outstanding represent 11 loans to 10 operators. Included below are the significant new loans entered into during the years ended December 31, 2024 and 2023 and significant updates to any existing loans. Preferred Equity Investment in Joint Venture - $27.3 million In July 2024, we made a $27.3 million preferred equity investment in a new real estate joint venture that was formed to acquire a facility in Massachusetts, which is treated as a real estate loan receivable for accounting purposes. Omega’s preferred equity investment bears a 10.0% return per annum and provides for mandatory redemption by the joint venture at the earlier of July 2030 or the occurrence of certain significant events within the joint venture. We have determined that the joint venture is a VIE, but we are not the primary beneficiary as we do not have the power to direct the activities that most significantly impact the joint venture’s economic performance, so this $27.3 million preferred equity investment is included in the unconsolidated VIE table presented in Note 10 – Variable Interest Entities.

NON-REAL ESTATE LOANS RECEIVABL

NON-REAL ESTATE LOANS RECEIVABLE	12 Months Ended
	Dec. 31, 2024
NON-REAL ESTATE LOANS RECEIVABLE [Abstract]
NON-REAL ESTATE LOANS RECEIVABLE	NOTE 8 – NON-REAL ESTATE LOANS RECEIVABLE Our non-real estate loans consist of fixed and variable rate loans to operators and/or principals. These loans may be either unsecured or secured by the collateral of the borrower, which may include the working capital of the borrower and/or personal guarantees. As of December 31, 2024, we had 48 loans with 30 different borrowers. ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ ​ (in thousands) ​ Notes due 2026; interest at 13.22% (1) ​ $ 115,913 ​ $ — ​ Notes due 2036; interest at 5.71% ​ ​ 73,142 ​ ​ 77,854 ​ Note due 2026; interest at 11.00% ​ ​ 47,126 ​ ​ 53,300 ​ Notes due 2025-2029; interest at 11.81% (1)(2) ​ ​ 45,226 ​ 92,681 ​ Note due 2025; interest at 9.12% (1) ​ ​ 42,499 ​ ​ 44,999 ​ Notes due 2025 and 2036; interest at 3.25% (1) ​ ​ 38,308 ​ ​ 32,308 ​ Other notes outstanding (3) ​ 92,855 ​ 96,104 ​ Non-real estate loans receivable – gross ​ ​ 455,069 ​ ​ 397,246 ​ Allowance for credit losses on non-real estate loans receivable ​ ​ (122,795) ​ ​ (121,631) ​ Total non-real estate loans receivable – net ​ $ 332,274 ​ $ 275,615 ​ (1) Approximate weighted average interest rate as of December 31, 2024. (2) During the second quarter of 2024, two working capital loans with maturity dates of June 30, 2024 were repaid in full. These two loans had an aggregate outstanding principal balance of $39.5 million as of December 31, 2023. (3) Other notes outstanding have a weighted average interest rate of 9.17% as of December 31, 2024, with maturity dates ranging from 2025 through 2034 (with $40.7 million maturing in 2025 ). Three of the other notes outstanding with an aggregate principal balance of $9.0 million are past due, two of which have been written down to the estimated fair value of the underlying collateral of zero , through our allowance for credit losses. The one other past due other loan outstanding has sufficient collateral to support the principal balance outstanding of $0.1 million as of December 31, 2024. ​ For the years ended December 31, 2024, 2023 and 2022, non-real estate loans generated interest income of $30.4 million, $22.1 million and $13.6 million, respectively. Interest income on non-real estate loans is included within interest income on the Consolidated Statements of Operations. During the year ended December 31, 2024, we funded $60.6 million under 13 non-real estate loans that were originated during 2024 with a weighted average interest rate of 8.4%. We advanced $14.8 million under existing non-real estate loans during the year ended December 31, 2024. We received principal repayments of $119.7 million on non-real estate loans during the year ended December 31, 2024. Notes due 2026 ; interest at 13.22% Notes due in 2026 consists of two secured term loans with Genesis with initial borrowings of $48.0 million and $16.0 million at issuance that previously were included as real estate loans receivables within our Consolidated Balance Sheets. The $48.0 million term loan was issued in July 2016 (the “2016 Term Loan”), with subsequent amendments in 2018, 2019, 2021 and 2023, and currently bears interest at a fixed rate of 14% per annum, of which 9% per annum is paid-in-kind. The 2016 Term Loan was initially scheduled to mature on July 29, 2020. The $16.0 million secured term loan was issued on March 6, 2018 (the “2018 Term Loan”), with subsequent amendments in 2021 and 2023, and bears interest at a fixed rate of 10% per annum, of which 5% per annum is paid-in-kind. The 2018 Term Loan was initially scheduled to mature on July 29, 2020. As amended, both loans had a maturity date of . Notes due 2036 ; interest at 5.71% As of December 31, 2022, Notes due 2036 consisted of a $32 million secured term loan (the “Agemo Term Loan”) and a $25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and bore interest at 9% per annum. The Agemo Term Loan had a maturity date of December 31, 2024 and was secured by a security interest in certain collateral of Agemo. The Agemo WC Loan was issued on May 7, 2018 and bore interest at 7% per annum. The Agemo WC Loan had a maturity date of April 30, 2025 and was primarily secured by a collateral package that includes a second lien on the accounts receivable of Agemo. The proceeds of the Agemo WC Loan were used to pay operating expenses, settlement payments, fees, taxes and other costs approved by the Company. As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, Agemo did not pay contractual rent and interest due under its lease and loan agreements throughout 2022. The loans are on non-accrual status and are accounted for under the cost recovery method and whereby any interest and fees received directly against the principal of the loan. During the year ended December 31, 2022, we recorded additional provisions for credit losses of $10.8 million related to the Agemo WC Loan because of reductions in the fair value of the underlying collateral assets supporting the current carrying values. As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo loans. Under the restructuring agreement, previously written off contractual unpaid interest related to the Agemo WC Loan and the Agemo Term Loan was forgiven. The outstanding principal of the Agemo Term Loan was refinanced into a new $32.0 million loan (“Agemo Replacement Loan A”). The outstanding principal of the Agemo WC Loan and the aggregate rent deferred and outstanding under the Agemo lease agreement was combined and refinanced into a new $50.2 million loan (“Agemo Replacement Loan B” and with Agemo Replacement Loan A, the “Agemo Replacement Loans”). The Agemo Replacement Loans bear interest at 5.63% per annum through October 2024, which increases to 5.71% per annum until maturity. The Agemo Replacement Loans mature on December 31, 2036. Interest payments were scheduled to resume on April 1, 2023, contingent upon Agemo’s compliance with certain conditions of the restructuring agreement; however, Agemo had the option to defer the interest payment due on April 1, 2023. Beginning in January 2025, Agemo will be required to make principal payments on the Agemo Replacement Loans dependent on certain metrics. These amendments were treated as loan modifications provided to a borrower experiencing financial difficulty. Both of these loans are on non-accrual status, and we are utilizing the cost recovery method, under which any payments, if received, are applied against the principal amount. Prior to the restructuring, the principal of the Agemo WC Loan and the Agemo Term Loan were written down to $5.9 million and zero, respectively, the fair value of the underlying collateral of these loans. No changes to the collateral supporting the loans were made because of the refinancing of these loans into the Agemo Replacement Loans. Additional principal of $25.2 million related to deferred rent due under the master lease was combined with the principal of the Agemo WC Loan under Agemo Replacement Loan B. This deferred rent balance was previously written off when the Agemo master lease was taken to a cash basis of revenue recognition in 2020. We believe it is not probable that we will collect the additional $25.2 million of principal balance associated with the deferred rent under Agemo Replacement Loan B. As such, we added an additional allowance for credit losses of $25.2 million related to Agemo Replacement Loan B concurrent with the increase in loan principal during the first quarter of 2023. There is no income statement impact as a result of this additional reserve due to the balance previously being written off. Agemo exercised its option to defer the interest payments due on April 1, 2023 and resumed making interest payments in May 2023 in accordance with the restructuring terms discussed above. During the years ended December 31, 2024 and 2023, we received $4.7 million and $3.2 million of interest payments from Agemo that we applied against the outstanding principal of the loans and recognized a recovery for credit loss equal to the amount of payments applied against the principal. As of December 31, 2024, the amortized cost basis of these loans was $73.1 million, which represents 16.1% of the total amortized cost basis of all non-real estate loans receivables. As of December 31, 2024, the total reserves related to the Agemo Replacement loans was $70.9 million. Note due 2026 ; interest at 11.00% In December 2023, the Company entered into a $50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11% per annum and matures on December 19, 2026. In connection with entering into this loan, we also entered into two lease amendments to extend the term of two leases with entities associated with this principal. The loan is collateralized by a pledge of equity interests in a closely held corporation of which the principal is the majority owner. The loan requires monthly interest and principal payments commencing January 19, 2024. As of December 31, 2024, there was approximately $47.1 million outstanding on the secured term loan. Notes due 2025 - 2029 ; interest at 11.81% Notes due 2025-2029 consist of 11 loans with the same operator, the majority of which are primarily short-term revolving lines of credit that are collateralized by the accounts receivable of certain operations of the operator. During the second quarter of 2024, the most significant loan with this operator, which was a revolving line of credit that we entered into on June 28, 2022 in connection with the $35.6 million mezzanine loan discussed in Note 7 – Real Estate Loans Receivable above, was repaid in full. The line of credit bore interest at a fixed rate of 10% per annum and had an original maturity date of June 30, 2023 (or earlier based on certain state reimbursement conditions), which was subsequently extended during 2023 to June 30, 2024. The revolving line of credit was secured by a first priority interest on the operator’s accounts receivable related to the new operations. During the second quarter of 2023, we entered into two Note due 2025 ; interest at 9.12% On July 8, 2019, the Company entered into a $15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5% per annum and originally matured on July 8, 2022. The loan is collateralized by the assets of the principal and is cross-collateralized with the lease and other loans of the operator of which this borrower is the principal. During 2022, this revolving credit facility was amended multiple times to increase the maximum principal to $48 million, extend the maturity date to December 31, 2024 and amend the principal payment schedule to include escalating monthly principal payments beginning in July 2022. During 2023, this revolving credit facility was further amended to increase the maximum principal to $55 million, increase the interest rate on certain borrowings as discussed above and modify the principal payment schedule. During the third and fourth quarters of 2023, the borrower failed to make aggregate contractual principal payments of $8.5 million due under the revolving credit facility. In February 2024, we amended the revolving credit facility agreement to, among other items, extend the maturity date to December 31, 2025, reduce the maximum principal under the loan from $55.0 million to $45.0 million and to modify the mandatory principal payments required under the loan, such that the $8.5 million of missed principal payments are no longer past due and will be paid over the remaining loan term. Additionally, the amendment increased the interest rate on principal balances exceeding $15.0 million to 8% in January 2024, with further interest rate increases to 9% and 10% in April 2024 and June 2024, respectively. The interest rate remains at 7.5% for borrowings that do not exceed $15.0 million. In December 2024, the loan was amended to increase the interest rate on the entire balance outstanding to 12.5% per annum beginning January 1, 2025 and modify the principal payment schedule. Notes due 2025 and 2036 ; interest at 3.25% On September 1, 2021, we entered into an $8.3 million term loan with LaVie. This term loan bore interest at a fixed rate of 7% per annum, originally matured on March 31, 2031 and required monthly principal payments of $0.1 million commencing September 1, 2022. The loan is secured by a guarantee from LaVie’s parent entities. On March 25, 2022, we entered into a $25.0 million term loan with LaVie that bore interest at a fixed rate of 8.5% per annum and originally matured on March 31, 2032. This term loan required quarterly principal payments of $1.3 million commencing January 1, 2028 and is secured by a second priority lien on the operator’s accounts receivable. During the fourth quarter of 2022, we amended these loans rates On June 2 and 3, 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $4.5 million as of June 30, 2024, we reserved $4.2 million through the provision for credit losses in the second quarter of 2024 to write the loan down to the estimated fair value of the collateral of $0.3 million. The DIP loan was also placed on non-accrual status for interest recognition, and we will utilize the cost recovery method for any proceeds received on the DIP loan. As a result of the issuance of the DIP loans discussed above, Omega’s collateral position under the $25.0 million secured term loan decreased from second to third priority. We estimated that there will be insufficient collateral available for this loan following the decrease in priority and therefore recognized a $3.6 million provision for credit losses in the second quarter of 2024 to fully reserve the $25.0 million secured term loan. During the fourth quarter of 2024, we reserved an additional $1.8 million through the provision for credit losses to write the DIP loan down to zero following additional draws of $1.5 million during the fourth quarter of 2024. As of December 31, 2024, the amortized cost basis of the three LaVie loans was $38.3 million, which represents 8.4% of the total amortized cost basis of all non-real estate loan receivables. The total reserve as of December 31, 2024 related to the LaVie loans was $38.3 million. Other notes outstanding As of December 31, 2024, our other notes outstanding represent 28 loans to operators and/or principals that primarily consists of term loans and working capital loans or revolving credit facilities. Many of these loans are not individually significant and the use of proceeds of these loans can vary. Included below are the significant new loans entered into during the years ended December 31, 2024 and 2023 and significant updates to any existing loans. Working Capital Loan – $20 million In November 2021, we entered into a $20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $20.0 million WC loan bore interest at 3% per annum. The maturity date of the $20.0 million WC loan was December 31, 2022. The $20.0 million WC loan was secured by the accounts receivable of these facilities during the interim period of operation. During the year ended December 31, 2022, we recognized provisions for credit losses of $5.2 million related to the $20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed in Note 4 – Assets Held for Sale, Dispositions and Impairments, the remaining accounts receivable outstanding that collateralize the loan was insufficient to support the current outstanding balance, and as a result, we recorded the additional reserves to reduce the carrying value of the loan to the fair value of the collateral. The $20.0 million WC Loan was placed on non-accrual status during the third quarter of 2022 and was accounted for under the cost recovery method. During the year ended December 31, 2023, we recognized a recovery for credit loss of $0.8 million for principal payments received on this loan. During the second quarter of 2024, we wrote-off the loan and reserve balances. Gulf Coast – DIP Facility During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $2.2 million made under the facility during 2022 and a $2.0 million recovery for interest and fee payments received during 2022 that were applied against the outstanding principal. The DIP Facility matured on August 15, 2022, which resulted in a write-off of the loan and reserve balances. During the years ended December 31, 2024 and 2023, we received proceeds of $5.3 million and $1.0 million, respectively, from the liquidating trust which resulted in a recovery for credit losses equal to that amount. Revolving Credit Facility – $25 million Promissory Notes – $20 million In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $17.0 million, $2.5 million and $0.5 million. The loans bear interest at 9% and mature on September 30, 2027. All three loans require quarterly principal payments commencing on January 3, 2023. As of December 31, 2024, the loans have total outstanding principal of $14.7 million. $10.0 million Mezzanine Loan and Working Capital Loan On June 30, 2023, the Company entered into a $10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed rate of 11% per annum. The $10.0 million mezzanine loan also requires monthly amortizing payments of principal and interest in the amount of $0.2 million. The $10.0 million mezzanine loan is secured by an equity interest in a subsidiary of the operator.

ALLOWANCE FOR CREDIT LOSSES

ALLOWANCE FOR CREDIT LOSSES	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
ALLOWANCE FOR CREDIT LOSSES	NOTE 9 – ALLOWANCE FOR CREDIT LOSSES A rollforward of our allowance for credit losses, summarized by financial instrument type and internal credit risk rating, for the years ended December 31, 2024, 2023 and 2022 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss as of December 31, 2023 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2024 (1) ​ Write-offs charged against allowance for the year ended December 31, 2024 ​ Other additions to the allowance for the year ended December 31, 2024 ​ Allowance for Credit Loss as of December 31, 2024 ​ ​ ​ (in thousands) ​ ​ ​ 1 ​ Real estate loans receivable $ 1,501 ​ $ (1,189) ​ $ — ​ $ — ​ $ 312 2 ​ Real estate loans receivable ​ 291 ​ ​ 201 ​ ​ — ​ ​ — ​ ​ 492 3 ​ Real estate loans receivable ​ 12,635 ​ ​ (1,644) ​ ​ — ​ ​ — ​ ​ 10,991 4 ​ Real estate loans receivable ​ 65,113 ​ ​ (42,585) (2) ​ — ​ ​ — ​ ​ 22,528 5 ​ Real estate loans receivable ​ — ​ ​ 25,476 (2) ​ — ​ ​ — ​ ​ 25,476 6 ​ Real estate loans receivable ​ 11,450 ​ ​ — ​ ​ — ​ ​ — ​ ​ 11,450 ​ ​ Sub-total ​ 90,990 ​ ​ (19,741) ​ ​ — ​ ​ — ​ ​ 71,249 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 ​ Investment in direct financing leases ​ 2,489 ​ ​ (884) ​ ​ — ​ ​ — ​ ​ 1,605 ​ ​ Sub-total ​ 2,489 ​ ​ (884) ​ ​ — ​ ​ — ​ ​ 1,605 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 1,151 ​ ​ (1,114) ​ ​ — ​ ​ — ​ ​ 37 3 ​ Non-real estate loans receivable ​ 3,903 ​ ​ (2,035) ​ ​ — ​ ​ — ​ ​ 1,868 4 ​ Non-real estate loans receivable ​ 720 ​ ​ 1,548 ​ ​ — ​ ​ — ​ ​ 2,268 5 ​ Non-real estate loans receivable ​ 43,404 ​ ​ (117) ​ ​ — ​ ​ — ​ ​ 43,287 6 ​ Non-real estate loans receivable ​ 72,453 ​ ​ 16,393 ​ ​ (13,511) ​ ​ — ​ ​ 75,335 ​ ​ Sub-total ​ 121,631 ​ ​ 14,675 (3) ​ (13,511) ​ ​ — ​ ​ 122,795 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Unfunded real estate loan commitments ​ 10 ​ ​ (9) ​ ​ — ​ ​ — ​ ​ 1 3 ​ Unfunded real estate loan commitments ​ 335 ​ ​ 126 ​ ​ — ​ ​ — ​ ​ 461 4 ​ Unfunded real estate loan commitments ​ 4,314 ​ ​ (4,274) (2) ​ — ​ ​ — ​ ​ 40 5 ​ Unfunded real estate loan commitments ​ — ​ ​ 1,767 (2) ​ — ​ ​ — ​ ​ 1,767 2 ​ Unfunded non-real estate loan commitments ​ 692 ​ ​ (679) ​ ​ — ​ ​ — ​ ​ 13 3 ​ Unfunded non-real estate loan commitments ​ 46 ​ ​ 137 ​ ​ — ​ ​ — ​ ​ 183 4 ​ Unfunded non-real estate loan commitments ​ 63 ​ ​ 370 ​ ​ — ​ ​ — ​ ​ 433 5 ​ Unfunded non-real estate loan commitments ​ 1,594 ​ ​ (1,594) ​ ​ — ​ ​ — ​ ​ — 6 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 65 ​ ​ — ​ ​ — ​ ​ 65 ​ ​ Sub-total ​ 7,054 ​ ​ (4,091) ​ ​ — ​ ​ — ​ ​ 2,963 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 222,164 ​ $ (10,041) ​ $ (13,511) ​ $ — ​ $ 198,612 (1) During the year ended December 31, 2024, we received proceeds of $5.3 million from the liquidating trust related to the DIP Facility with Gulf Coast, which resulted in a recovery for credit losses of $5.3 million that is not included in the rollforward above since we had previously written-off the loan balance and related reserves. (2) Amount reflects the movement of reserves associated with the Maplewood Revolver due to an adjustment to the internal risk rating on the loan from 4 to a 5 during the first quarter of 2024. See Note 7 – Real Estate Loans Receivable for additional information. (3) This amount includes cash recoveries of $4.7 million related to interest payments received on loans that are written down to fair value and are being accounted for under the cost recovery in which any payments received are applied directly against the principal balance outstanding. This amount also includes $0.6 million related to principal payments received on loans that were fully reserved. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss at December 31, 2022 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2023 (1) ​ Write-offs charged against allowance for the year ended December 31, 2023 ​ Other additions to the allowance for the year ended December 31, 2023 ​ Allowance for Credit Loss as of December 31, 2023 ​ ​ ​ (in thousands) 1 ​ Real estate loans receivable $ 162 ​ $ 1,339 ​ $ — ​ $ — ​ $ 1,501 2 ​ Real estate loans receivable ​ 157 ​ ​ 134 ​ ​ — ​ ​ — ​ ​ 291 3 ​ Real estate loans receivable ​ 15,110 ​ ​ (2,475) ​ ​ — ​ ​ — ​ ​ 12,635 4 ​ Real estate loans receivable ​ 33,666 ​ ​ 31,447 ​ ​ — ​ ​ — ​ ​ 65,113 6 ​ Real estate loans receivable ​ 52,265 ​ ​ (3,860) ​ ​ (36,955) (2) ​ — ​ ​ 11,450 ​ ​ Sub-total ​ 101,360 ​ ​ 26,585 ​ ​ (36,955) ​ ​ — ​ ​ 90,990 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 ​ Investment in direct financing leases ​ 2,816 ​ ​ (327) ​ ​ — ​ ​ — ​ ​ 2,489 ​ ​ Sub-total ​ 2,816 ​ ​ (327) ​ ​ — ​ ​ — ​ ​ 2,489 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 859 ​ ​ 292 ​ ​ — ​ ​ — ​ ​ 1,151 3 ​ Non-real estate loans receivable ​ 2,079 ​ ​ 1,824 ​ ​ — ​ ​ — ​ ​ 3,903 4 ​ Non-real estate loans receivable ​ 634 ​ ​ 86 ​ ​ — ​ ​ — ​ ​ 720 5 ​ Non-real estate loans receivable ​ 18,619 ​ ​ (415) ​ ​ — ​ ​ 25,200 (3) ​ 43,404 6 ​ Non-real estate loans receivable ​ 61,677 ​ ​ 10,776 ​ ​ — ​ ​ — ​ ​ 72,453 ​ ​ Sub-total ​ 83,868 ​ ​ 12,563 ​ ​ — ​ ​ 25,200 ​ ​ 121,631 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Unfunded real estate loan commitments ​ — ​ ​ 10 ​ ​ — ​ ​ — ​ ​ 10 3 ​ Unfunded real estate loan commitments ​ — ​ ​ 335 ​ ​ — ​ ​ — ​ ​ 335 4 ​ Unfunded real estate loan commitments ​ 84 ​ ​ 4,230 ​ ​ — ​ ​ — ​ ​ 4,314 2 ​ Unfunded non-real estate loan commitments ​ 207 ​ ​ 485 ​ ​ — ​ ​ — ​ ​ 692 3 ​ Unfunded non-real estate loan commitments ​ 29 ​ ​ 17 ​ ​ — ​ ​ — ​ ​ 46 4 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 63 ​ ​ — ​ ​ — ​ ​ 63 5 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 1,594 ​ ​ — ​ ​ — ​ ​ 1,594 ​ ​ Sub-total ​ 320 ​ ​ 6,734 ​ ​ — ​ ​ — ​ ​ 7,054 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 188,364 ​ $ 45,555 ​ $ (36,955) ​ $ 25,200 ​ $ 222,164 (1) During the year ended December 31, 2023, we received proceeds of $1.0 million from the liquidating trust related to the DIP Facility with Gulf Coast, which resulted in a recovery for credit losses of $1.0 million that is not included in the rollforward above since we had previously written-off the loan balance and related reserves. (2) This amount relates to the write-off of the allowance for the Guardian mortgage note in connection with the settlement and partial forgiveness of the note in the second quarter of 2023. See Note 7 – Real Estate Loans Receivable for additional provision includes an additional details. (3) This amount relates to the additional $25.2 million allowance recorded during the first quarter of 2023 to reserve the aggregate deferred rent amount that is included within Agemo Replacement Loan B. See Note 8 – Non-Real Estate Loans Receivable for additional details. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss at December 31, 2021 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2022 ​ Write-offs charged against allowance for the year ended December 31, 2022 ​ Allowance for Credit Loss as of December 31, 2022 ​ ​ ​ (in thousands) 1 ​ Real estate loans receivable $ — ​ $ 162 ​ $ — ​ $ 162 2 ​ Real estate loans receivable ​ 14 ​ ​ 143 ​ ​ — ​ ​ 157 3 ​ Real estate loans receivable ​ 5,367 ​ ​ 9,743 ​ ​ — ​ ​ 15,110 4 ​ Real estate loans receivable ​ 20,577 ​ ​ 13,089 ​ ​ — ​ ​ 33,666 5 ​ Real estate loans receivable ​ 136 ​ ​ (136) ​ ​ — ​ ​ — 6 ​ Real estate loans receivable ​ 56,480 ​ ​ 248 ​ ​ (4,463) (1) ​ 52,265 ​ ​ Sub-total ​ 82,574 ​ ​ 23,249 ​ ​ (4,463) ​ ​ 101,360 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3 ​ Investment in direct financing leases ​ 530 ​ ​ (530) ​ ​ — ​ ​ — 5 ​ Investment in direct financing leases ​ - ​ ​ 2,816 ​ ​ — ​ ​ 2,816 ​ ​ Sub-total ​ 530 ​ ​ 2,286 ​ ​ — ​ ​ 2,816 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 29 ​ ​ 830 ​ ​ — ​ ​ 859 3 ​ Non-real estate loans receivable ​ 1,206 ​ ​ 873 ​ ​ — ​ ​ 2,079 4 ​ Non-real estate loans receivable ​ 56 ​ ​ 578 ​ ​ — ​ ​ 634 5 ​ Non-real estate loans receivable ​ 7,861 ​ ​ 10,758 (2) ​ — ​ ​ 18,619 6 ​ Non-real estate loans receivable ​ 51,269 ​ ​ 28,460 (3)(4) ​ (18,052) (5) ​ 61,677 ​ ​ Sub-total ​ 60,421 ​ ​ 41,499 ​ ​ (18,052) ​ ​ 83,868 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3 ​ Unfunded real estate loan commitments ​ 251 ​ ​ (251) ​ ​ — ​ ​ — 4 ​ Unfunded real estate loan commitments ​ 117 ​ ​ (33) ​ ​ — ​ ​ 84 2 ​ Unfunded non-real estate loan commitments ​ 7 ​ ​ 200 ​ ​ — ​ ​ 207 3 ​ Unfunded non-real estate loan commitments ​ 207 ​ ​ (178) ​ ​ — ​ ​ 29 4 ​ Unfunded non-real estate loan commitments ​ 216 ​ ​ (216) ​ ​ — ​ ​ — 6 ​ Unfunded non-real estate loan commitments ​ 143 ​ ​ 2,107 (5) ​ (2,250) (5) ​ — ​ ​ Sub-total ​ 941 ​ ​ 1,629 ​ ​ (2,250) ​ ​ 320 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 144,466 ​ $ 68,663 ​ $ (24,765) ​ $ 188,364 (1) During the third quarter of 2022, we wrote-off the loan balance and reserve for a loan that expired during the quarter which had previously been fully reserved. (2) This provision includes an additional $10.8 million allowance recorded on the Agemo WC Loan during the year ended December 31, 2022. See Note 8 – Non-Real Estate Loans Receivable for additional information on the Agemo WC Loan. (3) This provision includes an additional $23.3 million allowance recorded on the LaVie $25.0 million term loan and on the $8.3 million term loan during the fourth quarter of 2022. See Note 8 – Non-Real Estate Loans Receivable for additional information on the LaVie term loans. (4) This provision includes an additional $5.2 million allowance recorded on the $20 million WC loan during the year ended December 31, 2022 as discussed in Note 8 – Non-Real Estate Loans Receivable. (5) In the second quarter of 2022 we recorded an additional reserve of $2.2 million related to the remaining commitment under the Gulf Coast DIP Facility as we were notified of the operator’s intent to draw the funds in the third quarter of 2022. In the third quarter of 2022, the remaining commitment under the DIP Facility was drawn and the DIP Facility expired and as a result we wrote-off the loan balance and related reserves as we did not expect to collect amounts under the DIP Facility following the expiration. Included below is a summary of the amortized cost basis of our financial instruments by year of origination and internal risk rating and a summary of our gross write-offs by year of origination: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating Financial Statement Line Item 2024 2023 2022 2021 2020 2019 & older Revolving Loans Balance as of December 31, 2024 ​ ​ (in thousands) 1 Real estate loans receivable $ — $ — $ 20,000 $ — $ — $ — $ — $ 20,000 2 Real estate loans receivable ​ 29,700 ​ 8,680 ​ — ​ — ​ 21,325 ​ — ​ — ​ 59,705 3 Real estate loans receivable ​ 273,243 ​ 161,166 ​ 27,600 ​ 72,420 ​ — ​ — ​ — ​ 534,429 4 Real estate loans receivable ​ 73,991 ​ 90,403 ​ — ​ 31,626 ​ 82,615 ​ 330,276 ​ — ​ 608,911 5 Real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ — ​ 263,580 ​ 263,580 6 Real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ 12,922 ​ — ​ 12,922 ​ Sub-total ​ 376,934 ​ 260,249 ​ 47,600 ​ 104,046 ​ 103,940 ​ 343,198 ​ 263,580 ​ 1,499,547 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 Investment in direct financing leases ​ — ​ — ​ — ​ — ​ — ​ 11,058 ​ — ​ 11,058 ​ Sub-total ​ — ​ — ​ — ​ — ​ — ​ 11,058 ​ — ​ 11,058 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 Non-real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ — ​ 15,989 ​ 15,989 3 Non-real estate loans receivable ​ 4,175 ​ 81,333 ​ 17,687 ​ — ​ — ​ 2,551 ​ 55,761 ​ 161,507 4 Non-real estate loans receivable ​ 4,411 ​ — ​ — ​ — ​ — ​ 117,477 ​ 27,822 ​ 149,710 5 Non-real estate loans receivable ​ 6,000 ​ 1,500 ​ — ​ — ​ — ​ 45,028 ​ — ​ 52,528 6 Non-real estate loans receivable ​ 5,027 ​ 3,812 ​ 24,457 ​ 7,851 ​ — ​ 28,188 ​ 6,000 ​ 75,335 ​ Sub-total ​ 19,613 ​ 86,645 ​ 42,144 ​ 7,851 ​ — ​ 193,244 ​ 105,572 ​ 455,069 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 396,547 $ 346,894 $ 89,744 $ 111,897 $ 103,940 $ 547,500 $ 369,152 $ 1,965,674 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year to date gross write-offs $ — $ (5,879) $ — $ — $ — $ (3,092) $ (4,540) $ (13,511) ​ Interest Receivable on Real Estate Loans and Non-real Estate Loans We have elected the practical expedient to exclude interest receivable from our allowance for credit losses. As of December 31, 2024 and 2023, we have excluded $11.1 million and $10.2 million, respectively, of contractual interest receivables and $1.8 million and $3.1 million, respectively, of effective yield interest receivables from our allowance for credit losses. We write-off interest receivable to provision for credit losses in the period we determine the interest is no longer considered collectible. During the years ended December 31, 2024, 2023 and 2022, we recognized $3.3 million, $1.7 million and $17.2 million, respectively, of interest income related to loans on non-accrual status as of December 31, 2024.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	12 Months Ended
	Dec. 31, 2024
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	NOTE 10 – VARIABLE INTEREST ENTITIES Below is a summary of our assets, liabilities, collateral, and maximum exposure to loss associated with these unconsolidated VIEs as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2024 ​ 2023 ​ ​ ​ (in thousands) ​ Assets ​ ​ ​ ​ ​ ​ ​ Real estate assets – net ​ $ 1,250,131 ​ $ 996,540 ​ Assets held for sale ​ ​ — ​ ​ 51,700 ​ Real estate loans receivable – net ​ 534,048 ​ ​ 370,147 ​ Investments in unconsolidated joint ventures ​ ​ 9,754 ​ ​ 9,009 ​ Non-real estate loans receivable – net ​ 38,463 ​ ​ 10,679 ​ Contractual receivables – net ​ 994 ​ ​ 746 ​ Other assets ​ ​ 1,539 ​ ​ 1,423 ​ Total assets ​ 1,834,929 ​ 1,440,244 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ ​ ​ ​ ​ Accrued expenses and other liabilities ​ ​ (52,692) ​ ​ (46,677) ​ Total liabilities ​ (52,692) ​ (46,677) ​ ​ ​ ​ ​ ​ ​ ​ ​ Collateral ​ ​ ​ Personal guarantee ​ (48,000) ​ ​ (48,000) ​ Other collateral (1) ​ (1,422,096) ​ ​ (1,090,953) ​ Total collateral ​ (1,470,096) ​ ​ (1,138,953) ​ ​ ​ ​ ​ ​ ​ ​ ​ Maximum exposure to loss ​ $ 312,141 ​ $ 254,614 ​ (1) Amount excludes accounts receivable amounts that Omega has a security interest in as collateral under the two working capital loans with entities that are unconsolidated VIEs. The fair value of the accounts receivable available to Omega was $5.5 million and $8.9 million as of December 31, 2024 and December 31, 2023, respectively. In determining our maximum exposure to loss from these VIEs, we considered the underlying carrying value of the real estate subject to leases with these entities and other collateral, if any, supporting our other investments, which may include accounts receivable, security deposits, letters of credit or personal guarantees, if any, as well as other liabilities recognized with respect to these entities. The table below reflects our total revenues from the entities that are considered unconsolidated VIEs, following the date they were determined to be VIEs, for the years ended December 31, 2024, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ ​ 2022 ​ (in thousands) Revenue ​ ​ ​ ​ ​ ​ ​ ​ Rental income (1) $ 106,911 ​ $ 81,900 ​ $ 53,158 Interest income ​ 16,414 ​ ​ 5,512 ​ ​ 16,456 Total $ 123,325 ​ $ 87,412 ​ $ 69,614 (1) The rental income for the year ended December 31, 2023, reflects the $12.5 million option termination fee payment made to Maplewood in the first quarter of 2023 that was accounted for as a lease inducement (see Note 5 – Contractual Receivables and Other Receivables and Lease Inducements). The rental income for the year ended December 31, 2022, reflects the write-off of approximately $29.3 million of straight-line rent receivables and lease inducements related to Maplewood (see Note 5 – Contractual Receivables and Other Receivables and Lease Inducements). Consolidated VIEs We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic performance and our rights to receive residual returns and obligation to absorb losses arising from the joint venture. We also sold an ALF to the joint venture In addition, as discussed in Note 3 – Real Estate Asset Acquisitions and Development, we consolidated the EATs that were classified as VIEs. See further discussion of EATs that were consolidated in Note 3 – Real Estate Asset Acquisitions and Development.

INVESTMENT IN JOINT VENTURES

INVESTMENT IN JOINT VENTURES	12 Months Ended
	Dec. 31, 2024
INVESTMENTS IN JOINT VENTURES [Abstract]
INVESTMENTS IN JOINT VENTURES	NOTE 11 – INVESTMENTS IN JOINT VENTURES Unconsolidated Joint Ventures Omega owns an interest in a number of joint ventures which generally invest in the long-term healthcare industry. The following is a summary of our investments in unconsolidated joint ventures (dollars in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying Amount ​ ​ Ownership ​ Facility ​ Facility ​ December 31, ​ December 31, Entity ​ % (1) ​ Type ​ Count (1) ​ 2024 2023 Lakeway Realty, L.L.C. (2) ​ 51% ​ Specialty facility ​ 1 ​ $ 67,541 ​ $ 68,902 Second Spring Healthcare Investment ​ 15% ​ N/A ​ — ​ ​ 7,117 ​ 8,945 Cindat Joint Venture (3) ​ N/A ​ N/A ​ N/A ​ ​ — ​ ​ 97,559 Other Real Estate JVs (4)(5)(6) ​ 20% – 50% ​ Various ​ 6 ​ 6,736 ​ 6,009 Other Healthcare JVs (6)(7) ​ 9% – 25% ​ N/A ​ N/A ​ ​ 7,317 ​ ​ 6,994 ​ ​ ​ ​ ​ ​ ​ ​ $ 88,711 ​ $ 188,409 (1) Ownership percentages and facility counts are as of December 31, 2024. (2) The joint venture owns the Lakeway Regional Medical Center (the “Lakeway Hospital”) in Lakeway, Texas. Our initial basis difference of approximately $69.9 million is being amortized on a straight-line basis over 40 years to income (loss) from unconsolidated joint ventures in the Consolidated Statements of Operations. The lessee of the Lakeway Hospital has an option to purchase the facility from the joint venture. The lessee also has a right of first refusal and a right of first offer in the event the joint venture intends to sell or otherwise transfer Lakeway Hospital. As of December 31, 2023, we had $62.0 million outstanding under a mortgage loan to this joint venture, which was repaid in full in December 2024. (3) As of December 31, 2023, we held a 49% interest in the Cindat Joint Venture that owned 63 care homes leased to two operators in the U.K. pursuant to operating leases. In July 2024, we acquired the remaining 51% ownership interest in the Cindat Joint Venture, such that we now own 100% of the ownership interest in the entity that owns the Cindat portfolio. See Note 3 – Real Estate Asset Acquisitions and Development for additional information. (4) Includes three joint ventures formed for the purpose of owning or providing financing for SNFs, ALFs or specialties facilities. (5) During the third quarter of 2024, one of the other real estate JVs, OMG Senior Holdings, LLC, sold one specialty facility to an unrelated third party for approximately $40.7 million in net cash proceeds and recognized a gain on sale of approximately $12.9 million ( $6.5 million of which represents the Company’s share of the gain). (6) As of December 31, 2024 and 2023, we had an aggregate of $18.5 million and $17.5 million, respectively, of loans outstanding with these joint ventures. (7) Includes six joint ventures engaged in businesses that support the long-term healthcare industry and our operators.

GOODWILL AND OTHER INTANGIBLES

GOODWILL AND OTHER INTANGIBLES	12 Months Ended
	Dec. 31, 2024
Goodwill and Other Intangibles [Abstract]
GOODWILL AND OTHER INTANGIBLES	NOTE 12 – GOODWILL AND OTHER INTANGIBLES The following is a summary of our goodwill: ​ ​ ​ ​ ​ (in thousands) Balance as of December 31, 2023 ​ $ 643,897 Foreign currency translation ​ (233) Balance as of December 31, 2024 ​ $ 643,664 ​ The following is a summary of our lease intangibles as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 ​ 2023 ​ ​ ​ (in thousands) ​ Assets: ​ ​ ​ ​ Above market leases (1) ​ $ 31,864 ​ $ 4,214 ​ Accumulated amortization ​ (3,800) (3,532) ​ Net above market leases ​ $ 28,064 ​ $ 682 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Below market leases ​ $ 34,723 ​ $ 48,791 ​ Accumulated amortization ​ (26,647) (37,177) ​ Net below market leases ​ $ 8,076 ​ $ 11,614 ​ (1) As of December 31, 2024, includes $27.4 million of intangible assets related to above market leases assumed in connection with the acquisition of the remaining 51% interest in the Cindat Joint Venture during the third quarter of 2024 (see Note 3 – Real Estate Asset Acquisitions and Development). Above market leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Operations as an adjustment to rental income. For the years ended December 31, 2024, 2023 and 2022, our net amortization related to intangibles was $1.7 million, $9.4 million and $5.7 million, respectively. The estimated net amortization related to these intangibles for the subsequent five years is as follows: 2025 – $(0.9) million; 2026 – $(1.2) million; 2027 – $(1.3) million; 2028 – $(1.9) million; 2029 – $(2.2) million and $(12.5) million thereafter. As of December 31, 2024, the weighted average remaining amortization period of above market lease assets is approximately ten years and of below market lease liabilities is approximately seven years .

CONCENTRATION OF RISK

CONCENTRATION OF RISK	12 Months Ended
	Dec. 31, 2024
Concentration of Risk [Abstract]
CONCENTRATION OF RISK	NOTE 13 - CONCENTRATION OF RISK As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our investment in these facilities, net of impairments and allowances, totaled approximately $10.1 billion at December 31, 2024, with approximately 98% of our real estate investments related to long-term healthcare facilities. Our portfolio is made up of (i) 589 SNFs, 290 ALFs, 19 ILFs, 18 specialty facilities and one MOB, (ii) fixed rate mortgages on 52 SNFs, 43 ALFs, one specialty facility and one ILF, and (iii) 12 facilities that are held for sale. At December 31, 2024, we also held other real estate loans (excluding mortgages) receivable of $485.5 million and non-real estate loans receivable of $332.3 million, consisting primarily of secured loans to third-party operators of our facilities, and $88.7 million of investments in 11 unconsolidated joint ventures. At December 31, 2024 and 2023, we had investments with one operator/or manager that approximated or exceeded 10% of our total investments: Maplewood. Maplewood generated approximately 5.2%, 5.4% and 6.9% of our total revenues for the years ended December 31, 2024, 2023 and 2022, respectively. The revenue associated with Maplewood for the year ended December 31, 2023 reflects a reduction of revenue of $12.5 million related to a termination fee payment made by Omega as discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements. During the year ended December 31, 2024, we also have one operator with total revenues that exceeded 10% of our total revenues: CommuniCare Health Services, Inc. (“CommuniCare”). CommuniCare generated approximately 11.8%, 11.7% and 9.1% of our total revenues for the years ended December 31, 2024, 2023 and 2022, respectively. Revenue percentages above include the impact of straight-line rent receivable write-offs, lease inducement write-offs and effective yield interest receivable write-offs of $4.2 million, $20.6 million and $124.8 million for the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, CommuniCare represented approximately 8.2% of our total investments. At December 31, 2024, the three states in which we had our highest concentration of investments were Texas (9.2%), Indiana (6.2%) and California (5.7%). In addition, our concentration of investments in the U.K. is 14.1%.

BORROWING ACTIVITIES AND ARRANG

BORROWING ACTIVITIES AND ARRANGEMENTS	12 Months Ended
	Dec. 31, 2024
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]
BORROWING ACTIVITIES AND ARRANGEMENTS	NOTE 14 - BORROWING ARRANGEMENTS The following is a summary of our long-term borrowings: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Annual ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest Rate ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ December 31, ​ December 31, ​ Maturity 2024 ​ 2024 2023 ​ ​ ​ ​ (in thousands) Secured borrowings: ​ ​ ​ HUD mortgages (1) ​ 2049 - 2051 ​ N/A ​ ​ $ — ​ $ 41,878 2024 term loan (2) 2024 N/A ​ ​ ​ — ​ ​ 20,085 2026 mortgage loan (1) 2026 10.31 % ​ ​ 231,148 ​ ​ — Deferred financing costs – net ​ ​ ​ (3,753) ​ — Premium – net ​ ​ 15,915 ​ — Total secured borrowings ​ ​ ​ ​ ​ ​ ​ 243,310 ​ ​ 61,963 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Unsecured borrowings: ​ ​ ​ Revolving credit facility (3)(4) 2025 5.67 % ​ — ​ 20,397 ​ ​ ​ ​ ​ ​ ​ ​ — ​ ​ 20,397 Senior notes and other unsecured borrowings: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2024 notes (3)(5) 2024 N/A ​ ​ — ​ 400,000 2025 notes (3)(6) 2025 4.50 % ​ 400,000 ​ 400,000 2026 notes (3) 2026 5.25 % ​ 600,000 ​ 600,000 2027 notes (3) 2027 4.50 % ​ 700,000 ​ 700,000 2028 notes (3) 2028 4.75 % ​ 550,000 ​ 550,000 2029 notes (3) 2029 3.63 % ​ 500,000 ​ 500,000 2031 notes (3) ​ 2031 ​ 3.38 % ​ ​ 700,000 ​ ​ 700,000 2033 notes (3) ​ 2033 ​ 3.25 % ​ ​ 700,000 ​ ​ 700,000 2025 term loan (3)(7) ​ 2025 5.60 % ​ 428,500 ​ 428,500 OP term loan (8)(9) 2025 5.52 % ​ 50,000 ​ 50,000 Deferred financing costs – net ​ ​ ​ (14,843) ​ (20,442) Discount – net ​ ​ (18,108) ​ (23,102) Total senior notes and other unsecured borrowings – net ​ ​ 4,595,549 ​ 4,984,956 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total unsecured borrowings – net ​ ​ 4,595,549 ​ 5,005,353 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total secured and unsecured borrowings – net (10)(11) ​ ​ $ 4,838,859 ​ $ 5,067,316 (1) Wholly owned subsidiaries of Omega OP are or were the obligor on these borrowings. (2) Borrowing was the debt of the consolidated joint venture discussed in Note 8 – Variable Interest Entities which was formed in the first quarter of 2022. The borrowing was secured by two ALFs, which are owned by the joint venture. During the second quarter of 2024, Omega repaid this loan using available cash and proceeds from our $1.45 billion senior unsecured multicurrency revolving credit facility (“Revolving Credit Facility”). (3) Guaranteed by Omega OP. (4) During the second quarter of 2023, the Company transitioned its benchmark interest rate for its Revolving Credit Facility from LIBOR to SOFR . The applicable interest rate on the US Dollar tranche and on the GBP borrowings under the alternative currency tranche of the credit facility were 5.67% and 6.02% as of December 31, 2024, respectively. (5) The Company repaid the $400 million of 4.95% senior notes that matured on April 1, 2024 using available cash and proceeds from our Revolving Credit Facility. (6) Subsequent to December 31, 2024, the Company repaid the $400 million of 4.50% senior notes that matured on January 15, 2025 using available cash. (7) The weighted average interest rate of the $428.5 million 2025 term loan has been adjusted to reflect the impact of the interest rate swaps that effectively fix the SOFR -based portion of the interest rate at 4.047% . (8) Omega OP is the obligor on this borrowing. (9) During the second quarter of 2023, the Company transitioned its benchmark interest rate for its $50.0 million senior unsecured term loan facility (the “OP Term Loan”) from LIBOR to SOFR . The weighted average interest rate of the $50 million OP Term Loan has been adjusted to reflect the impact of the interest rate swaps that effectively fix the SOFR -based portion of the interest rate at 3.957% . (10) All borrowings are direct borrowings of Parent unless otherwise noted. (11) Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings. Secured Borrowings HUD Mortgage Debt ​ On October 31, 2019, we assumed $389 million in mortgage loans guaranteed by HUD. The HUD loans had maturity dates between 2046 and 2052 with fixed interest rates ranging from 2.82% per annum to 3.24% per annum. During 2020, we paid $13.7 million to retire two mortgage loans with an average interest rate of 3.08% per annum with maturities in 2051 and 2052. On August 31, 2022, we paid approximately $7.9 million to retire one mortgage loan with a fixed interest rate of 2.92% per annum with a maturity date in 2051. In connection with the sales made in the third and fourth quarters of 2023 (as discussed further in Note 4 – Assets Held for Sale, Dispositions and Impairments), 29 mortgage loans in the aggregate amount of $281.7 million were retired. These 29 loans had a weighted average fixed interest rate of 3.03% per annum with maturities between 2046 and 2052. During the fourth quarter of 2023, we paid approximately $14.8 million to retire three mortgage loans with a weighted average fixed interest rate of 2.97% per annum with maturity dates between 2046 and 2052. During the first quarter of 2024, the remaining nine HUD mortgages with outstanding principal of $41.6 million were paid off. We recognized $1.3 million, $0.5 million and $0.4 million, respectively, of losses on debt extinguishment for prepayment penalties incurred on the HUD mortgage payoffs, discussed above, for the years ended December 31, 2024, 2023 and 2022. 2026 Mortgage Loan As discussed in Note 3 – Real Estate Asset Acquisitions and Development, we assumed the 2026 Mortgage Loan as part of our acquisition of the remaining 51% interest in the Cindat Joint Venture. The 2026 Mortgage Loan matures in August 2026 but can be repaid without a prepayment penalty beginning November 2025. The 2026 Mortgage Loan bears interest at the Sterling Overnight Index Average (“SONIA Unsecured Borrowings 2025 Term Loan On August 8, 2023, Omega entered into a credit agreement (the “2025 Omega Credit Agreement”) providing it with a new $400 million senior unsecured term loan facility (the “2025 Term Loan”). The 2025 Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments thereunder to $500 million by requesting an increase in the aggregate commitments under the 2025 Term Loan. On September 27, 2023, Omega exercised the accordion feature to increase the aggregate commitment under the 2025 Term Loan by $28.5 million. The 2025 Term Loan bears interest at SOFR plus an adjustment of 0.1% per annum plus an applicable percentage (with a range of 85 to 185 basis points) based on our credit rating. The 2025 Term Loan matures on August 8, 2025, subject to Omega’s option to extend such maturity date for two sequential 12 Revolving Credit Facility On April 30, 2021, Omega entered into a credit agreement (the “Omega Credit Agreement”) providing us with a new Revolving Credit Facility, replacing our previous $1.25 billion senior unsecured multicurrency revolving credit facility obtained in 2017 and the related credit agreement. The Omega Credit Agreement contains an accordion feature permitting us, subject to compliance with customary conditions, to increase the maximum aggregate commitments thereunder to $2.5 billion, by requesting an increase in the aggregate commitments under the Revolving Credit Facility or by adding term loan tranches. The Revolving Credit Facility bears interest at SOFR plus an adjustment of 0.11448% per annum (or in the case of loans denominated in GBP, the SONIA reference rate plus an adjustment of 0.1193% per annum, and in the case of loans denominated in Euros, the Euro interbank offered rate, or EURIBOR) plus an applicable percentage (with a range of 95 to 185 basis points) based on our credit ratings. SOFR is a broad measure of the cost of borrowing cash in the overnight U.S. Treasury repo market, and is administered by the Federal Reserve Bank of New York. The Revolving Credit Facility may be drawn in Euros, GBP, Canadian Dollars (collectively, “Alternative Currencies”) or USD, with a $1.15 billion tranche available in USD and a $300 million tranche available in Alternative Currencies. The Revolving Credit Facility matures on April 30, 2025, subject to Omega’s option to extend such maturity date for two six-month periods. In January 2025, Omega provided notification to extend the maturity date to October 30, 2025. We incurred $12.9 million of deferred costs in connection with the Omega Credit Agreement. OP Term Loan On April 30, 2021, Omega OP entered into a credit agreement (the “Omega OP Credit Agreement”) providing it with a new OP Term Loan. The OP Term Loan replaces the $50 million senior unsecured term loan obtained in 2017 and the related credit agreement. The OP Term Loan bears interest at SOFR plus an adjustment of 0.11448% per annum plus an applicable percentage (with a range of 85 to 185 basis points) based on our credit ratings. The OP Term Loan matures on April 30, 2025, subject to Omega OP’s option to extend such maturity date for two, six-month periods. In January 2025, Omega provided notification to extend the maturity date to October 30, 2025. We incurred $0.4 million of deferred costs in connection with the Omega OP Credit Agreement. General Parent and Omega OP, on a combined basis, have no material assets, liabilities or operations other than financing activities (including borrowings under the senior unsecured revolving and term loan credit facility, OP term loan and the outstanding senior notes) and their investments in non-guarantor subsidiaries. Substantially all of our assets are held by non-guarantor subsidiaries. The required principal payments, excluding the premium or discount and deferred financing costs on our secured and unsecured borrowings, for each of the five years following December 31, 2024 and the aggregate due thereafter are set forth below: ​ ​ ​ ​ ​ (in thousands) 2025 $ 878,500 2026 ​ 831,148 2027 ​ 700,000 2028 ​ 550,000 2029 ​ 500,000 Thereafter ​ 1,400,000 Total ​ $ 4,859,648 ​

DERIVATIVES AND HEDGING

DERIVATIVES AND HEDGING	12 Months Ended
	Dec. 31, 2024
DERIVATIVES AND HEDGING [Abstract]
DERIVATIVES AND HEDGING	NOTE 15 – DERIVATIVES AND HEDGING We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our investments in the U.K. and interest rate risk related to our capital structure. As a matter of policy, we do not use derivatives for trading or speculative purposes. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, interest rate swaps and debt issued in foreign currencies to offset a portion of these risks. As of December 31, 2024, we have 12 interest rate swaps with $478.5 million in notional value and four interest rate caps with £190.0 million in notional value. The swaps and the majority of the caps are designated as cash flow hedges of the interest payments on three of Omega’s variable interest loans. Additionally, we have 11 foreign currency forward contracts with £258.0 million in notional value issued at a weighted average GBP-USD forward rate of 1.2899 that are designated as net investment hedges. Cash Flow Hedges of Interest Rate Risk We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt. On March 27, 2020, we entered into five forward starting swaps totaling $400 million, indexed to 3-month LIBOR, that were issued at a weighted average fixed rate of approximately 0.8675% and were subsequently designated as cash flow hedges of interest rate risk associated with interest payments on a forecasted issuance of fixed rate long-term debt, initially expected to occur within the next five years. The swaps had an effective date of August 1, 2023 and an expiration date of August 1, 2033. In conjunction with the October 2020 issuance of $700 million of 3.375% Senior Notes due 2031 and the March 2021 issuance of $700 million aggregate principal amount of our 3.25% Senior Notes due 2033, we applied hedge accounting for these five forward starting swaps and began amortization. Simultaneously, we re-designated these swaps in new cash flow hedging relationships of interest rate risk associated with interest payments on another forecasted issuance of long-term debt. We were hedging our exposure to the variability in future cash flows for forecasted transactions over a maximum period of 46 months (excluding forecasted transactions related to the payment of variable interest on existing financial instruments). As a result of these transactions, the aggregate unrealized gain of $41.2 million ($9.5 million gain related to the October 2020 issuance and $31.7 million gain related to the March 2021 issuance) included within accumulated other comprehensive income at the time of the bond issuances is being ratably reclassified as a reduction to interest expense, net over 10 years. On May 30, 2023, the five forward starting swaps were terminated, and Omega received a net cash settlement of $92.6 million from the swap counterparties. The incremental $51.4 million of gains related to the forward swaps, recorded in accumulated other comprehensive income, were frozen at the time of termination and will be recognized ratably over 10 years in earnings when the next qualifying debt issuance occurs. Consistent with our accounting policy and historical practice, the $92.6 million net cash settlement from the forward swap termination is reflected within net cash used in financing activities in the Consolidated Statements of Cash Flows. In June 2023, we entered into an interest rate swap with a notional amount of $50.0 million. The swap is effective June 30, 2023 and terminates on April 30, 2027 . This interest rate swap is designated as a hedge against our exposure to changes in interest payment cash flow fluctuations in the variable interest rates on the OP Term Loan. The interest rate swap contract effectively converts our $50.0 million OP Term Loan to an aggregate fixed rate of approximately 5.521% through its maturity. The effective fixed rate achieved by the combination of the Omega OP Credit Agreement and the interest rate swaps could fluctuate up by 40 basis points or down by 60 basis points based on future changes to our credit ratings. In August 2023, we entered into ten interest rate swaps with $400.0 million in notional value. The swaps are effective August 14, 2023 and terminate on August 6, 2027 . The interest rate swaps are designated as hedges against our exposure to changes in interest payment cash flows as a result of the variable interest rate on the 2025 Term Loan. The interest rate swap contracts effectively convert our $400.0 million 2025 Term Loan to an aggregate fixed rate of approximately 5.565% . In September 2023, in connection with the exercise of the accordion feature on the 2025 Term Loan, we entered into one additional interest rate swap with $28.5 million in notional value to hedge the additional $28.5 million under the 2025 Term Loan. This swap is effective September 29, 2023 and terminates on August 6, 2027 . These 11 interest rate swap contracts effectively convert our $428.5 million 2025 Term Loan to a new combined aggregate fixed rate of approximately 5.597% through its maturity. The effective fixed rate achieved by the combination of the 2025 Omega Credit Agreement and the interest rate swaps could fluctuate up by 40 basis points or down by 60 basis points based on future changes to our credit ratings. As discussed in Note 3 – Real Estate Asset Acquisitions and Development, we assumed four interest rate cap contracts as a part of our acquisition of the remaining 51% interest in the Cindat Joint Venture. The interest rate caps terminate on August 26, 2026. The interest rate cap contracts ensure that the annual interest rate on the 2026 Mortgage Loan does not exceed 10.38%. Foreign Currency Forward Contracts and Debt Designated as Net Investment Hedges We have historically used debt denominated in GBP and foreign currency forward contracts to hedge a portion of our net investments, including certain intercompany loans, in the U.K. against fluctuations in foreign exchange rates. In March 2021, we entered into four foreign currency forward contracts with notional amounts totaling £174.0 million, that matured on March 8, 2024 , to hedge a portion of our net investments in the U.K., including an intercompany loan and an investment in our U.K. joint venture, effectively replacing the terminated net investment hedge. The forwards were issued at a weighted average GBP-USD forward rate of 1.3890 . On May 17, 2022, we entered into two new foreign currency forward contracts with notional amounts totaling £76.0 million and a GBP-USD forward rate of 1.3071, each of which mature on May 21, 2029. These currency forward contracts hedge a portion of our net investments in U.K. subsidiaries, including an intercompany loan. On December 27, 2023, we terminated two foreign currency forward contracts that were entered into in March 2021 with notional amounts totaling £104.0 million. Omega received a net cash settlement of $11.4 million as a result of termination, which is included within net cash used in investing activities in the Consolidated Statements of Cash Flows. The $11.4 million related to the termination will remain in accumulated other comprehensive income until the underlying hedged items are liquidated. Concurrent with the termination of the two foreign currency forward contracts, also on December 27, 2023, we entered into six new foreign currency forward contracts with notional amounts totaling £104.0 million and a GBP-USD forward rate of 1.2916, each of which mature between March 8, 2027 and March 8, 2030. Consistent with the terminated forwards, the new currency forward contracts hedge an intercompany loan between a U.S. and U.K. subsidiary. On February 27, 2024, we terminated two foreign currency forward contracts that were entered into in March 2021 with notional amounts totaling £70.0 million. Omega received a net cash settlement of $8.4 million as a result of termination, which is included within net cash used in investing activities in the Consolidated Statements of Cash Flows. The $8.4 million related to the termination will remain in accumulated other comprehensive income until the underlying hedged items are liquidated. Concurrent with the termination of the two foreign currency forward contracts, also on February 27, 2024, we entered into three new foreign currency forward contracts with notional amounts totaling £78.0 million and a GBP-USD forward rate of 1.2707, each of which mature between March 8, 2027 and March 7, 2031. The new currency forward contracts hedge an intercompany loan between a U.S. and a U.K. subsidiary. The location and the fair value of derivative instruments designated as hedges, at the respective balance sheet dates, were as follows: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 Cash flow hedges: (in thousands) Other assets $ 381 ​ $ — Accrued expenses and other liabilities $ 554 ​ $ 6,533 ​ ​ ​ ​ ​ ​ Net investment hedges: ​ ​ ​ ​ ​ Other assets $ 8,434 ​ $ 8,903 Accrued expenses and other liabilities $ — ​ $ 8 ​ The fair value of the interest rate swaps and foreign currency forwards is derived from observable market data such as yield curves and foreign exchange rates and represents a Level 2 measurement on the fair value hierarchy.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2024
Financial Instruments [Abstract]
FINANCIAL INSTRUMENTS	NOTE 16 - FINANCIAL INSTRUMENTS The net carrying amount of cash and cash equivalents, restricted cash, contractual receivables, other assets and accrued expenses and other liabilities reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (Level 1). At December 31, 2024 and 2023, the net carrying amounts and fair values of other financial instruments were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2024 ​ December 31, 2023 ​ Carrying Fair Carrying Fair ​ Amount Value Amount Value ​ ​ (in thousands) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments in direct financing leases – net $ 9,453 ​ $ 9,453 $ 8,716 $ 8,716 Real estate loans receivable – net ​ 1,428,298 ​ 1,447,262 ​ 1,212,162 ​ 1,258,838 Non-real estate loans receivable – net ​ 332,274 ​ 340,025 ​ 275,615 ​ 279,710 Total ​ $ 1,770,025 ​ $ 1,796,740 ​ $ 1,496,493 ​ $ 1,547,264 Liabilities: ​ ​ ​ ​ Revolving credit facility ​ $ — ​ $ — ​ $ 20,397 ​ $ 20,397 2026 mortgage loan ​ 243,310 ​ 247,063 ​ — ​ — 2024 term loan ​ — ​ — ​ 20,085 ​ 19,750 2025 term loan ​ ​ 427,044 ​ ​ 428,500 ​ ​ 424,662 ​ ​ 428,500 OP term loan ​ 49,966 ​ 50,000 ​ 49,864 ​ 50,000 4.95% notes due 2024 – net ​ — ​ — ​ 399,747 ​ 398,888 4.50% notes due 2025 – net ​ 399,968 ​ 399,856 ​ 399,207 ​ 393,240 5.25% notes due 2026 – net ​ 599,259 ​ 600,714 ​ 598,553 ​ 596,508 4.50% notes due 2027 – net ​ 696,766 ​ 691,040 ​ 695,302 ​ 671,538 4.75% notes due 2028 – net ​ 546,933 ​ 542,553 ​ 545,925 ​ 528,704 3.63% notes due 2029 – net ​ ​ 494,308 ​ ​ 461,180 ​ ​ 493,099 ​ ​ 440,785 3.38% notes due 2031 – net ​ ​ 688,962 ​ ​ 620,809 ​ ​ 687,172 ​ ​ 594,734 3.25% notes due 2033 – net ​ ​ 692,343 ​ ​ 585,389 ​ ​ 691,425 ​ ​ 564,809 HUD mortgages – net ​ ​ — ​ ​ — ​ ​ 41,878 ​ ​ 31,322 Total ​ $ 4,838,859 ​ $ 4,627,104 ​ $ 5,067,316 ​ $ 4,739,175 ​ Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies). The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. The following methods and assumptions were used in estimating fair value disclosures for financial instruments. ​ ● Real estate loans receivable: The fair value of the real estate loans receivable are estimated using a discounted cash flow analysis, using current interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). ● Non-real estate loans receivable: Non-real estate loans receivable are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using current interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). ● Revolving Credit Facility, OP Term Loan, 2024 term loan and 2025 term loan: The carrying amount of these approximate fair value because the borrowings are interest rate adjusted. Differences between carrying value and the fair value in the table above are due to the inclusion of deferred financing costs in the carrying value. ● 2026 Mortgage Loan: The 2026 Mortgage Loan was recorded at fair market value in July 2024, as of the date we assumed it as part of our acquisition of the remaining 51% interest in the Cindat Joint Venture. The fair market value was determined by discounting the remaining contractual cash flows using a current market rate of interest of comparable debt instruments. Differences between carrying value and the fair value in the table above are due to the inclusion of deferred financing costs in the carrying value. ● Senior notes: The fair value of the senior unsecured notes payable was estimated based on publicly available trading prices (Level 1). ● HUD mortgages: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).

TAXES

TAXES	12 Months Ended
	Dec. 31, 2024
Taxes [Abstract]
TAXES	NOTE 17 – TAXES Omega and Omega OP, including their wholly owned subsidiaries were organized, have operated, and intend to continue to operate in a manner that enables Omega to qualify for taxation as a REIT under Sections 856 through 860 of the Code. On a quarterly and annual basis we perform several analyses to test our compliance within the REIT taxation rules. If we fail to meet the requirements for qualification as a REIT in any tax year, we will be subject to federal income tax on our taxable income at regular corporate rates and may not be able to qualify as a REIT for the four We are also subject to federal taxation of 100% of the net income derived from the sale or other disposition of property, other than foreclosure property, that we held primarily for sale to customers in the ordinary course of a trade or business. We believe that we do not hold assets for sale to customers in the ordinary course of business and that none of the assets currently held for sale or that have been sold would be considered a prohibited transaction within the REIT taxation rules. As a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions. In 2024, 2023 and 2022, we distributed dividends in excess of our taxable income. We currently own stock in certain subsidiary REITs. These subsidiary entities are required to individually satisfy all of the rules for qualification as a REIT. If we fail to meet the requirements for qualification as a REIT for any of the subsidiary REITs, it may cause the Parent REIT to fail the requirements for qualification as a REIT also. We have elected to treat certain of our active subsidiaries as TRSs. Our domestic TRSs are subject to federal, state and local income taxes at the applicable corporate rates. Our foreign TRSs are subject to foreign income taxes and may be subject to current-year income inclusion relating to ownership of a controlled foreign corporation for U.S. income tax purposes. As of December 31, 2024, one of our TRSs that is subject to income taxes at the applicable corporate rates had a net operating loss (“NOL”) carry-forward of approximately $9.8 million. Our NOL carry-forward was partially reserved as of December 31, 2024, with a valuation allowance due to uncertainties regarding realization. Under current law, NOL carry-forwards generated up through December 31, 2017 may be carried forward for no more than 20 years, and NOL carry-forwards generated in taxable years ended after December 31, 2017, may be carried forward indefinitely. We do not anticipate that such changes will materially impact the computation of Omega’s taxable income, or the taxable income of any Omega entity, including our TRSs. Our foreign subsidiaries are subject to foreign income taxes and withholding taxes. The majority of our U.K. portfolio elected to enter the U.K. REIT regime with an effective date of April 1, 2023. In connection with entering the U.K. REIT regime, we recognized several adjustments to our deferred tax balances in the first quarter of 2023 as summarized below. As discussed in Note 3 – Real Estate Asset Acquisitions and Development, we acquired foreign net operating losses of $47.8 million resulting in a NOL deferred tax asset of $11.9 million in connection with our acquisition of one U.K. entity in the second quarter of 2024 and we acquired foreign net operating losses of $55.0 million resulting in a NOL deferred tax asset of $13.4 million in connection with the acquisition of one U.K. entity in the first quarter of 2022. As of December 31, 2024, we have aggregate NOL carryforwards of approximately $76.4 million associated with two U.K. subsidiaries. These U.K. NOLs have no expiration date and may be available to offset future taxable income. We believe these foreign NOLs are realizable under a “more likely than not” measurement and have not recorded a valuation allowance against the deferred tax asset. The Organization for Economic Co-operation and Development (OECD) has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as Pillar 2), with certain aspects of Pillar 2 effective January 1, 2024 and other aspects effective January 1, 2025. While it is uncertain whether the U.S. will enact legislation to adopt Pillar 2, the U.K. has adopted legislation. We do not expect Pillar 2 to have a material impact on our effective tax rate or our consolidated results of operation, financial position, and cash flows. The following is a summary of our provision for income taxes: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 ​ 2022 ​ ​ (in millions) Federal, state and local income tax expense (1) ​ $ 1.5 ​ $ 2.0 ​ $ 1.2 Foreign income tax expense (2) ​ ​ 9.4 ​ ​ 4.3 ​ ​ 3.4 Total income tax expense (3) ​ $ 10.9 ​ $ 6.3 ​ $ 4.6 (1) For the years ended December 31, 2024, 2023 and 2022, income before income tax expense and income from unconsolidated joint ventures from domestic operations was $386.4 million, $234.2 million and $418.5 million, respectively. (2) For the years ended December 31, 2024, 2023 and 2022, income before income tax expense and income from unconsolidated joint ventures from foreign operations was $34.3 million, $21.5 million and $17.6 million, respectively. (3) The above amounts do not include gross income receipts or franchise taxes payable to certain states and municipalities. The following is a summary of deferred tax assets and liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 ​ ​ (in thousands) U.S. Federal net operating loss carryforward ​ $ 2,048 ​ $ 2,079 Valuation allowance on deferred tax asset ​ (1,925) ​ (2,024) Foreign net operating loss carryforward ​ ​ 19,101 ​ ​ 9,491 Foreign deferred tax asset (1) ​ ​ 200 ​ ​ — Net deferred tax asset ​ $ 19,424 ​ $ 9,546 ​ ​ ​ ​ ​ ​ ​ Foreign deferred tax liability (1) ​ $ — ​ $ 1,508 Net deferred tax liability ​ $ — ​ $ 1,508 (1) The deferred tax asset and liability resulted from book to tax differences recorded in the U.S. relating to depreciation and revenue recognition in the U.K.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	12 Months Ended
	Dec. 31, 2024
Stockholders Equity [Abstract]
STOCKHOLDERS EQUITY	NOTE 18 – STOCKHOLDERS’ EQUITY Stock Repurchase Program On January 27, 2022, the Company authorized the repurchase of up to $500 million of our outstanding common stock from time to time through March 2025. The Company is authorized to repurchase shares of its common stock in open market and privately negotiated transactions or in any other manner as determined by the Company’s management and in accordance with applicable law. The timing and amount of stock repurchases will be determined, in management’s discretion, based on a variety of factors, including but not limited to market conditions, other capital management needs and opportunities, and corporate and regulatory considerations. The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be discontinued at any time. Under Maryland law, shares repurchased become authorized but unissued shares. The Company reduced the common stock at par value and to the extent the cost acquired exceeds par value, it is recorded through additional paid-in capital on our Consolidated Balance Sheets and Consolidated Statements of Equity. During the year ended December 31, 2022, the Company repurchased 5.2 million shares of our outstanding common stock at an average price of $27.32 per share, for a total repurchase cost of $142.3 million. The average price per share and repurchase cost includes the cost of commissions. Omega did not repurchase any of its outstanding common stock under this announced program during 2023 or 2024. At-The-Market Offering Program During the second quarter of 2021, we entered into a new “at-the-market” (“ATM”) Equity Offering Sales Agreement pursuant to which shares of common stock having an aggregate gross sales price of up to $1.0 billion (the “2021 ATM Program”) may be sold from time to time by Omega through several financial institutions acting as a sales agent or directly to the financial institutions as principals. Under the 2021 ATM Program, compensation for sales of the shares was limited to 2% or less of the gross sales price per share for shares sold through each financial institution. During the third quarter of 2024, we terminated the 2021 ATM Program and entered into a new ATM Equity Offering Sales Agreement pursuant to which shares of common stock having an aggregate gross sales price of up to $1.25 billion (the “2024 ATM Program,” and together with the 2021 ATM Program, the “ATM Program”) may be sold from time to time (i) by Omega through several financial institutions acting as a sales agent or directly to the financial institutions as principals, or (ii) by several financial institutions acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement. Under the 2024 ATM Program, compensation for sales of the shares will not exceed 2% of the gross sales price per share for shares sold through each financial institution. The use of forward sales under the 2024 ATM Program generally allows Omega to lock in a price on the sale of shares of common stock when sold by the forward sellers but defer receiving the net proceeds from such sales until the shares of our common stock are issued at settlement on a later date. We did not utilize the forward provisions under the ATM Program during 2022, 2023 or 2024. The following is a summary of the shares issued under our ATM Program for each of the years ended December 31, 2022, 2023, and 2024 (in thousands except average price per share): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average Net Price ​ ​ ​ ​ Period Ended Shares issued Per Share (1) Gross Proceeds Net Proceeds December 31, 2022 — $ — $ — $ — December 31, 2023 7,243 ​ 30.25 ​ 221,732 ​ 219,140 December 31, 2024 28,714 ​ 36.49 ​ 1,058,080 ​ 1,047,767 (1) Represents the average price per share after commissions. Dividend Reinvestment and Common Stock Purchase Plan We have a Dividend Reinvestment and Common Stock Purchase Plan (the “DRCSPP”) that allows for the reinvestment of dividends and the optional purchase of our common stock. The table below presents information regarding the shares issued under the DRCSPP for each of the years ended December 31, 2022, 2023, and 2024 (in thousands): ​ ​ ​ ​ ​ ​ Period Ended Shares issued ​ Gross Proceeds December 31, 2022 308 ​ $ 9,229 December 31, 2023 3,715 ​ ​ 117,259 December 31, 2024 5,078 ​ ​ 187,969 ​ ​ ​ ​ ​ ​ Dividends The Board of Directors has declared common stock dividends as set forth below: ​ ​ ​ ​ ​ ​ ​ Record ​ Payment ​ Dividend per Date Date Common Share February 5, 2024 ​ February 15, 2024 ​ $ 0.67 April 30, 2024 ​ May 15, 2024 ​ ​ 0.67 August 5, 2024 ​ August 15, 2024 ​ ​ 0.67 November 4, 2024 ​ November 15, 2024 ​ ​ 0.67 February 10, 2025 ​ February 18, 2025 ​ ​ 0.67 ​ Per Share Distributions Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, Common 2024 2023 2022 Ordinary income ​ $ 1.862 ​ $ 2.258 ​ $ 1.264 Return of capital ​ 0.712 ​ 0.212 ​ 0.095 Capital gains ​ 0.106 ​ 0.210 ​ 1.321 Total dividends paid ​ $ 2.680 ​ $ 2.680 ​ $ 2.680 ​ Pursuant to Treasury Regulation Section 1.1061-6(c), Omega Healthcare Investors Inc. is disclosing the following information to its shareholders. “One Year Amounts Disclosure” is zero percent of the capital gain distributions allocated to each shareholder and “Three Year Amounts Disclosure” is zero percent of the capital gain distributions allocated to each shareholder. All capital gain distributions reported are related to Section 1231 gain. For additional information regarding dividends, see Note 17 – Taxes. Accumulated Other Comprehensive Income (Loss) The following is a summary of our accumulated other comprehensive income (loss), net of tax as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 ​ ​ (in thousands) Foreign currency translation $ (66,110) $ (49,770) Derivative instruments designated as cash flow hedges (1) ​ 76,713 ​ ​ 75,111 Derivative instruments designated as net investment hedges 11,898 ​ 3,931 Total accumulated other comprehensive income before noncontrolling interest 22,501 ​ 29,272 Add: portion included in noncontrolling interest 230 ​ 66 Total accumulated other comprehensive income for Omega $ 22,731 ​ $ 29,338 (1) During the years ended December 31, 2024, 2023 and 2022, we reclassified $9.6 million, $6.7 million and $4.2 million, respectively, of realized gains out of accumulated other comprehensive income into interest expense on our Consolidated Statements of Operations associated with our cash flow hedges.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2024
Stock-Based Compensation [Abstract]
STOCK-BASED COMPENSATION	NOTE 19 – STOCK-BASED COMPENSATION At December 31, 2024, we maintained several stock-based compensation plans as described below. For the years ended December 31, 2024, 2023 and 2022, we recognized stock-based compensation of $36.7 million, $35.1 million and $27.3 million, respectively, related to these plans. For purposes of measuring stock-based compensation expense, we consider whether an adjustment to the observable market price is necessary to reflect material nonpublic information that is known to us at the time the award is granted. No adjustments were deemed necessary for the years ended December 31, 2024, 2023 or 2022. Time-Based Restricted Equity Awards Restricted stock, restricted stock units (“RSUs”) and profits interest units (“PIUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of service or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. The restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. PIUs accrue distributions, which are equivalent to dividend equivalents, but have no voting rights. Once vested, each RSU is settled by the issuance of one share of Omega common stock and each PIU is settled by the issuance of one Omega OP Unit, subject to certain conditions. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. The PIUs are valued using a Monte Carlo model to estimate fair value. We expense the cost of these awards ratably over their vesting period. Performance-Based Restricted Equity Awards Performance-based restricted equity awards include performance restricted stock units (“PRSUs”) and PIUs. PRSUs and PIUs are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. PRSUs and PIUs have varying degrees of performance requirements to achieve vesting, and each PRSU and PIU award represents the right to a variable number of shares of common stock or partnership units. Each PIU once earned is convertible into one Omega OP Unit in Omega OP, subject to certain conditions. The vesting requirements are based on either the (i) total shareholder return (“TSR”) of Omega or (ii) Omega’s TSR relative to other REITs in the FTSE NAREIT Equity Health Care Index (“Relative TSR”). We expense the cost of these awards ratably over their service period. Prior to vesting and the distribution of shares or Omega OP Units, ownership of the PRSUs or PIUs cannot be transferred. Dividend equivalents on the PRSUs are accrued and paid to the extent the applicable performance requirements are met. While each PIU is unearned, the employee receives a partnership distribution equal to 10% of the quarterly approved regular periodic distributions per Omega OP Unit. Partnership distributions (which in the case of normal periodic distributions is equal to the total approved quarterly dividend on Omega’s common stock), less the 10% already paid, on the PIUs accumulate, and if the PIUs are earned, the accumulated distributions are paid. We used a Monte Carlo model to estimate the fair value for the PRSUs and PIUs granted to the employees. The following are the significant assumptions used in estimating the value of the awards for grants made on the following dates: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 1, ​ January 1, ​ January 1, ​ 2024 2023 ​ 2022 Closing price on date of grant ​ $ 30.66 ​ ​ $ 27.95 ​ ​ $ 29.59 ​ Dividend yield ​ 8.74 % ​ ​ 9.59 % ​ ​ 9.06 % Risk free interest rate at time of grant ​ 4.15 % ​ ​ 4.28 % ​ ​ 0.98 % Expected volatility (1) ​ 25.27 % ​ ​ 40.28 % ​ ​ 38.74 % (1) Expected volatility is using 50% historical volatility and 50% implied volatility. ​ The following table summarizes the activity in restricted stock, RSUs, PRSUs, and PIUs for the years ended December 31, 2022, 2023 and 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Time-Based ​ Performance-Based ​ ​ ​ ​ Weighted - ​ Weighted - Total ​ ​ Number of ​ Average Grant- ​ Number of ​ Average Grant- ​ Compensation ​ ​ Shares/Omega ​ Date Fair Value ​ Shares/Omega ​ Date Fair Value ​ Cost (1) ​ OP Units per Share ​ OP Units per Share (in millions) Non-vested at December 31, 2021 318,412 ​ $ 38.62 ​ 2,222,047 ​ $ 17.94 ​ ​ Granted during 2022 256,818 ​ 29.40 ​ 1,620,330 ​ 14.73 ​ $ 31.40 Cancelled during 2022 (2,000) ​ 29.59 ​ (5,232) ​ 11.90 ​ Forfeited during 2022 ​ — ​ — ​ (621,199) ​ 13.68 ​ ​ ​ Vested during 2022 (165,206) ​ 40.91 ​ — ​ — ​ Non-vested at December 31, 2022 408,024 ​ ​ 31.93 ​ 3,215,946 ​ ​ 17.16 ​ Granted during 2023 309,927 ​ 28.15 ​ 2,139,421 ​ 13.42 ​ $ 37.40 Cancelled during 2023 — ​ — ​ (1,228) ​ 11.35 ​ Forfeited during 2023 ​ — ​ — ​ (539,312) ​ 17.50 ​ ​ ​ Vested during 2023 (208,119) ​ 34.31 ​ (482,772) ​ 21.52 ​ Non-vested at December 31, 2023 509,832 ​ ​ 28.66 ​ 4,332,055 ​ ​ 14.78 ​ Granted during 2024 306,526 ​ 30.73 ​ 2,368,170 ​ 13.22 ​ $ 40.70 Cancelled during 2024 — ​ — ​ (20,811) ​ 12.98 ​ Vested during 2024 (2) (251,457) ​ 29.56 ​ (578,763) ​ 19.93 ​ Non-vested at December 31, 2024 564,901 ​ $ 29.38 ​ 6,100,651 ​ $ 13.69 ​ (1) Total compensation cost to be recognized on the awards based on grant date fair value (2) PRSUs are shown as vesting in the year that the Compensation Committee determines the level of achievement of the applicable performance measures As of December 31, 2024, unrecognized compensation costs related to unvested awards to employees is as follows: ● $5.1 million on RSUs and PIUs expected to be recognized over a weighted average period of approximately 28 months . ● $1.4 million on RSUs and PIUs expected to be recognized over a weighted average period of approximately 12 months . ● $16.9 million on TSR PRSUs and PIUs expected to be recognized over a weighted average period of approximately 42 months . ● $20.6 million on Relative TSR PRSUs and PIUs expected to be recognized over a weighted average period of approximately 42 months . In addition, we have a deferred stock compensation plan that allows employees and directors the ability to defer the receipt of stock awards (units). The deferred stock awards (units) participate in future dividend equivalents as well as the change in the value of the Company’s common stock. As of December 31, 2024 and 2023, the Company had 667,986 and 653,842 deferred stock units outstanding. Tax Withholding for Stock Compensation Plans Stock withheld to pay tax withholdings for equity instruments granted under stock-based payment arrangements for the years ended December 31, 2024, 2023 and 2022, was $0.3 million, $0.6 million and $1.1 million, respectively. Shares Available for Issuance for Compensation Purposes On June 8, 2018, at the Annual Meeting of Stockholders, our stockholders approved the 2018 Stock Incentive Plan (the “2018 Plan”), which amended and restated the Company’s 2013 Stock Incentive Plan (the “2013 Plan”). The 2018 Plan is a comprehensive incentive compensation plan that allows for various types of equity-based compensation, including RSUs (including PRSUs), stock awards (including restricted stock), deferred RSUs, incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance unit awards, certain cash-based awards (including performance-based cash awards), PIUs and other stock-based awards. The 2018 Plan increased the number of shares of common stock available for issuance under the 2013 Plan by 4.5 million. On June 5, 2023, our stockholders approved an amendment to the 2018 Plan to increase the number of shares of common stock authorized for issuance from 10.5 million shares to 17.2 million shares, an increase of 6.7 million shares. As of December 31, 2024, approximately 3.8 million shares of common stock were reserved for issuance to our employees, directors and consultants under our stock incentive plans.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2024
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 20 – COMMITMENTS AND CONTINGENCIES Litigation Shareholder Litigation Settlement The Company and certain of its officers, C. Taylor Pickett, Robert O. Stephenson, and Daniel J. Booth Certain derivative actions were brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. In February 2024, formal stipulations of settlement incorporating the substantive terms of the memoranda of understanding and detailing the proposed settlements’ operational terms were submitted for court approval. The orders approving the formal stipulations of settlement became final and non-appealable in the second and third quarters of 2024, respectively, . The settlements are without any admission of the allegations in the complaints, which the defendants deny. Other Gulf Coast Subordinated Debt In August 2021, we filed suit in the Circuit Court for Baltimore County (the “Court”) against the holders of certain Subordinated Debt (the “Debt Holders”) associated with our Gulf Coast master lease agreement, following an assertion by the Debt Holders that our prior exercise of offset rights in connection with Gulf Coast’s non-payment of rent had resulted in defaults under the terms of the Subordinated Debt. The suit seeks a declaratory judgment to, among other items, declare that the aggregate amount of unpaid rent due from Gulf Coast under the master lease agreement exceeds all amounts which otherwise would be due and owing by an indirect subsidiary of Omega (“Omega Obligor”) under the Subordinated Debt, and that all principal and interest due and owing under the Subordinated Debt may be (and was) offset in full as of December 31, 2021. In October 2021, the Debt Holders filed a motion to dismiss for lack of personal jurisdiction. On November 3, 2022, the Court granted the Debt Holders’ motion to dismiss for lack of personal jurisdiction, and Omega filed a timely appeal of the ruling. While Omega believes Omega Obligor is entitled to the enforcement of the offset rights sought in the action, Omega cannot predict the outcome of the declaratory judgment action, irrespective of whether (a) it is ultimately litigated in the Court if Omega Obligor prevails in its appeal or (b) if the order granting the motion to dismiss for lack of personal jurisdiction is affirmed and the issues are litigated in the Delaware Court (as defined below). On or about January 19, 2023, the Debt Holders served a lawsuit against the Omega Obligor in the Superior Court of the State of Delaware (the “Delaware Court”), asserting claims for (i) breach of the instruments evidencing the Subordinated Debt, (ii) declaratory judgment, and (iii) unjust enrichment, all claims that are factually based on the claims that are the subject of Omega Obligor’s suit in the Court and that are now on appeal. On February 8, 2023, Omega Obligor filed a motion to dismiss or, in the alternative, to stay this action pending the outcome of the above-referenced lawsuit in Maryland. On July 10, 2023, the Delaware state court case stayed the proceeding pending further developments in the Maryland litigation. Omega believes that the claims are baseless and is evaluating procedural and substantive legal options in connection with this recently filed suit to the extent the stay is lifted. Other In addition to the matters above, we are subject to various other legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations. Indemnification Agreements In connection with certain facility transitions, we have agreed to indemnify certain operators in certain events. As of December 31, 2024, our maximum funding commitment under these indemnification agreements was approximately $11.4 million. Claims under these indemnification agreements generally may be made within 18 months to 72 months of the transition date. These indemnification agreements were provided to certain operators in connection with facility transitions and generally would be applicable if the prior operators do not perform under their transition agreements. Commitments We have committed to fund the construction of new leased and mortgaged facilities, capital improvements and other commitments. We expect the funding of these commitments to be completed over the next several years. Our remaining commitments at December 31, 2024, are outlined in the table below (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Lessor construction and capital commitments under lease agreements ​ $ 221,839 ​ ​ Non-real estate loan commitments ​ 65,709 ​ ​ Real estate loan commitments ​ 50,446 ​ ​ Total remaining commitments (1) ​ $ 337,994 ​ ​ (1) Includes finance costs . During the third quarter of 2024, we amended the existing master lease with Brookdale Senior Living Inc. (“Brookdale”) to extend the maturity date from December 2027 to December 2037. As part of the amendment, we agreed to provide up to $80.0 million in funding for capital expenditures on the facilities subject to the master lease (included in the table above). The annual rent under the lease will not be adjusted for fundings of capital expenditures in the aggregate amount of up to $30.0 million of the $80.0 million commitment. With respect to the remaining $50.0 million of the $80.0 million commitment, the annual rent under the lease will increase by the amount of each capital expenditure multiplied by 9.5%.

SUPPLEMENTAL DISCLOSURE TO CONS

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS	NOTE 21 – SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS The following are supplemental disclosures to the consolidated statements of cash flows for the years ended December 31, 2024, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ (in thousands) Reconciliation of cash and cash equivalents and restricted cash: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 518,340 $ 442,810 $ 297,103 Restricted cash ​ 30,395 ​ 1,920 ​ 3,541 Cash, cash equivalents and restricted cash at end of year ​ $ 548,735 ​ $ 444,730 ​ $ 300,644 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Supplemental information: ​ ​ ​ Interest paid during the year, net of amounts capitalized ​ $ 230,993 ​ $ 234,453 ​ $ 220,748 Taxes paid during the year ​ $ 8,414 ​ $ 3,615 ​ $ 5,793 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash investing activities ​ ​ ​ Non-cash acquisition of real estate (see Note 3) ​ $ (344,008) ​ $ — ​ $ (9,818) Non-cash proceeds from sale of business ​ $ — ​ $ — ​ $ 7,532 Non-cash investment in non-real estate loans receivables (See Note 3) ​ $ (1,632) ​ $ — ​ $ — Non-cash investment in other investments ​ $ — ​ $ — ​ $ (7,532) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash financing activities ​ ​ ​ ​ ​ ​ Assumption of debt (see Note 3 and Note 14) ​ $ 263,989 ​ $ — ​ $ — Non-cash contribution from noncontrolling member in consolidated joint venture ​ $ — ​ $ — ​ $ 2,903 Change in fair value of hedges ​ $ 13,737 ​ $ (21,649) ​ $ 88,460 Remeasurement of debt denominated in a foreign currency ​ $ (6,638) ​ $ 1,150 ​ $ (4,077) ​

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2024
Earnings per Share [Abstract]
EARNINGS PER SHARE	NOTE 22 - EARNINGS PER SHARE The following tables set forth the computation of basic and diluted earnings per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ ​ (in thousands, except per share amounts) Numerator: ​ ​ ​ Net income available to common stockholders – basic ​ $ 406,326 ​ $ 242,180 ​ $ 426,927 Add: net income attributable to OP Units ​ 12,060 ​ 7,077 ​ 11,914 Net income available to common stockholders – diluted ​ $ 418,386 ​ $ 249,257 ​ $ 438,841 Denominator: ​ ​ ​ Denominator for basic earnings per share ​ 258,118 ​ 240,493 ​ 236,256 Effect of dilutive securities: ​ ​ ​ Common stock equivalents ​ 4,664 ​ 2,923 ​ 1,198 Noncontrolling interest – Omega OP Units ​ 7,668 ​ 7,035 ​ 6,836 Denominator for diluted earnings per share ​ 270,450 ​ 250,451 ​ 244,290 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings per share – basic: ​ ​ ​ Net income available to common stockholders ​ $ 1.57 ​ $ 1.01 ​ $ 1.81 Earnings per share – diluted: ​ ​ ​ Net income available to common stockholders ​ $ 1.55 ​ $ 1.00 ​ $ 1.80 ​

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2024
SEGMENTS [Abstract]
SEGMENTS	NOTE 23 – SEGMENTS We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our CODM, our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. The reportable segment derives revenues from operators primarily through providing financing and capital to the long-term healthcare industry. Our core portfolio consists of long-term “triple net” leases and real estate loans with our operators. In addition to our core investments, we make loans to operators and/or their principals. From time to time, we also acquire equity interests in joint ventures or entities that support the long-term healthcare industry and our operators. Omega derives revenue primarily in the U.S. and manages the business activities on a consolidated basis. The accounting policies of the business segment are the same as those described in the summary of significant accounting policies. The CODM evaluates performance and makes resource and operating decisions for the business based on net income that is reported on the Consolidated Statements of Operations. The measure of segment assets is reported on the Consolidated Balance Sheets as total assets. The CODM uses net income to evaluate whether to make new investments, borrow or pay-off debt and/or issue or repurchase equity. The Company’s CODM periodically reviews interest expense and treats it as a significant segment expense. Interest expense is the largest recurring cash expense of the Company because debt is one of our primary sources of funds for new investments. Dependent on market conditions, our CODM seeks to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with long-term fixed rate borrowings to the extent possible. Additionally, the CODM also utilizes hedging instruments as discussed in Note 15 – Derivatives and Hedging, to help manage interest rate risk and limit significant fluctuations in interest expense for variable rate borrowings. Interest expense related to the Company’s reportable segment is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ (in thousands) Interest expense $ 211,319 ​ $ 221,832 ​ $ 220,296 Interest – amortization of deferred financing costs (1) 10,397 ​ 13,697 ​ 12,948 Interest expense – net $ 221,716 ​ $ 235,529 ​ $ 233,244 (1) Includes amortization of deferred financing costs, discounts and premiums.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 24 – SUBSEQUENT EVENTS Leadership Transition In January 2025, the Company and Daniel J. Booth, Chief Operating Officer, mutually agreed that Mr. Booth’s employment agreement with the Company would terminate effective January 2, 2025. The Company entered into a Transition Agreement and Release (the “Transition Agreement”) as of January 1, 2025 with Mr. Booth in connection with his departure and transitioning of his responsibilities. The Transition Agreement provides that Mr. Booth will be entitled to receive the payments and benefits due in connection with a termination of employment by the Company without cause pursuant to his Employment Agreement, as amended, dated effective January 1, 2024, provided that vesting of his previously granted equity incentives shall be prorated through January 1, 2026, and he shall be entitled to certain continued benefits under his supplemental life insurance policy. In addition, in connection with the Transition Agreement, Mr. Booth will be eligible to receive a transition payment of $2.0 million to be made in equal installments not less frequently than twice per month over the 24 month period commencing as of January 2, 2025. In addition, pursuant to a Consulting Agreement entered into between the Company and Mr. Booth as of January 3, 2025, Mr. Booth has agreed to perform such consulting and advisory services from January 3, 2025 through January 1, 2026 as the Company may require in connection with transitioning Mr. Booth’s responsibilities. We account for our stock-based awards in accordance with provisions of ASC 718, Compensation – 2025 New Investments In January 2025, we funded a $15.4 million mortgage loan to one operator. The loan bears interest at 11.0% and matures in June 2030. In January 2025, we acquired two facilities in Texas for consideration of $10.6 million and leased them to one new operator. The facilities have an initial annual cash yield of 9.9% with annual escalators of 2.0%.

SCHEDULE III - REAL ESTATE AND

SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2024
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
REAL ESTATE AND ACCUMULATED DEPRECIATION	SC HEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATI ON (in thousands) December 31, 2024 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Gross Amount at ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Initial Cost to ​ Cost Capitalized ​ Which Carried at ​ ​ ​ ​ ​ ​ ​ ​ Life on Which ​ ​ Company ​ Subsequent to ​ Close of Period (2) (4) ​ ​ ​ ​ ​ ​ ​ ​ Depreciation ​ ​ ​ ​ ​ ​ ​ ​ Acquisition ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (3) ​ ​ ​ (6) ​ in Latest ​ ​ ​ ​ ​ Buildings and ​ ​ ​ ​ Carrying ​ (5) ​ (7) ​ Buildings and ​ ​ ​ ​ Accumulated ​ Date of ​ Date ​ Income Statements Description (1) Encumbrances Land Improvements Improvements Cost Other Land Improvements Total Depreciation Construction Acquired is Computed Alabama (SNF) ​ $ 1,817 ​ $ 33,356 ​ $ 14,328 ​ $ — ​ $ — ​ $ 1,817 ​ $ 47,684 ​ $ 49,501 ​ $ (42,820) 1960 - 1982 1992 - 1997 31 years - 33 years Arizona (ALF, ILF, SNF) ​ 11,502 ​ 117,878 ​ 4,287 ​ — ​ — ​ 11,502 ​ 122,165 ​ 133,667 ​ (38,377) 1949 - 1999 2005 - 2021 25 years - 40 years Arkansas (ALF, SNF) 2,810 ​ 48,765 ​ 4,911 ​ — ​ (36) ​ 2,810 ​ 53,640 ​ 56,450 ​ (33,668) 1967 - 1988 1992 - 2014 25 years - 31 years California (ALF, SF, SNF) ​ 81,970 ​ 464,633 ​ 14,384 ​ — ​ (478) ​ 81,970 ​ 478,539 ​ 560,509 ​ (178,143) 1938 - 2013 1997 - 2021 5 years - 35 years Colorado (ILF, SNF) ​ 11,283 ​ 88,830 ​ 8,188 ​ — ​ (10) ​ 11,272 ​ 97,019 ​ 108,291 ​ (56,612) 1925 - 1975 1998 - 2016 20 years - 39 years Connecticut (ALF) ​ 25,063 ​ 252,417 ​ 11,253 ​ 1,320 ​ — ​ 25,063 ​ 264,990 ​ 290,053 ​ (84,581) 1968 - 2019 2010 - 2017 30 years - 33 years Florida (ALF, ILF, SNF) ​ 59,622 ​ 432,694 ​ 22,447 ​ 7 ​ (20,832) ​ 58,632 ​ 435,306 ​ 493,938 ​ (217,371) 1942 - 2018 1993 - 2021 2 years - 39 years Georgia (ALF, SNF) ​ 3,740 ​ 47,689 ​ 1,626 ​ — ​ — ​ 3,740 ​ 49,315 ​ 53,055 ​ (19,564) 1967 - 1997 1998 - 2016 30 years - 40 years Idaho (SNF) ​ 5,735 ​ 47,530 ​ 1,920 ​ — ​ (542) ​ 5,193 ​ 49,450 ​ 54,643 ​ (25,253) 1920 - 2008 ​ 1997 - 2014 ​ 25 years - 39 years Illinois (ALF) ​ 1,830 ​ 13,967 ​ 1,597 ​ — ​ — ​ 1,830 ​ 15,564 ​ 17,394 ​ (3,049) 1999 ​ 2021 ​ 25 years Indiana (ALF, ILF, SF, SNF) ​ 47,657 ​ 566,170 ​ 16,864 ​ — ​ (7,453) ​ 47,563 ​ 575,675 ​ 623,238 ​ (239,855) 1942 - 2015 1992 - 2020 20 years - 40 years Iowa (ALF, SNF) ​ 2,343 ​ 59,310 ​ 352 ​ — ​ (7,330) ​ 2,332 ​ 52,343 ​ 54,675 ​ (22,342) 1961 - 1998 2010 - 2014 23 years - 33 years Kansas (SNF) ​ 4,092 ​ 38,693 ​ 14,219 ​ — ​ — ​ 4,092 ​ 52,912 ​ 57,004 ​ (31,352) 1957 - 1977 2005 - 2011 25 years Kentucky (ALF, SNF) ​ 15,556 ​ 130,819 ​ 7,517 ​ — ​ — ​ 15,556 ​ 138,336 ​ 153,892 ​ (64,103) 1964 - 2002 1999 - 2016 20 years - 33 years Louisiana (ALF, SNF) ​ 6,692 ​ 121,675 ​ 4,877 ​ 448 ​ (1,495) ​ 6,692 ​ 125,505 ​ 132,197 ​ (35,891) 1951 - 2020 1997 - 2024 22 years - 39 years Maryland (SNF) ​ 17,526 ​ 131,741 ​ 14,723 ​ — ​ — ​ 17,526 ​ 146,464 ​ 163,990 ​ (47,590) 1921 - 2016 2008 - 2023 25 years - 30 years Massachusetts (ALF, SNF) ​ 23,621 ​ 143,172 ​ 24,378 ​ — ​ (693) ​ 23,621 ​ 166,857 ​ 190,478 ​ (76,938) 1964 - 2017 1997 - 2014 20 years - 33 years Michigan (SNF) ​ 1,915 ​ 45,585 ​ — ​ — ​ (15,925) ​ 1,635 ​ 29,940 ​ 31,575 ​ (879) 1950 - 1973 2011 - 2024 25 years Minnesota (ALF, ILF, SNF) ​ 10,502 ​ 52,585 ​ 5,972 ​ — ​ — ​ 10,502 ​ 58,557 ​ 69,059 ​ (26,338) 1966 - 1983 2014 33 years Mississippi (SNF) ​ 8,803 ​ 191,448 ​ 827 ​ — ​ — ​ 8,803 ​ 192,275 ​ 201,078 ​ (58,878) 1965 - 2008 2009 - 2019 20 years - 30 years Missouri (SNF) ​ 608 ​ 11,694 ​ — ​ — ​ (7,211) ​ 247 ​ 4,844 ​ 5,091 ​ (3,812) 1965 - 1989 1999 33 years Montana (SNF) ​ 1,319 ​ 11,698 ​ 432 ​ — ​ — ​ 1,319 ​ 12,130 ​ 13,449 ​ (4,604) 1963 - 1971 2005 33 years Nebraska (SNF) ​ ​ 750 ​ ​ 14,892 ​ ​ 108 ​ ​ — ​ ​ (1,050) ​ ​ 750 ​ ​ 13,950 ​ ​ 14,700 ​ ​ (6,197) ​ 1966 - 1969 ​ 2012 - 2015 ​ 20 years - 33 years Nevada (SNF, SF) ​ 8,811 ​ 92,797 ​ 8,350 ​ — ​ — ​ 8,811 ​ 101,147 ​ 109,958 ​ (42,022) 1972 - 2012 2009 - 2017 25 years - 33 years New Hampshire (ALF, SNF) ​ 1,782 ​ 19,837 ​ 1,463 ​ — ​ — ​ 1,782 ​ 21,300 ​ 23,082 ​ (12,990) 1963 - 1999 1998 - 2006 33 years - 39 years New Jersey (ALF) ​ 12,953 ​ 58,199 ​ 1,954 ​ 1,559 ​ — ​ 12,953 ​ 61,712 ​ 74,665 ​ (10,008) 1999 - 2021 ​ 2019 - 2021 ​ 25 years New Mexico (SNF) ​ ​ 6,008 ​ ​ 45,285 ​ ​ 1,318 ​ ​ — ​ ​ — ​ ​ 6,008 ​ ​ 46,603 ​ ​ 52,611 ​ ​ (17,174) ​ 1960 - 1985 2005 33 years New York (ALF) ​ ​ 118,606 ​ ​ 176,921 ​ ​ 3,658 ​ ​ 40,543 ​ ​ (5,900) ​ ​ 118,606 ​ ​ 215,222 ​ ​ 333,828 ​ ​ (42,050) ​ 2020 ​ 2015 ​ 25 years North Carolina (ALF, SNF) ​ ​ 29,063 ​ ​ 369,884 ​ ​ 12,040 ​ ​ 336 ​ ​ (902) ​ ​ 28,876 ​ ​ 381,545 ​ ​ 410,421 ​ ​ (132,982) ​ 1963 - 2019 1994 - 2024 25 years - 36 years Ohio (ALF, SNF, SF) ​ ​ 28,026 ​ ​ 332,613 ​ ​ 20,265 ​ ​ 345 ​ ​ (28,680) ​ ​ 27,776 ​ ​ 324,793 ​ ​ 352,569 ​ ​ (108,846) ​ 1929 - 2021 1994 - 2020 25 years - 39 years Oklahoma (SNF) ​ ​ 1,280 ​ ​ 11,190 ​ ​ 573 ​ ​ — ​ ​ — ​ ​ 1,280 ​ ​ 11,763 ​ ​ 13,043 ​ ​ (8,678) ​ 1965 - 1993 2010 20 years Oregon (ALF, ILF, SNF) ​ ​ 8,740 ​ ​ 128,799 ​ ​ 11,483 ​ ​ — ​ ​ — ​ ​ 8,740 ​ ​ 140,282 ​ ​ 149,022 ​ ​ (32,532) ​ 1959 - 2007 2005 - 2024 25 years - 33 years Pennsylvania (ALF, ILF, SNF) ​ ​ 26,876 ​ ​ 360,250 ​ ​ 19,421 ​ ​ — ​ ​ (18,321) ​ ​ 26,871 ​ ​ 361,355 ​ ​ 388,226 ​ ​ (140,943) ​ 1873 - 2012 2004 - 2022 20 years - 39 years Rhode Island (SNF) ​ ​ 3,299 ​ ​ 23,487 ​ ​ 3,805 ​ ​ — ​ ​ — ​ ​ 3,299 ​ ​ 27,292 ​ ​ 30,591 ​ ​ (17,345) ​ 1965 - 1981 2006 39 years South Carolina (SNF) ​ ​ 8,480 ​ ​ 76,912 ​ ​ 2,860 ​ ​ — ​ ​ — ​ ​ 8,480 ​ ​ 79,772 ​ ​ 88,252 ​ ​ (33,454) ​ 1959 - 2007 2014 - 2016 20 years - 33 years Tennessee (ALF, SNF, SF) ​ ​ 12,976 ​ ​ 268,846 ​ ​ 9,092 ​ ​ — ​ ​ — ​ ​ 12,976 ​ ​ 277,938 ​ ​ 290,914 ​ ​ (128,878) ​ 1968 - 2018 1992 - 2021 20 years - 31 years Texas (ALF, ILF, MOB, SNF, SF) ​ 75,922 ​ 798,209 ​ 44,579 ​ 197 ​ 7,106 ​ 78,495 ​ 847,518 ​ 926,013 ​ (304,280) 1949 - 2019 1997 - 2024 20 years - 40 years United Kingdom (ALF) ​ 267,973 ​ 1,028,908 ​ 19,471 ​ — ​ (71,967) ​ 255,544 ​ 988,841 ​ 1,244,385 ​ (133,272) 1650 - 2012 2015 - 2024 25 years - 30 years Vermont (SNF) ​ 318 ​ 6,005 ​ 602 ​ — ​ — ​ 318 ​ 6,607 ​ 6,925 ​ (3,756) 1971 2004 39 years Virginia (ALF, SNF) ​ ​ 35,653 ​ ​ 381,065 ​ ​ 11,997 ​ ​ 26 ​ ​ (579) ​ ​ 35,479 ​ ​ 392,683 ​ ​ 428,162 ​ ​ (118,058) ​ 1964 - 2017 2010 - 2023 25 years - 40 years Washington (ALF, SNF) ​ 14,565 ​ 184,114 ​ 6,770 ​ — ​ (23,664) ​ 12,912 ​ 168,873 ​ 181,785 ​ (50,094) 1951 - 2004 1999 - 2021 25 years - 33 years Washington DC (ALF) ​ 68,017 ​ — ​ 124,527 ​ 15,496 ​ — ​ 68,017 ​ 140,023 ​ 208,040 ​ — N/A ​ 2021 ​ N/A West Virginia (SNF) ​ 3,475 ​ 202,085 ​ 7,062 ​ — ​ — ​ 3,475 ​ 209,147 ​ 212,622 ​ (61,540) 1850 - 2016 1994 - 2024 25 years - 39 years Wisconsin (SNF) ​ 399 ​ 4,581 ​ 2,153 ​ — ​ — ​ 399 ​ 6,734 ​ 7,133 ​ (3,897) 1974 2005 33 years Total ​ $ 1,079,978 ​ $ 7,637,228 ​ $ 488,653 ​ $ 60,277 ​ $ (205,962) ​ $ 1,065,564 ​ $ 7,994,610 ​ $ 9,060,174 ​ $ (2,721,016) ​ (1) The real estate included in this schedule is being used in either the operation of skilled nursing facilities (“SNF”), assisted living facilities (“ALF”), independent living facilities (“ILF”), specialty facilities (“SF”) (consisting of specialty hospitals, long-term acute care hospitals, independent rehabilitation facilities, behavioral health substance facilities, behavioral health psychology facilities and traumatic brain injury facilities) or medical office buildings (“MOB”), located in the states or country indicated. SCHEDULE III – REAL ESTATE AND ACCUMULATED DEPRECIATION — continued (in thousands) December 31, 2024 (2) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 Balance at beginning of period ​ $ 8,372,419 ​ $ 8,860,264 ​ $ 9,028,745 Acquisitions (a) ​ 740,661 ​ 262,453 ​ 225,336 Impairment ​ (23,728) ​ (89,985) ​ (38,451) Improvements ​ 114,610 ​ 87,760 ​ 60,931 Disposals/other ​ (143,788) ​ (748,073) ​ (416,297) Balance at close of period ​ $ 9,060,174 ​ $ 8,372,419 ​ $ 8,860,264 ​ (a) Includes approximately $344.0 million and $8.2 million of non-cash consideration exchanged and/or valuation adjustments during the year ended December 31, 2024 and 2022 respectively. (3) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 Balance at beginning of period ​ $ 2,469,893 ​ $ 2,322,773 ​ $ 2,181,528 Provisions for depreciation ​ 302,088 ​ 317,536 ​ 331,963 Dispositions/other ​ (50,965) ​ (170,416) ​ (190,718) Balance at close of period ​ $ 2,721,016 ​ $ 2,469,893 ​ $ 2,322,773 ​ ​ (4) The reported amount of our real estate at December 31, 2024 is greater than the tax basis of the real estate by approximately $504.6 million (unaudited). (5) Reflects bed sales, impairments (including the write-off of accumulated depreciation), land easements and impacts from foreign currency exchange rates. (6) To the extent that we acquired an entity previously owning the underlying facility, the acquisition date reflects the date that the entity acquired the facility. (7) Includes $68.9 million of construction in progress related to land, all other amounts related to construction in progress are reflected in buildings and improvements.

SCHEDULE IV - MORTGAGE LOANS ON

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2024
Mortgage Loans On Real Estate [Abstract]
MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV – MORTGAGE LOANS ON REAL ESTATE (in thousands) December 31, 2024 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amount of ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Loans ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Face ​ ​ Carrying Subject to ​ ​ ​ ​ ​ ​ ​ ​ Final ​ ​ ​ ​ ​ Amount ​ ​ Amount Delinquent ​ ​ ​ ​ Interest ​ Fixed/ ​ Maturity ​ ​ ​ Prior ​ of ​ ​ of Principal Grouping Description (1) Rate Variable Date Periodic Payment Terms Liens Mortgages ​ Mortgages (3) (4) (6) or Interest ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ First Mortgages ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 1 Michigan (36 SNFs and 1 ALF) 11.44 % F (2) 2030 Interest plus approximately $108.2 of principal payable monthly with $417,336 due at maturity None ​ $ 606,325 ​ $ 451,516 ​ $ — ​ 2 Ohio (8 SNFs) 10.50 % F (2) 2037 Interest payable monthly until maturity None ​ 72,420 ​ 72,420 ​ — ​ 3 ​ Ohio (2 SNFs) ​ 12.00 % F ​ 2027 ​ Interest payable monthly until maturity ​ None ​ ​ 7,300 ​ ​ 7,300 ​ ​ — ​ 4 Illinois (2 ALFs, 1 SNF and 1 ILF) 10.00 % F 2028 Interest payable monthly until maturity None ​ 60,000 ​ 53,750 ​ — ​ 5 Pennsylvania (4 ALFs) 10.00 % F 2027 Interest payable monthly until maturity None ​ 38,626 ​ 36,404 ​ — ​ 6 Michigan (1 ALF) 10.00 % F 2027 Interest payable monthly until maturity None ​ 8,000 ​ 8,000 ​ — ​ 7 ​ Florida (1 ALF) ​ 10.00 % F ​ 2027 ​ Interest payable monthly until maturity ​ None ​ ​ 8,332 ​ ​ 8,332 ​ ​ — ​ 8 Tennessee (1 ALF) 8.00 % F 2025 Interest payable monthly until maturity None ​ 8,680 ​ 8,680 ​ — ​ 9 Oregon (1 ALF) 9.00 % F 2026 Interest payable monthly until maturity None ​ 5,000 ​ 5,000 ​ — ​ 10 Massachusetts (1 specialty facility) 9.00 % F 2023 Past due None ​ 9,000 ​ — ​ — (5) 11 Tennessee (1 SNF) 8.35 % F 2015 Past due None ​ 6,377 ​ 1,472 ​ 1,472 (5) 12 ​ Connecticut (1 SNF) ​ 10.00 % F ​ 2027 ​ Interest payable monthly until maturity ​ None ​ ​ 5,058 ​ ​ 5,058 ​ ​ ​ ​ 13 ​ Ohio (1 SNF) ​ 10.00 % F (2) ​ 2024 (7) ​ Interest payable monthly until maturity ​ None ​ ​ 21,325 ​ ​ 21,325 ​ ​ — ​ 14 ​ Georgia (2 ALFs) ​ 10.00 % F ​ 2029 ​ Interest payable monthly until maturity ​ None ​ ​ 9,551 ​ ​ 9,551 ​ ​ — ​ 15 ​ Georgia (2 SNFs, 1 ALF), Florida (1 SNF) ​ 10.00 % F ​ 2027 ​ Interest payable monthly until maturity ​ None ​ ​ 29,700 ​ ​ 29,700 ​ ​ — ​ 16 ​ United Kingdom (1 ALF ) ​ 11.00 % F ​ 2025 ​ Interest payable monthly until maturity ​ None ​ ​ 10,081 ​ ​ 10,081 ​ ​ — ​ 17 ​ United Kingdom (15 ALFs) ​ 11.00 % F ​ 2025 ​ Interest payable monthly until maturity ​ None ​ ​ 39,069 ​ ​ 39,069 ​ ​ — ​ 18 ​ United Kingdom (11 ALFs) ​ 11.00 % F ​ 2025 ​ Interest payable monthly until maturity ​ None ​ ​ 61,742 ​ ​ 61,742 ​ ​ — ​ 19 ​ Florida (1 ALF) ​ 10.00 % F ​ 2027 ​ Interest payable monthly until maturity ​ None ​ ​ 11,891 ​ ​ 11,890 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Capital Expenditure Mortgages ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 20 ​ Ohio ​ 10.00 % F (2) ​ 2037 ​ Interest plus approximately $16.2 of principal payable monthly with $979 due at maturity ​ None ​ ​ 7,200 ​ ​ 5,231 ​ ​ — ​ 21 Michigan 10.25 % F (2) 2030 Interest payable monthly until maturity None ​ 560 ​ 263 ​ — ​ 22 ​ Michigan ​ 10.00 % F (2) ​ 2030 ​ No interest due on the first $300 , then interest payable monthly until maturity ​ None ​ ​ 500 ​ ​ 227 ​ ​ — ​ 23 ​ Michigan ​ 11.62 % F (2) ​ 2030 ​ Interest plus approximately $6.4 of principal payable monthly with $51,644 due at maturity ​ None ​ ​ 54,223 ​ ​ 52,200 ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Construction Mortgages ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 24 United Kingdom (1 ALF) 10.00 % F 2025 Interest payable monthly until maturity None ​ 18,446 ​ 18,446 ​ — ​ 25 United Kingdom (1 ALF) 10.00 % F 2025 Interest payable monthly until maturity None ​ 53,220 ​ 53,220 ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allowance for credit loss on mortgage loans (8) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (28,112) ​ ​ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ $ 1,152,626 ​ $ 942,765 ​ $ 1,472 ​ (1) Loans included in this schedule represent first mortgages, capital expenditure mortgages and construction mortgages on facilities used in the delivery of long-term healthcare of which such facilities are located in the states indicated. (2) Interest on the loans escalates at a fixed rate. (3) The aggregate cost for federal income tax purposes is approximately $982.3 million (unaudited). ​ ​ SCHEDULE IV – MORTGAGE LOANS ON REAL ESTATE — continued (in thousands) December 31, 2024 (4) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 Balance at beginning of period ​ $ 698,776 ​ $ 648,130 ​ $ 835,086 Additions during period - new mortgage loans or additional fundings (a) ​ 292,722 ​ 102,332 ​ 12,977 Deductions during period - collection of principal/other (b) ​ (63,876) ​ (79,418) ​ (190,141) Allowance for credit loss on mortgage loans ​ 15,143 ​ 27,732 ​ (9,792) Balance at close of period ​ $ 942,765 ​ $ 698,776 ​ $ 648,130 (a) The 2024, 2023 and 2022 amounts include $1.5 million, $2.3 million and $1.2 million, respectively, of non-cash interest paid-in-kind. The 2024 amount also includes $7.3 million of non-cash placement of mortgage capital. (b) The 2023 and 2022 amounts include $3.9 million and $6.0 million, respectively, of interest payments that were directly applied against the principal balance outstanding using the cost recovery method. The 2023 amounts also include $37.0 million of non-cash principal reductions. ​ (5) Mortgage written down to the fair value of the underlying collateral. (6) Mortgages included in the schedule which were extended during 2024 aggregated approximately $112.0 million. (7) Subsequent to year end, this mortgage note was amended to extend the maturity date to December 31, 2025. (8) The allowance for credit loss on mortgage loans represents the allowance calculated utilizing a PD and LGD methodology. For mortgages that the risk of loss was evaluated on an individual basis, the allowance is included as a reduction to the carrying amount of the mortgage. ​ ​

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non Rule 10b5-1 Arrangement Modified	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Risk Management and Strategy Technical Safeguards As part Risk Assessment Our Cybersecurity Program also includes an annual risk assessment which is generally based on frameworks established by the National Institute of Standards and Technology (“NIST”). Third-Party Risk Management We also maintain policies and procedures use Incident Response and Recovery Planning We maintain an Information Security Incident Response Plan (the “Response Plan”) governing prevention, detection, mitigation and remediation of cybersecurity incidents and threats. The Response Plan includes controls and procedures that provide for the prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by management in a timely manner, with appropriate involvement by our Board. We regularly test the effectiveness of the Response Plan. External Assessments We obtain periodic assessments by third party experts to assess our vulnerability management and security controls and to assist us in identifying and mitigating security risks. Education and Awareness We provide cybersecurity training for all directors, officers and employees and periodic additional training of senior management through our cyber insurance carrier. As of the date of this report, we are not aware We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology, including related to artificial intelligence, could harm our business. Privacy and security laws and regulations may also increase costs for our business.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Our Cybersecurity Program also includes an annual risk assessment which is generally based on frameworks established by the National Institute of Standards and Technology (“NIST”).
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Our Board and management exercise oversight over the Company’s cybersecurity program, which represents an important component of the Company’s overall approach to enterprise risk management.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Omega’s Vice President of Information Technology (“ VP of IT
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The VP of IT reports directly
Cybersecurity Risk Role of Management [Text Block]	Vice President of Information Technology (“ VP of IT
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Vice President of Information Technology (“ VP of IT
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	The VP of IT has served in various roles in information technology and information security for over 30 years and, along with other members of the IT department, holds relevant and applicable certifications.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	The Board and Audit Committee receive periodic reports about the prevention, detection, mitigation and remediation of cybersecurity incidents, including material security risks and information security vulnerabilities. Additionally, risks associated with the Cybersecurity Program are integrated into the Company’s enterprise risk management assessment and reported to our Board at least twice per year. We also share the key results of third-party assessments with our Board and Audit Committee.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2024
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Accounting Estimates	Accounting Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Consolidation	Consolidation The consolidated financial statements include the accounts of Omega Healthcare Investors, Inc, its wholly-owned subsidiaries, joint venture (“JVs”) and variable interest entities (“VIEs”) that it controls, through voting rights or other means. All intercompany transactions and balances have been eliminated in consolidation. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise, if any, is the primary beneficiary of VIEs. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. We may change our original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affects the characteristics or adequacy of the entity’s equity investments at risk and the disposition of all or a portion of an interest held by the primary beneficiary. Our variable interests in VIEs may be in the form of equity ownership, leases and/or loans with our operators. We analyze our agreements and investments to determine whether our operators or unconsolidated joint ventures are VIEs and, if so, whether we are the primary beneficiary. We consolidate a VIE when we determine that we are its primary beneficiary. We identify the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Factors considered in determining whether we are the primary beneficiary of an entity include: (i) our voting rights, if any; (ii) our involvement in day-to-day capital and operating decisions; (iii) our risk and reward sharing; (iv) the financial condition of the operator or joint venture and (iv) our representation on the VIE’s board of directors. We perform this analysis on an ongoing basis. As of December 31, 2024 and 2023, we have one joint venture that is a consolidated VIE as we have concluded that we are the primary beneficiary through our equity investment in the entity.
Revenue Recognition	Revenue Recognition Rental Income Rental income from operating leases is recognized on a straight-line basis, inclusive of fixed annual escalators, over the lease term when we have determined that the collectibility of substantially all of the lease payments is probable. Certain of our operating leases contain provisions for an increase based on the change in pre-determined formulas from year to year (e.g., increases in the Consumer Price Index). We do not include in our measurement of our lease receivables these variable increases until the specific events that trigger the variable payments have occurred. Certain payments made to operators are treated as lease inducements and are amortized as a reduction of revenue over the lease term. Our leased real estate properties are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years. Some of our leases have options to extend, terminate or purchase the facilities, which are considered when determining the lease term. We assess the probability of collecting substantially all payments due under our leases on several factors, including, among other things, payment history, the financial strength of the lessee and any guarantors, as applicable, historical operations and operating trends, current and future economic conditions, and expectations of performance (which includes known substantial doubt about an operator’s ability to continue as a going concern). If our evaluation of these factors indicates it is not probable that we will be able to collect substantially all rents, we recognize a charge to rental income to write off straight-line rent receivables, contractual receivables and lease inducements and limit our rental income to the lesser of lease income on a straight-line basis plus variable rents when they become accruable or cash collected. Provisions for uncollectible lease payments are recognized as a direct reduction to rental income. If we change our conclusion regarding the probability of collecting rent payments required by a lessee, we may recognize an adjustment to rental income in the period we make a change to our prior conclusion, potentially resulting in increased volatility of rental income. Under the terms of our leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties. Certain of our operating leases require the operators to reimburse us for property taxes and other expenditures that are not considered components of the lease and therefore no consideration is allocated to them as they do not result in the transfer of a good or service to the operators. We have determined that all of our leases qualify for the practical expedient, under Accounting Standards Codification (“ASC”) 842, Leases (“Topic 842”), to not separate the lease and non-lease components because (i) the lease components are operating leases and (ii) the timing and pattern of recognition of the non-lease components are the same as the lease components. Certain operators are obligated to pay directly their obligations under their leases for real estate taxes, insurance and certain other expenses. These obligations, which have been assumed by the tenants under the terms of their respective leases, are not reflected in our consolidated financial statements. To the extent any tenant responsible for these obligations under their respective lease defaults on its lease or if it is deemed probable that the tenant will fail to pay for such costs, we would record a liability for such obligation. We have elected to exclude sales and other similar taxes from the measurement of lease revenue and expense. Loan Interest Income Interest income is recognized as earned over the term of the related real estate and non-real estate loans receivable. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method. In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms. Direct Financing Lease Income As of December 31, 2024 and 2023, we have one lease for a facility that is classified as a direct financing lease. For leases accounted for as direct financing leases, we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record interest income based on the contractual terms of the lease agreement. Costs related to originating direct financing leases are deferred and amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases. Income from direct financing leases is included within rental income on the Consolidated Statements of Operations. Real Estate Sales We recognize gains on the disposition of real estate when the recognition criteria have been met, generally at the time the risks and rewards and title have transferred, and we no longer have substantial continuing involvement with the real estate sold. Gains on the sale of real estate are recognized pursuant to provisions under Accounting Standards Codification (“ASC”) 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets. Under ASC 610-20, we determine whether the transaction is a sale to a customer or non-customer. As a REIT, we do not sell real estate within the ordinary course of our business and therefore, expect that our sale transactions will not be contracts with customers. ASC 610-20 refers to the revenue recognition principles under ASC 606, Revenue from Contracts with Customers. Under ASC 610-20, if we determine we do not have a controlling financial interest in the entity that holds the asset and the arrangement meets the criteria to be accounted for as a contract, we will dispose of the asset and recognize a gain or loss on the sale of the real estate when control of the underlying asset transfers to the buyer. If we determine a sale has not occurred under ASC 610-20, we continue to record the asset on the Consolidated Balance Sheets and related depreciation expense on the Consolidated Statements of Operations.
Fair Value Measurement	Fair Value Measurement The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: ● Level 1 - quoted prices for identical instruments in active markets; ● Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and ● Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies such items in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, these items could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Monte Carlo valuation models.
Real Estate Acquisitions	Real Estate Acquisitions Upon acquisition of real estate properties, we evaluate the acquisition to determine if it is a business combination or an asset acquisition. Our real estate acquisitions are generally accounted for as asset acquisitions as substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the acquisition is determined to be an asset acquisition, the Company records the purchase price and other related costs incurred to the acquired tangible assets and identified intangible assets and liabilities on a relative fair value basis. In addition, costs incurred for asset acquisitions, including transaction costs, are capitalized. If the acquisition is determined to be a business combination, we record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at fair value. Goodwill is measured as the excess of the fair value of the consideration transferred over the fair value of the identifiable net assets. Transaction costs are expensed as incurred as part of a business combination. In making estimates of fair value for purposes of recording asset acquisitions and business combinations, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. The Company determines the fair value of acquired assets and liabilities as follows: ● Land is determined based on third-party appraisals which typically include market comparables. ● Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenues and costs and consider capitalization and discount rates using current market conditions as well as the residual approach. ● Furniture and fixtures are determined based on third-party appraisals which typically utilize a replacement cost approach. ● Real estate loans and non-real estate loans are valued using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings. ● Investments in joint ventures are valued based on the fair value of the joint ventures’ assets and liabilities. Differences, if any, between the Company’s basis and the joint venture’s basis are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings (losses) of the joint venture. ● Intangible assets and liabilities acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset or liability being acquired. When evaluating below market leases we consider extension options controlled by the lessee in our evaluation. ● Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition. ● Assumed debt balances are valued by discounting the remaining contractual cash flows using a current market rate of interest. ● Noncontrolling interests are valued using a stock price, if available, or by other methods to estimate the fair value on the acquisition date.
Real Estate Properties	Real Estate Properties Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $7.3 million, $4.3 million and $3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings, eight three Management evaluates our real estate properties for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance including the current payment status of contractual obligations and expectations of the ability to meet future contractual obligations, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to management’s estimate of future undiscounted cash flows of the underlying facilities. The estimated future undiscounted cash flows are generally based on the related lease which relates to one or more properties and may include cash flows from the eventual disposition of the asset. In some instances, there may be various potential outcomes for a real estate investment and its potential future cash flows. In these instances, the undiscounted future cash flows used to assess the recoverability of the assets are probability-weighted based on management’s best estimates as of the date of evaluation. Impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined based on current market conditions and considers matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. Additionally, our evaluation of fair value may consider valuing the property as a nursing home or other healthcare facility as well as alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property as well as the fair value of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment to our assets in a future period that could be material to our results of operations.
Assets Held for Sale	Assets Held for Sale We consider properties to be assets held for sale when (1) management commits to a plan to sell the property; (2) it is unlikely that the disposal plan will be significantly modified or discontinued; (3) the property is available for immediate sale in its present condition; (4) actions required to complete the sale of the property have been initiated; (5) sale of the property is probable and we expect the completed sale will occur within one year; and (6) the property is actively being marketed for sale at a price that is reasonable given our estimate of current market value. Upon designation of a property as an asset held for sale, we record the property’s value at the lower of its carrying value or its estimated fair value, less estimated costs to sell, and we cease depreciation.
Lessee Accounting	Lessee Accounting Omega leases real estate (corporate headquarters and certain other facilities), office equipment and is party to certain ground leases on our owned facilities. We determine if an arrangement is or contains a lease at inception. Leases are classified as either finance or operating at inception of the lease. Short-term leases, defined as leases with an initial term of 12 months or less that do not contain a purchase option, are not recorded on the balance sheet. Lease expense for short-term leases is recognized on a straight-line basis over the lease term. As of December 31, 2024 and 2023, all of the leases where we are the lessee were classified as operating leases. We have leases that contain both lease and non-lease components and have elected, as an accounting policy, to not separate lease components and non-lease components. Operating and finance lease right-of-use ("ROU") assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Our ROU assets and lease liabilities are included in other assets and accrued expenses and other liabilities, respectively, on our Consolidated Balance Sheets. The lease liability is calculated as the present value of the remaining minimum rental payments for existing leases using either the rate implicit in the lease or, if none exists, the Company's incremental borrowing rate, as the discount rate. Certain leases have options to extend, terminate or purchase the asset and have been considered in our analysis of the lease term and the measurement of the ROU assets and lease liabilities. On a quarterly basis, we record our lease liabilities at the present value of the future lease payments using the discount rate determined at lease commencement. Rental expense from operating leases is generally recognized on a straight-line basis over the lease term. Lease expense derived from our operating leases is recorded in general and administrative in our Consolidated Statements of Operations. We do not include in our measurement of our lease liability certain variable payments, including changes in an index until the specific events that trigger the variable payments have occurred. We record on a straight-line basis rental income and ground lease expense for those assets we lease and are reimbursed by our operators and/or are paid for directly by our operators.
In-Place Leases	In-Place Leases In-place lease assets and liabilities result when we assume a lease as part of an asset acquisition or business combination. The fair value of in-place leases consists of the following components, as applicable (1) the estimated cost to replace the leases and (2) the above or below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases. Above market leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Operations as an adjustment to rental income over the estimated remaining term of the underlying leases. Should a tenant terminate the lease, the unamortized portion of the lease intangible is recognized immediately as an adjustment to rental income.
Allowance for Credit Losses	Allowance for Credit Losses The allowance for credit losses reflects our current estimate of the potential credit losses on our real estate loans, non-real estate loans, and our investment in direct financing leases and is recorded as a valuation account as a direct offset against these financial instruments on our Consolidated Balance Sheets. Expected credit losses inherent in non-cancelable unfunded loan commitments are accounted for as separate liabilities included in accrued expenses and other liabilities on the Consolidated Balance Sheets. The Company has elected to not measure an allowance for credit losses on accrued interest receivables related to all of its real estate loans and non-real estate loans because we write off uncollectible accrued interest receivable in a timely manner pursuant to our non-accrual policy, described below. Changes to the allowance for credit losses on loans resulting from quarterly evaluations are recorded through provision for credit losses on the Consolidated Statements of Operations. We assess the creditworthiness of our borrowers on a quarterly basis. For purposes of determining our allowance for credit loss, we pool financial assets that have similar risk characteristics. We aggregate our financial assets by financial instrument type (i.e. real estate loan, non-real estate loan, etc.) and by our internal risk rating. Our internal credit ratings consider several factors including the collateral and/or security, the performance of borrowers underlying facilities, if applicable, available credit support (e.g., guarantees), borrowings with third parties, and other ancillary business ventures and real estate operations of the borrower. Our internal ratings range between 1 and 7. An internal rating of 1 reflects the lowest likelihood of loss and a 7 reflects the highest likelihood of loss. The characteristics associated with each risk rating is as follows: ● Risk Rating 1 through 3 – Instruments with minimal to marginally acceptable risk. ● Risk Rating 4 - Instruments with potential weaknesses identified (Special mention). ● Risk Rating 5 - Instruments with well-defined weaknesses that may result in possible losses (Substandard). ● Risk Rating 6 – Instruments that are unlikely to be repaid in full and will probably result in losses (Doubtful). ● Risk Rating 7 – Instrument that will not be repaid in full and losses will occur (Loss). Periodically, the Company may identify an individual loan for impairment. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreements. Our assessment of collectibility considers several factors, including, among other things, payment history, the financial strength of the borrower and any guarantors, historical operations and operating trends, current and future economic conditions, expectations of performance (which includes known substantial doubt about an operator’s ability to continue as a going concern) and the fair value of the underlying collateral of the agreement, a Level 3 measurement, if any. Consistent with this definition, all loans on non-accrual status may be deemed impaired. To the extent circumstances improve and the risk of collectibility is diminished, we will return these loans to full accrual status. When we identify a loan impairment, the loan is written down to the present value of the expected future cash flows or to the fair value of the underlying collateral. Financial instruments are charged off against the allowance for credit losses when collectibility is determined to be permanently impaired. We account for impaired loans using (a) the cost-recovery method, and/or (b) the cash basis method. We generally utilize the cost-recovery method for impaired loans for which impairment reserves were recorded. Under the cost-recovery method, we apply cash received against the outstanding loan balance prior to recording interest income. Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement.
Investments in Unconsolidated Joint Ventures	Investments in Unconsolidated Joint Ventures We account for our investments in unconsolidated joint ventures using the equity method of accounting as we exercise significant influence, but do not control the entities. Under the equity method of accounting, the net equity investments of the Company are reflected in the accompanying Consolidated Balance Sheets and the Company’s share of net income and comprehensive income from the joint ventures are included in the accompanying Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income, respectively. On a periodic basis, management assesses whether there are any indicators that the value of the Company’s investments in the unconsolidated joint ventures may be other-than-temporarily-impaired. An investment is impaired only if management’s estimate of the value of the investment is less than the carrying value of the investment, and such a decline in value is deemed to be other than-temporary. To the extent impairment has occurred, the loss is measured as the excess of the carrying amount of the investment over the estimated fair value of the investment. The estimated fair value of the investment is determined using a discounted cash flow model which is a Level 3 valuation. We consider a number of assumptions that are subject to economic and market uncertainties including, among others, rental rates, operating costs, capitalization rates, holding periods and discount rates.
In Substance Real Estate Investments	In Substance Real Estate Investments We provide loans to third parties for the acquisition, development and construction of real estate. Under these arrangements, it is possible that we will participate in the expected residual profits of the project through the sale, refinancing or acquisition of the property. We evaluate the characteristics of each arrangement, including its risks and rewards, to determine whether they are more similar to those associated with a loan or an investment in real estate. Arrangements with characteristics implying loan classification are presented as real estate loans receivable and result in the recognition of interest income. Arrangements with characteristics implying real estate joint ventures are treated as in substance real estate investments and presented as investments in unconsolidated joint ventures and are accounted for using the equity method. The classification of each arrangement as either a real estate loan receivable or investment in unconsolidated joint venture involves judgment and relies on various factors, including market conditions, amount and timing of expected residual profits, credit enhancements in the form of guarantees, estimated fair value of the collateral, and significance of borrower equity in the project, among others. The classification of such arrangements is performed at inception, and periodically reassessed when significant changes occur in the circumstances or conditions described above.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased. The majority of our cash, cash equivalents and restricted cash are held at major commercial banks. Certain cash account balances exceed FDIC insurance limits of $250,000 per account and, as a result, there is a concentration of credit risk related to amounts in excess of the insurance limits.
Restricted Cash	Restricted Cash Restricted cash consists primarily of liquidity deposits escrowed for tenant obligations required by us pursuant to certain contractual terms and other deposits required by our lenders in connection with financing arrangements.
Deposits	Deposits We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three The liquidity deposits and other deposits, security deposits and the letters of credit may be used in the event of lease and/or loan defaults, subject to applicable limitations under bankruptcy law with respect to operators filing under Chapter 11 of the U.S. Bankruptcy Code. Liquidity deposits and other deposits are recorded as restricted cash on our Consolidated Balance Sheets with the offset recorded as a liability in accrued expenses and other liabilities on our Consolidated Balance Sheets. Security deposits related to cash received from the operators are primarily recorded in cash and cash equivalents on our Consolidated Balance Sheets with a corresponding offset in accrued expenses and other liabilities on our Consolidated Balance Sheets. Additional security for rental and loan interest revenue from operators is provided by covenants regarding minimum working capital and net worth, liens on accounts receivable and other operating assets of the operators, provisions for cross-default, provisions for cross-collateralization and by corporate or personal guarantees.
Goodwill	Goodwill We test goodwill for potential impairment at least annually in the fourth quarter, or more frequently if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. An impairment loss is recognized to the extent that the carrying amount, including goodwill, exceeds the reporting unit’s fair value. Goodwill is not deductible for tax purposes. We have had no goodwill impairment charges for the last three fiscal years.
Income Taxes	Income Taxes Omega and its wholly-owned subsidiaries were organized to qualify for taxation as a REIT under Section 856 through 860 of the Internal Revenue Code (“Code”). As long as we qualify as a REIT, we will not be subject to federal income taxes on the REIT taxable income that we distributed to stockholders, subject to certain exceptions. However, with respect to certain of our subsidiaries that have elected to be treated as taxable REIT subsidiaries (“TRSs”), we record income tax expense or benefit, as those entities are subject to federal income tax similar to regular corporations. Omega OP is a pass-through entity for U.S. federal income tax purposes. We account for deferred income taxes using the asset and liability method and recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our financial statements or tax returns. Under this method, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes us to change our judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carry-forwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. We are subject to certain state and local income tax, franchise taxes and foreign taxes. The expense associated with these taxes are included in income tax expense on the Consolidated Statements of Operations.
Stock-Based Compensation	Stock-Based Compensation We recognize stock-based compensation expense to employees and directors, in general and administrative in our Consolidated Statements of Operations on a straight-line basis over the vesting period. Forfeitures of share-based awards are recognized as they occur.
Deferred Financing Costs, Discounts and Premiums	Deferred Financing Costs, Discounts and Premiums External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $10.4 million, $13.7 million and $12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations.
Earnings Per Share	Earnings Per Share The computation of basic earnings per share/unit (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period. Diluted EPS is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period. Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including restricted stock and profit interest units, performance restricted stock and profit interest units, the assumed issuance of additional shares related to Omega OP Units held by outside investors.
Noncontrolling Interests and Redeemable Limited Partnership Unitholder Interests	Noncontrolling Interests and Redeemable Limited Partnership Unitholder Interests Noncontrolling interests is the portion of equity not attributable to the respective reporting entity. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders’ equity on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Operations. As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest. The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one-for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97% of the issued and outstanding Omega OP Units, and investors own approximately 3% of the outstanding Omega OP Units.
Foreign Operations	Foreign Operations The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $93.6 million, $56.8 million and $47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $1.1 billion and $539.6 million as of December 31, 2024 and 2023, respectively. For our consolidated subsidiaries whose functional currency is not the USD, we translate their financial statements into the USD. We translate the balance sheet accounts at the exchange rate in effect as of the financial statement date. The income statement accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive income (loss) (“AOCI”), as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interests, if applicable. We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity’s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations within other income (expense) - net, unless it is intercompany debt that is deemed to be long-term in nature in which case the adjustments are included in AOCI and a proportionate amount of gain or loss is allocated to noncontrolling interests, if applicable.
Derivative Instruments	Derivative Instruments We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our investments in the U.K. and interest rate risk related to our capital structure. As a matter of policy, we do not use derivatives for trading or speculative purposes. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, interest rate swaps, interest rate caps and debt issued in foreign currencies to offset a portion of these risks. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized liabilities or assets on the Consolidated Balance Sheets. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities on the Consolidated Balance Sheets at fair value which is determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in the Consolidated Statements of Operations. For derivatives designated in qualifying cash flow hedging relationships, the gain or loss on the derivative is recognized in AOCI as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, if applicable. If it is determined that a derivative instrument ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, the Company discontinues its cash flow hedge accounting prospectively and records the appropriate adjustment to earnings based on the current fair value of the derivative instrument. For net investment hedge accounting, upon sale or liquidation of our U.K. investment, the cumulative balance of the remeasurement value is reclassified to the Consolidated Statements of Operations.
Reclassification	Reclassifications Certain amounts in the prior year period have been reclassified to conform to the current period presentation. Income from direct financing leases, which was previously reported separately on our Consolidated Statements of Operations, is now included in rental income for all periods presented. In addition, we previously reported assets held for sale of $93.7 million on the Consolidated Balance Sheet as of December 31, 2023. In the first quarter of 2024 and the fourth quarter of 2024, it was determined that $12.2 million and $14.4 million, respectively, of these assets no longer qualified as held for sale and were reclassified to assets held for use within the applicable line items in real estate assets – net on the Consolidated Balance Sheet as of December 31, 2023. Of the $26.6 million reclassified net of $11.1 million of accumulated depreciation, $30.9 million relates to buildings, $3.4 million relates to land and $3.4 million relates to furniture and equipment.
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU – 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, which requires disclosure of certain costs and expenses on an interim and annual basis in the notes to the financial statements. The guidance is effective for the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The amendments in this update are to be applied on a prospective basis, with the option for retrospective application. Early adoption is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and disclosures. ASU – 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, ASU – 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures In November 2023, the FASB issued ASU 2023-07, which is intended to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses, as well as how the Chief Operating Decision Maker (CODM) uses the reported measure(s) of segment profit or loss in assessing performance. We have adopted the guidance in the fourth quarter of 2024 and have included the required disclosures for all periods presented within Note 23 – Segments. The adoption of the new guidance and related codification improvements did not have a material impact to the Company’s financial position, results of operations and cash flows. ASU – 2020-04, Financial Instruments – Reference Rate Reform (Topic 848) On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extended the practical expedients under ASU 2020-04 to December 31, 2024. The Company had several derivative instruments that referenced LIBOR which were terminated during the second quarter of 2023 (see Note 15 – Derivatives and Hedging). The Company also had a $1.45 billion senior unsecured multicurrency revolving credit facility and a $50.0 million senior unsecured term loan facility (see Note 14 – Borrowing Activities and Arrangements) that referenced LIBOR. During the second quarter of 2023, the Company amended its $1.45 billion senior unsecured multicurrency revolving credit facility and $50.0 million senior unsecured term loan facility to adjust the interest on each loan from a LIBOR based interest rate to a Secured Overnight Financing Rate (“SOFR”) based interest rate. For both loans we have elected to apply the optional expedient pursuant to Topic 848. As such we will account for the amendments as if the modifications were not substantial and thus a continuation of the existing contract resulting in no change to the current loan carrying values or the related deferred financing costs.

REAL ESTATE ASSET ACQUISITION_2

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT (Tables)	12 Months Ended
	Dec. 31, 2024
REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT [Abstract]
Summary of asset acquisitions	The following table summarizes the significant asset acquisitions that occurred in 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ Cash Yield (1) ​ Q1 ​ 1 — WV ​ $ 8.1 ​ 10.0 % Q1 ​ — 1 ​ U.K. ​ ​ 5.2 ​ 9.5 % Q2 ​ 1 — ​ MI ​ ​ 31.0 ​ 11.5 % Q2 ​ — 32 ​ U.K. ​ ​ 50.8 (2) 10.0 % Q2 ​ 1 — ​ LA ​ ​ 21.0 ​ 10.0 % Q3 ​ — 63 ​ U.K. ​ ​ 421.0 (3) 9.9 % (4) Q3 ​ — 1 ​ U.K. ​ ​ 5.1 ​ 10.0 % Q3 ​ 1 — ​ NC ​ ​ 8.8 ​ 10.0 % Q3 ​ — 1 ​ U.K. ​ ​ 10.8 ​ 10.0 % Q4 ​ — 3 ​ U.K. ​ ​ 39.7 ​ 10.0 % Q4 ​ — 1 ​ OR ​ ​ 8.0 ​ 10.0 % Q4 ​ 2 — ​ TX ​ ​ 19.5 ​ 10.0 % Q4 ​ — 6 ​ U.K. ​ ​ 111.5 ​ 10.0 % Total 6 108 ​ ​ $ 740.5 ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) Total consideration paid for this acquisition was $62.7 million. We allocated $11.9 million of the purchase consideration to a deferred tax asset related to net operating losses acquired in the transaction. See Note 17 - Taxes for additional information. (3) Relates to our acquisition of the remaining 51% ownership interest in the Cindat Joint Venture, discussed below under “Cindat Portfolio Acquisition.” Total costs to be allocated for this acquisition was $461.9 million, inclusive of our previously held equity interest of $97.0 million. We allocated $53.8 million of the costs to be allocated to other assets acquired in the transaction and we allocated $13.0 million of the costs to be allocated to other liabilities assumed in the transaction. (4) Reflects the yield based on cash consideration, the assumption of a mortgage loan, deferred contingent consideration and the previously held equity interest in the unconsolidated real estate joint venture. See “Cindat Portfolio Acquisition” below for additional information. The following table summarizes the assets and liabilities recorded as part of the acquisition as of the date of the acquisition: ​ ​ ​ ​ ​ ​ (in thousands) Costs to be allocated: ​ ​ ​ ​ $ 96,971 Consideration for additional ​ ​ 100,921 Fair market value of debt assumed ​ ​ 263,990 Total acquisition cost to be allocated ​ $ 461,882 ​ ​ ​ ​ Net assets acquired: ​ ​ ​ Real estate assets ​ $ 421,044 Non-real estate loans receivable ​ ​ 1,632 Cash and cash equivalents ​ ​ 6,866 Restricted cash ​ ​ 14,050 Contractual receivables ​ ​ 8 Other assets ​ ​ 31,278 Total assets ​ ​ 474,878 Accrued expenses and other liabilities ​ ​ (12,996) Net assets acquired ​ $ 461,882 The following table summarizes the significant asset acquisitions that occurred in 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ Cash Yield (1) ​ Q1 — 6 U.K. ​ $ 26.4 (2) 8.0 % Q2 ​ 4 — ​ WV ​ ​ 114.8 (3) 9.5 % Q2 ​ 1 — ​ WV ​ ​ 13.7 ​ 10.0 % Q3 ​ 1 — ​ VA ​ ​ 15.6 ​ 10.0 % Q3 ​ — 14 ​ U.K. ​ ​ 39.5 ​ 10.2 % Q4 ​ 1 — ​ MD ​ ​ 22.5 ​ 10.0 % (4) Q4 ​ — 1 ​ U.K. ​ ​ 3.8 ​ 9.0 % Q4 ​ 2 — ​ LA ​ ​ 24.9 ​ 10.0 % Total 9 21 ​ $ 261.2 ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) In connection with this acquisition, the Company recorded $9.9 million of right-of-use assets and lease liabilities associated with ground leases assumed in the acquisition. (3) In connection with this acquisition, the Company also provided $104.6 million of mezzanine financing discussed further in Note 7 – Real Estate Loans Receivable and Note 8 – Non-Real Estate Receivable. (4) Of the 10% initial annual cash yield for this acquisition, 2% can be deferred. The following table summarizes the significant asset acquisitions that occurred in 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Number of ​ ​ ​ Total Real Estate ​ ​ Initial ​ ​ Facilities ​ Assets Acquired Annual ​ Period ​ SNF ALF ​ Country/State ​ (in millions) ​ ​ Cash Yield (1) ​ Q1 — 1 U.K. ​ $ 8.7 (2) 8.0 % Q1 ​ — 1 ​ U.K. ​ ​ 5.0 ​ ​ 8.0 % Q1 — 27 U.K. ​ 86.6 (2) 8.0 % Q1 ​ 1 — ​ MD ​ ​ 8.2 (3) ​ 9.5 % Q3 ​ — 4 ​ U.K. ​ ​ 28.2 ​ ​ 8.0 % Q4 6 1 PA, NC ​ 88.5 (4) 9.0 % Total 7 34 ​ $ 225.2 ​ ​ ​ (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) The total consideration paid for the one-facility U.K. acquisition and the 27 -facility U.K. acquisition was $8.2 million and $100.0 million, respectively. In connection with these acquisitions, we allocated $0.5 million of the purchase consideration to a deferred tax liability related to the one -facility U.K. acquisition, and $13.4 million to a deferred tax asset related to the 27 -facility U.K. acquisition. See Note 17 – Taxes for additional information. (3) Total consideration for the one -facility Maryland acquisition was paid on December 30, 2021, but the closing of the acquisition did not occur until January 1, 2022. (4) During the fourth quarter of 2022, we acquired seven facilities using a reverse like-kind exchange structure pursuant to Section 1031 of the Code (a “reverse 1031 exchange”). As of December 31, 2022, we had completed the reverse 1031 exchange for three of the acquired facilities and the remaining four acquired facilities remained in the possession of the EATs. During the second quarter of 2023, the remaining four facilities were released from the possession of the EATs, as we did not identify any qualifying exchange transactions. The EATs were classified as VIEs as they do not have sufficient equity investment at risk to permit the entity to finance its activities. The Company consolidated the EATs because it had the ability to control the activities that most significantly impacted the economic performance of the EATs and was, therefore, the primary beneficiary of the EATs. The properties held by the EATs were reflected as real estate with a carrying value of $55.2 million as of December 31, 2022. The EATs also held cash of $23.9 million as of December 31, 2022.

ASSETS HELD FOR SALE, DISPOSI_2

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS [Abstract]
Schedule of Properties Held-for-Sale	The following is a summary of our assets held for sale: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 Number of facilities held for sale ​ 12 ​ ​ 14 Amount of assets held for sale (in thousands) $ 56,194 ​ $ 67,116

CONTRACTUAL RECEIVABLES AND O_2

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
Schedule of Net Accounts Receivable	A summary of our net receivables by type is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Contractual receivables – net ​ $ 12,611 ​ $ 11,888 ​ ​ ​ ​ ​ ​ ​ ​ ​ Effective yield interest receivables ​ $ 1,839 ​ $ 3,127 ​ Straight-line rent receivables ​ 238,690 ​ 202,748 ​ Lease inducements ​ 8,788 ​ 8,782 ​ Other receivables and lease inducements ​ $ 249,317 ​ $ 214,657 ​

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2024
LEASES [Abstract]
Schedule of operating lease income	The following table summarizes the Company’s rental income: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ 2022 ​ (in thousands) Fixed income from operating leases $ 871,189 ​ $ 811,123 ​ $ 735,247 Variable income from operating leases ​ 15,718 ​ ​ 14,257 ​ ​ 14,961 Interest income from direct financing leases ​ 1,003 ​ ​ 1,014 ​ ​ 1,023 Total rental income $ 887,910 ​ $ 826,394 ​ $ 751,231
Schedule of estimated contractual rent receivables under operating leases	The following amounts reflect the future minimum lease payments due to us for the remainder of the initial terms of our operating leases as of December 31, 2024: ​ ​ ​ ​ (in thousands) 2025 $ 927,069 2026 ​ 947,098 2027 ​ 941,009 2028 ​ 917,667 2029 ​ 905,495 Thereafter ​ 6,282,523 Total $ 10,920,861
Schedule of summarized balance sheet information related to leases	The following table summarizes the balance sheet information related to leases where the Company is a lessee: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 ​ 2023 ​ ​ (in thousands) Other assets - right of use assets ​ $ 28,302 ​ $ 30,178 ​ ​ ​ ​ ​ ​ ​ Accrued expenses and other liabilities – lease liabilities ​ $ 30,328 ​ $ 31,625
Schedule of Components of Investment in Direct Financing Leases	The components of investments in direct financing leases consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Minimum lease payments receivable ​ $ 21,478 ​ $ 22,628 ​ Less unearned income ​ (10,420) ​ (11,423) ​ Investment in direct financing leases ​ 11,058 ​ 11,205 ​ Less allowance for credit losses on direct financing leases ​ (1,605) ​ (2,489) ​ Investment in direct financing leases – net ​ $ 9,453 ​ $ 8,716 ​ ​ ​ ​ ​ ​ ​ ​ ​ Properties subject to direct financing leases ​ 1 ​ 1 ​ Number of direct financing leases ​ 1 ​ 1 ​

REAL ESTATE LOANS RECEIVABLE (T

REAL ESTATE LOANS RECEIVABLE (Tables) - Mortgage Receivables and Other Real Estate Loans [Member]	12 Months Ended
	Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Investments	A summary of our real estate loans receivable by loan type and by borrower and/or guarantor is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ (in thousands) ​ Mortgage notes due 2030; interest at 11.39% (1)(2) ​ $ 525,530 $ 514,866 ​ Mortgage notes due 2025; interest at 10.59% (1) ​ ​ 172,476 ​ ​ — ​ Mortgage notes due 2027 and 2037; interest at 10.60% (1) ​ ​ 84,951 ​ ​ 72,420 ​ Mortgage note due 2028; interest at 10.00% ​ ​ 53,750 ​ ​ 50,000 ​ Mortgage note due 2025; interest at 7.85% ​ ​ — ​ ​ 62,010 ​ Other mortgage notes outstanding (3) ​ 145,620 ​ 55,141 ​ Mortgage notes receivable – gross ​ 982,327 ​ 754,437 ​ Allowance for credit losses on mortgage notes receivable ​ ​ (39,562) ​ ​ (55,661) ​ Mortgage notes receivable – net ​ ​ 942,765 ​ ​ 698,776 ​ Other real estate loan due 2035; interest at 7.00% ​ ​ 263,580 ​ ​ 263,520 ​ Other real estate loans due 2025-2030; interest at 11.85% (1) ​ ​ 101,904 ​ ​ 120,576 ​ Other real estate loan due 2025; interest at 10.00% (4) ​ ​ 13,000 ​ ​ 106,807 ​ Other real estate loans outstanding (5) ​ ​ 138,736 ​ ​ 57,812 ​ Other real estate loans – gross ​ ​ 517,220 ​ ​ 548,715 ​ Allowance for credit losses on other real estate loans ​ (31,687) ​ (35,329) ​ Other real estate loans – net ​ ​ 485,533 ​ ​ 513,386 ​ Total real estate loans receivable – net ​ $ 1,428,298 ​ $ 1,212,162 ​ (1) Approximates the weighted average interest rate on facilities as of December 31, 2024. (2) All mortgage notes mature in 2030 with the exception of one mortgage note with an outstanding principal balance of $21.3 million with a maturity date of December 31, 2024, which was extended to December 31, 2025 subsequent to year end. (3) Other mortgage notes outstanding consists of 12 loans to multiple borrowers that have a weighted average interest rate of 9.80% as of December 31, 2024, with maturity dates ranging from 2025 through 2029 (with $18.8 million maturing in 2025). Two of the mortgage notes with an aggregate principal balance of $12.9 million are past due and have been written down, through our allowance for credit losses, to the estimated fair value of the underlying collateral of $1.5 million. (4) During the third quarter of 2024, we modified the priority of collateral available to use under the loan agreements for two loans with aggregate principal balances of $115.9 million and $106.8 million as of December 31, 2024 and December 31, 2023, respectively. As a result of these modifications, we adjusted the presentation of the loans from real estate loans receivable to non-real estate loans receivable as of September 30, 2024. See Note 8 – Non-Real Estate Loans Receivable for additional information. Additionally, we issued a new $13.0 million other real estate loan to the same borrower during the third quarter of 2024. (5) Other real estate loans outstanding consists of 11 loans to multiple borrowers that have a weighted average interest rate of 11.0% as of December 31, 2024, with maturity dates ranging from 2027 to 2033 .
Summary of Real Estate interest income	Interest income on real estate loans is included within interest income on the Consolidated Statements of Operations and is summarized as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ 2022 ​ (in thousands) Mortgage notes – interest income $ 91,434 ​ $ 68,340 ​ $ 74,233 Other real estate loans – interest income ​ 35,366 ​ ​ 29,426 ​ ​ 36,089 Total real estate loans interest income $ 126,800 ​ $ 97,766 ​ $ 110,322

NON-REAL ESTATE LOANS RECEIVA_2

NON-REAL ESTATE LOANS RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2024
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Investments	Our non-real estate loans consist of fixed and variable rate loans to operators and/or principals. These loans may be either unsecured or secured by the collateral of the borrower, which may include the working capital of the borrower and/or personal guarantees. As of December 31, 2024, we had 48 loans with 30 different borrowers. ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 2023 ​ ​ ​ (in thousands) ​ Notes due 2026; interest at 13.22% (1) ​ $ 115,913 ​ $ — ​ Notes due 2036; interest at 5.71% ​ ​ 73,142 ​ ​ 77,854 ​ Note due 2026; interest at 11.00% ​ ​ 47,126 ​ ​ 53,300 ​ Notes due 2025-2029; interest at 11.81% (1)(2) ​ ​ 45,226 ​ 92,681 ​ Note due 2025; interest at 9.12% (1) ​ ​ 42,499 ​ ​ 44,999 ​ Notes due 2025 and 2036; interest at 3.25% (1) ​ ​ 38,308 ​ ​ 32,308 ​ Other notes outstanding (3) ​ 92,855 ​ 96,104 ​ Non-real estate loans receivable – gross ​ ​ 455,069 ​ ​ 397,246 ​ Allowance for credit losses on non-real estate loans receivable ​ ​ (122,795) ​ ​ (121,631) ​ Total non-real estate loans receivable – net ​ $ 332,274 ​ $ 275,615 ​ (1) Approximate weighted average interest rate as of December 31, 2024. (2) During the second quarter of 2024, two working capital loans with maturity dates of June 30, 2024 were repaid in full. These two loans had an aggregate outstanding principal balance of $39.5 million as of December 31, 2023. (3) Other notes outstanding have a weighted average interest rate of 9.17% as of December 31, 2024, with maturity dates ranging from 2025 through 2034 (with $40.7 million maturing in 2025 ). Three of the other notes outstanding with an aggregate principal balance of $9.0 million are past due, two of which have been written down to the estimated fair value of the underlying collateral of zero , through our allowance for credit losses. The one other past due other loan outstanding has sufficient collateral to support the principal balance outstanding of $0.1 million as of December 31, 2024.

ALLOWANCE FOR CREDIT LOSSES (Ta

ALLOWANCE FOR CREDIT LOSSES (Tables)	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Schedule of expected credit loss	A rollforward of our allowance for credit losses, summarized by financial instrument type and internal credit risk rating, for the years ended December 31, 2024, 2023 and 2022 is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss as of December 31, 2023 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2024 (1) ​ Write-offs charged against allowance for the year ended December 31, 2024 ​ Other additions to the allowance for the year ended December 31, 2024 ​ Allowance for Credit Loss as of December 31, 2024 ​ ​ ​ (in thousands) ​ ​ ​ 1 ​ Real estate loans receivable $ 1,501 ​ $ (1,189) ​ $ — ​ $ — ​ $ 312 2 ​ Real estate loans receivable ​ 291 ​ ​ 201 ​ ​ — ​ ​ — ​ ​ 492 3 ​ Real estate loans receivable ​ 12,635 ​ ​ (1,644) ​ ​ — ​ ​ — ​ ​ 10,991 4 ​ Real estate loans receivable ​ 65,113 ​ ​ (42,585) (2) ​ — ​ ​ — ​ ​ 22,528 5 ​ Real estate loans receivable ​ — ​ ​ 25,476 (2) ​ — ​ ​ — ​ ​ 25,476 6 ​ Real estate loans receivable ​ 11,450 ​ ​ — ​ ​ — ​ ​ — ​ ​ 11,450 ​ ​ Sub-total ​ 90,990 ​ ​ (19,741) ​ ​ — ​ ​ — ​ ​ 71,249 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 ​ Investment in direct financing leases ​ 2,489 ​ ​ (884) ​ ​ — ​ ​ — ​ ​ 1,605 ​ ​ Sub-total ​ 2,489 ​ ​ (884) ​ ​ — ​ ​ — ​ ​ 1,605 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 1,151 ​ ​ (1,114) ​ ​ — ​ ​ — ​ ​ 37 3 ​ Non-real estate loans receivable ​ 3,903 ​ ​ (2,035) ​ ​ — ​ ​ — ​ ​ 1,868 4 ​ Non-real estate loans receivable ​ 720 ​ ​ 1,548 ​ ​ — ​ ​ — ​ ​ 2,268 5 ​ Non-real estate loans receivable ​ 43,404 ​ ​ (117) ​ ​ — ​ ​ — ​ ​ 43,287 6 ​ Non-real estate loans receivable ​ 72,453 ​ ​ 16,393 ​ ​ (13,511) ​ ​ — ​ ​ 75,335 ​ ​ Sub-total ​ 121,631 ​ ​ 14,675 (3) ​ (13,511) ​ ​ — ​ ​ 122,795 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Unfunded real estate loan commitments ​ 10 ​ ​ (9) ​ ​ — ​ ​ — ​ ​ 1 3 ​ Unfunded real estate loan commitments ​ 335 ​ ​ 126 ​ ​ — ​ ​ — ​ ​ 461 4 ​ Unfunded real estate loan commitments ​ 4,314 ​ ​ (4,274) (2) ​ — ​ ​ — ​ ​ 40 5 ​ Unfunded real estate loan commitments ​ — ​ ​ 1,767 (2) ​ — ​ ​ — ​ ​ 1,767 2 ​ Unfunded non-real estate loan commitments ​ 692 ​ ​ (679) ​ ​ — ​ ​ — ​ ​ 13 3 ​ Unfunded non-real estate loan commitments ​ 46 ​ ​ 137 ​ ​ — ​ ​ — ​ ​ 183 4 ​ Unfunded non-real estate loan commitments ​ 63 ​ ​ 370 ​ ​ — ​ ​ — ​ ​ 433 5 ​ Unfunded non-real estate loan commitments ​ 1,594 ​ ​ (1,594) ​ ​ — ​ ​ — ​ ​ — 6 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 65 ​ ​ — ​ ​ — ​ ​ 65 ​ ​ Sub-total ​ 7,054 ​ ​ (4,091) ​ ​ — ​ ​ — ​ ​ 2,963 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 222,164 ​ $ (10,041) ​ $ (13,511) ​ $ — ​ $ 198,612 (1) During the year ended December 31, 2024, we received proceeds of $5.3 million from the liquidating trust related to the DIP Facility with Gulf Coast, which resulted in a recovery for credit losses of $5.3 million that is not included in the rollforward above since we had previously written-off the loan balance and related reserves. (2) Amount reflects the movement of reserves associated with the Maplewood Revolver due to an adjustment to the internal risk rating on the loan from 4 to a 5 during the first quarter of 2024. See Note 7 – Real Estate Loans Receivable for additional information. (3) This amount includes cash recoveries of $4.7 million related to interest payments received on loans that are written down to fair value and are being accounted for under the cost recovery in which any payments received are applied directly against the principal balance outstanding. This amount also includes $0.6 million related to principal payments received on loans that were fully reserved. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss at December 31, 2022 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2023 (1) ​ Write-offs charged against allowance for the year ended December 31, 2023 ​ Other additions to the allowance for the year ended December 31, 2023 ​ Allowance for Credit Loss as of December 31, 2023 ​ ​ ​ (in thousands) 1 ​ Real estate loans receivable $ 162 ​ $ 1,339 ​ $ — ​ $ — ​ $ 1,501 2 ​ Real estate loans receivable ​ 157 ​ ​ 134 ​ ​ — ​ ​ — ​ ​ 291 3 ​ Real estate loans receivable ​ 15,110 ​ ​ (2,475) ​ ​ — ​ ​ — ​ ​ 12,635 4 ​ Real estate loans receivable ​ 33,666 ​ ​ 31,447 ​ ​ — ​ ​ — ​ ​ 65,113 6 ​ Real estate loans receivable ​ 52,265 ​ ​ (3,860) ​ ​ (36,955) (2) ​ — ​ ​ 11,450 ​ ​ Sub-total ​ 101,360 ​ ​ 26,585 ​ ​ (36,955) ​ ​ — ​ ​ 90,990 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 ​ Investment in direct financing leases ​ 2,816 ​ ​ (327) ​ ​ — ​ ​ — ​ ​ 2,489 ​ ​ Sub-total ​ 2,816 ​ ​ (327) ​ ​ — ​ ​ — ​ ​ 2,489 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 859 ​ ​ 292 ​ ​ — ​ ​ — ​ ​ 1,151 3 ​ Non-real estate loans receivable ​ 2,079 ​ ​ 1,824 ​ ​ — ​ ​ — ​ ​ 3,903 4 ​ Non-real estate loans receivable ​ 634 ​ ​ 86 ​ ​ — ​ ​ — ​ ​ 720 5 ​ Non-real estate loans receivable ​ 18,619 ​ ​ (415) ​ ​ — ​ ​ 25,200 (3) ​ 43,404 6 ​ Non-real estate loans receivable ​ 61,677 ​ ​ 10,776 ​ ​ — ​ ​ — ​ ​ 72,453 ​ ​ Sub-total ​ 83,868 ​ ​ 12,563 ​ ​ — ​ ​ 25,200 ​ ​ 121,631 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Unfunded real estate loan commitments ​ — ​ ​ 10 ​ ​ — ​ ​ — ​ ​ 10 3 ​ Unfunded real estate loan commitments ​ — ​ ​ 335 ​ ​ — ​ ​ — ​ ​ 335 4 ​ Unfunded real estate loan commitments ​ 84 ​ ​ 4,230 ​ ​ — ​ ​ — ​ ​ 4,314 2 ​ Unfunded non-real estate loan commitments ​ 207 ​ ​ 485 ​ ​ — ​ ​ — ​ ​ 692 3 ​ Unfunded non-real estate loan commitments ​ 29 ​ ​ 17 ​ ​ — ​ ​ — ​ ​ 46 4 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 63 ​ ​ — ​ ​ — ​ ​ 63 5 ​ Unfunded non-real estate loan commitments ​ — ​ ​ 1,594 ​ ​ — ​ ​ — ​ ​ 1,594 ​ ​ Sub-total ​ 320 ​ ​ 6,734 ​ ​ — ​ ​ — ​ ​ 7,054 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 188,364 ​ $ 45,555 ​ $ (36,955) ​ $ 25,200 ​ $ 222,164 (1) During the year ended December 31, 2023, we received proceeds of $1.0 million from the liquidating trust related to the DIP Facility with Gulf Coast, which resulted in a recovery for credit losses of $1.0 million that is not included in the rollforward above since we had previously written-off the loan balance and related reserves. (2) This amount relates to the write-off of the allowance for the Guardian mortgage note in connection with the settlement and partial forgiveness of the note in the second quarter of 2023. See Note 7 – Real Estate Loans Receivable for additional provision includes an additional details. (3) This amount relates to the additional $25.2 million allowance recorded during the first quarter of 2023 to reserve the aggregate deferred rent amount that is included within Agemo Replacement Loan B. See Note 8 – Non-Real Estate Loans Receivable for additional details. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating ​ Financial Statement Line Item Allowance for Credit Loss at December 31, 2021 ​ Provision (recovery) for Credit Loss for the year ended December 31, 2022 ​ Write-offs charged against allowance for the year ended December 31, 2022 ​ Allowance for Credit Loss as of December 31, 2022 ​ ​ ​ (in thousands) 1 ​ Real estate loans receivable $ — ​ $ 162 ​ $ — ​ $ 162 2 ​ Real estate loans receivable ​ 14 ​ ​ 143 ​ ​ — ​ ​ 157 3 ​ Real estate loans receivable ​ 5,367 ​ ​ 9,743 ​ ​ — ​ ​ 15,110 4 ​ Real estate loans receivable ​ 20,577 ​ ​ 13,089 ​ ​ — ​ ​ 33,666 5 ​ Real estate loans receivable ​ 136 ​ ​ (136) ​ ​ — ​ ​ — 6 ​ Real estate loans receivable ​ 56,480 ​ ​ 248 ​ ​ (4,463) (1) ​ 52,265 ​ ​ Sub-total ​ 82,574 ​ ​ 23,249 ​ ​ (4,463) ​ ​ 101,360 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3 ​ Investment in direct financing leases ​ 530 ​ ​ (530) ​ ​ — ​ ​ — 5 ​ Investment in direct financing leases ​ - ​ ​ 2,816 ​ ​ — ​ ​ 2,816 ​ ​ Sub-total ​ 530 ​ ​ 2,286 ​ ​ — ​ ​ 2,816 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 ​ Non-real estate loans receivable ​ 29 ​ ​ 830 ​ ​ — ​ ​ 859 3 ​ Non-real estate loans receivable ​ 1,206 ​ ​ 873 ​ ​ — ​ ​ 2,079 4 ​ Non-real estate loans receivable ​ 56 ​ ​ 578 ​ ​ — ​ ​ 634 5 ​ Non-real estate loans receivable ​ 7,861 ​ ​ 10,758 (2) ​ — ​ ​ 18,619 6 ​ Non-real estate loans receivable ​ 51,269 ​ ​ 28,460 (3)(4) ​ (18,052) (5) ​ 61,677 ​ ​ Sub-total ​ 60,421 ​ ​ 41,499 ​ ​ (18,052) ​ ​ 83,868 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 3 ​ Unfunded real estate loan commitments ​ 251 ​ ​ (251) ​ ​ — ​ ​ — 4 ​ Unfunded real estate loan commitments ​ 117 ​ ​ (33) ​ ​ — ​ ​ 84 2 ​ Unfunded non-real estate loan commitments ​ 7 ​ ​ 200 ​ ​ — ​ ​ 207 3 ​ Unfunded non-real estate loan commitments ​ 207 ​ ​ (178) ​ ​ — ​ ​ 29 4 ​ Unfunded non-real estate loan commitments ​ 216 ​ ​ (216) ​ ​ — ​ ​ — 6 ​ Unfunded non-real estate loan commitments ​ 143 ​ ​ 2,107 (5) ​ (2,250) (5) ​ — ​ ​ Sub-total ​ 941 ​ ​ 1,629 ​ ​ (2,250) ​ ​ 320 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 144,466 ​ $ 68,663 ​ $ (24,765) ​ $ 188,364 (1) During the third quarter of 2022, we wrote-off the loan balance and reserve for a loan that expired during the quarter which had previously been fully reserved. (2) This provision includes an additional $10.8 million allowance recorded on the Agemo WC Loan during the year ended December 31, 2022. See Note 8 – Non-Real Estate Loans Receivable for additional information on the Agemo WC Loan. (3) This provision includes an additional $23.3 million allowance recorded on the LaVie $25.0 million term loan and on the $8.3 million term loan during the fourth quarter of 2022. See Note 8 – Non-Real Estate Loans Receivable for additional information on the LaVie term loans. (4) This provision includes an additional $5.2 million allowance recorded on the $20 million WC loan during the year ended December 31, 2022 as discussed in Note 8 – Non-Real Estate Loans Receivable. (5) In the second quarter of 2022 we recorded an additional reserve of $2.2 million related to the remaining commitment under the Gulf Coast DIP Facility as we were notified of the operator’s intent to draw the funds in the third quarter of 2022. In the third quarter of 2022, the remaining commitment under the DIP Facility was drawn and the DIP Facility expired and as a result we wrote-off the loan balance and related reserves as we did not expect to collect amounts under the DIP Facility following the expiration.
Schedule by segment balance by vintage and credit quality indicator	Included below is a summary of the amortized cost basis of our financial instruments by year of origination and internal risk rating and a summary of our gross write-offs by year of origination: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Rating Financial Statement Line Item 2024 2023 2022 2021 2020 2019 & older Revolving Loans Balance as of December 31, 2024 ​ ​ (in thousands) 1 Real estate loans receivable $ — $ — $ 20,000 $ — $ — $ — $ — $ 20,000 2 Real estate loans receivable ​ 29,700 ​ 8,680 ​ — ​ — ​ 21,325 ​ — ​ — ​ 59,705 3 Real estate loans receivable ​ 273,243 ​ 161,166 ​ 27,600 ​ 72,420 ​ — ​ — ​ — ​ 534,429 4 Real estate loans receivable ​ 73,991 ​ 90,403 ​ — ​ 31,626 ​ 82,615 ​ 330,276 ​ — ​ 608,911 5 Real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ — ​ 263,580 ​ 263,580 6 Real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ 12,922 ​ — ​ 12,922 ​ Sub-total ​ 376,934 ​ 260,249 ​ 47,600 ​ 104,046 ​ 103,940 ​ 343,198 ​ 263,580 ​ 1,499,547 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 5 Investment in direct financing leases ​ — ​ — ​ — ​ — ​ — ​ 11,058 ​ — ​ 11,058 ​ Sub-total ​ — ​ — ​ — ​ — ​ — ​ 11,058 ​ — ​ 11,058 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2 Non-real estate loans receivable ​ — ​ — ​ — ​ — ​ — ​ — ​ 15,989 ​ 15,989 3 Non-real estate loans receivable ​ 4,175 ​ 81,333 ​ 17,687 ​ — ​ — ​ 2,551 ​ 55,761 ​ 161,507 4 Non-real estate loans receivable ​ 4,411 ​ — ​ — ​ — ​ — ​ 117,477 ​ 27,822 ​ 149,710 5 Non-real estate loans receivable ​ 6,000 ​ 1,500 ​ — ​ — ​ — ​ 45,028 ​ — ​ 52,528 6 Non-real estate loans receivable ​ 5,027 ​ 3,812 ​ 24,457 ​ 7,851 ​ — ​ 28,188 ​ 6,000 ​ 75,335 ​ Sub-total ​ 19,613 ​ 86,645 ​ 42,144 ​ 7,851 ​ — ​ 193,244 ​ 105,572 ​ 455,069 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total $ 396,547 $ 346,894 $ 89,744 $ 111,897 $ 103,940 $ 547,500 $ 369,152 $ 1,965,674 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year to date gross write-offs $ — $ (5,879) $ — $ — $ — $ (3,092) $ (4,540) $ (13,511) ​

VARIABLE INTEREST ENTITIES (Tab

VARIABLE INTEREST ENTITIES (Tables)	12 Months Ended
	Dec. 31, 2024
Variable Interest Entities [Abstract]
Schedule of Variable Interest Entities	Below is a summary of our assets, liabilities, collateral, and maximum exposure to loss associated with these unconsolidated VIEs as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2024 ​ 2023 ​ ​ ​ (in thousands) ​ Assets ​ ​ ​ ​ ​ ​ ​ Real estate assets – net ​ $ 1,250,131 ​ $ 996,540 ​ Assets held for sale ​ ​ — ​ ​ 51,700 ​ Real estate loans receivable – net ​ 534,048 ​ ​ 370,147 ​ Investments in unconsolidated joint ventures ​ ​ 9,754 ​ ​ 9,009 ​ Non-real estate loans receivable – net ​ 38,463 ​ ​ 10,679 ​ Contractual receivables – net ​ 994 ​ ​ 746 ​ Other assets ​ ​ 1,539 ​ ​ 1,423 ​ Total assets ​ 1,834,929 ​ 1,440,244 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities ​ ​ ​ ​ ​ ​ ​ Accrued expenses and other liabilities ​ ​ (52,692) ​ ​ (46,677) ​ Total liabilities ​ (52,692) ​ (46,677) ​ ​ ​ ​ ​ ​ ​ ​ ​ Collateral ​ ​ ​ Personal guarantee ​ (48,000) ​ ​ (48,000) ​ Other collateral (1) ​ (1,422,096) ​ ​ (1,090,953) ​ Total collateral ​ (1,470,096) ​ ​ (1,138,953) ​ ​ ​ ​ ​ ​ ​ ​ ​ Maximum exposure to loss ​ $ 312,141 ​ $ 254,614 ​ (1) Amount excludes accounts receivable amounts that Omega has a security interest in as collateral under the two working capital loans with entities that are unconsolidated VIEs. The fair value of the accounts receivable available to Omega was $5.5 million and $8.9 million as of December 31, 2024 and December 31, 2023, respectively.
Schedule of Variable Interest Entities revenue	The table below reflects our total revenues from the entities that are considered unconsolidated VIEs, following the date they were determined to be VIEs, for the years ended December 31, 2024, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 ​ 2023 ​ ​ 2022 ​ (in thousands) Revenue ​ ​ ​ ​ ​ ​ ​ ​ Rental income (1) $ 106,911 ​ $ 81,900 ​ $ 53,158 Interest income ​ 16,414 ​ ​ 5,512 ​ ​ 16,456 Total $ 123,325 ​ $ 87,412 ​ $ 69,614 (1) The rental income for the year ended December 31, 2023, reflects the $12.5 million option termination fee payment made to Maplewood in the first quarter of 2023 that was accounted for as a lease inducement (see Note 5 – Contractual Receivables and Other Receivables and Lease Inducements). The rental income for the year ended December 31, 2022, reflects the write-off of approximately $29.3 million of straight-line rent receivables and lease inducements related to Maplewood (see Note 5 – Contractual Receivables and Other Receivables and Lease Inducements).

INVESTMENT IN JOINT VENTURES (T

INVESTMENT IN JOINT VENTURES (Tables)	12 Months Ended
	Dec. 31, 2024
INVESTMENTS IN JOINT VENTURES [Abstract]
Schedule of equity method investments	Omega owns an interest in a number of joint ventures which generally invest in the long-term healthcare industry. The following is a summary of our investments in unconsolidated joint ventures (dollars in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying Amount ​ ​ Ownership ​ Facility ​ Facility ​ December 31, ​ December 31, Entity ​ % (1) ​ Type ​ Count (1) ​ 2024 2023 Lakeway Realty, L.L.C. (2) ​ 51% ​ Specialty facility ​ 1 ​ $ 67,541 ​ $ 68,902 Second Spring Healthcare Investment ​ 15% ​ N/A ​ — ​ ​ 7,117 ​ 8,945 Cindat Joint Venture (3) ​ N/A ​ N/A ​ N/A ​ ​ — ​ ​ 97,559 Other Real Estate JVs (4)(5)(6) ​ 20% – 50% ​ Various ​ 6 ​ 6,736 ​ 6,009 Other Healthcare JVs (6)(7) ​ 9% – 25% ​ N/A ​ N/A ​ ​ 7,317 ​ ​ 6,994 ​ ​ ​ ​ ​ ​ ​ ​ $ 88,711 ​ $ 188,409 (1) Ownership percentages and facility counts are as of December 31, 2024. (2) The joint venture owns the Lakeway Regional Medical Center (the “Lakeway Hospital”) in Lakeway, Texas. Our initial basis difference of approximately $69.9 million is being amortized on a straight-line basis over 40 years to income (loss) from unconsolidated joint ventures in the Consolidated Statements of Operations. The lessee of the Lakeway Hospital has an option to purchase the facility from the joint venture. The lessee also has a right of first refusal and a right of first offer in the event the joint venture intends to sell or otherwise transfer Lakeway Hospital. As of December 31, 2023, we had $62.0 million outstanding under a mortgage loan to this joint venture, which was repaid in full in December 2024. (3) As of December 31, 2023, we held a 49% interest in the Cindat Joint Venture that owned 63 care homes leased to two operators in the U.K. pursuant to operating leases. In July 2024, we acquired the remaining 51% ownership interest in the Cindat Joint Venture, such that we now own 100% of the ownership interest in the entity that owns the Cindat portfolio. See Note 3 – Real Estate Asset Acquisitions and Development for additional information. (4) Includes three joint ventures formed for the purpose of owning or providing financing for SNFs, ALFs or specialties facilities. (5) During the third quarter of 2024, one of the other real estate JVs, OMG Senior Holdings, LLC, sold one specialty facility to an unrelated third party for approximately $40.7 million in net cash proceeds and recognized a gain on sale of approximately $12.9 million ( $6.5 million of which represents the Company’s share of the gain). (6) As of December 31, 2024 and 2023, we had an aggregate of $18.5 million and $17.5 million, respectively, of loans outstanding with these joint ventures. (7) Includes six joint ventures engaged in businesses that support the long-term healthcare industry and our operators.

GOODWILL AND OTHER INTANGIBLES

GOODWILL AND OTHER INTANGIBLES (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Other Intangibles [Abstract]
Schedule of Reconciliation of Goodwill	The following is a summary of our goodwill: ​ ​ ​ ​ ​ (in thousands) Balance as of December 31, 2023 ​ $ 643,897 Foreign currency translation ​ (233) Balance as of December 31, 2024 ​ $ 643,664
Schedule of Intangibles	The following is a summary of our lease intangibles as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ ​ 2024 ​ 2023 ​ ​ ​ (in thousands) ​ Assets: ​ ​ ​ ​ Above market leases (1) ​ $ 31,864 ​ $ 4,214 ​ Accumulated amortization ​ (3,800) (3,532) ​ Net above market leases ​ $ 28,064 ​ $ 682 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Below market leases ​ $ 34,723 ​ $ 48,791 ​ Accumulated amortization ​ (26,647) (37,177) ​ Net below market leases ​ $ 8,076 ​ $ 11,614 ​ (1) As of December 31, 2024, includes $27.4 million of intangible assets related to above market leases assumed in connection with the acquisition of the remaining 51% interest in the Cindat Joint Venture during the third quarter of 2024 (see Note 3 – Real Estate Asset Acquisitions and Development).

BORROWING ACTIVITIES AND ARRA_2

BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]
Schedule of Borrowings	The following is a summary of our long-term borrowings: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Annual ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest Rate ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ as of ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ December 31, ​ December 31, ​ Maturity 2024 ​ 2024 2023 ​ ​ ​ ​ (in thousands) Secured borrowings: ​ ​ ​ HUD mortgages (1) ​ 2049 - 2051 ​ N/A ​ ​ $ — ​ $ 41,878 2024 term loan (2) 2024 N/A ​ ​ ​ — ​ ​ 20,085 2026 mortgage loan (1) 2026 10.31 % ​ ​ 231,148 ​ ​ — Deferred financing costs – net ​ ​ ​ (3,753) ​ — Premium – net ​ ​ 15,915 ​ — Total secured borrowings ​ ​ ​ ​ ​ ​ ​ 243,310 ​ ​ 61,963 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Unsecured borrowings: ​ ​ ​ Revolving credit facility (3)(4) 2025 5.67 % ​ — ​ 20,397 ​ ​ ​ ​ ​ ​ ​ ​ — ​ ​ 20,397 Senior notes and other unsecured borrowings: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2024 notes (3)(5) 2024 N/A ​ ​ — ​ 400,000 2025 notes (3)(6) 2025 4.50 % ​ 400,000 ​ 400,000 2026 notes (3) 2026 5.25 % ​ 600,000 ​ 600,000 2027 notes (3) 2027 4.50 % ​ 700,000 ​ 700,000 2028 notes (3) 2028 4.75 % ​ 550,000 ​ 550,000 2029 notes (3) 2029 3.63 % ​ 500,000 ​ 500,000 2031 notes (3) ​ 2031 ​ 3.38 % ​ ​ 700,000 ​ ​ 700,000 2033 notes (3) ​ 2033 ​ 3.25 % ​ ​ 700,000 ​ ​ 700,000 2025 term loan (3)(7) ​ 2025 5.60 % ​ 428,500 ​ 428,500 OP term loan (8)(9) 2025 5.52 % ​ 50,000 ​ 50,000 Deferred financing costs – net ​ ​ ​ (14,843) ​ (20,442) Discount – net ​ ​ (18,108) ​ (23,102) Total senior notes and other unsecured borrowings – net ​ ​ 4,595,549 ​ 4,984,956 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total unsecured borrowings – net ​ ​ 4,595,549 ​ 5,005,353 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total secured and unsecured borrowings – net (10)(11) ​ ​ $ 4,838,859 ​ $ 5,067,316 (1) Wholly owned subsidiaries of Omega OP are or were the obligor on these borrowings. (2) Borrowing was the debt of the consolidated joint venture discussed in Note 8 – Variable Interest Entities which was formed in the first quarter of 2022. The borrowing was secured by two ALFs, which are owned by the joint venture. During the second quarter of 2024, Omega repaid this loan using available cash and proceeds from our $1.45 billion senior unsecured multicurrency revolving credit facility (“Revolving Credit Facility”). (3) Guaranteed by Omega OP. (4) During the second quarter of 2023, the Company transitioned its benchmark interest rate for its Revolving Credit Facility from LIBOR to SOFR . The applicable interest rate on the US Dollar tranche and on the GBP borrowings under the alternative currency tranche of the credit facility were 5.67% and 6.02% as of December 31, 2024, respectively. (5) The Company repaid the $400 million of 4.95% senior notes that matured on April 1, 2024 using available cash and proceeds from our Revolving Credit Facility. (6) Subsequent to December 31, 2024, the Company repaid the $400 million of 4.50% senior notes that matured on January 15, 2025 using available cash. (7) The weighted average interest rate of the $428.5 million 2025 term loan has been adjusted to reflect the impact of the interest rate swaps that effectively fix the SOFR -based portion of the interest rate at 4.047% . (8) Omega OP is the obligor on this borrowing. (9) During the second quarter of 2023, the Company transitioned its benchmark interest rate for its $50.0 million senior unsecured term loan facility (the “OP Term Loan”) from LIBOR to SOFR . The weighted average interest rate of the $50 million OP Term Loan has been adjusted to reflect the impact of the interest rate swaps that effectively fix the SOFR -based portion of the interest rate at 3.957% . (10) All borrowings are direct borrowings of Parent unless otherwise noted. (11) Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings.
Schedule of principal payments, excluding the premium/discount and the aggregate due thereafter	The required principal payments, excluding the premium or discount and deferred financing costs on our secured and unsecured borrowings, for each of the five years following December 31, 2024 and the aggregate due thereafter are set forth below: ​ ​ ​ ​ ​ (in thousands) 2025 $ 878,500 2026 ​ 831,148 2027 ​ 700,000 2028 ​ 550,000 2029 ​ 500,000 Thereafter ​ 1,400,000 Total ​ $ 4,859,648 ​

DERIVATIVES AND HEDGING (Tables

DERIVATIVES AND HEDGING (Tables)	12 Months Ended
	Dec. 31, 2024
DERIVATIVES AND HEDGING [Abstract]
Location and the fair value of derivative instruments designated as hedges	The location and the fair value of derivative instruments designated as hedges, at the respective balance sheet dates, were as follows: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 Cash flow hedges: (in thousands) Other assets $ 381 ​ $ — Accrued expenses and other liabilities $ 554 ​ $ 6,533 ​ ​ ​ ​ ​ ​ Net investment hedges: ​ ​ ​ ​ ​ Other assets $ 8,434 ​ $ 8,903 Accrued expenses and other liabilities $ — ​ $ 8

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
Financial Instruments [Abstract]
Schedule of Financial Instruments	At December 31, 2024 and 2023, the net carrying amounts and fair values of other financial instruments were as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2024 ​ December 31, 2023 ​ Carrying Fair Carrying Fair ​ Amount Value Amount Value ​ ​ (in thousands) Assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments in direct financing leases – net $ 9,453 ​ $ 9,453 $ 8,716 $ 8,716 Real estate loans receivable – net ​ 1,428,298 ​ 1,447,262 ​ 1,212,162 ​ 1,258,838 Non-real estate loans receivable – net ​ 332,274 ​ 340,025 ​ 275,615 ​ 279,710 Total ​ $ 1,770,025 ​ $ 1,796,740 ​ $ 1,496,493 ​ $ 1,547,264 Liabilities: ​ ​ ​ ​ Revolving credit facility ​ $ — ​ $ — ​ $ 20,397 ​ $ 20,397 2026 mortgage loan ​ 243,310 ​ 247,063 ​ — ​ — 2024 term loan ​ — ​ — ​ 20,085 ​ 19,750 2025 term loan ​ ​ 427,044 ​ ​ 428,500 ​ ​ 424,662 ​ ​ 428,500 OP term loan ​ 49,966 ​ 50,000 ​ 49,864 ​ 50,000 4.95% notes due 2024 – net ​ — ​ — ​ 399,747 ​ 398,888 4.50% notes due 2025 – net ​ 399,968 ​ 399,856 ​ 399,207 ​ 393,240 5.25% notes due 2026 – net ​ 599,259 ​ 600,714 ​ 598,553 ​ 596,508 4.50% notes due 2027 – net ​ 696,766 ​ 691,040 ​ 695,302 ​ 671,538 4.75% notes due 2028 – net ​ 546,933 ​ 542,553 ​ 545,925 ​ 528,704 3.63% notes due 2029 – net ​ ​ 494,308 ​ ​ 461,180 ​ ​ 493,099 ​ ​ 440,785 3.38% notes due 2031 – net ​ ​ 688,962 ​ ​ 620,809 ​ ​ 687,172 ​ ​ 594,734 3.25% notes due 2033 – net ​ ​ 692,343 ​ ​ 585,389 ​ ​ 691,425 ​ ​ 564,809 HUD mortgages – net ​ ​ — ​ ​ — ​ ​ 41,878 ​ ​ 31,322 Total ​ $ 4,838,859 ​ $ 4,627,104 ​ $ 5,067,316 ​ $ 4,739,175

TAXES (Tables)

TAXES (Tables)	12 Months Ended
	Dec. 31, 2024
Taxes [Abstract]
Schedule of components of income tax expense	The following is a summary of our provision for income taxes: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 ​ 2022 ​ ​ (in millions) Federal, state and local income tax expense (1) ​ $ 1.5 ​ $ 2.0 ​ $ 1.2 Foreign income tax expense (2) ​ ​ 9.4 ​ ​ 4.3 ​ ​ 3.4 Total income tax expense (3) ​ $ 10.9 ​ $ 6.3 ​ $ 4.6 (1) For the years ended December 31, 2024, 2023 and 2022, income before income tax expense and income from unconsolidated joint ventures from domestic operations was $386.4 million, $234.2 million and $418.5 million, respectively. (2) For the years ended December 31, 2024, 2023 and 2022, income before income tax expense and income from unconsolidated joint ventures from foreign operations was $34.3 million, $21.5 million and $17.6 million, respectively. (3) The above amounts do not include gross income receipts or franchise taxes payable to certain states and municipalities.
Schedule of deferred tax assets and liabilities	The following is a summary of deferred tax assets and liabilities: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 ​ ​ (in thousands) U.S. Federal net operating loss carryforward ​ $ 2,048 ​ $ 2,079 Valuation allowance on deferred tax asset ​ (1,925) ​ (2,024) Foreign net operating loss carryforward ​ ​ 19,101 ​ ​ 9,491 Foreign deferred tax asset (1) ​ ​ 200 ​ ​ — Net deferred tax asset ​ $ 19,424 ​ $ 9,546 ​ ​ ​ ​ ​ ​ ​ Foreign deferred tax liability (1) ​ $ — ​ $ 1,508 Net deferred tax liability ​ $ — ​ $ 1,508 (1) The deferred tax asset and liability resulted from book to tax differences recorded in the U.S. relating to depreciation and revenue recognition in the U.K.

STOCKHOLDERS EQUITY (Tables)

STOCKHOLDERS EQUITY (Tables)	12 Months Ended
	Dec. 31, 2024
Stockholders Equity [Abstract]
Schedule of ATM Issuances	The following is a summary of the shares issued under our ATM Program for each of the years ended December 31, 2022, 2023, and 2024 (in thousands except average price per share): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average Net Price ​ ​ ​ ​ Period Ended Shares issued Per Share (1) Gross Proceeds Net Proceeds December 31, 2022 — $ — $ — $ — December 31, 2023 7,243 ​ 30.25 ​ 221,732 ​ 219,140 December 31, 2024 28,714 ​ 36.49 ​ 1,058,080 ​ 1,047,767 (1) Represents the average price per share after commissions.
Schedule of dividend reinvestment and common stock purchase plan	The table below presents information regarding the shares issued under the DRCSPP for each of the years ended December 31, 2022, 2023, and 2024 (in thousands): ​ ​ ​ ​ ​ ​ Period Ended Shares issued ​ Gross Proceeds December 31, 2022 308 ​ $ 9,229 December 31, 2023 3,715 ​ ​ 117,259 December 31, 2024 5,078 ​ ​ 187,969 ​ ​ ​ ​ ​
Schedule of common stock dividends	The Board of Directors has declared common stock dividends as set forth below: ​ ​ ​ ​ ​ ​ ​ Record ​ Payment ​ Dividend per Date Date Common Share February 5, 2024 ​ February 15, 2024 ​ $ 0.67 April 30, 2024 ​ May 15, 2024 ​ ​ 0.67 August 5, 2024 ​ August 15, 2024 ​ ​ 0.67 November 4, 2024 ​ November 15, 2024 ​ ​ 0.67 February 10, 2025 ​ February 18, 2025 ​ ​ 0.67
Schedule of per share distribution for income tax purpose	Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, Common 2024 2023 2022 Ordinary income ​ $ 1.862 ​ $ 2.258 ​ $ 1.264 Return of capital ​ 0.712 ​ 0.212 ​ 0.095 Capital gains ​ 0.106 ​ 0.210 ​ 1.321 Total dividends paid ​ $ 2.680 ​ $ 2.680 ​ $ 2.680
Schedule of accumulated other comprehensive income (loss)	The following is a summary of our accumulated other comprehensive income (loss), net of tax as of December 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ December 31, ​ December 31, ​ 2024 2023 ​ ​ (in thousands) Foreign currency translation $ (66,110) $ (49,770) Derivative instruments designated as cash flow hedges (1) ​ 76,713 ​ ​ 75,111 Derivative instruments designated as net investment hedges 11,898 ​ 3,931 Total accumulated other comprehensive income before noncontrolling interest 22,501 ​ 29,272 Add: portion included in noncontrolling interest 230 ​ 66 Total accumulated other comprehensive income for Omega $ 22,731 ​ $ 29,338 (1) During the years ended December 31, 2024, 2023 and 2022, we reclassified $9.6 million, $6.7 million and $4.2 million, respectively, of realized gains out of accumulated other comprehensive income into interest expense on our Consolidated Statements of Operations associated with our cash flow hedges.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2024
Stock-Based Compensation [Abstract]
Schedule of assumptions used for estimating fair value of stock awards using Monte-Carlo model	The following are the significant assumptions used in estimating the value of the awards for grants made on the following dates: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ January 1, ​ January 1, ​ January 1, ​ 2024 2023 ​ 2022 Closing price on date of grant ​ $ 30.66 ​ ​ $ 27.95 ​ ​ $ 29.59 ​ Dividend yield ​ 8.74 % ​ ​ 9.59 % ​ ​ 9.06 % Risk free interest rate at time of grant ​ 4.15 % ​ ​ 4.28 % ​ ​ 0.98 % Expected volatility (1) ​ 25.27 % ​ ​ 40.28 % ​ ​ 38.74 % (1) Expected volatility is using 50% historical volatility and 50% implied volatility.
Schedule of activity in RSUs, PRSUs and PIUs	The following table summarizes the activity in restricted stock, RSUs, PRSUs, and PIUs for the years ended December 31, 2022, 2023 and 2024: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Time-Based ​ Performance-Based ​ ​ ​ ​ Weighted - ​ Weighted - Total ​ ​ Number of ​ Average Grant- ​ Number of ​ Average Grant- ​ Compensation ​ ​ Shares/Omega ​ Date Fair Value ​ Shares/Omega ​ Date Fair Value ​ Cost (1) ​ OP Units per Share ​ OP Units per Share (in millions) Non-vested at December 31, 2021 318,412 ​ $ 38.62 ​ 2,222,047 ​ $ 17.94 ​ ​ Granted during 2022 256,818 ​ 29.40 ​ 1,620,330 ​ 14.73 ​ $ 31.40 Cancelled during 2022 (2,000) ​ 29.59 ​ (5,232) ​ 11.90 ​ Forfeited during 2022 ​ — ​ — ​ (621,199) ​ 13.68 ​ ​ ​ Vested during 2022 (165,206) ​ 40.91 ​ — ​ — ​ Non-vested at December 31, 2022 408,024 ​ ​ 31.93 ​ 3,215,946 ​ ​ 17.16 ​ Granted during 2023 309,927 ​ 28.15 ​ 2,139,421 ​ 13.42 ​ $ 37.40 Cancelled during 2023 — ​ — ​ (1,228) ​ 11.35 ​ Forfeited during 2023 ​ — ​ — ​ (539,312) ​ 17.50 ​ ​ ​ Vested during 2023 (208,119) ​ 34.31 ​ (482,772) ​ 21.52 ​ Non-vested at December 31, 2023 509,832 ​ ​ 28.66 ​ 4,332,055 ​ ​ 14.78 ​ Granted during 2024 306,526 ​ 30.73 ​ 2,368,170 ​ 13.22 ​ $ 40.70 Cancelled during 2024 — ​ — ​ (20,811) ​ 12.98 ​ Vested during 2024 (2) (251,457) ​ 29.56 ​ (578,763) ​ 19.93 ​ Non-vested at December 31, 2024 564,901 ​ $ 29.38 ​ 6,100,651 ​ $ 13.69 ​ (1) Total compensation cost to be recognized on the awards based on grant date fair value (2) PRSUs are shown as vesting in the year that the Compensation Committee determines the level of achievement of the applicable performance measures

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2024
COMMITMENTS AND CONTINGENCIES [Abstract]
Schedule of remaining commitments	Our remaining commitments at December 31, 2024, are outlined in the table below (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Lessor construction and capital commitments under lease agreements ​ $ 221,839 ​ ​ Non-real estate loan commitments ​ 65,709 ​ ​ Real estate loan commitments ​ 50,446 ​ ​ Total remaining commitments (1) ​ $ 337,994 ​ ​ (1) Includes finance costs .

SUPPLEMENTAL DISCLOSURE TO CO_2

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Tables)	12 Months Ended
	Dec. 31, 2024
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Schedule of Cash Flow Supplemental Disclosures	The following are supplemental disclosures to the consolidated statements of cash flows for the years ended December 31, 2024, 2023 and 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ (in thousands) Reconciliation of cash and cash equivalents and restricted cash: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cash and cash equivalents ​ $ 518,340 $ 442,810 $ 297,103 Restricted cash ​ 30,395 ​ 1,920 ​ 3,541 Cash, cash equivalents and restricted cash at end of year ​ $ 548,735 ​ $ 444,730 ​ $ 300,644 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Supplemental information: ​ ​ ​ Interest paid during the year, net of amounts capitalized ​ $ 230,993 ​ $ 234,453 ​ $ 220,748 Taxes paid during the year ​ $ 8,414 ​ $ 3,615 ​ $ 5,793 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash investing activities ​ ​ ​ Non-cash acquisition of real estate (see Note 3) ​ $ (344,008) ​ $ — ​ $ (9,818) Non-cash proceeds from sale of business ​ $ — ​ $ — ​ $ 7,532 Non-cash investment in non-real estate loans receivables (See Note 3) ​ $ (1,632) ​ $ — ​ $ — Non-cash investment in other investments ​ $ — ​ $ — ​ $ (7,532) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Non-cash financing activities ​ ​ ​ ​ ​ ​ Assumption of debt (see Note 3 and Note 14) ​ $ 263,989 ​ $ — ​ $ — Non-cash contribution from noncontrolling member in consolidated joint venture ​ $ — ​ $ — ​ $ 2,903 Change in fair value of hedges ​ $ 13,737 ​ $ (21,649) ​ $ 88,460 Remeasurement of debt denominated in a foreign currency ​ $ (6,638) ​ $ 1,150 ​ $ (4,077) ​

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings per Share [Abstract]
Schedule of Computation of Basic and Diluted Earnings per Share	The following tables set forth the computation of basic and diluted earnings per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ ​ (in thousands, except per share amounts) Numerator: ​ ​ ​ Net income available to common stockholders – basic ​ $ 406,326 ​ $ 242,180 ​ $ 426,927 Add: net income attributable to OP Units ​ 12,060 ​ 7,077 ​ 11,914 Net income available to common stockholders – diluted ​ $ 418,386 ​ $ 249,257 ​ $ 438,841 Denominator: ​ ​ ​ Denominator for basic earnings per share ​ 258,118 ​ 240,493 ​ 236,256 Effect of dilutive securities: ​ ​ ​ Common stock equivalents ​ 4,664 ​ 2,923 ​ 1,198 Noncontrolling interest – Omega OP Units ​ 7,668 ​ 7,035 ​ 6,836 Denominator for diluted earnings per share ​ 270,450 ​ 250,451 ​ 244,290 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings per share – basic: ​ ​ ​ Net income available to common stockholders ​ $ 1.57 ​ $ 1.01 ​ $ 1.81 Earnings per share – diluted: ​ ​ ​ Net income available to common stockholders ​ $ 1.55 ​ $ 1.00 ​ $ 1.80 ​

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2024
SEGMENTS [Abstract]
Interest expense by reportable segment	Additionally, the CODM also utilizes hedging instruments as discussed in Note 15 – Derivatives and Hedging, to help manage interest rate risk and limit significant fluctuations in interest expense for variable rate borrowings. Interest expense related to the Company’s reportable segment is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Year Ended December 31, ​ 2024 2023 2022 ​ (in thousands) Interest expense $ 211,319 ​ $ 221,832 ​ $ 220,296 Interest – amortization of deferred financing costs (1) 10,397 ​ 13,697 ​ 12,948 Interest expense – net $ 221,716 ​ $ 235,529 ​ $ 233,244

ORGANIZATION (Details)

ORGANIZATION (Details) - Omega OP Units	12 Months Ended
	Dec. 31, 2024
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of limited partnership interests owned	97%
Other Investors [Member]
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of limited partnership interests owned	3%

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	3 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($)	Dec. 31, 2024 USD ($) lease entity facility item $ / shares shares	Dec. 31, 2023 USD ($) entity lease $ / shares	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($)	Jun. 30, 2023 USD ($)	Apr. 30, 2021 USD ($)
Accounting Policies [Line Items]
Impairment on real estate properties		$ 23,831,000	$ 91,943,000	$ 38,451,000
Cash, FDIC insured amount		250,000
Accrued expenses and other liabilities		328,193,000	287,795,000
Impairment of goodwill		$ 0	0	0
Number of operating segments		1
Number of reportable segment		1
Straight line rent receivable wrote off	$ 8,300,000
Amortization of financing cost		$ 10,400,000	$ 13,700,000	12,900,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.1	$ 0.1
Number of units tendered for redemption of unregistered shares | shares		1
Net cash provided by (used in) operating activities		$ 749,430,000	$ 617,736,000	625,727,000
Increase in cash, cash equivalents, and restricted cash		104,005,000	144,086,000	276,233,000
Right of use assets		28,302,000	30,178,000
Lease liabilities		30,328,000	31,625,000
Real estate tax expense		14,561,000	15,025,000	15,500,000
Accrued investment income receivable		11,100,000	10,200,000
Interest receivable		$ 1,839,000	$ 3,127,000
Number of operators | item		87
Number of leases accounted for direct finance leases | lease		1	1
Capitalized interest		$ 7,300,000	$ 4,300,000	3,200,000
Revenues		1,051,390,000	949,740,000	878,244,000
Assets held for sale		$ 56,194,000	$ 67,116,000
Number of joint venture variable interest entities consolidated | entity		1	1
Number of Facilities | facility		1,026
United Kingdom | Subsidiaries [Member]
Accounting Policies [Line Items]
Long lived assets and goodwill		$ 1,100,000,000	$ 539,600,000
Revenues		93,600,000	56,800,000	$ 47,700,000
Unsecured Debt [Member] | Revolving Credit Facility
Accounting Policies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		1,450,000,000					$ 1,450,000,000
Omega OP Term Loan Facility | Unsecured Debt [Member]
Accounting Policies [Line Items]
Term loans - net		50,000,000	50,000,000			$ 50,000,000	50,000,000
Lease and Mortgage Liquidity and Other Deposits [Member]
Accounting Policies [Line Items]
Security deposit		15,500,000	1,900,000
Lease and Mortgage Security Deposits [Member]
Accounting Policies [Line Items]
Security deposit		52,700,000	36,000,000
Lease and Mortgage Letter of Credit [Member]
Accounting Policies [Line Items]
Security deposit		29,100,000	27,100,000
Restatement Adjustment [Member]
Accounting Policies [Line Items]
Assets held for sale, reclassified to assets held for use		$ 14,400,000	26,600,000		$ 12,200,000
Previously Reported [Member]
Accounting Policies [Line Items]
Assets held for sale			93,700,000
Minimum [Member]
Accounting Policies [Line Items]
Lessor, operating lease, term of contract		5 years
Period specified for rental and mortgage interest		3 months
Maximum [Member]
Accounting Policies [Line Items]
Lessor, operating lease, term of contract		15 years
Period specified for rental and mortgage interest		6 months
Maximum [Member] | Unsecured Debt [Member] | Revolving Credit Facility
Accounting Policies [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity							$ 2,500,000,000
Cash Flow Hedging [Member] | Other Assets [Member]
Accounting Policies [Line Items]
Cash flow hedges recorded at fair value, asset		$ 381,000
Omega OP Units
Accounting Policies [Line Items]
Percentage of limited partnership interests owned		97%
Omega Op Units [Member] | Omega OP Units
Accounting Policies [Line Items]
Percentage of limited partnership interests owned		97%
Other Investors [Member] | Omega OP Units
Accounting Policies [Line Items]
Percentage of limited partnership interests owned		3%
Gulf Coast LLC [Member]
Accounting Policies [Line Items]
Provision (Recovery) for Credit Losses		$ (5,300,000)	(1,000,000)
Site Improvements And Equipment [Member] | Minimum [Member]
Accounting Policies [Line Items]
Estimated useful lives		8 years
Site Improvements And Equipment [Member] | Maximum [Member]
Accounting Policies [Line Items]
Estimated useful lives		15 years
Furniture, fixtures and equipment
Accounting Policies [Line Items]
Assets held for sale, reclassified to assets held for use			3,400,000
Furniture, fixtures and equipment | Minimum [Member]
Accounting Policies [Line Items]
Estimated useful lives		3 years
Furniture, fixtures and equipment | Maximum [Member]
Accounting Policies [Line Items]
Estimated useful lives		10 years
Accumulated Depreciation [Member]
Accounting Policies [Line Items]
Assets held for sale, reclassified to assets held for use			11,100,000
Land [Member]
Accounting Policies [Line Items]
Assets held for sale, reclassified to assets held for use			3,400,000
Building [Member]
Accounting Policies [Line Items]
Assets held for sale, reclassified to assets held for use			$ 30,900,000
Building [Member] | Minimum [Member]
Accounting Policies [Line Items]
Estimated useful lives		20 years
Building [Member] | Maximum [Member]
Accounting Policies [Line Items]
Estimated useful lives		40 years

REAL ESTATE ASSET ACQUISITION_3

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT (Narrative) (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($)	Sep. 30, 2021 USD ($) item	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Apr. 30, 2022
Real Estate Properties [Line Items]
Number of real estate properties | facility			1,026
Noncash consideration exchanged			$ 344,000		$ 8,200
Payments To Acquire Commercial Real Estate			408,628	$ 262,453	229,987
Percentage of annual escalators						2.25%
Payments for construction in progress and capital improvement programs			106,700	82,500	64,400
Real estate investments			9,060,174	8,372,419
Construction in progress			210,870	138,410
DISTRICT OF COLUMBIA
Real Estate Properties [Line Items]
Development project capitalized costs excluding initial acquisition costs			72,000	51,200	$ 14,900
Construction in progress			208,000	136,000
Virginia
Real Estate Properties [Line Items]
Payments To Acquire Commercial Real Estate	$ 800
Total commitments	$ 15,200
Construction in progress			2,500	2,400
Maplewood Real Estate Holdings
Real Estate Properties [Line Items]
Rental income				$ 62,600
Maplewood Real Estate Holdings | DISTRICT OF COLUMBIA
Real Estate Properties [Line Items]
Payments To Acquire Commercial Real Estate		$ 68,000
Total commitments			225,800
Security deposit			$ 5,500
Deferred rent interest percentage			5%
Maplewood Real Estate Holdings | DISTRICT OF COLUMBIA | Scenario, Plan [Member]
Real Estate Properties [Line Items]
Number of beds | item		174
Maplewood Real Estate Holdings | DISTRICT OF COLUMBIA | Scenario, Construction Phase [Member]
Real Estate Properties [Line Items]
Financing accrual interest rate, expected percentage			5%
Maplewood Real Estate Holdings | DISTRICT OF COLUMBIA | Scenario, Following Construction Phase [Member]
Real Estate Properties [Line Items]
Percentage of annual cash yield increase in year one			6%
Percentage of annual cash yield increase in year two			7%
Percentage of annual cash yield increase in year three			8%
Percentage of annual escalators			2.50%

REAL ESTATE ASSET ACQUISITION_4

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT (Schedule of Significant Acquisitions) (Details)	3 Months Ended											9 Months Ended	12 Months Ended
	Dec. 31, 2024 USD ($) facility	Sep. 30, 2024 USD ($) facility	Jun. 30, 2024 USD ($) facility	Mar. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Sep. 30, 2023 USD ($) facility	Jun. 30, 2023 USD ($) facility	Mar. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility	Mar. 31, 2022 USD ($) facility	Sep. 30, 2024 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Jul. 31, 2024	Jul. 24, 2024 USD ($)	Jun. 30, 2022 facility	Jan. 01, 2022 USD ($)	Dec. 18, 2019 facility
Real Estate Properties [Line Items]
Number of real estate properties | facility	1,026												1,026
Real Estate Assets Acquired													$ 740,500,000	$ 261,200,000	$ 225,200,000
Deferred tax assets related to net operating loss carryforwards	$ 19,101,000				$ 9,491,000								19,101,000	9,491,000
Deferred income tax liability					1,508,000									1,508,000
Real estate investments - net	6,339,158,000				5,902,526,000								6,339,158,000	5,902,526,000
Noncash consideration exchanged													344,000,000		8,200,000
Investments in unconsolidated joint ventures	$ 88,711,000				$ 188,409,000								$ 88,711,000	$ 188,409,000
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility					63									63						63
Asset acquisition, consideration transferred												$ 461,882,000
Investments in unconsolidated joint ventures					$ 97,559,000									$ 97,559,000			$ 97,000,000
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Real Estate Properties [Line Items]
Percentage of ownership interest, asset acquisition	51%	51%										51%	51%			51%
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Percentage of ownership interest					49%									49%			49%			49%
Virginia
Real Estate Properties [Line Items]
Real Estate Assets Acquired						$ 15,600,000
Initial Annual Cash Yield (%)						10%
North Carolina
Real Estate Properties [Line Items]
Real Estate Assets Acquired		$ 8,800,000
Initial Annual Cash Yield (%)		10%
United Kingdom
Real Estate Properties [Line Items]
Real Estate Assets Acquired			$ 50,800,000	$ 5,200,000	$ 3,800,000	$ 39,500,000		$ 26,400,000		$ 28,200,000
Initial Annual Cash Yield (%)			10%	9.50%	9%	10.20%		8%		8%
Deferred tax asset, net			$ 11,900,000
Non Cash Lease Liability Ground Lease								$ 9,900,000						$ 9,900,000
NonCash Right of Use Ground Lease								$ 9,900,000						$ 9,900,000
Asset acquisition, consideration transferred			62,700,000
UNITED KINGDOM One [Member]
Real Estate Properties [Line Items]
Real Estate Assets Acquired	$ 39,700,000
Total Value of Real Estate Assets Acquired		$ 421,000,000									$ 8,700,000
Initial Annual Cash Yield (%)	10%	9.90%									8%
Asset acquisition, consideration transferred		$ 461,900,000
Asset acquisition, costs allocated to other assets		53,800,000
Asset acquisition, costs allocated to other liabilities		13,000,000
UNITED KINGDOM Two [Member]
Real Estate Properties [Line Items]
Real Estate Assets Acquired	$ 111,500,000	$ 5,100,000									$ 5,000,000
Initial Annual Cash Yield (%)	10%	10%									8%
UNITED KINGDOM Three [Member]
Real Estate Properties [Line Items]
Real Estate Assets Acquired		$ 10,800,000
Total Value of Real Estate Assets Acquired											$ 86,600,000
Initial Annual Cash Yield (%)		10%									8%
Texas
Real Estate Properties [Line Items]
Real Estate Assets Acquired	$ 19,500,000
Initial Annual Cash Yield (%)	10%
Maryland
Real Estate Properties [Line Items]
Real Estate Assets Acquired					$ 22,500,000						$ 8,200,000
Initial Annual Cash Yield (%)					10%						9.50%
Pennsylvania and North Carolina
Real Estate Properties [Line Items]
Real Estate Assets Acquired									$ 88,500,000
Initial Annual Cash Yield (%)									9%
West Virginia
Real Estate Properties [Line Items]
Real Estate Assets Acquired				$ 8,100,000			$ 114,800,000
Initial Annual Cash Yield (%)				10%			9.50%
Financing receivable, face amount							$ 104,600,000
West Virginia Two [Member]
Real Estate Properties [Line Items]
Real Estate Assets Acquired							$ 13,700,000
Initial Annual Cash Yield (%)							10%
Louisiana
Real Estate Properties [Line Items]
Real Estate Assets Acquired			$ 21,000,000		$ 24,900,000
Initial Annual Cash Yield (%)			10%		10%
Percentage of initial yield that could be deferred					2%
Michigan
Real Estate Properties [Line Items]
Real Estate Assets Acquired			$ 31,000,000
Initial Annual Cash Yield (%)			11.50%
Oregon
Real Estate Properties [Line Items]
Real Estate Assets Acquired	$ 8,000,000
Initial Annual Cash Yield (%)	10%
4 of 7 Facilities | Exchange Accommodation Titleholders [Member] | Variable Interest Entity, Primary Beneficiary [Member]
Real Estate Properties [Line Items]
Real estate investments - net									$ 55,200,000						55,200,000
Cash									$ 23,900,000						$ 23,900,000
Skilled Nursing Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	589												589
Assisted Living Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	290												290
Specialty [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	18												18
Medical Office Building [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	1												1
Facilities Acquired | Exchange Accommodation Titleholders [Member]
Real Estate Properties [Line Items]
Number of real estate properties									7						7
Facilities Acquired | Skilled Nursing Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	6				9				7				6	9	7
Facilities Acquired | Skilled Nursing Facilities [Member] | Virginia
Real Estate Properties [Line Items]
Number of real estate properties | facility						1
Facilities Acquired | Skilled Nursing Facilities [Member] | North Carolina
Real Estate Properties [Line Items]
Number of real estate properties | facility		1										1
Facilities Acquired | Skilled Nursing Facilities [Member] | Texas
Real Estate Properties [Line Items]
Number of real estate properties | facility	2												2
Facilities Acquired | Skilled Nursing Facilities [Member] | Maryland
Real Estate Properties [Line Items]
Number of real estate properties					1						1			1					1
Facilities Acquired | Skilled Nursing Facilities [Member] | Pennsylvania and North Carolina
Real Estate Properties [Line Items]
Number of real estate properties | facility									6						6
Facilities Acquired | Skilled Nursing Facilities [Member] | West Virginia
Real Estate Properties [Line Items]
Number of real estate properties | facility				1			4
Facilities Acquired | Skilled Nursing Facilities [Member] | West Virginia Two [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility							1
Facilities Acquired | Skilled Nursing Facilities [Member] | Louisiana
Real Estate Properties [Line Items]
Number of real estate properties | facility			1		2									2
Facilities Acquired | Skilled Nursing Facilities [Member] | Michigan
Real Estate Properties [Line Items]
Number of real estate properties | facility			1
Facilities Acquired | Assisted Living Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	108				21				34				108	21	34
Facilities Acquired | Assisted Living Facilities [Member] | United Kingdom
Real Estate Properties [Line Items]
Number of real estate properties | facility			32	1	1	14		6		4				1
Facilities Acquired | Assisted Living Facilities [Member] | UNITED KINGDOM One [Member]
Real Estate Properties [Line Items]
Number of real estate properties	3	63									1	63	3
Real Estate Assets Acquired											$ 8,200,000
Deferred tax liability											$ 500,000
Facilities Acquired | Assisted Living Facilities [Member] | UNITED KINGDOM Two [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility	6	1									1	1	6
Facilities Acquired | Assisted Living Facilities [Member] | UNITED KINGDOM Three [Member]
Real Estate Properties [Line Items]
Number of real estate properties		1									27	1
Real Estate Assets Acquired											$ 100,000,000
Deferred tax asset, net											$ 13,400,000
Facilities Acquired | Assisted Living Facilities [Member] | Pennsylvania and North Carolina
Real Estate Properties [Line Items]
Number of real estate properties | facility									1						1
Facilities Acquired | Assisted Living Facilities [Member] | Oregon
Real Estate Properties [Line Items]
Number of real estate properties | facility	1												1
Facilities Acquired Acquisition Completed [Member] | 3 of 7 Facilities | Variable Interest Entity, Primary Beneficiary [Member]
Real Estate Properties [Line Items]
Number of real estate properties									3						3
Facilities Acquired Acquisition Pending [Member] | 4 of 7 Facilities | Exchange Accommodation Titleholders [Member] | Variable Interest Entity, Primary Beneficiary [Member]
Real Estate Properties [Line Items]
Number of real estate properties									4						4
Facilities Acquired Released From EAT [Member] | 4 of 7 Facilities | Exchange Accommodation Titleholders [Member] | Variable Interest Entity, Primary Beneficiary [Member]
Real Estate Properties [Line Items]
Number of real estate properties							4
Facilities Transitioned to Other Operators [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility																		1

REAL ESTATE ASSET ACQUISITION_5

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT (Cindat Portfolio Acquisition) (Narrative) (Details) $ in Thousands, £ in Millions	1 Months Ended	9 Months Ended	12 Months Ended
	Jul. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($)	Aug. 01, 2024	Jul. 31, 2024 GBP (£)	Jul. 24, 2024 USD ($)	Apr. 30, 2022	Dec. 18, 2019 facility
Real Estate Properties [Line Items]
Number of real estate properties | facility			1,026
Payments to Acquire Interest in Joint Venture			$ 971	$ 12,350	$ 113
Contractual rent income expected to be received			69,300
Percentage of annual escalators									2.25%
Investments in unconsolidated joint ventures			$ 88,711	$ 188,409
Total of payments made and liabilities assumed, asset acquisition	$ 364,900
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Ownership by parent						100%
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Number of real estate properties | facility				63						63
Loans Assumed		$ 263,990
Contractual rent income expected to be received				$ 43,600
Investments in unconsolidated joint ventures				$ 97,559				$ 97,000
Cindat Ice Portfolio JV GP Limited [Member] | Maximum [Member]
Real Estate Properties [Line Items]
Percentage of annual escalators				2%
Cindat Ice Portfolio JV GP Limited [Member] | Minimum [Member]
Real Estate Properties [Line Items]
Percentage of annual escalators				1%
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Real Estate Properties [Line Items]
Percentage of ownership interest, asset acquisition	51%	51%	51%				51%
Payments to Acquire Interest in Joint Venture	$ 98,900
Loans Assumed	264,000
Asset acquisition, contingent consideration liability	$ 2,000
Asset acquisition, liability assumed, long-term debt | £							£ 188.6
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Percentage of ownership interest				49%				49%		49%

REAL ESTATE ASSET ACQUISITION_6

REAL ESTATE ASSET ACQUISITIONS AND DEVELOPMENT (Cindat Portfolio Acquisition) (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Jul. 31, 2024	Sep. 30, 2024	Dec. 31, 2024	Jul. 24, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 18, 2019
Costs to be allocated:
Investments in unconsolidated joint ventures			$ 88,711		$ 188,409
Fair value of net assets acquired:
Real estate assets			7,921,814		7,378,929
Non-real estate loans receivable - net			332,274		275,615
Cash and cash equivalents			518,340		442,810	$ 297,103
Restricted cash			30,395		1,920	$ 3,541
Contractual receivables - net			12,611		11,888
Other assets			189,476		147,686
Total Assets			9,897,891		9,117,402
Accrued expenses and other liabilities			$ (328,193)		$ (287,795)
Cindat Ice Portfolio JV GP Limited [Member]
Fair value of net assets acquired:
Percentage of ownership interest				49%	49%		49%
Cindat Ice Portfolio JV GP Limited [Member]
Costs to be allocated:
Investments in unconsolidated joint ventures				$ 97,000	$ 97,559
Loans Assumed		$ 263,990
Total acquisition cost to be allocated		461,882
Fair value of net assets acquired:
Real estate assets		421,044
Non-real estate loans receivable - net		1,632
Cash and cash equivalents		6,866
Restricted cash		14,050
Contractual receivables - net		8
Other assets		31,278
Total Assets		474,878
Accrued expenses and other liabilities		(12,996)
Fair value of net assets acquired		461,882
Cindat Ice Portfolio JV GP Limited 49% Acquisition [Member]
Costs to be allocated:
Payments to acquire asset		96,971
Cindat Ice Portfolio JV GP Limited 51% Acquisition [Member]
Costs to be allocated:
Payments to acquire asset		$ 100,921
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Costs to be allocated:
Loans Assumed	$ 264,000
Fair value of net assets acquired:
Percentage of ownership interest, asset acquisition	51%	51%	51%

ASSETS HELD FOR SALE, DISPOSI_3

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Schedule of Properties Held-for-Sale) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2025 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility
Number of real estate properties		1,026
Amount of Assets Held for Sale | $		$ 56,194	$ 67,116
10 Facilities | Subsequent Event [Member]
Total proceeds | $	$ 54,200
Facilities Held for Sale [Member]
Number of real estate properties		12	14
Facilities with Classified Held for Sale and Subsequently Sold | Subsequent Event [Member]
Number of real estate properties	10

ASSETS HELD FOR SALE, DISPOSI_4

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Asset Sales) (Details)	3 Months Ended					6 Months Ended		12 Months Ended
	Mar. 31, 2024 item	Dec. 31, 2023 USD ($) facility	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2022 USD ($) facility	Dec. 31, 2022 USD ($) facility	Jun. 30, 2022 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Dec. 30, 2022 facility	Sep. 30, 2022 facility
Number of real estate properties | facility								1,026
Interest received recorded as contract liability								$ 1,700,000	$ 6,400,000
Collection of loan principal								207,617,000	165,191,000	$ 345,665,000
Accrued expenses and other liabilities		$ 287,795,000						$ 328,193,000	287,795,000
Number Of Assumed Loans Retired | item	9
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of real estate properties			11
Seven Hud Mortgages [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number Of Assumed Loans Retired			7
Twenty Two Hud Mortgages [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Amount of gain (loss) from sale of facilities		(6,500,000)
Non Cash Proceeds From Sale Of Real Estate Investments		$ 213,300,000
Number Of Assumed Loans Retired		22
Medical Office Building [Member]
Number of real estate properties | facility								1
Skilled Nursing Facilities [Member]
Number of real estate properties | facility								589
Independent Living Facilities [Member]
Number of real estate properties | facility								19
Assisted Living Facilities [Member]
Number of real estate properties | facility								290
1 Facility | Guardian [Member]
Financing receivable, face amount				$ 12,000,000
1 of 6 Facilities | Guardian [Member]
Total proceeds				12,000,000
5 of 6 Facilities | Guardian [Member]
Total proceeds				23,800,000
Amount of gain (loss) from sale of facilities				$ 0
7 Facilities | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Total proceeds			$ 84,400,000
Amount of gain (loss) from sale of facilities			(5,500,000)
Cash Proceeds From Sale Of Real Estate Investments			14,800,000
Non Cash Proceeds From Sale Of Real Estate Investments			69,600,000
9 Facilities | Guardian [Member]
Total proceeds							$ 39,500,000
Amount of gain (loss) from sale of facilities							$ 13,700,000
11 Facilities
Amount of gain (loss) from sale of facilities									50,200,000
Interest received recorded as contract liability									5,700,000
Collection of loan principal			$ 104,800,000
Accrued expenses and other liabilities		$ 25,000,000							25,000,000
21 Facilities
Total proceeds								$ 95,000,000
Amount of gain (loss) from sale of facilities								$ 13,200,000
22 Facilities | Gulf Coast LLC [Member]
Total proceeds					$ 304,900,000
Amount of gain (loss) from sale of facilities					114,500,000
Potential earnout amount per sales agreement					$ 18,700,000
22 Facilities | Agemo Holdings LLC [Member]
Total proceeds						$ 358,700,000
Amount of gain (loss) from sale of facilities						$ 218,900,000
30 Facilities | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Total proceeds		317,900,000
Cash Proceeds From Sale Of Real Estate Investments		$ 104,600,000
66 Facilities
Total proceeds										759,000,000
Amount of gain (loss) from sale of facilities										$ 360,000,000
69 Facilities
Total proceeds									585,000,000
Amount of gain (loss) from sale of facilities									$ 79,700,000
Facilities Sold
Number of real estate properties		69				66		21	69	66
Facilities Sold | Gulf Coast LLC [Member]
Number of real estate properties | facility					22
Facilities Sold | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of real estate properties		30	7			11			30	11	11
Facilities Sold | Guardian [Member]
Number of real estate properties				6	9		9
Facilities Sold | Agemo Holdings LLC [Member]
Number of real estate properties | facility						22				22		22
Facilities Sold | Medical Office Building [Member]
Number of real estate properties		1							1
Facilities Sold | Skilled Nursing Facilities [Member]
Number of real estate properties		64						14	64
Facilities Sold | Independent Living Facilities [Member]
Number of real estate properties		1							1
Facilities Sold | Specialty Facility
Number of real estate properties		1						1	1
Facilities Sold | Assisted Living Facilities [Member]
Number of real estate properties		2						6	2
Facilities Sold | 1 of 6 Facilities | Guardian [Member]
Number of real estate properties				1
Facilities Sold | 5 of 6 Facilities | Guardian [Member]
Number of real estate properties				5
Facilities Sold Not Yet Recognized [Member]
Number of real estate properties | facility		1						3	1
Facilities Transitioned to Other Operators [Member]
Number of real estate properties | facility							1
Facilities Transitioned to Other Operators [Member] | Guardian [Member]
Number of real estate properties | facility					8

ASSETS HELD FOR SALE, DISPOSI_5

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Real Estate Impairment) (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Sep. 30, 2023 USD ($)	Jun. 30, 2022 facility
Impairment of Real Estate	$ 23,831,000	$ 91,943,000	$ 38,451,000
Number of Facilities | facility	1,026
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of Facilities				11
Facilities Transitioned to Other Operators [Member]
Number of Facilities | facility					1
14 Facilities
Impairment of Real Estate	$ 23,800,000
14 Facilities | Facilities With Impairment Charges [Member]
Number of Facilities | facility	14
6 of 14 Facilities
Impairment of Real Estate	$ 10,900,000
6 of 14 Facilities | Facilities with Impairment Charges and Classified to Assets Held for Sale [Member]
Number of Facilities | facility	6
4 of 6 Facilities | Facilities with Impairment Charges Held for Sale and Subsequently Sold [Member]
Number of Facilities | facility	4
8 of 14 Facilities
Impairment of Real Estate	$ 12,900,000
8 of 14 Facilities | Facilities With Impairment Charges Held For Use [Member]
Number of Facilities | facility	8
3 of 8 Facilities
Impairment of Real Estate	$ 5,300,000
3 of 8 Facilities | Facilities With Impairments Held for Use And Later Sold [Member]
Number of Facilities | facility	3
4 of 8 Facilities
Impairment of Real Estate	$ 7,200,000
4 of 8 Facilities | Facilities With Impairment Charges Held For Use Later Closed [Member]
Number of Facilities | facility	4
22 Facilities
Impairment of Real Estate			$ 38,500,000
22 Facilities | Facilities With Impairment Charges [Member]
Number of Facilities | facility			22
2 of 22 Facilities
Impairment of Real Estate			$ 3,500,000
2 of 22 Facilities | Facilities with Impairment Charges and Classified to Assets Held for Sale and Subsequently Sold [Member]
Number of Facilities | facility			2
20 of 22 Facilities
Impairment of Real Estate			$ 35,000,000
20 of 22 Facilities | Facilities With Impairment Charges Held For Use [Member]
Number of Facilities | facility			20
12 of 20 Facilities | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Impairment of Real Estate			$ 17,200,000
12 of 20 Facilities | Facilities With Impairment Charges [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of Facilities | facility			12
4 of 20 Facilities | Facilities With Impairment Charges Held For Use [Member]
Number of Facilities | facility			4
4 of 20 Facilities | Facilities With Impairment Charges [Member] | 2.0% Operator
Impairment of Real Estate			$ 10,000,000
25 Facilities
Impairment of Real Estate		$ 91,900,000
25 Facilities | Facilities With Impairment Charges [Member]
Number of Facilities		25
23 of 25 Facilities | Facilities With Impairment Charges Held For Use [Member]
Impairment of Real Estate		$ 89,300,000
Number of Facilities		23
3 of 23 Facilities | Facilities With Impairment Charges Held For Use And Later Closed [Member]
Impairment of Real Estate		$ 48,000,000
Number of Facilities		3
20 of 23 Facilities | Facilities With Impairments Held for Use And Later Sold [Member]
Impairment of Real Estate		$ 51,700,000
Number of Facilities		20
2 of 25 Facilities
Impairment of Real Estate		$ 2,600,000
2 of 25 Facilities | Facilities with Impairment Charges and Classified to Assets Held for Sale [Member]
Number of Facilities		2

CONTRACTUAL RECEIVABLES AND O_3

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Schedule of Net Accounts Receivable) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
Contractual receivables - net	$ 12,611	$ 11,888
Effective yield interest receivables	1,839	3,127
Straight-line rent receivables	238,690	202,748
Lease inducements	8,788	8,782
Other receivables and lease inducements	$ 249,317	$ 214,657

CONTRACTUAL RECEIVABLES AND O_4

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Cash Basis Operators and Straight Line Receivable Write Offs Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) facility	Jun. 30, 2022 USD ($) facility	Dec. 31, 2024 USD ($) item facility	Dec. 31, 2023 USD ($) item facility	Dec. 31, 2022 USD ($) item	Jun. 30, 2023 item
Number of operators | item			87
Number Of Operators Placed On A Cash Basis | item					9
Number of Facilities | facility			1,026
Straight Line Rent Receivable Wrote Off		$ 8,300,000
Straight line rent receivable write-offs, lease inducements write-offs and effective yield interest receivable write-offs			$ 4,200,000	$ 20,600,000	$ 124,800,000
48 Facilities | Scenario, Plan [Member]
Expected amount to be received				$ 48,000,000
14 of 48 Facilities
Termination fee incurred cost	$ 15,500,000
Facilities Transitioned From Operators [Member] | 48 Facilities
Number Of Operators Placed On A Cash Basis				4
Facilities Transitioned To Operators [Member] | 48 Facilities
Number of operators | item				5
Facilities Transitioned From 4 Cash Basis Operators To 5 Operators [Member]
Number of Facilities | facility				48
Facilities Transitioned to Other Operators [Member]
Number of Facilities | facility		1
Straight Line Rent Receivable Wrote Off			$ 1,400,000	$ 8,100,000	3,200,000
Operator Placed On Cash Basis [Member]
Number of operators			21	19
9 Operators Placed On Cash Basis
Straight line accounts receivable and lease inducements write-offs					$ 119,800,000
19 Operators Placed On Cash Basis [Member] | Revenue, Product and Service Benchmark [Member] | Customer Concentration Risk [Member]
Concentration risk, percentage				23.10%	25.90%
21 Operators Placed On Cash Basis | Revenue, Product and Service Benchmark [Member] | Customer Concentration Risk [Member]
Concentration risk, percentage			20.50%	22.10%	25.60%
Existing Operator [Member]
Number Of Operators Placed On A Cash Basis			1	1
Straight line rent receivable write off related to placing operators on cash basis			$ 2,800,000	$ 0
New Operator [Member]
Number of operators | item						2
Number Of Operators Placed On A Cash Basis			3	2
Straight line rent receivable write off related to placing operators on cash basis			$ 0	$ 0
1.2% Operator | Facilities Transitioned To Operators [Member] | 14 of 48 Facilities
Number of Facilities	14			14
1.2% Operator | Revenue, Product and Service Benchmark [Member] | Customer Concentration Risk [Member]
Concentration risk, percentage					1.20%
2.0% Operator
Straight line accounts receivable and lease inducements write-offs					$ 10,500,000
2.0% Operator | Facilities Transitioned To Operators [Member]
Number of Facilities	20				3
2.0% Operator | Facilities Being Transitioned To Other Operator [Member] | 20 of 48 Facilities
Number of Facilities | facility				20
2.0% Operator | Revenue, Product and Service Benchmark [Member] | Customer Concentration Risk [Member]
Concentration risk, percentage					2%

CONTRACTUAL RECEIVABLES AND O_5

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Rent Deferrals and Applications of Collateral Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Number of operators in which deferred rent was allowed	4	10	10
Deferred aggregate rent	$ 4,300,000	$ 35,900,000	$ 27,000,000
The number of operators in which security deposit was applied to pay rent	6	6	7
Deferred rent received	$ 2,100,000	$ 1,400,000	$ 300,000
Collateral used against uncollectible receivables	2,200,000	17,600,000	$ 11,000,000
Maplewood Real Estate Holdings
Deferred aggregate rent	$ 3,500,000	1,800,000
Security deposit used against uncollected receivables		4,800,000
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Deferred aggregate rent		19,000,000
Healthcare Homes Limited [Member]
Deferred aggregate rent		8,200,000
Agemo Holdings LLC [Member]
Deferred aggregate rent		$ 1,900,000

CONTRACTUAL RECEIVABLES AND O_6

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - Agemo) (Details)

1 Months Ended

3 Months Ended

12 Months Ended

Jan. 31, 2023 USD ($)

Sep. 30, 2022 USD ($) facility

Mar. 31, 2023 USD ($) contract

Dec. 31, 2024 USD ($) facility

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($) facility

Nov. 01, 2024

Oct. 31, 2024

Jun. 30, 2023

May 31, 2018 USD ($)

May 17, 2018 USD ($)

May 07, 2018 USD ($)

Sep. 30, 2016 USD ($)

Interest income related to loans on non-accrual status

$ 3,300,000

$ 1,700,000

$ 17,200,000

Deferred aggregate rent

$ 4,300,000

$ 35,900,000

$ 27,000,000

Number of real estate properties | facility

1,026

Facilities Sold

Number of real estate properties

21

69

66

Notes Receivable Due 2036 [Member]

Interest rate

5.71%

Working Capital Loans [Member]

Interest rate

10%

Agemo Holdings LLC [Member]

Deferred aggregate rent

$ 1,900,000

Lease expiration date

Dec. 31, 2036

Dec. 31, 2030

Number of Extension Options | contract

3

Agreement for lease extension period duration

10 years

Agemo Holdings LLC [Member] | Facilities Sold

Number of real estate properties | facility

22

22

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]

Rental income

$ 23,800,000

$ 17,400,000

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Notes Receivable Due 2036 [Member]

Interest rate

5.71%

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Notes Receivable Term Loan [Member]

Financing receivable, face amount

$ 32,000,000

Interest rate

9%

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Working Capital Loans [Member]

Financing receivable, face amount

$ 25,000,000

$ 25,000,000

Interest rate

7%

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Notes Receivable $82.2 Million Due 2036 [Member]

Interest income related to loans on non-accrual status

$ 0

$ 0

Financing receivable, face amount

$ 82,200,000

Interest rate

5.63%

5.71%

5.71%

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Operator Placed On Cash Basis [Member]

Potential accumulated deferred rent payments

$ 6,300,000

Deferred aggregate rent

$ 25,200,000

Monthly expected payment amount to be received

$ 4,800,000

Restructured contractual rent amount

$ 1,900,000

Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Operator Placed On Cash Basis [Member] | Facilities Sold

Number of real estate properties | facility

22

22

CONTRACTUAL RECEIVABLES AND O_7

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - LaVie) (Details)		1 Months Ended			3 Months Ended				4 Months Ended	6 Months Ended	12 Months Ended
	Dec. 31, 2022 USD ($) facility	Jun. 30, 2024 USD ($)	May 31, 2024 USD ($)	Apr. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) facility	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Apr. 30, 2023 USD ($)	Dec. 29, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Jun. 03, 2024 USD ($) facility	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Dec. 30, 2022 facility
Number of real estate properties | facility					1,026						1,026
Contractual rent income expected to be received											$ 69,300,000
Interest income related to loans on non-accrual status											3,300,000	$ 1,700,000	$ 17,200,000
Deferred aggregate rent											$ 4,300,000	$ 35,900,000	$ 27,000,000
Facilities Sold
Number of real estate properties	66				21		69	66			21	69	66
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of real estate properties															11
Monthly expected payment amount to be received							$ 3,300,000			$ 8,300,000
Rental income		$ 2,900,000	$ 1,500,000	$ 1,500,000	$ 9,100,000	$ 9,200,000	5,300,000				$ 28,600,000	$ 37,000,000
Short paid amount of rent paid		$ 100,000	$ 1,500,000	$ 1,700,000			7,800,000					21,100,000
Contractual rent income expected to be received							$ 13,100,000					58,100,000
Interest income related to loans on non-accrual status											$ 0	0	$ 0
Straight line accounts receivable and lease inducements write-offs								$ 58,000,000
Deferred aggregate rent												$ 19,000,000
Restructured contractual rent amount	$ 7,300,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Maximum [Member]
Deferred aggregate rent									$ 19,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Scenario, Plan [Member]
Termination fee incurred cost								$ 35,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Omega Healthcare And TIX 33433 LLC DIP Sponsor Loan [Member]
Debtor-in-Possession Financing, Amount Arranged														$ 20,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Omega Healthcare DIP Sponsor Loan [Member]
Debtor-in-Possession Financing, Amount Arranged														$ 10,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Third Party Operator [Member] | 11 Facilities
Termination fee incurred cost													$ 25,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Facilities Being Transitioned To Other Operator [Member]
Number of real estate properties																2
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Facilities Sold
Number of real estate properties	11						30	11				30	11		7		11
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Facilities Previously Subject to Master Lease [Member]
Number of real estate properties							30					30			7
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Facilities Operated While in Chapter 11 [Member]
Number of real estate properties | facility														30

CONTRACTUAL RECEIVABLES AND O_8

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - Maplewood) (Details)	1 Months Ended	3 Months Ended			12 Months Ended
	Jan. 31, 2025 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2025	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 22, 2022 USD ($)	Jul. 31, 2020 USD ($)
Contractual rent income expected to be received						$ 69,300,000
Contractual interest income expected to be received						2,700,000
Restructuring agreement limited unconditional guaranty contractual receivable		$ 40,000,000
Interest income related to loans on non-accrual status						3,300,000	$ 1,700,000	$ 17,200,000
Interest income						$ 157,207,000	119,888,000	123,919,000
Number of real estate properties | facility						1,026
Contractual obligation						$ 337,994,000
Other Real Estate Loans [Member]
Contractual obligation						$ 50,446,000
Other Real Estate Loans Due 2035 [Member]
Interest rate						7%
Other Real Estate Loans Due 2035 [Member] | Scenario, Plan [Member]
Interest Paid In Cash					4%	1%
Interest Paid In Kind					3%	6%
Investment Type Characteristic Real Estate Related Loans [Member]
Interest income						$ 126,800,000	97,766,000	110,322,000
Investment Type Characteristic Real Estate Related Loans [Member] | Other Real Estate Loans [Member]
Interest income						35,366,000	29,426,000	36,089,000
Maplewood Real Estate Holdings
Revenue from collecting rental and interest payments						47,500,000	57,800,000
Rental income							62,600,000
Contractual income expected to be received, rent and interest						72,000,000
Contractual rent income expected to be received							69,300,000
Restructuring Agreement Expected Rent			$ 69,300,000
Termination fee incurred cost			$ 12,500,000				12,500,000
Security deposit used against uncollected receivables							4,800,000
Straight line accounts receivable and lease inducements write-offs				$ 29,300,000
Lease expiration month year			2037-12	2033-12
Deferred percentage of annual escalators			2.50%
Short paid amount of rent paid						24,500,000	11,500,000
Maplewood Real Estate Holdings | Subsequent Event [Member]
Short paid amount of rent paid	$ 1,300,000
Maplewood Real Estate Holdings | Other Real Estate Loans Due 2030 [Member]
Financing receivable, face amount				$ 250,500,000				250,500,000
Interest rate										7%	7%
Maplewood Real Estate Holdings | Other Real Estate Loans Due 2035 [Member]
Interest income related to loans on non-accrual status						0	$ 1,500,000	14,700,000
Financing receivable, face amount			$ 320,000,000						$ 250,500,000	$ 250,500,000	$ 220,500,000
Financing receivable, gross, including accrued interest						$ 301,700,000
Interest rate										7%	7%
Interest Paid In Cash					4%	1%
Interest Paid In Kind					3%	6%
Maplewood Real Estate Holdings | Capital Expenditure Committed [Member] | Scenario, Plan [Member]
Contractual obligation			22,500,000
Maplewood Real Estate Holdings | Investment Type Characteristic Real Estate Related Loans [Member] | Other Real Estate Loans Due 2035 [Member]
Contractual interest income expected to be received						$ 2,700,000
Interest income			$ 1,500,000					$ 14,700,000

CONTRACTUAL RECEIVABLES AND O_9

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - Guardian) (Details)		1 Months Ended	3 Months Ended				12 Months Ended
	Jul. 01, 2022 USD ($)	Apr. 30, 2024 USD ($) facility	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($) facility	Dec. 31, 2024 USD ($) facility item	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Apr. 30, 2022 USD ($)	Mar. 31, 2022 item facility
Number of real estate properties | facility							1,026
Contractual rent income expected to be received							$ 69,300,000
Straight Line Rent Receivable Wrote Off						$ 8,300,000
Number of operators | item							87
Percentage of annual escalators										2.25%
Potential accumulated deferred rent payments - rent portion										$ 12,200,000
Potential accumulated deferred rent payments - interest portion										5,800,000
Operator Placed On Cash Basis [Member]
Number of operators							21	19
Facilities Sold
Number of real estate properties							21	69	66
Facilities Transitioned to Other Operators [Member]
Number of real estate properties | facility						1
Straight Line Rent Receivable Wrote Off							$ 1,400,000	$ 8,100,000	$ 3,200,000
Guardian [Member]
Rental income			$ 100,000					$ 16,800,000
Security deposit used against uncollected receivables				$ 6,300,000
Reduced combined rent and interest following restructuring activities					$ 1,500,000
Guardian [Member] | Financing Restructuring Agreement And Amendments [Member]
Reduced combined rent and interest following restructuring activities	$ 24,000,000
Restructuring agreement rent	15,000,000
Restructuring agreement mortgage interest	$ 9,000,000
Potential accumulated deferred rent payments										$ 18,000,000
Guardian [Member] | Operator Placed On Cash Basis [Member]
Rental income									$ 11,300,000
Guardian [Member] | Facilities Being Transitioned To Other Operator [Member]
Rental income							$ 8,300,000
Number of real estate properties | facility		6
Guardian [Member] | Facilities Being Transitioned To Other Operator [Member] | Minimum [Member]
Contractual rent income expected to be received		$ 5,500,000
Guardian [Member] | Facilities Sold
Number of real estate properties					6	9					9
Guardian [Member] | Three Facilities Previously Subject To Mortgage Financing From Entity [Member]
Number of real estate properties | facility											3
Guardian [Member] | Facilities Previously Subject To Mortgage Financing From Entity [Member]
Number of real estate properties					4
Guardian [Member] | Facilities Transitioned to Other Operators [Member]
Number of real estate properties | facility											8
Guardian [Member] | Facilities Transitioned to Other Operators [Member] | 8 Facilities
Number of operators | item											2

CONTRACTUAL RECEIVABLES AND _10

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - Healthcare Homes) (Details) £ in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Apr. 30, 2023 GBP (£)
Deferred aggregate rent	$ 4.3	$ 35.9	$ 27
Healthcare Homes Limited [Member]
Potential accumulated deferred rent payments | £				£ 6.7
Deferred aggregate rent		$ 8.2

CONTRACTUAL RECEIVABLES AND _11

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Operator Collectibility - Specific Revenue Operator) (Details)	1 Months Ended	3 Months Ended			12 Months Ended
	Apr. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) facility
Straight Line Rent Receivable Wrote Off				$ 8,300,000
Restricted cash		$ 3,541,000			$ 30,395,000	$ 1,920,000	$ 3,541,000
Collateral used against uncollectible receivables					$ 2,200,000	$ 17,600,000	11,000,000
Number of Facilities | facility					1,026
1.2% Operator
Security deposit used against uncollected receivables	$ 2,000,000
Rental income		4,000,000	$ 4,000,000
1.2% Operator | Facilities Transitioned To Operators [Member] | 14 of 48 Facilities
Number of Facilities						14		14
2.0% Operator
Straight line accounts receivable and lease inducements write-offs							10,500,000
Rental income		2,200,000
Short paid amount of uncollectible receivables				600,000
Letter of credit used against uncollectible receivables		3,300,000		600,000			$ 3,300,000
Collateral used against uncollectible receivables		$ 1,500,000
2.0% Operator | Asset Pledged as Collateral with Right [Member] | Letter of Credit [Member]
Restricted cash				$ 5,400,000
2.0% Operator | Facilities Transitioned To Operators [Member]
Number of Facilities		3					3	20

CONTRACTUAL RECEIVABLES AND _12

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Lease Inducements) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2024
Lease inducements		$ 8,782	$ 8,788
Existing Operator [Member]
Lease inducements			$ 1,000
Maplewood Real Estate Holdings
Termination fee incurred cost	$ 12,500	12,500
Healthcare Homes Limited [Member]
Lease inducements		$ 3,400

LEASES (Narrative) (Detail)

LEASES (Narrative) (Detail)	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($) facility	Dec. 31, 2024 USD ($) facility property Office	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Jan. 31, 2025 facility	Jun. 30, 2024 facility	Mar. 31, 2024 facility	Sep. 30, 2023 facility	Sep. 30, 2022 facility	Jun. 30, 2022 facility
Lessee, Lease, Description [Line Items]
Number of real estate properties		1,026
Investments in direct financing leases | $		$ 11,058,000	$ 11,205,000
Accounts receivable - net | $		332,274,000	275,615,000
Other assets | $		189,476,000	147,686,000
Recovery on direct financing leases | $		(884,000)	(327,000)	$ 2,286,000
Ground Leases and/or Facility Leases [Member] | General and Administrative Expense [Member]
Lessee, Lease, Description [Line Items]
Operating lease expenses | $		$ 3,200,000	2,800,000	$ 2,200,000
United Kingdom
Lessee, Lease, Description [Line Items]
Initial non cash right of use asset - ground leases | $	$ 9,900,000		9,900,000
Initial non cash lease liability - ground leases | $	$ 9,900,000		$ 9,900,000
Facilities Sold
Lessee, Lease, Description [Line Items]
Number of real estate properties		21	69	66
Facilities Acquired | Texas | Subsequent Event [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties					2
Facilities Transitioned to Other Operators [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties										1
Facilities Held for Sale or Closed [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties		12
Skilled Nursing Facilities [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties		589
Skilled Nursing Facilities [Member] | Ground Leases and/or Facility Leases [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties | property		10
Skilled Nursing Facilities [Member] | Facilities Sold
Lessee, Lease, Description [Line Items]
Number of real estate properties		14	64
Skilled Nursing Facilities [Member] | Facilities Acquired
Lessee, Lease, Description [Line Items]
Number of real estate properties		6	9	7
Skilled Nursing Facilities [Member] | Facilities Acquired | Texas
Lessee, Lease, Description [Line Items]
Number of real estate properties		2
Assisted Living Facilities [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties		290
Assisted Living Facilities [Member] | Ground Leases and/or Facility Leases [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties | property		4
Assisted Living Facilities [Member] | Facilities Sold
Lessee, Lease, Description [Line Items]
Number of real estate properties		6	2
Assisted Living Facilities [Member] | Facilities Acquired
Lessee, Lease, Description [Line Items]
Number of real estate properties		108	21	34
Assisted Living Facilities [Member] | Facilities Acquired | United Kingdom
Lessee, Lease, Description [Line Items]
Number of real estate properties	6		1			32	1	14	4
Office leases | Ground Leases and/or Facility Leases [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties		1
Medical Office Building [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties		1
Medical Office Building [Member] | Ground Leases and/or Facility Leases [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties | Office		1
Medical Office Building [Member] | Facilities Sold
Lessee, Lease, Description [Line Items]
Number of real estate properties | $			1

LEASES (Schedule of operating l

LEASES (Schedule of operating lease income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
LEASES [Abstract]
Fixed income from operating leases	$ 871,189	$ 811,123	$ 735,247
Variable income from operating leases	15,718	14,257	14,961
Interest income from direct financing leases	1,003	1,014	1,023
Total rental income	$ 887,910	$ 826,394	$ 751,231

LEASES (Schedule of estimated c

LEASES (Schedule of estimated contractual rents due under operating leases) (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Estimated contractual rents due under operating leases
2025	$ 927,069
2026	947,098
2027	941,009
2028	917,667
2029	905,495
Thereafter	6,282,523
Total	$ 10,920,861

LEASES (Balance sheet informati

LEASES (Balance sheet information) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
LEASES [Abstract]
Right of use assets	$ 28,302	$ 30,178
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Lease liabilities	$ 30,328	$ 31,625
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Accrued Expenses and Other Liabilities	Accrued Expenses and Other Liabilities

LEASES (Schedule of Components

LEASES (Schedule of Components of Investment in Direct Financing Leases) (Detail)	Dec. 31, 2024 USD ($) property facility	Dec. 31, 2023 USD ($) property	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Lessee, Lease, Description [Line Items]
Minimum lease payments receivable	$ 21,478,000	$ 22,628,000
Less unearned income	(10,420,000)	(11,423,000)
Investment in direct financing leases	11,058,000	11,205,000
Less allowance for expected credit losses on direct financing leases	(1,605,000)	(2,489,000)	$ (2,816,000)	$ (530,000)
Investment in direct financing leases - net	$ 9,453,000	$ 8,716,000
Number of real estate properties | facility	1,026
Number of direct financing leases	1	1
Facilities Subject to Direct Financing Leases [Member]
Lessee, Lease, Description [Line Items]
Number of real estate properties | property	1	1

REAL ESTATE LOANS RECEIVABLE (N

REAL ESTATE LOANS RECEIVABLE (Narrative) (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) state loan property item facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	1,026
Number of states and U.K. | state	42
Number of other real estate loans | loan	11
Payments to acquire loans receivable	$ 470,011,000	$ 420,626,000	$ 371,987,000
Collection of loan principal	207,617,000	165,191,000	$ 345,665,000
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	1,499,547,000
Collection of loan principal	$ 77,900,000
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	589
Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	290
Facilities Under Fixed Rate Mortgage Loans [Member] | Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	52
Facilities Under Fixed Rate Mortgage Loans [Member] | Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	43
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of fixed rate mortgage | property	21
Number of states and U.K. | state	10
Number of independent healthcare operating companies operating under mortgage notes receivable | item	16
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 982,327,000	754,437,000
Mortgage Receivable [Member] | Facilities Considered Long Term [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | property	97
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of other real estate loans	18
Number of operators with other real estate loans | item	13
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 517,220,000	$ 548,715,000
Twenty Nine New Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans, real estate | loan	29
Payments to acquire loans receivable	$ 370,200,000
Twenty Nine New Real Estate Loans [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate during the period	10.50%
Advancements On Existing Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Payments to acquire loans receivable	$ 7,900,000

REAL ESTATE LOANS RECEIVABLE (S

REAL ESTATE LOANS RECEIVABLE (Schedule of Receivables) (Details)		1 Months Ended	12 Months Ended
	Jan. 17, 2014	May 31, 2024	Dec. 31, 2024 USD ($) facility loan	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jan. 31, 2025	Sep. 30, 2024 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate loans receivable - net			$ 1,428,298,000	$ 1,212,162,000
Number of real estate properties | facility			1,026
Number of other mortgage note loans | loan			12
Number of other real estate loans | loan			11
Collection of loan principal			$ 207,617,000	165,191,000	$ 345,665,000
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			982,327,000	754,437,000
Allowance for credit losses			(39,562,000)	(55,661,000)
Real estate loans receivable - net			$ 942,765,000	698,776,000
Mortgage Note Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss				62,010,000
Interest rate			7.85%
Investment Maturity Year			2025
Mortgage Notes Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 172,476,000
Interest rate		10.59%
Investment Maturity Year		2025	2025
Mortgage Notes Due 2025 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			10.59%
Mortgage Note Due 2028 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 53,750,000	50,000,000
Interest rate			10%
Investment Maturity Year			2028
Mortgage Note Due 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 525,530,000	514,866,000
Interest rate			11.39%
Investment Maturity Year			2030
Mortgage Note Due 2030 [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 525,500,000
Mortgage Note Due 2030 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11.39%
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ciena Healthcare [Member] | Ohio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 21,300,000
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ciena Healthcare [Member] | Subsequent Event [Member] | Ohio
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment maturity date						Dec. 31, 2025
Mortgage Note Due 2031 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	11.27%
Investment Maturity Year	2031
Mortgage Note Due 2027 and 2037 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 84,951,000	72,420,000
Mortgage Note Due 2027 and 2037 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2027
Mortgage Note Due 2027 and 2037 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2037
Mortgage Note Due 2027 and 2037 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			10.60%
Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 145,620,000	55,141,000
Number of other real estate loans | loan			12
Other Mortgage Notes Related to Twelve Loans [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2025
Other Mortgage Notes Related to Twelve Loans [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2029
Other Mortgage Notes Related to Twelve Loans [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			9.80%
Other Mortgage Notes Two Currently Past Due
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 12,900,000
Financing Receivable Fair Value of Collateral			1,500,000
Other Mortgage Notes Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			18,800,000
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			517,220,000	548,715,000
Allowance for credit losses			(31,687,000)	(35,329,000)
Real estate loans receivable - net			$ 485,533,000	513,386,000
Number of other real estate loans			18
Other Real Estate Loans Due 2035 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 263,580,000	263,520,000
Interest rate			7%
Investment Maturity Year			2035
Other Real Estate Loans Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 13,000,000	106,807,000			$ 13,000,000
Interest rate			10%
Investment Maturity Year			2025
Other Real Estate Loans Due 2025 [Member] | Priority of Collateral Modified [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 115,900,000	106,800,000
Other Real Estate Loans Due 2025 - 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 101,904,000	120,576,000
Interest rate			11.85%
Other Real Estate Loans Due 2025 - 2030 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2025
Other Real Estate Loans Due 2025 - 2030 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2030
Other Real Estate Loans Due 2025 - 2030 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11.85%
Other Real Estate Loans Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 138,736,000	57,812,000
Number of other real estate loans			11
Other Real Estate Loans Other [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2027
Other Real Estate Loans Other [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2033
Other Real Estate Loans Other [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11%
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 455,069,000	397,246,000
Allowance for credit losses			$ (122,795,000)	$ (121,631,000)

REAL ESTATE LOANS RECEIVABLE _2

REAL ESTATE LOANS RECEIVABLE (Summary of investments income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 157,207	$ 119,888	$ 123,919
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	126,800	97,766	110,322
Mortgage Receivable [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	91,434	68,340	74,233
Other Real Estate Loans [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 35,366	$ 29,426	$ 36,089

REAL ESTATE LOANS RECEIVABLE (M

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2030 Narrative) (Detail)	1 Months Ended		3 Months Ended			12 Months Ended
	May 31, 2020 facility	Jun. 30, 2018 USD ($) facility	Dec. 31, 2024 USD ($) facility	Mar. 31, 2023 USD ($)	Mar. 31, 2021	Dec. 31, 2025	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jan. 31, 2025	Jan. 01, 2024	Apr. 01, 2023	Jun. 30, 2022 USD ($)	Jun. 22, 2022 USD ($)	Apr. 01, 2022	Jul. 31, 2020 USD ($)	Jun. 30, 2020 USD ($) facility	May 01, 2020 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal							$ 207,617,000	$ 165,191,000	$ 345,665,000
Number of real estate properties | facility			1,026				1,026
Interest income							$ 157,207,000	119,888,000	123,919,000
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal							77,900,000
Financing receivable, gross			$ 1,499,547,000				1,499,547,000
Interest income							$ 126,800,000	97,766,000	110,322,000
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			589				589
Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			290				290
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 982,327,000				$ 982,327,000	754,437,000
Mortgage Receivable [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income							91,434,000	68,340,000	74,233,000
Mortgage Note Due 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 525,530,000				$ 525,530,000	$ 514,866,000
Investment Maturity Year							2030
Interest rate			11.39%				11.39%
Mortgage Note Due 2030 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11.39%				11.39%
Mortgage Note Due 2030 [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 525,500,000				$ 525,500,000
Mortgage Note Due 2030 [Member] | Master Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal									$ 92,400,000
Investment Maturity Date			Jun. 30, 2030				Jun. 30, 2030
Interest rate	10.67%
Percentage of mortgage loan fixed annual escalators	0.225%
Financing receivable, face amount			$ 415,000,000				$ 415,000,000
Mortgage Note Due 2030 [Member] | Master Mortgage [Member] | Ciena Healthcare [Member] | 19 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 277,000,000				$ 277,000,000
Interest rate			11.80%				11.80%
Mortgage Note Due 2030 [Member] | Amended Master Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 116,100,000				$ 116,100,000
Investment Maturity Year							2030
Percentage of mortgage loan interest rate increase per annum							0.225%
Mortgage Note Due 2030 [Member] | Amended Master Mortgage [Member] | Ciena Healthcare [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			8.50%				8.50%
Percentage of mortgage loan fixed annual escalators			2%				2%
Mortgage Note Due 2030 [Member] | Amended Master Mortgage [Member] | Ciena Healthcare [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			10%				10%
Percentage of mortgage loan fixed annual escalators			2.50%				2.50%
Mortgage Note Due 2030 [Member] | Second Amended Master Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date		Jun. 30, 2030
Interest rate		9.50%
Percentage of mortgage loan interest rate increase per annum		0.225%
Mortgage Note Due 2030 [Member] | Second Amended Master Mortgage [Member] | Ciena Healthcare [Member] | 5 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount		$ 44,700,000
Mortgage Note Due 2030 [Member] | Third Amended Master Mortgage [Member] | Michigan | Ciena Healthcare [Member] | 9 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 82,600,000				$ 82,600,000
Investment Maturity Date	Jun. 30, 2030
Interest rate	10.31%		11.16%				11.16%
Percentage of mortgage loan interest rate increase per annum	2%
Financing receivable, face amount																		$ 83,500,000
Mortgage Note Due 2030 [Member] | Construction Loans [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans			1
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Michigan | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility		5
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Master Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			19				19
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Amended Master Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			5				5
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Amended Master Mortgage [Member] | Ciena Healthcare [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			10.96%				10.96%
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Third Amended Master Mortgage [Member] | Michigan | Ciena Healthcare [Member] | Skilled Nursing Facilities [Member] | 8 of 9 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	8
Mortgage Note Due 2030 [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Third Amended Master Mortgage [Member] | Michigan | Ciena Healthcare [Member] | Assisted Living Facilities [Member] | 1 of 9 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	1
Mortgage Note Due 2030 [Member] | Mortgage Liens on Facilities Removed [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties									5
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ohio | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 21,300,000				$ 21,300,000
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ohio | Ciena Healthcare [Member] | Subsequent Event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date										Dec. 31, 2025
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ohio | Ciena Healthcare Subsidiaries [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date								Dec. 31, 2024									Mar. 31, 2022
Interest rate											10%						9.50%
Financing receivable, face amount																	$ 21,300,000
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Ohio | Ciena Healthcare Subsidiaries [Member] | Scenario, Plan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate												9.98%			9.74%
One Mortgage Note Secured by One Skilled Nursing Facility [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Ohio | Ciena Healthcare Subsidiaries [Member] | Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility																	1
One Mortgage Note Due Through 2023 Extended To 2030 [Member] | Construction Loans [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2030		2023
Mortgage Note Due 2030 $44.7 Million Mortgage [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal									$ 15,100,000
Mortgage Note Due 2030 $44.7 Million Mortgage [Member] | Ciena Healthcare [Member] | 4 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 28,500,000				$ 28,500,000
Mortgage Note Due 2030 $44.7 Million Mortgage [Member] | Facilities Covered by Mortgage and Used as Collateral [Member] | Michigan | Ciena Healthcare [Member] | Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			4				4
Interest rate			10.85%				10.85%
Mortgage Note Due 2030 $44.7 Million Mortgage [Member] | Mortgage Liens on Facilities Removed [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties									1
Mortgage Note Due 2030 7 Additional Mortgages [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal									$ 51,000,000
Number of loans									7
Mortgage Note Due 2030 2 of 7 Additional Mortgages [Member] | Mortgage Liens on Facilities Removed [Member] | Ciena Healthcare [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties									2
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 517,220,000				$ 517,220,000	$ 548,715,000
Other Real Estate Loans [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income							35,366,000	29,426,000	$ 36,089,000
Other Real Estate Loans Due 2035 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 263,580,000				$ 263,580,000	$ 263,520,000
Investment Maturity Year							2035
Interest rate			7%				7%
Other Real Estate Loans Due 2035 [Member] | Scenario, Plan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Paid In Cash						4%	1%
Interest Paid In Kind						3%	6%
Other Real Estate Loans Due 2035 [Member] | Maplewood Real Estate Holdings
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 263,600,000				$ 263,600,000
Investment Maturity Date																Jun. 30, 2030
Investment Maturity Year							2035
Interest rate														7%		7%
Financing receivable, face amount				$ 320,000,000									$ 250,500,000	$ 250,500,000		$ 220,500,000
Interest Paid In Cash						4%	1%
Interest Paid In Kind						3%	6%
Financing receivable, loan percentage of all financing receivables			17.60%				17.60%
Remaining commitment and paid in kind interest			$ 18,300,000				$ 18,300,000
Other Real Estate Loans Due 2035 [Member] | Maplewood Real Estate Holdings | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income				$ 1,500,000					$ 14,700,000

REAL ESTATE LOANS RECEIVABLE _3

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2025 Narrative) (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	May 31, 2024	Dec. 31, 2024	Nov. 30, 2024	Oct. 31, 2024	Dec. 31, 2023
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		$ 982,327			$ 754,437
Mortgage Notes Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	10.59%
Financing receivable, gross		$ 172,476
Investment Maturity Year	2025	2025
Mortgage Note Due 2025 10 Percent Interest Rate Two Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	10%
Financing receivable, gross	$ 71,700
Investment Maturity Date	Oct. 28, 2024
Mortgage Note Due 2025 10 Percent Interest Rate $18.5 Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 18,500
Investment Maturity Date		Feb. 28, 2025
Mortgage Note Due 2025 10 Percent Interest Rate $53.2 Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 53,200
Investment Maturity Date		May 31, 2025
Mortgage Note Due 2025 11 Percent Interest Rate $61.7 Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate				11%
Financing receivable, gross		$ 61,700		$ 61,700
Investment Maturity Date				Oct. 29, 2025
Mortgage Note Due 2025 11 Percent Interest Rate $39.1 Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11%
Financing receivable, gross		$ 39,100	$ 39,100
Investment Maturity Date			Nov. 27, 2025

REAL ESTATE LOANS RECEIVABLE _4

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2027 and 2037 Narrative) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Sep. 30, 2023	Jul. 31, 2021 USD ($) facility	Jul. 01, 2021 facility
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	1,026
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	589
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss | $	$ 982,327	$ 754,437
Mortgage Note Due 2027 and 2037 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss | $	$ 84,951	$ 72,420
Mortgage Note Due 2027 and 2037 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2027
Mortgage Note Due 2027 and 2037 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2037
Mortgage Note Due 2027 and 2037 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	10.60%
Mortgage Note Due 2027 and 2037 [Member] | Ohio | Eight Facilities Financed [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties					8
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss | $				$ 72,400
Interest rate				10.50%
Investment Maturity Date			Dec. 31, 2037
Mortgage Note Due 2027 and 2037 [Member] | Ohio | Two Facilities Financed [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties				2
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss | $				$ 6,400
Mortgage Note Due 2027 and 2037 [Member] | Ohio | Six Facilities Financed [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties				6

REAL ESTATE LOANS RECEIVABLE _5

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2028 Narrative) (Detail) $ in Thousands	Dec. 28, 2023	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility		1,026
Mortgage notes receivable-net		$ 1,428,298	$ 1,212,162
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		982,327	754,437
Mortgage notes receivable-net		942,765	698,776
Mortgage Notes Due 2028 [Member] | New Operator [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		53,800	$ 50,000
Interest rate	10%		10%
Investment Maturity Date			Dec. 28, 2028
Investment Maturity Year	2028
Mortgage Notes Due 2028 [Member] | New Operator [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Owned, Face Amount		$ 60,000
Mortgage Notes Due 2028 [Member] | Facilities Acquired by Operator Related to Other Real Estate Loans [Member] | New Operator [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility		4	4

REAL ESTATE LOANS RECEIVABLE _6

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2025 Narrative) (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
	May 17, 2019	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Collection of loan principal			$ 207,617	$ 165,191	$ 345,665
Mortgage Note Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate		7.85%	7.85%
Investment Maturity Year			2025
Mortgage Note Due 2025 7.85 Percent Interest Rate [Member] | Lakeway Realty LLC [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount						$ 73,000
Interest rate	7.85%					8%
Collection of loan principal		$ 60,100
Investment Maturity Year	2025
Investment Maturity Date						Mar. 20, 2025

REAL ESTATE LOANS RECEIVABLE _7

REAL ESTATE LOANS RECEIVABLE (Mortgage Notes Due 2031 Narrative) (Detail)		1 Months Ended	3 Months Ended		6 Months Ended	12 Months Ended
	Jan. 17, 2014	Feb. 28, 2022 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2022 USD ($) facility	Jun. 30, 2022 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Jan. 31, 2014 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility						1,026
Mortgage notes receivable-net						$ 1,428,298,000	$ 1,212,162,000
Interest payments applied against principal for cost recovery loans							3,900,000	$ 6,000,000
Collection of loan principal						$ 207,617,000	$ 165,191,000	$ 345,665,000
Four Facilities Previously Subject To Mortgage Financing From Entity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties			4
Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties						21	69	66
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility						589
Skilled Nursing Facilities [Member] | Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties						14	64
Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility						290
Assisted Living Facilities [Member] | Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties						6	2
Guardian [Member] | 9 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total proceeds					$ 39,500,000
Guardian [Member] | Three Facilities Previously Subject To Mortgage Financing From Entity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility				3
Guardian [Member] | Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties			6	9	9
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross						$ 982,327,000	$ 754,437,000
Mortgage notes receivable-net						942,765,000	698,776,000
Financing receivable, allowance for credit losses						$ 39,562,000	55,661,000
Mortgage Note Due 2031 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2031
Interest rate	11.27%
Mortgage Note Due 2031 [Member] | Four Facilities Previously Subject To Mortgage Financing From Entity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable-net			$ 35,200,000
Collection of loan principal			35,200,000
Mortgage Note Due 2031 [Member] | Four Facilities Previously Subject To Mortgage Financing From Entity [Member] | Principal Forgiveness [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, forgiven amount			$ 46,800,000
Mortgage Note Due 2031 [Member] | Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision (Recovery) for Credit Losses				$ (5,100,000)
Partial paydown received from the sale of facilities in exchange for release of mortgage liens		$ 21,700,000
Interest payments applied against principal for cost recovery loans							$ 3,900,000	$ 6,000,000
Mortgage Note Due 2031 [Member] | Guardian [Member] | 9 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount									$ 112,500,000
Mortgage Note Due 2031 [Member] | Guardian [Member] | Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties		3

REAL ESTATE LOANS RECEIVABLE (O

REAL ESTATE LOANS RECEIVABLE (Other Mortgage Notes Outstanding) (Details)	12 Months Ended
	Dec. 31, 2024 item facility loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of operators | item	87
Number of real estate properties	1,026
Number of other real estate loans | loan	11
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	589
Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	290
Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of operators | item	12
Number of other real estate loans | loan	12
Other Mortgage Notes Member | Facilities Covered by Mortgage and Used as Collateral [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	19

REAL ESTATE LOANS RECEIVABLE _8

REAL ESTATE LOANS RECEIVABLE (Other Mortgage Notes Outstanding Mortgage Note Due 2027) (Detail) $ in Millions	Dec. 31, 2024 facility	Jun. 30, 2024 USD ($) facility	Jan. 31, 2024 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	1,026
Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	589
Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	290
Mortgage Note Due 2027 [Member] | New Operator [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount | $		$ 18	$ 11.7
Interest rate		10%
Investment Maturity Date		Jan. 31, 2027
Mortgage Note Due 2027 [Member] | New Operator [Member] | Facilities Covered by Mortgages [Member] | Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties		3
Mortgage Note Due 2027 [Member] | New Operator [Member] | Facilities Covered by Mortgages [Member] | Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties		1

REAL ESTATE LOANS RECEIVABLE _9

REAL ESTATE LOANS RECEIVABLE (Other Mortgage Notes Outstanding Mortgage Note Due 2026) (Detail) - Mortgage Note Due 2026 [Member] - 2 Facilities $ in Millions	1 Months Ended
	Oct. 31, 2023 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount	$ 29.5
Interest rate	10%
Investment Maturity Date	Oct. 01, 2026
Maximum Interest Paid In Kind Allowable	$ 3

REAL ESTATE LOANS RECEIVABLE_10

REAL ESTATE LOANS RECEIVABLE (Other Real Estate Loans Due 2035) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Jun. 22, 2022	Jul. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income			$ 157,207,000	$ 119,888,000	$ 123,919,000
Contractual interest income expected to be received			2,700,000
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			1,499,547,000
Interest income			126,800,000	97,766,000	110,322,000
Maplewood Real Estate Holdings
Accounts, Notes, Loans and Financing Receivable [Line Items]
Rental income				62,600,000
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			517,220,000	548,715,000
Other Real Estate Loans [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income			$ 35,366,000	29,426,000	36,089,000
Other Real Estate Loans Due 2035 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2035
Financing receivable, gross			$ 263,580,000	263,520,000
Interest rate			7%
Other Real Estate Loans Due 2035 [Member] | Scenario, Plan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Paid In Kind		3%	6%
Interest Paid In Cash		4%	1%
Other Real Estate Loans Due 2035 [Member] | Maplewood Real Estate Holdings
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2035
Financing receivable, face amount	$ 320,000,000					$ 250,500,000	$ 250,500,000	$ 220,500,000
Financing receivable, gross			$ 263,600,000
Interest rate							7%	7%
Investment Maturity Date								Jun. 30, 2030
Interest Paid In Kind		3%	6%
Interest Paid In Cash		4%	1%
Maximum interest paid in kind allowable	52,200,000
Financing Receivable, Loan Percentage Of All Financing Receivables			17.60%
Remaining Commitment And Paid In Kind Interest			$ 18,300,000
Other Real Estate Loans Due 2035 [Member] | Maplewood Real Estate Holdings | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 1,500,000				$ 14,700,000
Contractual interest income expected to be received			2,700,000
Other Real Estate Loans Due 2035 Related to PIK Interest [Member] | Maplewood Real Estate Holdings | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income			$ 0	$ 0

REAL ESTATE LOANS RECEIVABLE_11

REAL ESTATE LOANS RECEIVABLE (Other Real Estate Loans Due 2025-2030 Narrative) (Detail)	1 Months Ended		12 Months Ended
	Apr. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Apr. 14, 2023 USD ($)	Jun. 28, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility			1,026
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 982,327,000	$ 754,437,000
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			517,220,000	548,715,000
Other Real Estate Loans 6.6 Million Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date	Apr. 14, 2029
Financing receivable, face amount	$ 6,600,000
Interest rate	8%
Other Real Estate Loans 6.6 Million Principal [Member] | RCA NH Holdings RE CO LLC Investment [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount	$ 6,600,000
Other Real Estate Loans 68.0 Million Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date	Apr. 13, 2029
Financing receivable, face amount	$ 68,000,000
Quarterly expected payment amount to be received	$ 1,000,000
Other Real Estate Loans 6.6 And 68.0 Million Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			63,800,000
Other Real Estate Loans 35.6 Million Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date		Jun. 30, 2025
Financing receivable, face amount		$ 35,600,000					$ 35,600,000
Interest rate		12%
Quarterly expected payment amount to be received		$ 1,000,000
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 27,600,000
Other Real Estate Loans 6.6 And 68.0 And 15.0 Million Principal One And 15.0 Million Principal Two [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	12%
Other Real Estate Loans Due 2025 - 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11.85%
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 101,904,000	120,576,000
Other Real Estate Loans Due 2025 - 2030 [Member] | Facilities Acquired by Operator Related to Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties	13
Other Real Estate Loans Due 2025 - 2030 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2025
Other Real Estate Loans Due 2025 - 2030 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2030
Other Real Estate Loans Due 2025 - 2030 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			11.85%
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 455,069,000	$ 397,246,000
Note 2028 Mezzanine [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date					Apr. 01, 2028
Financing receivable, face amount					$ 15,000,000	$ 15,000,000
Note 2028 Mezzanine [Member] | Facilities Acquired by Operator Related to Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties					13
Note 2029 Mezzanine [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date					Apr. 13, 2029
Financing receivable, face amount	$ 15,000,000				$ 15,000,000
Interest rate					12%

REAL ESTATE LOANS RECEIVABLE_12

REAL ESTATE LOANS RECEIVABLE (Other Real Estate Loans Other) (Detail)	12 Months Ended
	Dec. 31, 2024 USD ($) item facility loan	Jul. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility	1,026
Number of Other Real Estate Loans | loan	11
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 1,499,547,000
Financing receivable, gross	1,499,547,000
Variable Interest Entity, Not Primary Beneficiary [Member] | Massachusetts | Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount		$ 27,300,000
Interest rate		10%
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	982,327,000		$ 754,437,000
Financing receivable, gross	982,327,000		754,437,000
Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 517,220,000		548,715,000
Number Of Operators With Other Real Estate Loans | item	13
Number of Other Real Estate Loans	18
Financing receivable, gross	$ 517,220,000		548,715,000
Other Real Estate Loans Other [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 138,736,000		57,812,000
Number Of Operators With Other Real Estate Loans	10
Number of Other Real Estate Loans	11
Financing receivable, gross	$ 138,736,000		$ 57,812,000

NON-REAL ESTATE LOANS RECEIVA_3

NON-REAL ESTATE LOANS RECEIVABLE (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) loan item	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 157,207	$ 119,888	$ 123,919
Collection of loan principal	207,617	165,191	345,665
Payments to acquire loans receivable	470,011	420,626	371,987
Investment Type Characteristic Non Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income	$ 30,400	$ 22,100	$ 13,600
Number of Borrowers | item	30
Number of non real estate loans receivable | loan	48
Collection of loan principal	$ 119,700
Payments to acquire loans receivable	$ 14,800
Investment Type Characteristic Non Real Estate Related Loans [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	8.40%
Investment Type Characteristic Non Real Estate Related Loans [Member] | Non Real Estate Loans Receivable 13 Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of non real estate loans receivable | loan	13
Payments to acquire loans receivable	$ 60,600

NON-REAL ESTATE LOANS RECEIVA_4

NON-REAL ESTATE LOANS RECEIVABLE (Schedule of receivables) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Jan. 01, 2025	Jun. 30, 2024	Apr. 30, 2024	Feb. 29, 2024	Jan. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jul. 18, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Non-real estate loans receivable - net	$ 332,274,000						$ 275,615,000
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	455,069,000						397,246,000
Allowance for credit losses	(122,795,000)						(121,631,000)
Non-real estate loans receivable - net	332,274,000						275,615,000
Notes Receivable Due 2036 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 73,142,000						77,854,000
Investment Maturity Year	2036
Interest rate	5.71%
Notes Receivable Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 42,499,000						44,999,000
Investment Maturity Year	2025
Interest rate	9.12%								7.50%
Financing receivable, benchmark amount for interest rate determination					$ 15,000,000
Investment Maturity Date					Dec. 31, 2025			Dec. 31, 2024	Jul. 08, 2022
Financing receivable, face amount							55,000,000	$ 48,000,000	$ 15,000,000
Notes Receivable Due 2025 [Member] | Subsequent Event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate		12.50%
Notes Receivable Due 2025 [Member] | Greater Than $15 Million [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate						8%
Notes Receivable Due 2025 [Member] | Scenario, Plan [Member] | Greater Than $15 Million [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			10%	9%
Notes Receivable Due 2025 Through 2036 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 38,308,000						32,308,000
Interest rate	3.25%
Notes Receivable Due 2025 Through 2036 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2025
Notes Receivable Due 2025 Through 2036 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2036
Notes Receivable Due 2025 Through 2036 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	3.25%
Notes Receivable Due 2025 Through 2029 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 45,226,000						92,681,000
Interest rate	11.81%
Notes Receivable Due 2025 Through 2029 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2025
Notes Receivable Due 2025 Through 2029 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2029
Notes Receivable Due 2025 Through 2029 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	11.81%
Notes Receivable Due 2025 Through 2029 Two Working Capital Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross							39,500,000
Notes Receivable Due 2026 13.22 Percent Interest Rate [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 115,913,000
Investment Maturity Year	2026
Interest rate	13.22%
Notes Receivable Due 2026 13.22 Percent Interest Rate [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	13.22%
Notes Receivable Due 2026 11.00 Percent Interest Rate [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 47,126,000						$ 53,300,000
Investment Maturity Year	2026
Interest rate	11%						11%
Investment Maturity Date							Dec. 19, 2026
Financing receivable, face amount							$ 50,000,000
Other Notes [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 92,855,000						$ 96,104,000
Other Notes [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2025
Other Notes [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year	2034
Other Notes [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	9.17%
Other Notes Two Loans Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable Fair Value of Collateral	$ 0
Other Notes Three Loans Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	9,000,000
Other Notes One Loans Past Due [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	100,000
Other Notes Maturing 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 40,700,000
Investment Maturity Year	2025

NON-REAL ESTATE LOANS RECEIVA_5

NON-REAL ESTATE LOANS RECEIVABLE (Notes due 2026 at 13.22 Percent) (Details) - USD ($) $ in Thousands		12 Months Ended
	Sep. 01, 2025	Dec. 31, 2024	Sep. 30, 2024	Aug. 31, 2024	Dec. 31, 2023	Mar. 06, 2018	Jul. 31, 2016
Investment Type Characteristic Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		$ 1,499,547
Investment Type Characteristic Non Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		455,069
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		455,069			$ 397,246
Notes Receivable Due 2026 | Investment Type Characteristic Non Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Date			Jun. 30, 2026	Jun. 30, 2025
Notes Receivable Due 2026 13.22% interest
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		$ 115,913
Interest rate		13.22%
Investment Maturity Year		2026
Notes Receivable Due 2026 10% interest | Investment Type Characteristic Non Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		$ 22,500				$ 16,000
Interest rate		10%
Interest Paid In Kind		5%
Investment Maturity Date						Jul. 29, 2020
Notes Receivable Due 2026 10% interest | Investment Type Characteristic Non Real Estate Related Loans [Member] | Scenario, Plan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Paid In Kind	2.50%
Notes Receivable Due 2026 14% interest | Investment Type Characteristic Non Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross		$ 93,400					$ 48,000
Interest rate		14%
Interest Paid In Kind		9%
Investment Maturity Date							Jul. 29, 2020
Notes Receivable Due 2026 14% interest | Investment Type Characteristic Non Real Estate Related Loans [Member] | Scenario, Plan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Paid In Kind	3.50%

NON-REAL ESTATE LOANS RECEIVA_6

NON-REAL ESTATE LOANS RECEIVABLE (Notes due 2036 at 5.71 Percent) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Nov. 01, 2024	Oct. 31, 2024	Jun. 30, 2023	May 17, 2018	May 07, 2018	Sep. 30, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable allowance, increase (decrease)			$ 25,200,000
Interest payments applied against principal for cost recovery loans			3,900,000	$ 6,000,000
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 455,069,000	397,246,000
Allowance for loss on notes receivable		$ 122,795,000	121,631,000
Notes Receivable Due 2036 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year		2036
Interest rate		5.71%
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 73,142,000	77,854,000
Notes Receivable Due 2036 [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year		2036
Interest rate		5.71%
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 73,100,000
Financing receivable, loan percentage of all financing receivables		16.10%
Interest payments applied against principal for cost recovery loans		$ 4,700,000	$ 3,200,000
Notes Receivable Term Loan [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate										9%
Financing Receivable Fair Value of Collateral				0
Financing receivable, face amount										$ 32,000,000
Investment Maturity Date										Dec. 31, 2024
Working Capital Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate							10%
Investment Maturity Date							Jun. 30, 2026
Working Capital Loans [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate									7%
Provision (Recovery) for Credit Losses				10,800,000
Financing Receivable Fair Value of Collateral				$ 5,900,000
Financing receivable, face amount								$ 25,000,000	$ 25,000,000
Investment Maturity Date									Apr. 30, 2025
Notes Receivable $82.2 Million Due 2036 [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	5.63%				5.71%	5.71%
Allowance for loss on notes receivable		$ 70,900,000
Financing receivable, face amount	$ 82,200,000
Investment Maturity Date	Dec. 31, 2036
Notes Receivable Due Loan A [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	$ 32,000,000
Notes Receivable Due Loan B [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	50,200,000
Additional Principal Deferred Rent Working Capital [Member] | Agemo Holdings LLC [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss	25,200,000
Financing receivable allowance, increase (decrease)	$ 25,200,000

NON-REAL ESTATE LOANS RECEIVA_7

NON-REAL ESTATE LOANS RECEIVABLE (Notes due 2026 at 11.00 Percent) (Details)	1 Months Ended	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($)
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross	$ 397,246,000	$ 455,069,000
Notes Receivable Due 2026 11.00 Percent Interest Rate [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year		2026
Interest rate	11%	11%
Financing receivable, face amount	$ 50,000,000
Investment Maturity Date	Dec. 19, 2026
Number of lease amendments	2
Number of lease agreements	2
Financing receivable, gross	$ 53,300,000	$ 47,126,000

NON-REAL ESTATE LOANS RECEIVA_8

NON-REAL ESTATE LOANS RECEIVABLE (Notes due 2025-2029) (Details)	1 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Apr. 30, 2023 USD ($)	Apr. 14, 2023 USD ($)	Jun. 28, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties | facility		1,026
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 455,069,000	$ 397,246,000
Notes Receivable Due 2025 Through 2029 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate		11.81%
Number of Non Real Estate Loans		11
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 45,226,000	$ 92,681,000
Notes Receivable Due 2025 Through 2029 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year		2025
Notes Receivable Due 2025 Through 2029 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year		2029
Other Real Estate Loans 35.6 Million Principal [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount	$ 35,600,000						$ 35,600,000
Interest rate	12%
Investment Maturity Date	Jun. 30, 2025
Quarterly expected payment amount to be received	$ 1,000,000
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss		$ 27,600,000
Notes Receivable Revolving Line of Credit [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate							10%
Investment Maturity Date			Jun. 30, 2024				Jun. 30, 2023
Note 2028 Mezzanine [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount				$ 15,000,000		$ 15,000,000
Investment Maturity Date				Apr. 01, 2028
Basis spread on variable interest rate				8.60%
Note 2028 Mezzanine [Member] | Facilities Acquired by Operator Related to Other Real Estate Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties				13
Note 2029 Mezzanine [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount				$ 15,000,000	$ 15,000,000
Interest rate				12%
Investment Maturity Date				Apr. 13, 2029

NON-REAL ESTATE LOANS RECEIVA_9

NON-REAL ESTATE LOANS RECEIVABLE (Note due 2025 at 9.12 percent) (Details) - USD ($) $ in Millions	1 Months Ended	6 Months Ended	12 Months Ended
	Feb. 29, 2024	Dec. 31, 2023	Dec. 31, 2024	Jan. 01, 2025	Jun. 30, 2024	Apr. 30, 2024	Jan. 31, 2024	Dec. 31, 2022	Jul. 18, 2019
Notes Receivable Due 2025 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year			2025
Investment Owned, Face Amount		$ 55						$ 48	$ 15
Investment owned modification outstanding principal no longer past due	$ 8.5
Interest rate			9.12%						7.50%
Investment Maturity Date	Dec. 31, 2025							Dec. 31, 2024	Jul. 08, 2022
Principal payment due but not received		$ 8.5
Financing receivable, benchmark amount for interest rate determination	$ 15
Notes Receivable Due 2025 [Member] | Greater Than $15 Million [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate							8%
Notes Receivable Due 2025 [Member] | Subsequent Event [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate				12.50%
Notes Receivable Due 2025 [Member] | Scenario, Plan [Member] | Greater Than $15 Million [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate					10%	9%
Notes Receivable Due 2025 $45 Million Revolving Credit Facility [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Owned, Face Amount	$ 45						$ 55

NON-REAL ESTATE LOANS RECEIV_10

NON-REAL ESTATE LOANS RECEIVABLE (Notes due 2025 and 2036 at 3.25 percent) (Details)			3 Months Ended				6 Months Ended	12 Months Ended
	Mar. 25, 2022 USD ($)	Sep. 01, 2021 USD ($)	Dec. 31, 2024 USD ($) facility	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Dec. 29, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) facility	Jan. 01, 2025	Jun. 03, 2024 USD ($)	Sep. 30, 2023 USD ($)	Jan. 01, 2023	Dec. 30, 2022 facility	Sep. 01, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income								$ 157,207,000	$ 119,888,000	$ 123,919,000
Number of real estate properties | facility			1,026					1,026
Payments to acquire loans receivable								$ 470,011,000	$ 420,626,000	$ 371,987,000
Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties			21		69	66		21	69	66
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debtor-in-Possession Financing, Interest Rate on Borrowings Outstanding												10%
Number of real estate properties													11
Monthly expected payment amount to be received					$ 3,300,000		$ 8,300,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Facilities Sold
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties					30	11			30	11			7		11
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Omega Healthcare And TIX 33433 LLC DIP Sponsor Loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debtor-in-Possession Financing, Amount Arranged												$ 20,000,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Omega Healthcare DIP Sponsor Loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debtor-in-Possession Financing, Amount Arranged												10,000,000
Debtor-in-Possession Financing, Borrowings Outstanding				$ 4,500,000
Provision (Recovery) for Credit Losses			$ 1,800,000	4,200,000
Investment Maturity Date			Nov. 15, 2024					Nov. 15, 2024			Mar. 31, 2025
Financing Receivable Fair Value of Collateral			$ 0	300,000				$ 0
Payments to acquire loans receivable			1,500,000
LaVie Care Centers LLC (f/k/a Consulate Health Care) | TIX 33433 LLC DIP Sponsor Loan [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debtor-in-Possession Financing, Amount Arranged												$ 10,000,000
Non Real Estate Loans Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			455,069,000		$ 397,246,000			455,069,000	$ 397,246,000
Allowance for loss on notes receivable			$ 122,795,000		121,631,000			$ 122,795,000	121,631,000
Notes Receivable Due 2025 Through 2036 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			3.25%					3.25%
Financing receivable, gross			$ 38,308,000		$ 32,308,000			$ 38,308,000	$ 32,308,000
Notes Receivable Due 2025 Through 2036 [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year								2025
Notes Receivable Due 2025 Through 2036 [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Investment Maturity Year								2036
Notes Receivable Due 2025 Through 2036 [Member] | Weighted Average [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate			3.25%					3.25%
Notes Receivable Due 2025 Through 2036 [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, gross			$ 38,300,000					$ 38,300,000
Financing receivable, loan percentage of all financing receivables			8.40%					8.40%
Allowance for loss on notes receivable			$ 38,300,000					$ 38,300,000
Notes Receivable Due $8.3 Million Term Loan [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision (Recovery) for Credit Losses						$ 7,500,000
Financing receivable, face amount		$ 8,300,000
Interest rate		7%												2%
Investment Maturity Date						Nov. 30, 2036				Nov. 30, 2036						Mar. 31, 2031
Interest payments received applied against principal										$ 100,000
Monthly expected payment amount to be received		$ 100,000
Notes Receivable Due $25.0 Million Term Loan [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Provision (Recovery) for Credit Losses				3,600,000		$ 15,800,000
Financing receivable, face amount	$ 25,000,000			$ 25,000,000
Interest rate	8.50%					2%				2%
Investment Maturity Date	Mar. 31, 2032					Nov. 30, 2036				Nov. 30, 2036
Interest payments received applied against principal										$ 400,000
Quarterly expected payment amount to be received	$ 1,300,000

NON-REAL ESTATE LOANS RECEIV_11

NON-REAL ESTATE LOANS RECEIVABLE (Other Notes Outstanding) (Details) $ in Thousands

3 Months Ended

12 Months Ended

Jun. 30, 2023 USD ($)

Dec. 31, 2024 USD ($) facility loan

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($) facility

Oct. 31, 2024

Jun. 30, 2024 USD ($)

Sep. 30, 2023 USD ($)

Oct. 01, 2022

Nov. 30, 2021 USD ($) facility

Oct. 31, 2021 USD ($)

Oct. 01, 2021 USD ($)

Dec. 31, 2020 USD ($)

Accounts, Notes, Loans and Financing Receivable [Line Items]

Number of real estate properties | facility

1,026

Placement of mortgage loans

$ 470,011

$ 420,626

$ 371,987

Interest payments applied against principal for cost recovery loans

3,900

6,000

Second Spring Healthcare Investments [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Ownership %

15%

Gulf Coast LLC [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Provision (Recovery) for Credit Losses

$ (5,300)

(1,000)

Non Real Estate Loans Receivable [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, gross

455,069

397,246

Other Notes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, gross

$ 92,855

96,104

Number of non real estate loans receivable | loan

28

Other Notes $20 Million Working Capital [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Provision (Recovery) for Credit Losses

$ (800)

Other Notes $20 Million Working Capital [Member] | New Manager of Gulf Coast Facilities [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Interest rate

3%

Investment Maturity Date

Dec. 31, 2022

Provision (Recovery) for Credit Losses

$ 5,200

Number of facilities sold | facility

22

Financing receivable, face amount

$ 20,000

Other Notes $20 Million Working Capital [Member] | New Manager of Gulf Coast Facilities [Member] | Facilities with new manager

Accounts, Notes, Loans and Financing Receivable [Line Items]

Number of real estate properties | facility

23

Other Notes $25 Million Senior Secured Facility [Member] | Gulf Coast LLC [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Investment Maturity Date

Aug. 15, 2022

Provision (Recovery) for Credit Losses

$ 200

Debtor-in-Possession Financing, Amount Arranged

$ 25,000

Debtor-in-possession financing, additional funding

2,200

Interest payments applied against principal for cost recovery loans

2,000

Other Notes $25 Million Revolving Credit Facility [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, gross

$ 23,600

Interest rate

6%

5%

Investment Maturity Date

Sep. 30, 2024

Dec. 01, 2022

Financing receivable, face amount

25,000

$ 25,000

$ 20,000

$ 15,000

Other Notes $25 Million Revolving Credit Facility [Member] | Minimum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

$ 20,000

Other Notes $25 Million Revolving Credit Facility [Member] | Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Investment Maturity Date

Jun. 30, 2023

Other Notes $25 Million Revolving Credit Facility [Member] | Scenario, Plan [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Interest rate

8.50%

Investment Maturity Date

Dec. 31, 2025

Other Notes $20 Million Promissory Notes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, gross

14,700

Interest rate

9%

Investment Maturity Date

Sep. 30, 2027

Financing receivable, face amount

$ 20,000

Other Notes $17 of $20 Million Promissory Notes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

17,000

Other Notes $2.5 of $20 Million Promissory Notes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

2,500

Other Notes $0.5 of $20 Million Promissory Notes [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

$ 500

Other Investment Mezzanine Loan [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, gross

$ 7,700

Interest rate

11%

Investment Maturity Date

Jun. 30, 2028

Financing receivable, face amount

$ 10,000

Monthly expected payment amount to be received

$ 200

Working Capital Loans [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Interest rate

10%

Investment Maturity Date

Jun. 30, 2026

Working Capital Loans [Member] | Maximum [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

$ 34,000

Working Capital Loans [Member] | Scenario, Plan [Member]

Accounts, Notes, Loans and Financing Receivable [Line Items]

Financing receivable, face amount

$ 20,000

ALLOWANCE FOR CREDIT LOSSES (Na

ALLOWANCE FOR CREDIT LOSSES (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accrued investment income receivable	$ 11,100,000	$ 10,200,000
Effective yield interest receivables	1,839,000	3,127,000
Interest income related to loans on non-accrual status	$ 3,300,000	1,700,000	$ 17,200,000
Guardian [Member]
Interest income related to loans on non-accrual status		$ 0	$ 0

ALLOWANCE FOR CREDIT LOSSES (Sc

ALLOWANCE FOR CREDIT LOSSES (Schedule of expected credit loss per segment) (Details)	3 Months Ended				12 Months Ended
	Jun. 30, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)	Mar. 25, 2022 USD ($)	Dec. 31, 2021 USD ($)	Oct. 31, 2021 USD ($)	Sep. 01, 2021 USD ($)	May 17, 2018 USD ($)	May 07, 2018 USD ($)
Number of real estate properties | facility					1,026
CECL balance, total receivables			$ 188,364,000		$ 198,612,000	$ 222,164,000	$ 188,364,000			$ 144,466,000
Provision (Recovery) for Credit Losses, total receivables					(10,041,000)	45,555,000	68,663,000
Write-offs charged against allowance for the period ended, total receivables					(13,511,000)	(36,955,000)	(24,765,000)
Financing receivable allowance, increase (decrease)						25,200,000
Interest payments applied against principal for cost recovery loans						3,900,000	6,000,000
Financing receivable, principal payments received against fully reserved amounts					600,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Financing receivable allowance, increase (decrease)						25,200,000
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, beginning balance		$ 2,816,000			2,489,000	2,816,000	530,000
Provision (recovery) on direct financing leases					(884,000)	(327,000)	2,286,000
Direct Financing Lease, ending balance			2,816,000		1,605,000	2,489,000	2,816,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments		320,000				320,000	941,000
Provision (Recovery) for Credit Losses, unfunded loan commitments							1,629,000
Write-offs charged against allowance for the period ended, unfunded loan commitments							(2,250,000)
CECL Ending balance, unfunded loan commitments			320,000				320,000
Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		101,360,000			90,990,000	101,360,000	82,574,000
Provision (Recovery) for Credit Losses					(19,741,000)	26,585,000	23,249,000
Write-offs charged against allowance for the period ended						(36,955,000)	(4,463,000)
CECL Ending balance			101,360,000		71,249,000	90,990,000	101,360,000
Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing receivable allowance, increase (decrease)						25,200,000
Interest payments applied against principal for cost recovery loans					4,700,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		83,868,000			121,631,000	83,868,000	60,421,000
Provision (Recovery) for Credit Losses					14,675,000	12,563,000	41,499,000
Write-offs charged against allowance for the period ended					(13,511,000)		(18,052,000)
Financing receivable allowance, increase (decrease)						25,200,000
CECL Ending balance			83,868,000		122,795,000	121,631,000	83,868,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments					7,054,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					(4,091,000)
CECL Ending balance, unfunded loan commitments					2,963,000	7,054,000
Gulf Coast LLC [Member]
DIP financing, proceeds from trust					5,300,000	1,000,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses					(5,300,000)	(1,000,000)
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
Provision (Recovery) for Credit Losses, unfunded loan commitments				$ 2,200,000
Gulf Coast LLC [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses					(5,300,000)	(1,000,000)
LaVie Care Centers LLC (f/k/a Consulate Health Care)
Number of real estate properties								11
LaVie Care Centers LLC (f/k/a Consulate Health Care) | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses							23,300,000
Mortgage Receivable [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance					55,661,000
CECL Ending balance					39,562,000	55,661,000
Non Real Estate Loans Receivable [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance					121,631,000
CECL Ending balance					122,795,000	121,631,000
Working Capital Loans [Member] | Agemo Holdings LLC [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses							10,800,000
Working Capital Loans [Member] | New Manager of Gulf Coast Facilities [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing receivable, face amount						20,000,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses							5,200,000
Working Capital Loans [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Agemo Holdings LLC [Member]
Financing receivable, face amount													$ 25,000,000	$ 25,000,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses							10,800,000
Notes Receivable Due 2036 [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Agemo Holdings LLC [Member]
Interest payments applied against principal for cost recovery loans					4,700,000	3,200,000
Notes Receivable Due $8.3 Million Term Loan [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Financing receivable, face amount												$ 8,300,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses			7,500,000
Notes Receivable Due $25.0 Million Term Loan [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)
Financing receivable, face amount	$ 25,000,000								$ 25,000,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses	$ 3,600,000		15,800,000
Notes Receivable $82.2 Million Due 2036 [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Agemo Holdings LLC [Member]
Financing receivable, face amount		82,200,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Ending balance					70,900,000
Additional Principal Deferred Rent Working Capital [Member] | Variable Interest Entity, Not Primary Beneficiary [Member] | Agemo Holdings LLC [Member]
Financing receivable allowance, increase (decrease)		25,200,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Financing receivable allowance, increase (decrease)		25,200,000
Other Notes $25 Million Senior Secured Facility [Member] | Gulf Coast LLC [Member]
Debtor-in-Possession Financing, Amount Arranged											$ 25,000,000
Interest payments applied against principal for cost recovery loans							2,000,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses							200,000
Internal Credit Rating One [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		162,000			1,501,000	162,000
Provision (Recovery) for Credit Losses					(1,189,000)	1,339,000	162,000
CECL Ending balance			162,000		312,000	1,501,000	162,000
Internal Credit Rating Two [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		157,000			291,000	157,000	14,000
Provision (Recovery) for Credit Losses					201,000	134,000	143,000
CECL Ending balance			157,000		492,000	291,000	157,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments					10,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					(9,000)	10,000
CECL Ending balance, unfunded loan commitments					1,000	10,000
Internal Credit Rating Two [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		859,000			1,151,000	859,000	29,000
Provision (Recovery) for Credit Losses					(1,114,000)		830,000
CECL Ending balance			859,000		37,000	1,151,000	859,000
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, beginning balance		859,000				859,000
Provision (recovery) on direct financing leases						292,000
Direct Financing Lease, ending balance			859,000				859,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments		207,000			692,000	207,000	7,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					(679,000)	485,000	200,000
CECL Ending balance, unfunded loan commitments			207,000		13,000	692,000	207,000
Internal Credit Rating Three [Member]
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, beginning balance							530,000
Provision (recovery) on direct financing leases							(530,000)
Internal Credit Rating Three [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		15,110,000			12,635,000	15,110,000	5,367,000
Provision (Recovery) for Credit Losses					(1,644,000)	(2,475,000)	9,743,000
CECL Ending balance			15,110,000		10,991,000	12,635,000	15,110,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments					335,000		251,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					126,000	335,000	(251,000)
CECL Ending balance, unfunded loan commitments					461,000	335,000
Internal Credit Rating Three [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		2,079,000			3,903,000	2,079,000	1,206,000
Provision (Recovery) for Credit Losses					(2,035,000)	1,824,000	873,000
CECL Ending balance			2,079,000		1,868,000	3,903,000	2,079,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments		29,000			46,000	29,000	207,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					137,000	17,000	(178,000)
CECL Ending balance, unfunded loan commitments			29,000		183,000	46,000	29,000
Internal Credit Rating Four [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		33,666,000			65,113,000	33,666,000	20,577,000
Provision (Recovery) for Credit Losses					(42,585,000)	31,447,000	13,089,000
CECL Ending balance			33,666,000		22,528,000	65,113,000	33,666,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments		84,000			4,314,000	84,000	117,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					(4,274,000)	4,230,000	(33,000)
CECL Ending balance, unfunded loan commitments			84,000		40,000	4,314,000	84,000
Internal Credit Rating Four [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		634,000			720,000	634,000	56,000
Provision (Recovery) for Credit Losses					1,548,000	86,000	578,000
CECL Ending balance			634,000		2,268,000	720,000	634,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments					63,000		216,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					370,000	63,000	(216,000)
CECL Ending balance, unfunded loan commitments					433,000	63,000
Internal Credit Rating Five [Member]
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, beginning balance		2,816,000			2,489,000	2,816,000
Provision (recovery) on direct financing leases					(884,000)	(327,000)	2,816,000
Direct Financing Lease, ending balance			2,816,000		1,605,000	2,489,000	2,816,000
Internal Credit Rating Five [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance							136,000
Provision (Recovery) for Credit Losses					25,476,000		(136,000)
CECL Ending balance					25,476,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
Provision (Recovery) for Credit Losses, unfunded loan commitments					1,767,000
CECL Ending balance, unfunded loan commitments					1,767,000
Internal Credit Rating Five [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing receivable allowance, increase (decrease)						25,200,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		18,619,000			43,404,000	18,619,000	7,861,000
Provision (Recovery) for Credit Losses					(117,000)	(415,000)	10,758,000
Financing receivable allowance, increase (decrease)						25,200,000
CECL Ending balance			18,619,000		43,287,000	43,404,000	18,619,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments					1,594,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					(1,594,000)	1,594,000
CECL Ending balance, unfunded loan commitments						1,594,000
Internal Credit Rating Six [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		52,265,000			11,450,000	52,265,000	56,480,000
Provision (Recovery) for Credit Losses						(3,860,000)	248,000
Write-offs charged against allowance for the period ended						(36,955,000)	(4,463,000)
CECL Ending balance			52,265,000		11,450,000	11,450,000	52,265,000
Internal Credit Rating Six [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
CECL Beginning balance		61,677,000			72,453,000	61,677,000	51,269,000
Provision (Recovery) for Credit Losses					16,393,000	10,776,000	28,460,000
Write-offs charged against allowance for the period ended					(13,511,000)		(18,052,000)
CECL Ending balance			61,677,000		75,335,000	72,453,000	61,677,000
Unfunded loan commitments, Credit Loss, Liability [Roll Forward]
CECL Beginning balance, unfunded loan commitments		$ 320,000			7,054,000	320,000	143,000
Provision (Recovery) for Credit Losses, unfunded loan commitments					65,000	6,734,000	2,107,000
Write-offs charged against allowance for the period ended, unfunded loan commitments							(2,250,000)
CECL Ending balance, unfunded loan commitments			$ 320,000		$ 65,000	$ 7,054,000	$ 320,000

ALLOWANCE FOR CREDIT LOSSES (_2

ALLOWANCE FOR CREDIT LOSSES (Schedule by segment balance by vintage and credit quality indicator) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Total 2024	$ 396,547
Total 2023	346,894
Total 2022	89,744
Total 2021	111,897
Total 2020	103,940
Total 2019 & older	547,500
Total receivable Revolving	369,152
Total receivables	1,965,674
2023, current-period gross write-offs	5,879
2019 & older, current-period gross write-offs	3,092
Revolving, current-period gross write-offs	4,540
Total write offs, current period	13,511
Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]
2019 & older, Investment in direct financing leases	11,058
Investment in direct financing leases	11,058	$ 11,205
Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	376,934
2023	260,249
2022	47,600
2021	104,046
2020	103,940
2019 & older	343,198
Revolving Loans	263,580
Total Balance	1,499,547
Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	19,613
2023	86,645
2022	42,144
2021	7,851
2019 & older	193,244
Revolving Loans	105,572
Total Balance	455,069
Internal Credit Rating One [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	20,000
Total Balance	20,000
Internal Credit Rating Two [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	29,700
2023	8,680
2020	21,325
Total Balance	59,705
Internal Credit Rating Two [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
Revolving Loans	15,989
Total Balance	15,989
Internal Credit Rating Three [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	273,243
2023	161,166
2022	27,600
2021	72,420
Total Balance	534,429
Internal Credit Rating Three [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	4,175
2023	81,333
2022	17,687
2019 & older	2,551
Revolving Loans	55,761
Total Balance	161,507
Internal Credit Rating Four [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	73,991
2023	90,403
2021	31,626
2020	82,615
2019 & older	330,276
Total Balance	608,911
Internal Credit Rating Four [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	4,411
2019 & older	117,477
Revolving Loans	27,822
Total Balance	149,710
Internal Credit Rating Five [Member]
Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]
2019 & older, Investment in direct financing leases	11,058
Investment in direct financing leases	11,058
Internal Credit Rating Five [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
Revolving Loans	263,580
Total Balance	263,580
Internal Credit Rating Five [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	6,000
2023	1,500
2019 & older	45,028
Total Balance	52,528
Internal Credit Rating Six [Member] | Investment Type Characteristic Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2019 & older	12,922
Total Balance	12,922
Internal Credit Rating Six [Member] | Investment Type Characteristic Non Real Estate Related Loans [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2024	5,027
2023	3,812
2022	24,457
2021	7,851
2019 & older	28,188
Revolving Loans	6,000
Total Balance	75,335
Mortgage Receivable [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Balance	982,327	754,437
Non Real Estate Loans Receivable [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
Total Balance	$ 455,069	$ 397,246

VARIABLE INTEREST ENTITIES (Sch

VARIABLE INTEREST ENTITIES (Schedule of variable interest entities) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Aug. 01, 2024	Jun. 30, 2023 USD ($)	Sep. 30, 2022 facility
Assets
Real estate assets - net			$ 6,339,158,000	$ 5,902,526,000
Assets held for sale			56,194,000	67,116,000
Real estate loans receivable - net			1,428,298,000	1,212,162,000
Investments in unconsolidated joint ventures			88,711,000	188,409,000
Non-real estate loans receivable - net			332,274,000	275,615,000
Contractual receivables - net			12,611,000	11,888,000
Other receivables and lease inducements			249,317,000	214,657,000
Lease inducements			8,788,000	8,782,000
Other assets			189,476,000	147,686,000
Total assets			9,897,891,000	9,117,402,000
Liabilities
Accrued expenses and other liabilities			(328,193,000)	(287,795,000)
Total Liabilities			(5,167,052,000)	(5,355,111,000)
Restricted cash			30,395,000	1,920,000	$ 3,541,000
Rental income			$ 887,910,000	$ 826,394,000	$ 751,231,000
Rental income, Statement of Income [Extensible Enumeration]			Rental income	Rental income	Rental income
Interest income			$ 157,207,000	$ 119,888,000	$ 123,919,000
Total revenues			$ 1,051,390,000	$ 949,740,000	$ 878,244,000
Number of Facilities | facility			1,026
Cindat Ice Portfolio JV GP Limited [Member]
Liabilities
Ownership by parent						100%
Assisted Living Facilities [Member]
Liabilities
Number of Facilities | facility			290
Facilities Sold
Liabilities
Number of Facilities			21	69	66
Facilities Sold | Assisted Living Facilities [Member]
Liabilities
Number of Facilities			6	2
Facilities Acquired | Assisted Living Facilities [Member]
Liabilities
Number of Facilities | facility			108	21	34
Facilities Acquired | Exchange Accommodation Titleholders [Member]
Liabilities
Number of Facilities					7
Non Real Estate Loans Receivable [Member]
Assets
Non-real estate loans receivable - net			$ 332,274,000	$ 275,615,000
Agemo Holdings LLC [Member] | Facilities Sold
Liabilities
Number of Facilities | facility					22			22
Maplewood Real Estate Holdings
Liabilities
Provision for straight-line rent and contractual receivables					$ 29,300,000
Termination fee incurred cost	$ 12,500,000			12,500,000
Variable Interest Entity, Primary Beneficiary [Member]
Assets
Total assets			24,300,000	27,900,000
Liabilities
Total Liabilities			(20,800,000)	(20,700,000)
Noncontrolling Interest in Joint Ventures		$ 2,900,000
Total proceeds		$ 7,700,000
Variable Interest Entity, Primary Beneficiary [Member] | Exchange Accommodation Titleholders [Member] | 4 of 7 Facilities
Assets
Real estate assets - net					55,200,000
Liabilities
Cash					$ 23,900,000
Variable Interest Entity, Primary Beneficiary [Member] | Facilities Sold | Assisted Living Facilities [Member]
Liabilities
Number of Facilities | facility		1
Variable Interest Entity, Primary Beneficiary [Member] | Facilities Acquired Acquisition Completed [Member] | 3 of 7 Facilities
Liabilities
Number of Facilities					3
Variable Interest Entity, Primary Beneficiary [Member] | Facilities Acquired Acquisition Pending [Member] | Exchange Accommodation Titleholders [Member] | 4 of 7 Facilities
Liabilities
Number of Facilities					4
Variable Interest Entity, Primary Beneficiary [Member] | Facilities Acquired Released From EAT [Member] | Exchange Accommodation Titleholders [Member] | 4 of 7 Facilities
Liabilities
Number of Facilities							4
Variable Interest Entity, Not Primary Beneficiary [Member]
Assets
Real estate assets - net			1,250,131,000	996,540,000
Assets held for sale				51,700,000
Real estate loans receivable - net			534,048,000	370,147,000
Investments in unconsolidated joint ventures			9,754,000	9,009,000
Non-real estate loans receivable - net			38,463,000	10,679,000
Contractual receivables - net			994,000	746,000
Other assets			1,539,000	1,423,000
Total assets			1,834,929,000	1,440,244,000
Liabilities
Accrued expenses and other liabilities			(52,692,000)	(46,677,000)
Total Liabilities			(52,692,000)	(46,677,000)
Total collateral			(1,470,096,000)	(1,138,953,000)
Maximum exposure to loss			312,141,000	254,614,000
Rental income			106,911,000	81,900,000	$ 53,158,000
Interest income			16,414,000	5,512,000	16,456,000
Total revenues			123,325,000	87,412,000	$ 69,614,000
Variable Interest Entity, Not Primary Beneficiary [Member] | Asset Pledged as Collateral with Right [Member] | Notes Payable, Other Payables [Member]
Liabilities
Accounts receivable			5,500,000	8,900,000
Variable Interest Entity, Not Primary Beneficiary [Member] | Personal Guarantee Collateral [Member]
Liabilities
Total collateral			(48,000,000)	(48,000,000)
Variable Interest Entity, Not Primary Beneficiary [Member] | Other Collateral [Member]
Liabilities
Total collateral			$ (1,422,096,000)	(1,090,953,000)
Variable Interest Entity, Not Primary Beneficiary [Member] | Maplewood Real Estate Holdings
Liabilities
Termination fee incurred cost				$ 12,500,000

INVESTMENT IN JOINT VENTURES (S

INVESTMENT IN JOINT VENTURES (Schedule of equity method investments) (Details)		3 Months Ended	12 Months Ended
	May 17, 2019 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($) facility item	Dec. 31, 2023 USD ($) facility	Dec. 31, 2022 USD ($) facility	Aug. 01, 2024	Jul. 31, 2024	Jul. 24, 2024 USD ($)	Dec. 18, 2019 facility item
Number of real estate properties | facility			1,026
Investments in unconsolidated joint ventures			$ 88,711,000	$ 188,409,000
Number of operators | item			87
Income (loss) from unconsolidated joint ventures			$ 7,916,000	$ (582,000)	$ 7,261,000
Number of Unconsolidated Joint Ventures | item			11
Cindat Ice Portfolio JV GP Limited [Member]
Number of real estate properties | facility				63					63
Investments in unconsolidated joint ventures				$ 97,559,000				$ 97,000,000
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Percentage of ownership interest, asset acquisition		51%	51%				51%
63 Facilities | Cindat Ice Portfolio JV GP Limited [Member]
Number of operators | item									2
Cindat Ice Portfolio JV GP Limited [Member]
Ownership by parent						100%
Second Spring Healthcare Investments [Member]
Ownership %			15%
Investments in unconsolidated joint ventures			$ 7,117,000	8,945,000
Lakeway Realty LLC [Member]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 0	$ 62,000,000
Equity method investment, difference between carrying amount and underlying equity	$ 69,900,000
Equity method investment difference between carrying amount and underlying equity treatment period	40 years
Cindat Ice Portfolio JV GP Limited [Member]
Ownership %				49%				49%	49%
Other Real Estate Joint Venture Investments [Member]
Number of Unconsolidated Joint Ventures | item			3
Other Real Estate Joint Venture Investments [Member] | Maximum [Member]
Ownership %			50%
Other Real Estate Joint Venture Investments [Member] | Minimum [Member]
Ownership %			20%
OMG Senior Housing LLC [Member]
Total cash proceeds		$ 6,500,000
OMG Senior Housing LLC [Member] | OMG Senior Housing LLC [Member]
Total cash proceeds		40,700,000
Amount of gain (loss) from sale of facilities		$ 12,900,000
Other Healthcare Joint Venture Investments [Member]
Investments in unconsolidated joint ventures			$ 7,317,000	$ 6,994,000
Number of Unconsolidated Joint Ventures | item			6
Other Healthcare Joint Venture Investments [Member] | Maximum [Member]
Ownership %			25%
Other Healthcare Joint Venture Investments [Member] | Minimum [Member]
Ownership %			9%
Other Real Estate Joint Ventures And Other Healthcare Joint Ventures [Member]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 18,500,000	17,500,000
Skilled Nursing Facilities [Member]
Number of real estate properties | facility			589
Specialty [Member]
Number of real estate properties | facility			18
Specialty [Member] | Lakeway Realty LLC [Member]
Ownership %			51%
Number of real estate properties | facility			1
Investments in unconsolidated joint ventures			$ 67,541,000	68,902,000
Assisted Living Facilities [Member]
Number of real estate properties | facility			290
Independent Living Facilities [Member]
Number of real estate properties | facility			19
Various Facility Types [Member] | Other Real Estate Joint Venture Investments [Member]
Number of real estate properties | facility			6
Investments in unconsolidated joint ventures			$ 6,736,000	6,009,000
Non Real Estate Loans Receivable [Member]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			455,069,000	397,246,000
Mortgage Receivable [Member]
Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss			$ 982,327,000	$ 754,437,000
Facilities Sold
Number of real estate properties			21	69	66
Facilities Sold | Skilled Nursing Facilities [Member]
Number of real estate properties			14	64
Facilities Sold | Assisted Living Facilities [Member]
Number of real estate properties			6	2
Facilities Sold | Independent Living Facilities [Member]
Number of real estate properties				1
Facilities Sold | Specialty Facility
Number of real estate properties			1	1
Facilities Acquired | Skilled Nursing Facilities [Member]
Number of real estate properties | facility			6	9	7
Facilities Acquired | Assisted Living Facilities [Member]
Number of real estate properties | facility			108	21	34

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLES (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Net amortization of intangible assets	$ 1.7	$ 9.4	$ 5.7
2025	(0.9)
2026	(1.2)
2027	(1.3)
2028	(1.9)
2029	(2.2)
Thereafter	$ (12.5)
Below market leases, weighted average remaining amortization, period	7 years
Above market leases
Weighted average remaining amortization	10 years

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLES (Schedule of Reconciliation of Goodwill) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Goodwill [Roll Forward]
Balance	$ 643,897
Foreign currency translation	(233)
Balance	$ 643,664

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLES (Schedule of Intangibles) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Sep. 30, 2024	Jul. 31, 2024	Dec. 31, 2023
Assets:
Gross intangible assets	$ 31,864			$ 4,214
Accumulated amortization	(3,800)			(3,532)
Net intangible assets	28,064			682
Liabilities:
Below market leases	34,723			48,791
Accumulated amortization	(26,647)			(37,177)
Net intangible liabilities	$ 8,076			$ 11,614
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Liabilities:
Percentage of ownership interest, asset acquisition	51%	51%	51%
Above market leases | Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Assets:
Gross intangible assets	$ 27,400

CONCENTRATION OF RISK (Narrativ

CONCENTRATION OF RISK (Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 USD ($) state facility item contract	Dec. 31, 2023 USD ($) facility contract	Dec. 31, 2022 USD ($)
Concentration Risk [Line Items]
Number of real estate properties | facility			1,026
Number of states and U.K. | state			42
Number of operators | item			87
Gross investment in facilities, net of impairments and reserves for uncollectible loans			$ 10,100,000,000
Real estate loans receivable - net			1,428,298,000	$ 1,212,162,000
Non-real estate loans receivable - net			332,274,000	275,615,000
Investment in unconsolidated joint venture			$ 88,711,000	188,409,000
Number of unconsolidated joint ventures | item			11
Straight line rent receivable write-offs, lease inducements write-offs and effective yield interest receivable write-offs			$ 4,200,000	20,600,000	$ 124,800,000
Other Real Estate Loans [Member]
Concentration Risk [Line Items]
Real estate loans receivable - net			485,533,000	513,386,000
Variable Interest Entity, Not Primary Beneficiary [Member]
Concentration Risk [Line Items]
Real estate loans receivable - net			534,048,000	370,147,000
Non-real estate loans receivable - net			38,463,000	10,679,000
Investment in unconsolidated joint venture			$ 9,754,000	$ 9,009,000
Maplewood Real Estate Holdings
Concentration Risk [Line Items]
Number of operators that met or exceeded ten percent of investments | contract			1	1
Termination fee incurred cost	$ 12,500,000			$ 12,500,000
Straight line accounts receivable and lease inducements write-offs		$ 29,300,000
Maplewood Real Estate Holdings | Variable Interest Entity, Not Primary Beneficiary [Member]
Concentration Risk [Line Items]
Termination fee incurred cost				$ 12,500,000
Communicare Health Services, Inc
Concentration Risk [Line Items]
Number of operators that met or exceeded ten percent threshold for revenues			1
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Maplewood Real Estate Holdings | Variable Interest Entity, Not Primary Beneficiary [Member]
Concentration Risk [Line Items]
Concentration percentage			5.20%	5.40%	6.90%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Communicare Health Services, Inc
Concentration Risk [Line Items]
Concentration percentage			11.80%	11.70%	9.10%
Assets, Total [Member] | Geographic Concentration Risk [Member] | Texas
Concentration Risk [Line Items]
Concentration percentage			9.20%
Assets, Total [Member] | Geographic Concentration Risk [Member] | Indiana
Concentration Risk [Line Items]
Concentration percentage			6.20%
Assets, Total [Member] | Geographic Concentration Risk [Member] | California
Concentration Risk [Line Items]
Concentration percentage			5.70%
Assets, Total [Member] | Geographic Concentration Risk [Member] | United Kingdom
Concentration Risk [Line Items]
Concentration percentage			14.10%
Assets, Total [Member] | Product Concentration Risk [Member] | Communicare Health Services, Inc
Concentration Risk [Line Items]
Concentration percentage			8.20%
Assets, Total [Member] | Product Concentration Risk [Member] | Real Estate Investment Related to Long Term Healthcare Facilities [Member]
Concentration Risk [Line Items]
Concentration percentage			98%
Skilled Nursing Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			589
Assisted Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			290
Specialty [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			18
Medical Office Building [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			1
Independent Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			19
Facilities Under Fixed Rate Mortgage Loans [Member] | Skilled Nursing Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			52
Facilities Under Fixed Rate Mortgage Loans [Member] | Assisted Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			43
Facilities Under Fixed Rate Mortgage Loans [Member] | Specialty [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			1
Facilities Under Fixed Rate Mortgage Loans [Member] | Independent Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties			1
Facilities Held for Sale [Member]
Concentration Risk [Line Items]
Number of real estate properties | facility			12	14

BORROWING ACTIVITIES AND ARRA_3

BORROWING ACTIVITIES AND ARRANGEMENTS (Schedule of Borrowings) (Details)

1 Months Ended

3 Months Ended

12 Months Ended

24 Months Ended

Sep. 27, 2023 USD ($)

Aug. 08, 2023 USD ($)

Aug. 31, 2022 USD ($)

Apr. 30, 2021 USD ($) item

Aug. 26, 2020

Oct. 31, 2019

Jan. 31, 2025 USD ($)

Mar. 31, 2021 USD ($)

Mar. 31, 2024 USD ($) item

Sep. 30, 2023 USD ($)

Jun. 30, 2023 USD ($)

Mar. 31, 2023

Dec. 31, 2024 USD ($) facility

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($) facility

Dec. 31, 2023 USD ($)

Jan. 15, 2025 USD ($)

Jul. 24, 2024

Apr. 01, 2024 USD ($)

Aug. 31, 2023 USD ($)

Dec. 30, 2022 facility

Sep. 30, 2022 facility

Oct. 31, 2020 USD ($)

Dec. 18, 2019

Debt Instrument [Line Items]

Total secured borrowings

$ 243,310,000

$ 61,963,000

$ 61,963,000

Revolving credit facility

20,397,000

20,397,000

Total senior notes and other unsecured borrowings - net

4,595,549,000

4,984,956,000

4,984,956,000

Total secured and unsecured borrowings - net

4,838,859,000

5,067,316,000

5,067,316,000

Real estate assets - net

6,339,158,000

5,902,526,000

$ 5,902,526,000

Loss on extinguishment of debt

$ 1,749,000

$ 492,000

$ 389,000

Debt instrument, covenant compliance

As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings.

As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings.

Number of Facilities | facility

1,026

Number Of Assumed Loans Retired | item

9

Cindat Ice Portfolio JV GP Limited [Member]

Debt Instrument [Line Items]

Percentage of ownership interest

49%

49%

49%

49%

LaVie Care Centers LLC (f/k/a Consulate Health Care)

Debt Instrument [Line Items]

Number of Facilities

11

Assisted Living Facilities [Member]

Debt Instrument [Line Items]

Number of Facilities | facility

290

Facilities Sold

Debt Instrument [Line Items]

Number of Facilities

21

69

66

69

Facilities Sold | LaVie Care Centers LLC (f/k/a Consulate Health Care)

Debt Instrument [Line Items]

Number of Facilities

7

30

11

30

11

Facilities Sold | Assisted Living Facilities [Member]

Debt Instrument [Line Items]

Number of Facilities

6

2

2

Hud Mortgage

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ (1,300,000)

$ (500,000)

$ (400,000)

Seven Hud Mortgages [Member] | LaVie Care Centers LLC (f/k/a Consulate Health Care)

Debt Instrument [Line Items]

Number Of Assumed Loans Retired

7

Nine Hud Mortgages [Member]

Debt Instrument [Line Items]

Repayments of secured debt

$ 41,600,000

4.95% notes due 2024

Debt Instrument [Line Items]

Rate

4.95%

4.50% notes due 2025

Debt Instrument [Line Items]

Rate

4.50%

5.25% notes due 2026

Debt Instrument [Line Items]

Rate

5.25%

4.50% notes due 2027

Debt Instrument [Line Items]

Rate

4.50%

4.75% notes due 2028

Debt Instrument [Line Items]

Rate

4.75%

3.63% notes due 2029

Debt Instrument [Line Items]

Rate

3.63%

3.38% notes due 2031

Debt Instrument [Line Items]

Rate

3.38%

3.25% notes due 2033

Debt Instrument [Line Items]

Rate

3.25%

2025 Term Loan [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

$ 28,500,000

$ 400,000,000

Mortgage Loan Due 2026 [Member]

Debt Instrument [Line Items]

Premium - net

$ 15,900,000

Secured Debt [Member]

Debt Instrument [Line Items]

Deferred financing costs - net

(3,753,000)

Premium - net

$ 15,915,000

Secured Debt [Member] | Hud Mortgage

Debt Instrument [Line Items]

Total secured borrowings

41,878,000

$ 41,878,000

Secured Debt [Member] | Hud Mortgage Assumed Maturity 2051 [Member]

Debt Instrument [Line Items]

Maturity

2051

2051

Rate

2.92%

Repayments of secured debt

$ 7,900,000

Secured Debt [Member] | Term Loan Maturity 2024 [Member]

Debt Instrument [Line Items]

Maturity

2024

Total secured borrowings

20,085,000

20,085,000

Secured Debt [Member] | Term Loan Maturity 2024 [Member] | Facilities Related to Joint Venture [Member] | Assisted Living Facilities [Member]

Debt Instrument [Line Items]

Number of Facilities | facility

2

Secured Debt [Member] | Mortgage Loan Due 2026 [Member]

Debt Instrument [Line Items]

Maturity

2026

Rate

10.31%

Total secured borrowings

$ 231,148,000

Unsecured Debt [Member]

Debt Instrument [Line Items]

Deferred financing costs - net

(14,843,000)

(20,442,000)

(20,442,000)

Discount - net

(18,108,000)

(23,102,000)

(23,102,000)

Total unsecured borrowings - net

$ 4,595,549,000

5,005,353,000

5,005,353,000

Unsecured Debt [Member] | Omega OP Term Loan Facility

Debt Instrument [Line Items]

Maturity

2025

Rate

5.52%

Total term loans - net

$ 50,000,000

$ 50,000,000

$ 50,000,000

50,000,000

50,000,000

Basis spread on variable rate

0.11448%

Debt instrument number of available extensions | item

2

Debt instrument extension period duration

6 months

Debt instrument, face amount

$ 50,000,000

Debt instrument, maturity date

Apr. 30, 2025

Description of variable rate basis

SOFR

LIBOR

Derivative, Variable Interest Rate

3.957%

Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]

us-gaap:SecuredOvernightFinancingRateSofrMember

Unsecured Debt [Member] | Omega OP Term Loan Facility | Subsequent Event [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Oct. 30, 2025

Unsecured Debt [Member] | Senior Notes And Other Unsecured Borrowings Net [Member]

Debt Instrument [Line Items]

Total senior notes and other unsecured borrowings - net

$ 4,595,549,000

4,984,956,000

4,984,956,000

Unsecured Debt [Member] | 4.50% notes due 2025 | Subsequent Event [Member]

Debt Instrument [Line Items]

Rate

4.50%

Repayments of senior debt

$ 400,000,000

Unsecured Debt [Member] | 2025 Term Loan [Member]

Debt Instrument [Line Items]

Maturity

2025

Rate

5.60%

Long-term debt, gross

$ 428,500,000

$ 428,500,000

$ 428,500,000

Basis spread on variable rate

0.10%

Debt instrument number of available extensions

2

Debt instrument extension period duration

12 months

Debt instrument, face amount

$ 28,500,000

$ 400,000,000

Debt instrument, maturity date

Aug. 08, 2025

Description of variable rate basis

SOFR

Derivative, Variable Interest Rate

4.047%

Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]

us-gaap:SecuredOvernightFinancingRateSofrMember

Senior Notes [Member] | 4.95% notes due 2024

Debt Instrument [Line Items]

Maturity

2024

Rate

4.95%

4.95%

Long-term debt, gross

$ 400,000,000

$ 400,000,000

$ 0

Repayments of senior debt

400,000,000

Senior Notes [Member] | 4.50% notes due 2025

Debt Instrument [Line Items]

Maturity

2025

Rate

4.50%

Long-term debt, gross

$ 400,000,000

400,000,000

400,000,000

Senior Notes [Member] | 4.50% notes due 2025 | Subsequent Event [Member]

Debt Instrument [Line Items]

Long-term debt, gross

$ 0

Senior Notes [Member] | 5.25% notes due 2026

Debt Instrument [Line Items]

Maturity

2026

Rate

5.25%

Long-term debt, gross

$ 600,000,000

600,000,000

600,000,000

Senior Notes [Member] | 4.50% notes due 2027

Debt Instrument [Line Items]

Maturity

2027

Rate

4.50%

Long-term debt, gross

$ 700,000,000

700,000,000

700,000,000

Senior Notes [Member] | 4.75% notes due 2028

Debt Instrument [Line Items]

Maturity

2028

Rate

4.75%

Long-term debt, gross

$ 550,000,000

550,000,000

550,000,000

Senior Notes [Member] | 3.63% notes due 2029

Debt Instrument [Line Items]

Maturity

2029

Rate

3.63%

Long-term debt, gross

$ 500,000,000

500,000,000

500,000,000

Senior Notes [Member] | 3.38% notes due 2031

Debt Instrument [Line Items]

Maturity

2031

Rate

3.38%

3.375%

Long-term debt, gross

$ 700,000,000

700,000,000

700,000,000

Debt instrument, face amount

$ 700,000,000

Senior Notes [Member] | 3.25% notes due 2033

Debt Instrument [Line Items]

Maturity

2033

2033

Rate

3.25%

3.25%

Long-term debt, gross

$ 700,000,000

700,000,000

700,000,000

Debt instrument, face amount

$ 700,000,000

Minimum [Member] | Secured Debt [Member] | Hud Mortgage

Debt Instrument [Line Items]

Maturity

2046

2049

Minimum [Member] | Unsecured Debt [Member] | Omega OP Term Loan Facility

Debt Instrument [Line Items]

Basis spread on variable rate

0.85%

Minimum [Member] | Unsecured Debt [Member] | 2025 Term Loan [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.85%

Maximum [Member] | Secured Debt [Member] | Hud Mortgage

Debt Instrument [Line Items]

Maturity

2052

2051

Maximum [Member] | Unsecured Debt [Member] | Omega OP Term Loan Facility

Debt Instrument [Line Items]

Basis spread on variable rate

1.85%

Maximum [Member] | Unsecured Debt [Member] | 2025 Term Loan [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

1.85%

Revolving Credit Facility | Unsecured Debt [Member]

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 1,450,000,000

$ 1,450,000,000

Basis spread on variable rate

0.11448%

Debt instrument number of available extensions | item

2

Debt instrument extension period duration

6 months

Debt instrument, maturity date

Apr. 30, 2025

Description of variable rate basis

SOFR

SOFR

LIBOR

Revolving Credit Facility | Unsecured Debt [Member] | Subsequent Event [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Oct. 30, 2025

Revolving Credit Facility | Unsecured Debt [Member] | United States Dollar Tranche [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate, effective percentage

5.67%

Revolving Credit Facility | Unsecured Debt [Member] | British Pound Sterling Tranche [Member]

Debt Instrument [Line Items]

Debt instrument, interest rate, effective percentage

6.02%

Revolving Credit Facility | Unsecured Debt [Member] | 2017 Revolving Credit Facility Replaced [Member]

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 1,250,000,000

Revolving Credit Facility | Unsecured Debt [Member] | Revolving Credit Facility Due 2025 [Member]

Debt Instrument [Line Items]

Maturity

2025

Rate

5.67%

Revolving credit facility

$ 20,397,000

$ 20,397,000

Revolving Credit Facility | Minimum [Member] | Unsecured Debt [Member]

Debt Instrument [Line Items]

Basis spread on variable rate

0.95%

Revolving Credit Facility | Maximum [Member] | Unsecured Debt [Member]

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 2,500,000,000

Basis spread on variable rate

1.85%

BORROWING ACTIVITIES AND ARRA_4

BORROWING ACTIVITIES AND ARRANGEMENTS (HUD Mortgage) (Details)				3 Months Ended		6 Months Ended	12 Months Ended
	Aug. 31, 2022 USD ($)	Aug. 26, 2020 USD ($) loan	Oct. 31, 2019 USD ($)	Mar. 31, 2024 USD ($) item	Dec. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) facility item	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Number of real estate properties | facility							1,026
Mortgage loans on real estate, new mortgage loans							$ 292,722,000	$ 102,332,000	$ 12,977,000
Number of operators | item							87
Number of assumed loans retired | item				9
Loss on debt extinguishment							$ (1,749,000)	(492,000)	(389,000)
Mortgage Loans Guaranteed By United States Department of Housing and Urban Development [Member]
Mortgage loans on real estate, new mortgage loans			$ 389,000,000
Escrow deposit					$ 4,900,000	$ 4,900,000		4,900,000
Hud Mortgage
Loss on debt extinguishment							$ 1,300,000	$ 500,000	$ 400,000
Nine Hud Mortgages [Member]
Repayments of secured debt				$ 41,600,000
Minimum [Member] | Mortgage Loans Guaranteed By United States Department of Housing and Urban Development [Member]
Debt instrument, interest rate, stated percentage			2.82%
Maximum [Member] | Mortgage Loans Guaranteed By United States Department of Housing and Urban Development [Member]
Debt instrument, interest rate, stated percentage			3.24%
Secured Debt [Member] | Two Hud Mortgages Assumed [Member]
Debt weighted average interest rate		3.08%
Repayments of secured debt		$ 13,700,000
Number of assumed loans retired | loan		2
Secured Debt [Member] | Hud Mortgage Assumed Maturity 2051 [Member]
Debt instrument, interest rate, stated percentage	2.92%
Repayments of secured debt	$ 7,900,000
Maturity	2051	2051
Secured Debt [Member] | Hud Mortgage Assumed Maturity 2052 [Member]
Maturity		2052
Secured Debt [Member] | Hud Mortgage Assumed Maturity 2046 to 2052 [Member]
Debt weighted average interest rate					3.03%	3.03%		3.03%
Repayments of secured debt						$ 281,700,000
Number of assumed loans retired						29
Secured Debt [Member] | Three Hud Mortgages Retired [Member]
Debt weighted average interest rate					2.97%	2.97%		2.97%
Repayments of secured debt					$ 14,800,000
Secured Debt [Member] | Minimum [Member] | Hud Mortgage
Maturity			2046				2049
Secured Debt [Member] | Minimum [Member] | Hud Mortgage Assumed Maturity 2046 to 2052 [Member]
Maturity						2046
Secured Debt [Member] | Minimum [Member] | Three Hud Mortgages Retired [Member]
Maturity					2046
Secured Debt [Member] | Maximum [Member] | Hud Mortgage
Maturity			2052				2051
Secured Debt [Member] | Maximum [Member] | Hud Mortgage Assumed Maturity 2046 to 2052 [Member]
Maturity						2052
Secured Debt [Member] | Maximum [Member] | Three Hud Mortgages Retired [Member]
Maturity					2052

BORROWING ACTIVITIES AND ARRA_5

BORROWING ACTIVITIES AND ARRANGEMENTS (2026 Mortgage Loan) (Details) $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
	Jul. 31, 2024 USD ($) contract	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)	Jul. 24, 2024	Dec. 31, 2023	Dec. 18, 2019
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Loans Assumed		$ 263,990
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Real Estate Properties [Line Items]
Loans Assumed	$ 264,000
Percentage of ownership interest, asset acquisition	51%	51%	51%
Mortgage Loan Due 2026 [Member]
Real Estate Properties [Line Items]
Premium - net			$ 15,900
Mortgage Loan Due 2026 [Member] | Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Basis spread on variable rate	5.38%
Debt issuance costs, gross	$ 4,900
Maturity			August 2026
Fair value liability, adjustment	$ 20,700
Mortgage Loan Due 2026 [Member] | Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Real Estate Properties [Line Items]
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]	Sterling Overnight Index Average Reference Rate [Member]
Interest Rate Cap [Member] | Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Derivative, number of instruments assumed | contract	4
Maximum [Member] | Mortgage Loan Due 2026 [Member] | Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Rate	10.38%
Maximum [Member] | Mortgage Loan Due 2026 [Member] | Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Real Estate Properties [Line Items]
Rate	10.38%
Cindat Ice Portfolio JV GP Limited [Member]
Real Estate Properties [Line Items]
Percentage of ownership interest				49%	49%	49%

BORROWING ACTIVITIES AND ARRA_6

BORROWING ACTIVITIES AND ARRANGEMENTS - UNSECURED BORROWINGS (Narrative) (Details) - 2025 Term Loan [Member] - USD ($)	Sep. 27, 2023	Aug. 08, 2023	Dec. 31, 2024	Sep. 30, 2023	Aug. 31, 2023
Debt Instrument [Line Items]
Debt instrument, face amount				$ 28,500,000	$ 400,000,000
Unsecured Debt [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	$ 28,500,000	$ 400,000,000
Debt instrument, maximum borrowing capacity, amount		$ 500,000,000
Debt instrument, maturity date		Aug. 08, 2025
Debt issuance costs, gross			$ 3,300,000
Basis spread on variable rate	0.10%
Debt instrument, discount, gross			$ 1,400,000
Debt Instrument Number Of Available Extensions		2
Debt Instrument Extension Period Duration		12 months
Description of variable rate basis	SOFR
Minimum [Member] | Unsecured Debt [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	0.85%
Maximum [Member] | Unsecured Debt [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	1.85%

BORROWING ACTIVITIES AND ARRA_7

BORROWING ACTIVITIES AND ARRANGEMENTS (Revolving Credit Facility) (Details) - Revolving Credit Facility - Unsecured Debt [Member] $ in Millions		1 Months Ended	3 Months Ended
	Apr. 30, 2021 USD ($) item	Jan. 31, 2025	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2024 USD ($)
Maximum borrowing capacity	$ 1,450				$ 1,450
Description of variable rate basis	SOFR		SOFR	LIBOR
Basis spread on variable rate	0.11448%
Debt instrument number of available extensions | item	2
Debt instrument extension period duration	6 months
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche one	$ 1,150
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche two	300
Debt issuance costs, gross	$ 12.9
Debt instrument, maturity date	Apr. 30, 2025
Subsequent Event [Member]
Debt instrument, maturity date		Oct. 30, 2025
Sterling Overnight Index Average Reference Rate [Member]
Basis spread on variable rate	0.1193%
2017 Revolving Credit Facility Replaced [Member]
Maximum borrowing capacity	$ 1,250
Minimum [Member]
Basis spread on variable rate	0.95%
Maximum [Member]
Maximum borrowing capacity	$ 2,500
Basis spread on variable rate	1.85%

BORROWING ACTIVITIES AND ARRA_8

BORROWING ACTIVITIES AND ARRANGEMENTS (OP Term Loan) (Details) $ in Thousands		1 Months Ended	12 Months Ended
	Apr. 30, 2021 USD ($) item	Jan. 31, 2025	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)
Senior notes and other unsecured borrowings - net			$ 4,595,549	$ 4,984,956
Omega OP Term Loan Facility | Unsecured Debt [Member]
Total term loans - net	$ 50,000		$ 50,000	$ 50,000	$ 50,000
Basis spread on variable rate	0.11448%
Debt instrument, maturity date			Apr. 30, 2025
Debt issuance costs, gross	$ 400
Debt instrument number of available extensions | item	2
Debt instrument extension period duration	6 months
Omega OP Term Loan Facility | Unsecured Debt [Member] | Subsequent Event [Member]
Debt instrument, maturity date		Oct. 30, 2025
Minimum [Member] | Omega OP Term Loan Facility | Unsecured Debt [Member]
Basis spread on variable rate	0.85%
Maximum [Member] | Omega OP Term Loan Facility | Unsecured Debt [Member]
Basis spread on variable rate	1.85%

BORROWING ACTIVITIES AND ARRA_9

BORROWING ACTIVITIES AND ARRANGEMENTS (General) (Narrative) (Detail) $ in Thousands		3 Months Ended		12 Months Ended	24 Months Ended
	Apr. 30, 2021 USD ($) item	Jun. 30, 2023 USD ($)	Mar. 31, 2023	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Long-term line of credit					$ 20,397
Debt instrument, covenant compliance				As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings.	As of December 31, 2024 and December 31, 2023, we were in compliance with all applicable covenants for our borrowings.
Debt instrument, covenant description				Parent and Omega OP, on a combined basis, have no material assets, liabilities or operations other than financing activities (including borrowings under the senior unsecured revolving and term loan credit facility, OP term loan and the outstanding senior notes) and their investments in non-guarantor subsidiaries. Substantially all of our assets are held by non-guarantor subsidiaries.
Unsecured Debt [Member]
Debt Instrument [Line Items]
Unsecured debt				$ 4,595,549	$ 5,005,353
Unsecured Debt [Member] | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 1,450,000			1,450,000
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche one	1,150,000
Revolving credit facility to be drawn in Alternative Currencies or U.S. Dollars in tranche two	$ 300,000
Description of variable rate basis	SOFR	SOFR	LIBOR
Basis spread on variable rate	0.11448%
Maturity date	Apr. 30, 2025
Debt instrument number of available extensions | item	2
Debt instrument extension period duration	6 months
Unsecured Debt [Member] | Minimum [Member] | Revolving Credit Facility
Debt Instrument [Line Items]
Basis spread on variable rate	0.95%
Unsecured Debt [Member] | Maximum [Member] | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 2,500,000
Basis spread on variable rate	1.85%
Unsecured Debt [Member] | Omega OP Term Loan Facility
Debt Instrument [Line Items]
Term loans - net	$ 50,000	$ 50,000		$ 50,000	$ 50,000
Description of variable rate basis		SOFR	LIBOR
Basis spread on variable rate	0.11448%
Rate				5.52%
Maturity date				Apr. 30, 2025
Debt instrument number of available extensions | item	2
Debt instrument extension period duration	6 months
Unsecured Debt [Member] | Omega OP Term Loan Facility | Minimum [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	0.85%
Unsecured Debt [Member] | Omega OP Term Loan Facility | Maximum [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	1.85%
Unsecured Debt [Member] | 2017 Revolving Credit Facility Replaced [Member] | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 1,250,000

BORROWING ACTIVITIES AND ARR_10

BORROWING ACTIVITIES AND ARRANGEMENTS (Schedule of principal payments, excluding the premium or discount and the aggregate due thereafter) (Detail) $ in Thousands	Dec. 31, 2024 USD ($)
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]
2025	$ 878,500
2026	831,148
2027	700,000
2028	550,000
2029	500,000
Thereafter	1,400,000
Totals	$ 4,859,648

DERIVATIVES AND HEDGING (Narrat

DERIVATIVES AND HEDGING (Narrative) (Details) £ in Millions

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Feb. 27, 2024 USD ($)

Dec. 27, 2023 USD ($)

Sep. 30, 2023 USD ($)

Sep. 27, 2023 USD ($)

Aug. 08, 2023 USD ($)

May 30, 2023 USD ($)

May 17, 2022 GBP (£) contract

Apr. 30, 2021 USD ($)

Mar. 27, 2020 USD ($) contract

Jan. 31, 2025

Jul. 31, 2024

Aug. 31, 2023 USD ($)

Jun. 30, 2023 USD ($)

Mar. 31, 2021 USD ($) contract

Mar. 31, 2021 GBP (£) contract

Oct. 31, 2020 USD ($)

Jun. 30, 2023 USD ($)

Mar. 31, 2023

Mar. 31, 2021 USD ($)

Dec. 31, 2024 USD ($) contract

Dec. 31, 2023 USD ($)

Dec. 31, 2022 USD ($)

Dec. 31, 2024 GBP (£) contract

Sep. 30, 2024

Jul. 24, 2024 contract

Feb. 27, 2024 GBP (£) contract

Dec. 27, 2023 GBP (£) USD ($)

Sep. 29, 2023 USD ($)

Dec. 18, 2019

Unrealized gain (loss)

$ 1,602,000

$ (11,245,000)

$ 55,949,000

Proceeds from hedge, financing activities

92,577,000

Proceeds from net investment hedges

$ 8,400,000

$ 8,429,000

$ 11,378,000

Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]

Percentage of ownership interest, asset acquisition

51%

51%

51%

51%

Cindat Ice Portfolio JV GP Limited [Member]

Percentage of ownership interest

49%

49%

49%

Omega OP Term Loan Facility | Unsecured Debt [Member]

Term loans - net

$ 50,000,000

$ 50,000,000

$ 50,000,000

$ 50,000,000

$ 50,000,000

Description of variable rate basis

SOFR

LIBOR

Basis spread on variable rate

0.11448%

Maturity date

Apr. 30, 2025

Debt instrument, face amount

50,000,000

$ 50,000,000

Maturity

2025

Interest rate

5.52%

5.52%

Omega OP Term Loan Facility | Unsecured Debt [Member] | Subsequent Event [Member]

Maturity date

Oct. 30, 2025

Omega OP Term Loan Facility | Minimum [Member] | Unsecured Debt [Member]

Basis spread on variable rate

0.85%

Omega OP Term Loan Facility | Maximum [Member] | Unsecured Debt [Member]

Basis spread on variable rate

1.85%

3.38% notes due 2031

Interest rate

3.38%

3.38%

3.38% notes due 2031 | Senior Notes [Member]

Debt instrument, face amount

$ 700,000,000

Maturity

2031

Long-term Debt, Gross

$ 700,000,000

700,000,000

Interest rate

3.375%

3.38%

3.38%

3.25% notes due 2033

Interest rate

3.25%

3.25%

3.25% notes due 2033 | Senior Notes [Member]

Debt instrument, face amount

$ 700,000,000

$ 700,000,000

Maturity

2033

2033

2033

Long-term Debt, Gross

$ 700,000,000

700,000,000

Interest rate

3.25%

3.25%

3.25%

3.25%

2025 Term Loan [Member]

Debt instrument, face amount

$ 28,500,000

$ 400,000,000

2025 Term Loan [Member] | Unsecured Debt [Member]

Description of variable rate basis

SOFR

Basis spread on variable rate

0.10%

Maturity date

Aug. 08, 2025

Debt instrument, face amount

$ 28,500,000

$ 400,000,000

Maturity

2025

Long-term Debt, Gross

$ 428,500,000

$ 428,500,000

Interest rate

5.60%

5.60%

2025 Term Loan [Member] | Minimum [Member] | Unsecured Debt [Member]

Basis spread on variable rate

0.85%

2025 Term Loan [Member] | Maximum [Member] | Unsecured Debt [Member]

Basis spread on variable rate

1.85%

Mortgage Loan Due 2026 [Member] | Cindat Ice Portfolio JV GP Limited [Member]

Basis spread on variable rate

5.38%

Maturity

August 2026

Mortgage Loan Due 2026 [Member] | Maximum [Member] | Cindat Ice Portfolio JV GP Limited [Member]

Debt instrument, interest rate, effective percentage

10.38%

Mortgage Loan Due 2026 [Member] | Maximum [Member] | Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]

Debt instrument, interest rate, effective percentage

10.38%

Net Investment Hedging [Member]

Derivative, Notional Amount Terminated | £

£ 70

£ 104

Derivative, maturity Date

Mar. 08, 2024

Mar. 08, 2024

Notional amount of nonderivative instruments | £

£ 174

Number of foreign currency forwards entered into | contract

4

4

Derivative, Number of Instruments Terminated

2

2

Proceeds from net investment hedges

$ 11,400,000

Interest Rate Swap | Cash Flow Hedging [Member]

Derivative, notional amount

$ 478,500,000

Number of Instruments Held, derivative

12

Interest Rate Swap | Cash Flow Hedging [Member] | Forward Starting Swaps [Member]

Derivative, notional amount

$ 400,000,000

Derivative, effective date

Aug. 01, 2023

Derivative, inception Date

Mar. 27, 2020

Derivative, maturity Date

Aug. 01, 2033

Derivative forecasted issuance period on long term debt

5 years

Derivative, fixed interest rate

0.8675%

Derivative, maximum period

46 months

Number of Instruments Held, derivative

5

Derivative, Number of Instruments Terminated

5

Unrealized gain (loss)

$ 31,700,000

$ 9,500,000

$ 41,200,000

Proceeds from hedge, financing activities

$ 92,600,000

Gains expected to be recognized next qualifying debt issuance

$ 51,400,000

Interest Rate Swap | Cash Flow Hedging [Member] | Omega OP Term Loan Facility

Derivative, notional amount

$ 50,000,000

$ 50,000,000

Derivative, effective date

Jun. 30, 2023

Derivative, maturity Date

Apr. 30, 2027

Interest Rate Swap | Cash Flow Hedging [Member] | Omega OP Term Loan Facility | Unsecured Debt [Member]

Derivative instrument potential fluctuate basis point up

0.40%

Derivative instrument potential fluctuate basis point down

0.60%

Debt instrument, interest rate, effective percentage

5.521%

5.521%

Interest Rate Swap | Cash Flow Hedging [Member] | 2025 Term Loan [Member]

Derivative, notional amount

28,500,000

$ 400,000,000

Derivative, effective date

Sep. 29, 2023

Aug. 14, 2023

Derivative, maturity Date

Aug. 06, 2027

Aug. 06, 2027

Debt instrument, face amount

$ 428,500,000

Number of Instruments Held, derivative

11

10

1

Debt instrument, interest rate, effective percentage

5.597%

Interest Rate Swap | Cash Flow Hedging [Member] | 2025 Term Loan [Member] | Unsecured Debt [Member]

Debt instrument, interest rate, effective percentage

5.565%

Interest Rate Swap | Cash Flow Hedging [Member] | 2025 Term Loan [Member] | Maximum [Member]

Derivative instrument potential fluctuate basis point up

0.40%

Derivative instrument potential fluctuate basis point down

0.60%

Interest Rate Cap [Member]

Derivative, notional amount | £

£ 190

Derivative, maturity Date

Aug. 26, 2026

Number of Instruments Held, derivative | contract

4

4

Interest Rate Cap [Member] | Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]

Number of Instruments Held, derivative | contract

4

Foreign Exchange Forward [Member] | Forward Starting Swaps [Member]

Derivative, notional amount | £

£ 104

Derivative, forward exchange rate

1.2916

Number of Instruments Held, derivative

6

Foreign Exchange Forward [Member] | Minimum [Member] | Forward Starting Swaps [Member]

Derivative, maturity Date

Mar. 08, 2027

Foreign Exchange Forward [Member] | Maximum [Member] | Forward Starting Swaps [Member]

Derivative, maturity Date

Mar. 08, 2030

Foreign Exchange Forward [Member] | Net Investment Hedging [Member]

Derivative, notional amount | £

£ 76

£ 258

£ 78

Derivative, maturity Date

May 21, 2029

Derivative, forward exchange rate

1.3071

1.389

1.389

1.2899

1.2899

1.2707

Number of foreign currency derivatives held | contract

3

Number of Instruments Held, derivative

2

11

Foreign Exchange Forward [Member] | Net Investment Hedging [Member] | Minimum [Member]

Derivative, maturity Date

Mar. 08, 2027

Foreign Exchange Forward [Member] | Net Investment Hedging [Member] | Maximum [Member]

Derivative, maturity Date

Mar. 07, 2031

DERIVATIVES AND HEDGING (Locati

DERIVATIVES AND HEDGING (Location and the fair value of derivative instruments designated as hedges) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Other Assets [Member] | Cash Flow Hedging [Member]
Cash flow hedges recorded at fair value, asset	$ 381
Other Assets [Member] | Net Investment Hedging [Member]
Net investment hedges recorded at fair value, asset	8,434	$ 8,903
Accounts Payable and Accrued Liabilities [Member] | Cash Flow Hedging [Member]
Cash flow hedges recorded at fair value, liability	$ 554	6,533
Accounts Payable and Accrued Liabilities [Member] | Net Investment Hedging [Member]
Net investment hedges recorded at fair value, liability		$ 8

FINANCIAL INSTRUMENTS (Schedule

FINANCIAL INSTRUMENTS (Schedule of Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Sep. 30, 2024	Jul. 31, 2024	Jul. 24, 2024	Dec. 31, 2023	Dec. 18, 2019
Cindat Ice Portfolio JV GP Limited Interest Acquired [Member]
Liabilities:
Percentage of ownership interest, asset acquisition	51%	51%	51%
Cindat Ice Portfolio JV GP Limited [Member]
Liabilities:
Percentage of ownership interest				49%	49%	49%
4.95% notes due 2024
Liabilities:
Notes issued, interest rate	4.95%
4.50% notes due 2025
Liabilities:
Notes issued, interest rate	4.50%
5.25% notes due 2026
Liabilities:
Notes issued, interest rate	5.25%
4.50% notes due 2027
Liabilities:
Notes issued, interest rate	4.50%
4.75% notes due 2028
Liabilities:
Notes issued, interest rate	4.75%
3.63% notes due 2029
Liabilities:
Notes issued, interest rate	3.63%
3.38% notes due 2031
Liabilities:
Notes issued, interest rate	3.38%
3.25% notes due 2033
Liabilities:
Notes issued, interest rate	3.25%
Carrying (Reported) Amount, Fair Value Disclosure [Member]
Assets:
Investments in direct financing leases - net	$ 9,453				$ 8,716
Real estate loans receivable - net	1,428,298				1,212,162
Non-real estate loans receivable - net	332,274				275,615
Total	1,770,025				1,496,493
Liabilities:
Sterling term loan	0				20,085
Total	4,838,859				5,067,316
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Revolving Credit Facility
Liabilities:
Revolving line of credit					20,397
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Omega OP Term Loan Facility
Liabilities:
Omega OP term loan	49,966				49,864
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 4.95% notes due 2024
Liabilities:
Notes Payable	0				399,747
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 4.50% notes due 2025
Liabilities:
Notes Payable	399,968				399,207
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 5.25% notes due 2026
Liabilities:
Notes Payable	599,259				598,553
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 4.50% notes due 2027
Liabilities:
Notes Payable	696,766				695,302
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 4.75% notes due 2028
Liabilities:
Notes Payable	546,933				545,925
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 3.63% notes due 2029
Liabilities:
Notes Payable	494,308				493,099
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 3.38% notes due 2031
Liabilities:
Notes Payable	688,962				687,172
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 3.25% notes due 2033
Liabilities:
Notes Payable	692,343				691,425
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Hud Mortgage
Liabilities:
HUD debt - net					41,878
Carrying (Reported) Amount, Fair Value Disclosure [Member] | 2025 Term Loan [Member]
Liabilities:
Term loan	427,044				424,662
Carrying (Reported) Amount, Fair Value Disclosure [Member] | Mortgage Loan Due 2026 [Member]
Liabilities:
Secured loans	243,310
Estimate Of Fair Value, Fair Value Disclosure [Member]
Assets:
Investments in direct financing leases - net	9,453				8,716
Real estate loans receivable - net	1,447,262				1,258,838
Non-real estate loans receivable - net	340,025				279,710
Total	1,796,740				1,547,264
Liabilities:
Sterling term loan	0				19,750
Total	4,627,104				4,739,175
Estimate Of Fair Value, Fair Value Disclosure [Member] | Revolving Credit Facility
Liabilities:
Revolving line of credit					20,397
Estimate Of Fair Value, Fair Value Disclosure [Member] | Omega OP Term Loan Facility
Liabilities:
Omega OP term loan	50,000				50,000
Estimate Of Fair Value, Fair Value Disclosure [Member] | 4.95% notes due 2024
Liabilities:
Notes Payable	0				398,888
Estimate Of Fair Value, Fair Value Disclosure [Member] | 4.50% notes due 2025
Liabilities:
Notes Payable	399,856				393,240
Estimate Of Fair Value, Fair Value Disclosure [Member] | 5.25% notes due 2026
Liabilities:
Notes Payable	600,714				596,508
Estimate Of Fair Value, Fair Value Disclosure [Member] | 4.50% notes due 2027
Liabilities:
Notes Payable	691,040				671,538
Estimate Of Fair Value, Fair Value Disclosure [Member] | 4.75% notes due 2028
Liabilities:
Notes Payable	542,553				528,704
Estimate Of Fair Value, Fair Value Disclosure [Member] | 3.63% notes due 2029
Liabilities:
Notes Payable	461,180				440,785
Estimate Of Fair Value, Fair Value Disclosure [Member] | 3.38% notes due 2031
Liabilities:
Notes Payable	620,809				594,734
Estimate Of Fair Value, Fair Value Disclosure [Member] | 3.25% notes due 2033
Liabilities:
Notes Payable	585,389				564,809
Estimate Of Fair Value, Fair Value Disclosure [Member] | Hud Mortgage
Liabilities:
HUD debt - net					31,322
Estimate Of Fair Value, Fair Value Disclosure [Member] | 2025 Term Loan [Member]
Liabilities:
Term loan	428,500				$ 428,500
Estimate Of Fair Value, Fair Value Disclosure [Member] | Mortgage Loan Due 2026 [Member]
Liabilities:
Secured loans	$ 247,063

TAXES (Narrative) (Details)

TAXES (Narrative) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) subsidiary	Jun. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)
Taxes [Line Items]
Minimum number of subsequent years the company may not be able to qualify as a REIT	4 years
Percentage of income subject to federal taxation	100%
Net operating loss carryforwards period	Under current law, NOL carry-forwards generated up through December 31, 2017 may be carried forward for no more than 20 years, and NOL carry-forwards generated in taxable years ended after December 31, 2017, may be carried forward indefinitely.
Number of TRSs subject to income taxes at corporate rate with net operating carry forward | subsidiary	1
Deferred tax assets related to net operating loss carryforwards	$ 19,101		$ 9,491
Taxable REIT Subsidiaries [Member]
Taxes [Line Items]
Net operating loss carry-forward	9,800
Foreign Tax Authority
Taxes [Line Items]
Net operating loss carry-forward	$ 76,400	$ 47,800		$ 55,000
Deferred tax assets related to net operating loss carryforwards		$ 11,900		$ 13,400

TAXES (Schedule of components o

TAXES (Schedule of components of income tax expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2024	Mar. 31, 2022
Federal, state and local income tax expense	$ 1,500	$ 2,000	$ 1,200
Foreign income tax expense (benefit)	9,400	4,300	3,400
Total income tax expense (benefit)	10,900	6,300	4,600
Income before income tax expense and income (loss) from unconsolidated joint ventures	420,746	255,633	436,141
Income (loss) from unconsolidated joint ventures	7,916	(582)	7,261
Income (Loss) from Continuing Operations before Income Taxes, Domestic	386,400	234,200	418,500
Income (Loss) from Continuing Operations before Income Taxes, Foreign	34,300	21,500	$ 17,600
Deferred tax assets related to net operating loss carryforwards	19,101	$ 9,491
Foreign Tax Authority
Net operating loss carry-forward	$ 76,400			$ 47,800	$ 55,000
Deferred tax assets related to net operating loss carryforwards				$ 11,900	$ 13,400

TAXES (Schedule of deferred tax

TAXES (Schedule of deferred tax assets and liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Jun. 30, 2024	Dec. 31, 2023	Mar. 31, 2022
Deferred tax assets:
Federal net operating loss carryforward	$ 2,048		$ 2,079
Valuation allowance on deferred tax asset	(1,925)		(2,024)
Foreign deferred tax assets	200
Foreign net operating loss carryforward	19,101		9,491
Net deferred tax asset	$ 19,424		9,546
Deferred tax liability:
Foreign deferred tax liability			1,508
Net deferred tax liability			$ 1,508
Foreign Tax Authority
Deferred tax assets:
Foreign net operating loss carryforward		$ 11,900		$ 13,400

STOCKHOLDERS EQUITY (Common Sto

STOCKHOLDERS EQUITY (Common Stock Repurchase) (Summary of shares repurchase) (Detail) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jan. 27, 2022
Shares Repurchased	0	0
Net Repurchase Cost			$ 142,267
$500 Million Stock Repurchase Program [Member]
Stock repurchase program, authorized amount				$ 500,000
Shares Repurchased			5.2
Average Price per Share			$ 27.32
Net Repurchase Cost			$ 142,300

STOCKHOLDERS EQUITY (At The Mar

STOCKHOLDERS EQUITY (At The Market Program Schedule and Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Sep. 30, 2024	Jun. 30, 2021	Dec. 31, 2024	Dec. 31, 2023
Equity Shelf Program 1.0 Billion and $1.25 Billion [Member]
Issuance of common stock (in shares)			28,714	7,243
Average issue price per share			$ 36.49	$ 30.25
Gross proceeds			$ 1,058,080	$ 221,732
Proceeds from issuance of common stock			$ 1,047,767	$ 219,140
$1 Billion ATM Program
Sales price, equity distribution agreement		$ 1,000,000
Compensation percentage for sale of shares		2%
$1.25 Billion ATM Programs
Sales price, equity distribution agreement	$ 1,250,000
Compensation percentage for sale of shares	2%

STOCKHOLDERS EQUITY (Schedule o

STOCKHOLDERS EQUITY (Schedule of dividend reinvestment and common stock purchase plan) (Details) - Dividend Reinvestment And Common Stock Purchase Plan [Member] - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Shares issued	5,078	3,715	308
Gross Proceeds	$ 187,969	$ 117,259	$ 9,229

STOCKHOLDERS EQUITY (Schedule_2

STOCKHOLDERS EQUITY (Schedule of Common Stock Dividends) (Details) - $ / shares	3 Months Ended					12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Dividends Payable [Line Items]
Common Stock, Dividends, Per Share, Declared						$ 2.68	$ 2.68	$ 2.68
O 2023 Q4 Dividends [Member]
Dividends Payable [Line Items]
Dividends Declared, Date Of Record					Feb. 05, 2024
Dividends Payable, Date to be Paid					Feb. 15, 2024
Common Stock, Dividends, Per Share, Declared					$ 0.67
O 2024 Q1 Dividends [Member]
Dividends Payable [Line Items]
Dividends Declared, Date Of Record				Apr. 30, 2024
Dividends Payable, Date to be Paid				May 15, 2024
Common Stock, Dividends, Per Share, Declared				$ 0.67
O 2024 Q2 Dividends [Member]
Dividends Payable [Line Items]
Dividends Declared, Date Of Record			Aug. 05, 2024
Dividends Payable, Date to be Paid			Aug. 15, 2024
Common Stock, Dividends, Per Share, Declared			$ 0.67
O 2024 Q3 Dividends [Member]
Dividends Payable [Line Items]
Dividends Declared, Date Of Record		Nov. 04, 2024
Dividends Payable, Date to be Paid		Nov. 15, 2024
Common Stock, Dividends, Per Share, Declared		$ 0.67
O 2024 Q4 Dividends [Member]
Dividends Payable [Line Items]
Dividends Declared, Date Of Record	Feb. 10, 2025
Dividends Payable, Date to be Paid	Feb. 18, 2025
Common Stock, Dividends, Per Share, Declared	$ 0.67

STOCKHOLDERS EQUITY (Schedule_3

STOCKHOLDERS EQUITY (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	$ 4,536,673	$ 3,574,584
Add: portion included in noncontrolling interest	194,166	187,707
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	4,730,839	3,762,291	$ 3,803,282	$ 4,108,226
Realized gain	9,600	6,700	4,200
AOCI Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	230	66
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	22,731	29,338	$ 20,325	$ (2,200)
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	22,501	29,272
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	(66,110)	(49,770)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	76,713	75,111
Accumulated Net Gain (Loss) from Net Investment Hedges Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	$ 11,898	$ 3,931

STOCKHOLDERS EQUITY (Per Share

STOCKHOLDERS EQUITY (Per Share Distributions) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Dividends Payable [Line Items]
Dividend Per Common Share	$ 2.68	$ 2.68	$ 2.68
One Year Amounts Disclosure, percentage	0%
Three Year Amounts Disclosure, percentage	0%
Ordinary Income [Member]
Dividends Payable [Line Items]
Dividend Per Common Share	$ 1.862	2.258	1.264
Return Of Capital [Member]
Dividends Payable [Line Items]
Dividend Per Common Share	0.712	0.212	0.095
Capital Gains [Member]
Dividends Payable [Line Items]
Dividend Per Common Share	$ 0.106	$ 0.21	$ 1.321

STOCK-BASED COMPENSATION (Narra

STOCK-BASED COMPENSATION (Narrative) (Detail) - USD ($) $ in Millions			12 Months Ended
	Jun. 05, 2023	Jun. 08, 2018	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jun. 04, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of operating partnership units distributions			10%
Deferred shares, outstanding			667,986	653,842
Shares paid for tax withholding for share based compensation			300,000	600,000	1,100,000
Stock-based compensation expense			$ 36.7	$ 35.1	$ 27.3
Time Based Restricted Stock Units and Profit Interest | Scenario, Recognized Period 12 Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 1.4
Weighted average period of expense recognition			12 months
Time Based Restricted Stock Units and Profit Interest | Scenario, Recognized Period 28 Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 5.1
Weighted average period of expense recognition			28 months
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sharebased compensation arrangement by sharebased payment award share number issuable upon each vested award			1
Profit Interest Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sharebased compensation arrangement by sharebased payment award partnership unit number issuable upon each vested award			1
Stock Incentive Plan 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase in number of shares reserved for issuance	6,700,000	4,500,000
Number of common shares reserved for future issuance	17,200,000		3,800,000			10,500,000
Performance Based Vesting Requirements on (TSR) Total Shareholder Return | Performance Based Restricted Stock Units and Profit Interest Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 16.9
Weighted average period of expense recognition			42 months
Performance Based Vesting Requirements on (Relative TSR) Total Shareholder Return [Member] | Performance Based Restricted Stock Units and Profit Interest Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost			$ 20.6
Weighted average period of expense recognition			42 months

STOCK-BASED COMPENSATION (Sched

STOCK-BASED COMPENSATION (Schedule of assumptions used for estimating fair value of stock awards using Monte-Carlo model) (Details) - $ / shares				36 Months Ended
	Jan. 01, 2024	Jan. 01, 2023	Jan. 01, 2022	Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 30.66	$ 27.95	$ 29.59
Dividend yield	8.74%	9.59%	9.06%
Risk free interest rate at time of grant	4.15%	4.28%	0.98%
Expected volatility	25.27%	40.28%	38.74%
Performance Based Restricted Stock Units and Profit Interest Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Historical volatility rate use to calculate expected volatility rate				50%
Implied volatility rate use to calculate expected volatility rate				50%

STOCK-BASED COMPENSATION (Summa

STOCK-BASED COMPENSATION (Summary of stock based compensation) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Stock-Based Compensation [Abstract]
Stock-based compensation expense	$ 36.7	$ 35.1	$ 27.3

STOCK-BASED COMPENSATION (Sch_2

STOCK-BASED COMPENSATION (Schedule of activity in restricted stock and RSUs) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Weighted - Average Grant-Date Fair Value per Share
Total Compensation Cost	$ 40,700	$ 37,400	$ 31,400
Time Based Restricted Stock Units and Profit Interest
Number of Shares/Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance	509,832	408,024	318,412
Granted	306,526	309,927	256,818
Cancelled			(2,000)
Vested	(251,457)	(208,119)	(165,206)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance	564,901	509,832	408,024
Weighted - Average Grant-Date Fair Value per Share
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance	$ 28.66	$ 31.93	$ 38.62
Granted	30.73	28.15	29.4
Cancelled			29.59
Vested	29.56	34.31	40.91
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance	$ 29.38	$ 28.66	$ 31.93
Performance Based Restricted Stock Units and Profit Interest Units [Member]
Number of Shares/Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance	4,332,055	3,215,946	2,222,047
Granted	2,368,170	2,139,421	1,620,330
Cancelled	(20,811)	(1,228)	(5,232)
Forfeited		(539,312)	(621,199)
Vested	(578,763)	(482,772)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance	6,100,651	4,332,055	3,215,946
Weighted - Average Grant-Date Fair Value per Share
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance	$ 14.78	$ 17.16	$ 17.94
Granted	13.22	13.42	14.73
Cancelled	12.98	11.35	11.9
Forfeited		17.5	13.68
Vested	19.93	21.52
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance	$ 13.69	$ 14.78	$ 17.16

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended		12 Months Ended
	May 25, 2023	Jun. 30, 2024	Sep. 30, 2022	Dec. 31, 2024	Sep. 30, 2024	Jul. 24, 2024	Dec. 31, 2023	Dec. 18, 2019
Litigation settlement, amount awarded to other party	$ 30,750
Increase (decrease) in legal reserve		$ 2,800	$ 31,000
Increase (decrease) in insurance receivable		(2,800)	$ 31,000
Insurance proceeds received and placed in escrow		$ 2,800
Remaining commitments				$ 337,994
Lessor construction and capital commitments under lease agreements
Remaining commitments				221,839
Other Real Estate Loans [Member]
Remaining commitments				50,446
Indemnification Agreement [Member]
Total commitments				11,400
Maplewood Real Estate Holdings | DISTRICT OF COLUMBIA
Total commitments				$ 225,800
Brookdale Senior Living Inc [Member] | Lessor construction and capital commitments under lease agreements
Remaining commitments					$ 80,000
Brookdale Senior Living Inc $30 Million Not Adjusting Rent Benchmark [Member] | Lessor construction and capital commitments under lease agreements
Remaining commitments					$ 30,000
Brookdale Senior Living Inc Remaining $50 Million Adjusting Rent Benchmark [Member] | Lessor construction and capital commitments under lease agreements
Other commitment multiplier percentage for annual rent increase for each capital expenditure					9.50%
Remaining commitments					$ 50,000
Cindat Ice Portfolio JV GP Limited [Member]
Percentage of ownership interest						49%	49%	49%
Minimum [Member] | Indemnification Agreement [Member]
Indemnification agreement occurrence period				18 months
Maximum [Member] | Indemnification Agreement [Member]
Indemnification agreement occurrence period				72 months

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Schedule of remaining commitments) (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Remaining commitments	$ 337,994
Investment Type Characteristic Non Real Estate Related Loans [Member]
Remaining commitments	65,709
Other Real Estate Loans [Member]
Remaining commitments	50,446
Lessor construction and capital commitments under lease agreements
Remaining commitments	$ 221,839

SUPPLEMENTAL DISCLOSURE TO CO_3

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents	$ 518,340	$ 442,810	$ 297,103
Restricted cash	30,395	1,920	3,541
Cash, cash equivalents and restricted cash at end of period	548,735	444,730	300,644	$ 24,411
Supplemental Information:
Interest paid during the period, net of amounts capitalized	230,993	234,453	220,748
Taxes paid during the period	8,414	3,615	5,793
Non cash investing activities
Non-cash acquisition of real estate (see Note 3)	(344,008)	0	(9,818)
Non-cash investment in non-real estate loans receivable (see Note 3)	(1,632)	0	0
Non-cash proceeds from sale of business	0	0	7,532
Non cash investment in other investments	0	0	(7,532)
Non cash financing activities
Assumption of debt (see Note 3 and Note 14)	263,989	0	0
Non-cash contribution from noncontrolling member of consolidated joint venture	0	0	2,903
Change in fair value of cash flow hedges	13,737	(21,649)	88,460
Remeasurement of debt denominated in a foreign currency	$ (6,638)	$ 1,150	$ (4,077)

EARNINGS PER SHARE (Schedule of

EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Earnings per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net income available to common stockholders - basic	$ 406,326	$ 242,180	$ 426,927
Add: net income attributable to OP Units	12,060	7,077	11,914
Net income available to common stockholders - diluted	$ 418,386	$ 249,257	$ 438,841
Denominator:
Denominator for basic earnings per share	258,118	240,493	236,256
Effect of dilutive securities:
Common stock equivalents	4,664	2,923	1,198
Noncontrolling interest - Omega OP Units	7,668	7,035	6,836
Denominator for diluted earnings per share	270,450	250,451	244,290
Earnings per share - basic:
Net income available to common stockholders	$ 1.57	$ 1.01	$ 1.81
Earnings per share - diluted:
Net income available to common stockholders	$ 1.55	$ 1	$ 1.8

SEGMENTS (Narrative) (Details)

SEGMENTS (Narrative) (Details)	12 Months Ended
	Dec. 31, 2024 USD ($)
SEGMENTS [Abstract]
Number of Operating Segments	1
Number of Reportable Segments	1

SEGMENTS (Interest expense by r

SEGMENTS (Interest expense by reportable segment) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Interest - amortization of deferred financing costs	$ 10,400	$ 13,700	$ 12,900
Interest expense - net	221,716	235,529	233,244
Operating Segments [Member]
Segment Reporting Information [Line Items]
Interest expense	211,319	221,832	220,296
Interest - amortization of deferred financing costs	10,397	13,697	12,948
Interest expense - net	$ 221,716	$ 235,529	$ 233,244

SUBSEQUENT EVENT (Narrative) (D

SUBSEQUENT EVENT (Narrative) (Details) $ in Thousands		1 Months Ended	3 Months Ended		12 Months Ended
	Jan. 02, 2025 USD ($)	Jan. 31, 2025 USD ($) facility item	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($) facility	Dec. 31, 2024 USD ($) facility	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Apr. 30, 2022
Share Based Compensation					$ 36,696	$ 35,068	$ 27,302
Number of Facilities | facility				1,026	1,026
Percentage of annual escalators								2.25%
Real Estate Assets Acquired					$ 740,500	$ 261,200	$ 225,200
Texas
Real Estate Assets Acquired				$ 19,500
Subsequent Event [Member] | Texas
Real Estate Assets Acquired		$ 10,600
Subsequent Event [Member] | New Operator [Member] | Texas
Percentage of initial annual cash yield		9.90%
Percentage of annual escalators		2%
Subsequent Event [Member] | One Operator [Member]
Financing receivable, gross		$ 15,400
Number Of Operators Provided Funding By Entity | item		1
Interest rate		11%
Investment Maturity Year		2030
Subsequent Event [Member] | Facilities Acquired | Texas
Number of Facilities | facility		2
Subsequent Event [Member] | Scenario, Plan [Member] | Employment Contracts [Member]
Transition agreement payment aggregate	$ 2,000
Share Based Compensation			$ 6,600

SCHEDULE III - REAL ESTATE AN_2

SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,079,978
Initial Cost to Company Buildings and Improvements	7,637,228
Cost Capitalized Subsequent to Acquisition Improvements	488,653
Cost Capitalized Subsequent to Acquisition Carrying Cost	60,277
Cost Capitalized Subsequent to Acquisition Other	(205,962)
Gross Amount at Which Carried at Close of Period Land	1,065,564
Gross Amount at Which Carried at Close of Period Buildings and Improvements	7,994,610
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	9,060,174	$ 8,372,419	$ 8,860,264	$ 9,028,745
Accumulated Depreciation	(2,721,016)	$ (2,469,893)	$ (2,322,773)	$ (2,181,528)
Alabama
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	1,817
Initial Cost to Company Buildings and Improvements	33,356
Cost Capitalized Subsequent to Acquisition Improvements	14,328
Gross Amount at Which Carried at Close of Period Land	1,817
Gross Amount at Which Carried at Close of Period Buildings and Improvements	47,684
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	49,501
Accumulated Depreciation	$ (42,820)
Date Of Construction	1960 - 1982
Date Acquired	1992 - 1997
Alabama | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	31 years
Alabama | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Arizona
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 11,502
Initial Cost to Company Buildings and Improvements	117,878
Cost Capitalized Subsequent to Acquisition Improvements	4,287
Gross Amount at Which Carried at Close of Period Land	11,502
Gross Amount at Which Carried at Close of Period Buildings and Improvements	122,165
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	133,667
Accumulated Depreciation	$ (38,377)
Date Of Construction	1949 - 1999
Date Acquired	2005 - 2021
Arizona | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Arizona | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years
Arkansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 2,810
Initial Cost to Company Buildings and Improvements	48,765
Cost Capitalized Subsequent to Acquisition Improvements	4,911
Cost Capitalized Subsequent to Acquisition Other	(36)
Gross Amount at Which Carried at Close of Period Land	2,810
Gross Amount at Which Carried at Close of Period Buildings and Improvements	53,640
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	56,450
Accumulated Depreciation	$ (33,668)
Date Of Construction	1967 - 1988
Date Acquired	1992 - 2014
Arkansas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Arkansas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	31 years
California
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 81,970
Initial Cost to Company Buildings and Improvements	464,633
Cost Capitalized Subsequent to Acquisition Improvements	14,384
Cost Capitalized Subsequent to Acquisition Other	(478)
Gross Amount at Which Carried at Close of Period Land	81,970
Gross Amount at Which Carried at Close of Period Buildings and Improvements	478,539
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	560,509
Accumulated Depreciation	$ (178,143)
Date Of Construction	1938 - 2013
Date Acquired	1997 - 2021
California | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	5 years
California | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	35 years
Colorado
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 11,283
Initial Cost to Company Buildings and Improvements	88,830
Cost Capitalized Subsequent to Acquisition Improvements	8,188
Cost Capitalized Subsequent to Acquisition Other	(10)
Gross Amount at Which Carried at Close of Period Land	11,272
Gross Amount at Which Carried at Close of Period Buildings and Improvements	97,019
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	108,291
Accumulated Depreciation	$ (56,612)
Date Of Construction	1925 - 1975
Date Acquired	1998 - 2016
Colorado | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Colorado | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Connecticut
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 25,063
Initial Cost to Company Buildings and Improvements	252,417
Cost Capitalized Subsequent to Acquisition Improvements	11,253
Cost Capitalized Subsequent to Acquisition Carrying Cost	1,320
Gross Amount at Which Carried at Close of Period Land	25,063
Gross Amount at Which Carried at Close of Period Buildings and Improvements	264,990
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	290,053
Accumulated Depreciation	$ (84,581)
Date Of Construction	1968 - 2019
Date Acquired	2010 - 2017
Connecticut | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years
Connecticut | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 59,622
Initial Cost to Company Buildings and Improvements	432,694
Cost Capitalized Subsequent to Acquisition Improvements	22,447
Cost Capitalized Subsequent to Acquisition Carrying Cost	7
Cost Capitalized Subsequent to Acquisition Other	(20,832)
Gross Amount at Which Carried at Close of Period Land	58,632
Gross Amount at Which Carried at Close of Period Buildings and Improvements	435,306
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	493,938
Accumulated Depreciation	$ (217,371)
Date Of Construction	1942 - 2018
Date Acquired	1993 - 2021
Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	2 years
Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Georgia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 3,740
Initial Cost to Company Buildings and Improvements	47,689
Cost Capitalized Subsequent to Acquisition Improvements	1,626
Gross Amount at Which Carried at Close of Period Land	3,740
Gross Amount at Which Carried at Close of Period Buildings and Improvements	49,315
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	53,055
Accumulated Depreciation	$ (19,564)
Date Of Construction	1967 - 1997
Date Acquired	1998 - 2016
Georgia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years
Georgia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years
Idaho
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 5,735
Initial Cost to Company Buildings and Improvements	47,530
Cost Capitalized Subsequent to Acquisition Improvements	1,920
Cost Capitalized Subsequent to Acquisition Other	(542)
Gross Amount at Which Carried at Close of Period Land	5,193
Gross Amount at Which Carried at Close of Period Buildings and Improvements	49,450
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	54,643
Accumulated Depreciation	$ (25,253)
Date Of Construction	1920 - 2008
Date Acquired	1997 - 2014
Idaho | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Idaho | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Illinois
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,830
Initial Cost to Company Buildings and Improvements	13,967
Cost Capitalized Subsequent to Acquisition Improvements	1,597
Gross Amount at Which Carried at Close of Period Land	1,830
Gross Amount at Which Carried at Close of Period Buildings and Improvements	15,564
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	17,394
Accumulated Depreciation	$ (3,049)
Date Of Construction	1999
Date Acquired	2021
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Indiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 47,657
Initial Cost to Company Buildings and Improvements	566,170
Cost Capitalized Subsequent to Acquisition Improvements	16,864
Cost Capitalized Subsequent to Acquisition Other	(7,453)
Gross Amount at Which Carried at Close of Period Land	47,563
Gross Amount at Which Carried at Close of Period Buildings and Improvements	575,675
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	623,238
Accumulated Depreciation	$ (239,855)
Date Of Construction	1942 - 2015
Date Acquired	1992 - 2020
Indiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Indiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years
Iowa
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 2,343
Initial Cost to Company Buildings and Improvements	59,310
Cost Capitalized Subsequent to Acquisition Improvements	352
Cost Capitalized Subsequent to Acquisition Other	(7,330)
Gross Amount at Which Carried at Close of Period Land	2,332
Gross Amount at Which Carried at Close of Period Buildings and Improvements	52,343
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	54,675
Accumulated Depreciation	$ (22,342)
Date Of Construction	1961 - 1998
Date Acquired	2010 - 2014
Iowa | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	23 years
Iowa | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Kansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 4,092
Initial Cost to Company Buildings and Improvements	38,693
Cost Capitalized Subsequent to Acquisition Improvements	14,219
Gross Amount at Which Carried at Close of Period Land	4,092
Gross Amount at Which Carried at Close of Period Buildings and Improvements	52,912
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	57,004
Accumulated Depreciation	$ (31,352)
Date Of Construction	1957 - 1977
Date Acquired	2005 - 2011
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Kentucky
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 15,556
Initial Cost to Company Buildings and Improvements	130,819
Cost Capitalized Subsequent to Acquisition Improvements	7,517
Gross Amount at Which Carried at Close of Period Land	15,556
Gross Amount at Which Carried at Close of Period Buildings and Improvements	138,336
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	153,892
Accumulated Depreciation	$ (64,103)
Date Of Construction	1964 - 2002
Date Acquired	1999 - 2016
Kentucky | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Kentucky | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Louisiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 6,692
Initial Cost to Company Buildings and Improvements	121,675
Cost Capitalized Subsequent to Acquisition Improvements	4,877
Cost Capitalized Subsequent to Acquisition Carrying Cost	448
Cost Capitalized Subsequent to Acquisition Other	(1,495)
Gross Amount at Which Carried at Close of Period Land	6,692
Gross Amount at Which Carried at Close of Period Buildings and Improvements	125,505
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	132,197
Accumulated Depreciation	$ (35,891)
Date Of Construction	1951 - 2020
Date Acquired	1997 - 2024
Louisiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	22 years
Louisiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Maryland
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 17,526
Initial Cost to Company Buildings and Improvements	131,741
Cost Capitalized Subsequent to Acquisition Improvements	14,723
Gross Amount at Which Carried at Close of Period Land	17,526
Gross Amount at Which Carried at Close of Period Buildings and Improvements	146,464
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	163,990
Accumulated Depreciation	$ (47,590)
Date Of Construction	1921 - 2016
Date Acquired	2008 - 2023
Maryland | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Maryland | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years
Massachusetts
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 23,621
Initial Cost to Company Buildings and Improvements	143,172
Cost Capitalized Subsequent to Acquisition Improvements	24,378
Cost Capitalized Subsequent to Acquisition Other	(693)
Gross Amount at Which Carried at Close of Period Land	23,621
Gross Amount at Which Carried at Close of Period Buildings and Improvements	166,857
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	190,478
Accumulated Depreciation	$ (76,938)
Date Of Construction	1964 - 2017
Date Acquired	1997 - 2014
Massachusetts | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Massachusetts | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Michigan
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,915
Initial Cost to Company Buildings and Improvements	45,585
Cost Capitalized Subsequent to Acquisition Other	(15,925)
Gross Amount at Which Carried at Close of Period Land	1,635
Gross Amount at Which Carried at Close of Period Buildings and Improvements	29,940
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	31,575
Accumulated Depreciation	$ (879)
Date Of Construction	1950 - 1973
Date Acquired	2011 - 2024
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Minnesota
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 10,502
Initial Cost to Company Buildings and Improvements	52,585
Cost Capitalized Subsequent to Acquisition Improvements	5,972
Gross Amount at Which Carried at Close of Period Land	10,502
Gross Amount at Which Carried at Close of Period Buildings and Improvements	58,557
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	69,059
Accumulated Depreciation	$ (26,338)
Date Of Construction	1966 - 1983
Date Acquired	2014
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Mississippi
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 8,803
Initial Cost to Company Buildings and Improvements	191,448
Cost Capitalized Subsequent to Acquisition Improvements	827
Gross Amount at Which Carried at Close of Period Land	8,803
Gross Amount at Which Carried at Close of Period Buildings and Improvements	192,275
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	201,078
Accumulated Depreciation	$ (58,878)
Date Of Construction	1965 - 2008
Date Acquired	2009 - 2019
Mississippi | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Mississippi | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years
Missouri
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 608
Initial Cost to Company Buildings and Improvements	11,694
Cost Capitalized Subsequent to Acquisition Other	(7,211)
Gross Amount at Which Carried at Close of Period Land	247
Gross Amount at Which Carried at Close of Period Buildings and Improvements	4,844
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	5,091
Accumulated Depreciation	$ (3,812)
Date Of Construction	1965 - 1989
Date Acquired	1999
Missouri | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Montana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,319
Initial Cost to Company Buildings and Improvements	11,698
Cost Capitalized Subsequent to Acquisition Improvements	432
Gross Amount at Which Carried at Close of Period Land	1,319
Gross Amount at Which Carried at Close of Period Buildings and Improvements	12,130
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	13,449
Accumulated Depreciation	$ (4,604)
Date Of Construction	1963 - 1971
Date Acquired	2005
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Nebraska
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 750
Initial Cost to Company Buildings and Improvements	14,892
Cost Capitalized Subsequent to Acquisition Improvements	108
Cost Capitalized Subsequent to Acquisition Other	(1,050)
Gross Amount at Which Carried at Close of Period Land	750
Gross Amount at Which Carried at Close of Period Buildings and Improvements	13,950
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	14,700
Accumulated Depreciation	$ (6,197)
Date Of Construction	1966 - 1969
Date Acquired	2012 - 2015
Nebraska | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Nebraska | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Nevada
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 8,811
Initial Cost to Company Buildings and Improvements	92,797
Cost Capitalized Subsequent to Acquisition Improvements	8,350
Gross Amount at Which Carried at Close of Period Land	8,811
Gross Amount at Which Carried at Close of Period Buildings and Improvements	101,147
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	109,958
Accumulated Depreciation	$ (42,022)
Date Of Construction	1972 - 2012
Date Acquired	2009 - 2017
Nevada | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Nevada | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
New Hampshire
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,782
Initial Cost to Company Buildings and Improvements	19,837
Cost Capitalized Subsequent to Acquisition Improvements	1,463
Gross Amount at Which Carried at Close of Period Land	1,782
Gross Amount at Which Carried at Close of Period Buildings and Improvements	21,300
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	23,082
Accumulated Depreciation	$ (12,990)
Date Of Construction	1963 - 1999
Date Acquired	1998 - 2006
New Hampshire | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
New Hampshire | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
New Jersey
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 12,953
Initial Cost to Company Buildings and Improvements	58,199
Cost Capitalized Subsequent to Acquisition Improvements	1,954
Cost Capitalized Subsequent to Acquisition Carrying Cost	1,559
Gross Amount at Which Carried at Close of Period Land	12,953
Gross Amount at Which Carried at Close of Period Buildings and Improvements	61,712
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	74,665
Accumulated Depreciation	$ (10,008)
Date Of Construction	1999 - 2021
Date Acquired	2019 - 2021
Life on Which Depreciation in Latest Income Statements is Computed	25 years
New Mexico
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 6,008
Initial Cost to Company Buildings and Improvements	45,285
Cost Capitalized Subsequent to Acquisition Improvements	1,318
Gross Amount at Which Carried at Close of Period Land	6,008
Gross Amount at Which Carried at Close of Period Buildings and Improvements	46,603
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	52,611
Accumulated Depreciation	$ (17,174)
Date Of Construction	1960 - 1985
Date Acquired	2005
Life on Which Depreciation in Latest Income Statements is Computed	33 years
New York
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 118,606
Initial Cost to Company Buildings and Improvements	176,921
Cost Capitalized Subsequent to Acquisition Improvements	3,658
Cost Capitalized Subsequent to Acquisition Carrying Cost	40,543
Cost Capitalized Subsequent to Acquisition Other	(5,900)
Gross Amount at Which Carried at Close of Period Land	118,606
Gross Amount at Which Carried at Close of Period Buildings and Improvements	215,222
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	333,828
Accumulated Depreciation	$ (42,050)
Date Of Construction	2020
Date Acquired	2015
Life on Which Depreciation in Latest Income Statements is Computed	25 years
North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 29,063
Initial Cost to Company Buildings and Improvements	369,884
Cost Capitalized Subsequent to Acquisition Improvements	12,040
Cost Capitalized Subsequent to Acquisition Carrying Cost	336
Cost Capitalized Subsequent to Acquisition Other	(902)
Gross Amount at Which Carried at Close of Period Land	28,876
Gross Amount at Which Carried at Close of Period Buildings and Improvements	381,545
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	410,421
Accumulated Depreciation	$ (132,982)
Date Of Construction	1963 - 2019
Date Acquired	1994 - 2024
North Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
North Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	36 years
Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 28,026
Initial Cost to Company Buildings and Improvements	332,613
Cost Capitalized Subsequent to Acquisition Improvements	20,265
Cost Capitalized Subsequent to Acquisition Carrying Cost	345
Cost Capitalized Subsequent to Acquisition Other	(28,680)
Gross Amount at Which Carried at Close of Period Land	27,776
Gross Amount at Which Carried at Close of Period Buildings and Improvements	324,793
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	352,569
Accumulated Depreciation	$ (108,846)
Date Of Construction	1929 - 2021
Date Acquired	1994 - 2020
Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Oklahoma
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 1,280
Initial Cost to Company Buildings and Improvements	11,190
Cost Capitalized Subsequent to Acquisition Improvements	573
Gross Amount at Which Carried at Close of Period Land	1,280
Gross Amount at Which Carried at Close of Period Buildings and Improvements	11,763
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	13,043
Accumulated Depreciation	$ (8,678)
Date Of Construction	1965 - 1993
Date Acquired	2010
Oklahoma | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Oregon
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 8,740
Initial Cost to Company Buildings and Improvements	128,799
Cost Capitalized Subsequent to Acquisition Improvements	11,483
Gross Amount at Which Carried at Close of Period Land	8,740
Gross Amount at Which Carried at Close of Period Buildings and Improvements	140,282
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	149,022
Accumulated Depreciation	$ (32,532)
Date Of Construction	1959 - 2007
Date Acquired	2005 - 2024
Oregon | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Oregon | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 26,876
Initial Cost to Company Buildings and Improvements	360,250
Cost Capitalized Subsequent to Acquisition Improvements	19,421
Cost Capitalized Subsequent to Acquisition Other	(18,321)
Gross Amount at Which Carried at Close of Period Land	26,871
Gross Amount at Which Carried at Close of Period Buildings and Improvements	361,355
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	388,226
Accumulated Depreciation	$ (140,943)
Date Of Construction	1873 - 2012
Date Acquired	2004 - 2022
Pennsylvania | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Pennsylvania | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Rhode Island
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 3,299
Initial Cost to Company Buildings and Improvements	23,487
Cost Capitalized Subsequent to Acquisition Improvements	3,805
Gross Amount at Which Carried at Close of Period Land	3,299
Gross Amount at Which Carried at Close of Period Buildings and Improvements	27,292
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	30,591
Accumulated Depreciation	$ (17,345)
Date Of Construction	1965 - 1981
Date Acquired	2006
Life on Which Depreciation in Latest Income Statements is Computed	39 years
South Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 8,480
Initial Cost to Company Buildings and Improvements	76,912
Cost Capitalized Subsequent to Acquisition Improvements	2,860
Gross Amount at Which Carried at Close of Period Land	8,480
Gross Amount at Which Carried at Close of Period Buildings and Improvements	79,772
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	88,252
Accumulated Depreciation	$ (33,454)
Date Of Construction	1959 - 2007
Date Acquired	2014 - 2016
South Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
South Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 12,976
Initial Cost to Company Buildings and Improvements	268,846
Cost Capitalized Subsequent to Acquisition Improvements	9,092
Gross Amount at Which Carried at Close of Period Land	12,976
Gross Amount at Which Carried at Close of Period Buildings and Improvements	277,938
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	290,914
Accumulated Depreciation	$ (128,878)
Date Of Construction	1968 - 2018
Date Acquired	1992 - 2021
Tennessee | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Tennessee | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	31 years
Texas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 75,922
Initial Cost to Company Buildings and Improvements	798,209
Cost Capitalized Subsequent to Acquisition Improvements	44,579
Cost Capitalized Subsequent to Acquisition Carrying Cost	197
Cost Capitalized Subsequent to Acquisition Other	7,106
Gross Amount at Which Carried at Close of Period Land	78,495
Gross Amount at Which Carried at Close of Period Buildings and Improvements	847,518
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	926,013
Accumulated Depreciation	$ (304,280)
Date Of Construction	1949 - 2019
Date Acquired	1997 - 2024
Texas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	20 years
Texas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years
United Kingdom
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 267,973
Initial Cost to Company Buildings and Improvements	1,028,908
Cost Capitalized Subsequent to Acquisition Improvements	19,471
Cost Capitalized Subsequent to Acquisition Other	(71,967)
Gross Amount at Which Carried at Close of Period Land	255,544
Gross Amount at Which Carried at Close of Period Buildings and Improvements	988,841
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	1,244,385
Accumulated Depreciation	$ (133,272)
Date Of Construction	1650 - 2012
Date Acquired	2015 - 2024
United Kingdom | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
United Kingdom | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	30 years
Vermont
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 318
Initial Cost to Company Buildings and Improvements	6,005
Cost Capitalized Subsequent to Acquisition Improvements	602
Gross Amount at Which Carried at Close of Period Land	318
Gross Amount at Which Carried at Close of Period Buildings and Improvements	6,607
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	6,925
Accumulated Depreciation	$ (3,756)
Date Of Construction	1971
Date Acquired	2004
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 35,653
Initial Cost to Company Buildings and Improvements	381,065
Cost Capitalized Subsequent to Acquisition Improvements	11,997
Cost Capitalized Subsequent to Acquisition Carrying Cost	26
Cost Capitalized Subsequent to Acquisition Other	(579)
Gross Amount at Which Carried at Close of Period Land	35,479
Gross Amount at Which Carried at Close of Period Buildings and Improvements	392,683
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	428,162
Accumulated Depreciation	$ (118,058)
Date Of Construction	1964 - 2017
Date Acquired	2010 - 2023
Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	40 years
Washington
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 14,565
Initial Cost to Company Buildings and Improvements	184,114
Cost Capitalized Subsequent to Acquisition Improvements	6,770
Cost Capitalized Subsequent to Acquisition Other	(23,664)
Gross Amount at Which Carried at Close of Period Land	12,912
Gross Amount at Which Carried at Close of Period Buildings and Improvements	168,873
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	181,785
Accumulated Depreciation	$ (50,094)
Date Of Construction	1951 - 2004
Date Acquired	1999 - 2021
Washington | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
Washington | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	33 years
Washington DC
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 68,017
Cost Capitalized Subsequent to Acquisition Improvements	124,527
Cost Capitalized Subsequent to Acquisition Carrying Cost	15,496
Gross Amount at Which Carried at Close of Period Land	68,017
Gross Amount at Which Carried at Close of Period Buildings and Improvements	140,023
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	$ 208,040
Date Of Construction	N/A
Date Acquired	2021
West Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 3,475
Initial Cost to Company Buildings and Improvements	202,085
Cost Capitalized Subsequent to Acquisition Improvements	7,062
Gross Amount at Which Carried at Close of Period Land	3,475
Gross Amount at Which Carried at Close of Period Buildings and Improvements	209,147
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	212,622
Accumulated Depreciation	$ (61,540)
Date Of Construction	1850 - 2016
Date Acquired	1994 - 2024
West Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	25 years
West Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	39 years
Wisconsin
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	$ 399
Initial Cost to Company Buildings and Improvements	4,581
Cost Capitalized Subsequent to Acquisition Improvements	2,153
Gross Amount at Which Carried at Close of Period Land	399
Gross Amount at Which Carried at Close of Period Buildings and Improvements	6,734
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	7,133
Accumulated Depreciation	$ (3,897)
Date Of Construction	1974
Date Acquired	2005
Life on Which Depreciation in Latest Income Statements is Computed	33 years

SCHEDULE III - REAL ESTATE AN_3

SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (Narrative) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule III, Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward]
Balance at beginning of period	$ 8,372,419	$ 8,860,264	$ 9,028,745
Acquisitions	740,661	262,453	225,336
Impairment	(23,728)	(89,985)	(38,451)
Improvements	114,610	87,760	60,931
Disposals/other	(143,788)	(748,073)	(416,297)
Balance at close of period	9,060,174	8,372,419	8,860,264
Reconciliation of real estate accumulated depreciation
Balance at beginning of period	2,469,893	2,322,773	2,181,528
Provisions for depreciation	302,088	317,536	331,963
Dispositions/other	(50,965)	(170,416)	(190,718)
Balance at close of period	$ 2,721,016	$ 2,469,893	$ 2,322,773

SCHEDULE III - REAL ESTATE AN_4

SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION (Narrative 1) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2022
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]
Noncash consideration exchanged	$ 344	$ 8.2
Reported amount of real estate in excess of the tax basis	504.6
Amount of construction in progress related to land	$ 68.9

SCHEDULE IV - MORTGAGE LOANS _2

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Mortgage Loans on Real Estate [Line Items]
Face Amount of Mortgages	$ 1,152,626,000
Carrying Amount of Mortgages	942,765,000	$ 698,776,000	$ 648,130,000	$ 835,086,000
Carrying Amount of Loans Subject to Delinquent Principal or Interest	1,472,000
Allowance for credit loss on mortgage loans	$ (28,112,000)
Michigan | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11.44%
Fixed/Variable	F(2)
Final Maturity Date	2030
Periodic Payment Terms	Interest plus approximately $108.2 of principal payable monthly with $417,336 due at maturity
Prior Liens	$ 0
Face Amount of Mortgages	606,325,000
Carrying Amount of Mortgages	451,516,000
Mortgage loans on real estate periodic payment, amount	108,200
Mortgage loans on real estate, periodic payment terms, balloon payment to be received	$ 417,336,000
Michigan | Group 6
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	8,000,000
Carrying Amount of Mortgages	$ 8,000,000
Michigan | Group 21
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Fixed/Variable	F(2)
Final Maturity Date	2030
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	560,000
Carrying Amount of Mortgages	$ 263,000
Michigan | Group 22
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F(2)
Final Maturity Date	2030
Periodic Payment Terms	No interest due on the first $300, then interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	500,000
Carrying Amount of Mortgages	227,000
Mortgage loans on real estate periodic payment, amount	0
Mortgage loans on real estate, periodic payment terms, balloon payment to be received	$ 300,000
Michigan | Group 23
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11.62%
Fixed/Variable	F(2)
Final Maturity Date	2030
Periodic Payment Terms	Interest plus approximately $6.4 of principal payable monthly with $51,644 due at maturity
Prior Liens	$ 0
Face Amount of Mortgages	54,223,000
Carrying Amount of Mortgages	52,200,000
Mortgage loans on real estate periodic payment, amount	6,400
Mortgage loans on real estate, periodic payment terms, balloon payment to be received	$ 51,644,000
Ohio | Group 2
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.50%
Fixed/Variable	F(2)
Final Maturity Date	2037
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	72,420,000
Carrying Amount of Mortgages	$ 72,420,000
Ohio | Group 3
Mortgage Loans on Real Estate [Line Items]
Interest Rate	12%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	7,300,000
Carrying Amount of Mortgages	$ 7,300,000
Ohio | Group 13
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F(2)
Final Maturity Date	2024
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	21,325,000
Carrying Amount of Mortgages	$ 21,325,000
Ohio | Group 20
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F(2)
Final Maturity Date	2037
Periodic Payment Terms	Interest plus approximately $16.2 of principal payable monthly with $979 due at maturity
Prior Liens	$ 0
Face Amount of Mortgages	7,200,000
Carrying Amount of Mortgages	5,231,000
Mortgage loans on real estate periodic payment, amount	16,200
Mortgage loans on real estate, periodic payment terms, balloon payment to be received	$ 979,000
Illinois | Group 4
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2028
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	60,000,000
Carrying Amount of Mortgages	$ 53,750,000
Pennsylvania | Group 5
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	38,626,000
Carrying Amount of Mortgages	$ 36,404,000
Florida | Group 7
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	8,332,000
Carrying Amount of Mortgages	$ 8,332,000
Florida | Group 19
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	11,891,000
Carrying Amount of Mortgages	$ 11,890,000
Tennessee | Group 8
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	8,680,000
Carrying Amount of Mortgages	$ 8,680,000
Tennessee | Group 11
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.35%
Fixed/Variable	F
Final Maturity Date	2015
Periodic Payment Terms	Past due
Prior Liens	$ 0
Face Amount of Mortgages	6,377,000
Carrying Amount of Mortgages	1,472,000
Carrying Amount of Loans Subject to Delinquent Principal or Interest	$ 1,472,000
Oregon | Group 9
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9%
Fixed/Variable	F
Final Maturity Date	2026
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	5,000,000
Carrying Amount of Mortgages	$ 5,000,000
Massachusetts | Group 10
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9%
Fixed/Variable	F
Final Maturity Date	2023
Periodic Payment Terms	Past due
Prior Liens	$ 0
Face Amount of Mortgages	$ 9,000,000
Connecticut | Group 12
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	5,058,000
Carrying Amount of Mortgages	$ 5,058,000
Georgia | Group 14
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2029
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	9,551,000
Carrying Amount of Mortgages	$ 9,551,000
Georgia and Florida | Group 15
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2027
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	29,700,000
Carrying Amount of Mortgages	$ 29,700,000
United Kingdom | Group 16
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	10,081,000
Carrying Amount of Mortgages	$ 10,081,000
United Kingdom | Group 17
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	39,069,000
Carrying Amount of Mortgages	$ 39,069,000
United Kingdom | Group 18
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	61,742,000
Carrying Amount of Mortgages	$ 61,742,000
United Kingdom | Group 24
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	18,446,000
Carrying Amount of Mortgages	$ 18,446,000
United Kingdom | Group 25
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10%
Fixed/Variable	F
Final Maturity Date	2025
Periodic Payment Terms	Interest payable monthly until maturity
Prior Liens	$ 0
Face Amount of Mortgages	53,220,000
Carrying Amount of Mortgages	$ 53,220,000

SCHEDULE IV - MORTGAGE LOANS _3

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Narrative 1) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at beginning of period	$ 698,776	$ 648,130	$ 835,086
Additions during period - new mortgage loans or additional fundings	292,722	102,332	12,977
Deductions during period - collection of principal/other	(63,876)	(79,418)	(190,141)
Allowance for credit loss on mortgage loans	15,143	27,732	(9,792)
Balance at close of period	942,765	698,776	648,130
Mortgage loans on real estate non cash interest paid-in kind	1,500	2,300	1,200
Non-cash placement of mortgage capital	$ 7,300
Interest payments applied against principal for cost recovery loans		3,900	$ 6,000
Noncash principal reduction of mortgages		$ 37,000

SCHEDULE IV - MORTGAGE LOANS _4

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Narrative 2) (Detail) $ in Millions	Dec. 31, 2024 USD ($)
Mortgage Loans On Real Estate [Abstract]
Aggregate cost for federal income tax purposes	$ 982.3
Mortgages included in the schedule which extended during 2024	$ 112